data_2kic_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kic _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.47 ' CD1' ' H ' ' A' ' 13' ' ' LEU . 5.5 mp . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 30.8 mtm105 -80.65 -39.49 27.24 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 54.7 mt -62.8 -14.68 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.446 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.35 -15.71 17.9 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -72.73 -31.91 65.32 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.6 -42.87 75.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.218 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 18' ' ' ALA . . . -39.9 -34.36 0.27 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.52 ' C ' ' H ' ' A' ' 22' ' ' LEU . 75.9 ttt-85 -67.23 -41.66 85.32 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.227 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -55.32 -6.73 0.18 Allowed 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.465 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.52 ' H ' ' C ' ' A' ' 20' ' ' ARG . 9.5 mt -116.23 149.33 43.34 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.27 -80.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 121.881 1.721 . . . . 0.0 112.548 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -116.24 7.89 18.48 Favored Glycine 0 N--CA 1.47 0.908 0 C-N-CA 121.44 -0.409 . . . . 0.0 112.467 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.0 m -73.97 126.84 31.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.43 0.615 . . . . 0.0 110.13 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.07 168.11 20.39 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.985 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -61.72 -61.15 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.23 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.91 10.64 4.11 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.085 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -98.57 -25.27 14.79 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 117.44 0.62 . . . . 0.0 110.391 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.2 tt -95.5 -17.8 21.16 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.588 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 tt . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 120.965 0.412 . . . . 0.0 110.785 -179.342 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.5 mt . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.722 0.296 . . . . 0.0 110.696 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -80.36 71.63 7.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.453 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -153.43 -0.28 0.2 Allowed Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.36 175.98 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.449 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 55.7 m -117.03 162.96 16.96 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 t -56.01 -43.71 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.905 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -56.52 -25.16 50.92 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.2 -31.76 62.78 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.08 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.545 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 5.8 mp -64.92 -65.36 0.68 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.378 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -53.58 -37.21 62.72 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.54 ' O ' ' N ' ' A' ' 61' ' ' GLY . 11.3 pt -77.95 -18.23 13.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.121 0.486 . . . . 0.0 109.994 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.72 -38.64 93.29 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.0 mm? -73.68 -56.94 4.37 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.242 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.42 -35.68 73.56 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 103.99 -33.86 6.24 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.798 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.55 ' C ' ' H ' ' A' ' 64' ' ' GLU . 68.8 m -136.3 127.68 28.43 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.037 0.446 . . . . 0.0 111.192 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -58.68 -0.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.453 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.55 ' H ' ' C ' ' A' ' 62' ' ' SER . 33.7 mt-10 -79.44 -45.22 19.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 67' ' ' ASP . 16.7 m-20 -99.05 -7.85 26.18 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.0 m -49.23 -27.24 2.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.62 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 17.8 p-10 -51.67 -35.36 42.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.012 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.22 -19.21 43.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.861 0.362 . . . . 0.0 110.61 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.5 tp -64.84 125.9 26.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.496 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -51.68 -22.82 3.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.048 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 m -64.49 115.94 24.35 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.232 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.68 -154.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.375 1.384 . . . . 0.0 111.126 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.439 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 29.7 ttm -112.66 1.82 15.88 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.2 t -109.58 -18.53 13.47 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.521 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.46 -33.46 71.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.822 0.344 . . . . 0.0 110.345 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.534 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -65.74 -47.14 76.28 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.447 ' CD ' ' N ' ' A' ' 77' ' ' LYS . 1.6 mptp? -55.96 -35.75 67.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.37 -58.84 3.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.852 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -63.23 -62.7 1.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.679 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.1 p -35.24 -26.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 120.922 0.392 . . . . 0.0 111.429 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.556 ' N ' ' O ' ' A' ' 79' ' ' ALA . 50.4 ttm-85 -75.98 -58.1 3.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.603 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 52.1 mt -47.49 -41.22 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.622 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.584 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -80.02 -32.08 39.61 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.587 179.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -49.12 -27.92 3.85 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.956 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.22 13.04 50.31 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 88' ' ' GLU . 74.8 mt-10 -113.88 8.69 17.36 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -28.08 -37.5 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.194 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 86' ' ' GLU . 5.8 pt-20 . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 120.835 0.35 . . . . 0.0 110.46 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.523 ' CD1' ' H ' ' A' ' 13' ' ' LEU . 5.6 mp . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 120.927 0.394 . . . . 0.0 112.062 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.42 ' O ' ' CG2' ' A' ' 82' ' ' ILE . 20.3 mmt85 -56.03 -30.38 61.8 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.7 mm -65.11 -18.21 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.369 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.66 -18.24 16.63 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.31 -28.57 65.28 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -57.77 -42.75 84.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.424 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 18' ' ' ALA . . . -40.48 -33.4 0.26 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.541 ' C ' ' H ' ' A' ' 22' ' ' LEU . 50.3 ttt85 -69.16 -42.59 75.72 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.23 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.13 -6.11 0.23 Allowed 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.243 0.544 . . . . 0.0 110.082 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.541 ' H ' ' C ' ' A' ' 20' ' ' ARG . 13.2 mt -117.0 149.52 44.32 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.177 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.43 -88.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.037 1.825 . . . . 0.0 112.485 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.12 -8.92 49.71 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.48 -0.391 . . . . 0.0 112.293 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.4 m -59.54 132.28 53.5 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.474 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.507 ' H ' ' NE2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -90.74 165.53 13.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.202 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.0 t -57.44 -55.88 18.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.149 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.18 8.36 8.89 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.808 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.507 ' NE2' ' H ' ' A' ' 26' ' ' THR . 19.2 mt-30 -96.82 -18.87 19.28 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.008 0.904 . . . . 0.0 110.753 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.4 tp -85.47 -37.93 19.18 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.526 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 pp . . . . . 0 N--CA 1.463 0.223 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.991 -179.643 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.3 mp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.777 0.322 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -73.0 67.17 0.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.456 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.68 15.03 0.81 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.469 ' CG2' ' OD2' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -127.61 177.38 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.445 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 5.2 m -119.23 164.01 16.25 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t -57.22 -45.49 84.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.751 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.4 m -54.3 -25.22 22.51 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.665 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.469 ' OD2' ' CG2' ' A' ' 50' ' ' VAL . 42.6 t0 -74.74 -31.1 61.72 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.916 0.388 . . . . 0.0 111.296 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.543 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 6.2 mp -65.94 -63.38 1.1 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -54.54 -36.29 64.13 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.1 pt -77.38 -19.22 14.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.035 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.63 -34.83 88.71 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.2 mm? -76.52 -57.07 4.07 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.658 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.81 -32.97 68.13 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.481 -0.487 . . . . 0.0 109.947 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 85.51 -9.13 68.79 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.535 ' C ' ' H ' ' A' ' 64' ' ' GLU . 3.2 m -137.87 107.53 6.23 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.101 0.477 . . . . 0.0 112.243 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -56.39 -4.6 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.016 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.535 ' H ' ' C ' ' A' ' 62' ' ' SER . 19.0 mm-40 -86.35 -43.48 12.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.762 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -92.47 -11.91 33.42 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.2 m -50.9 -26.65 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 119.689 -0.805 . . . . 0.0 110.283 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -56.25 -17.07 6.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.399 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 43.7 mtt -101.93 -32.47 10.19 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.529 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.5 tp -49.57 131.95 21.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.221 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 9.6 p-10 -57.05 -32.49 66.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.395 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 72' ' ' PRO . 10.7 m -46.45 105.45 0.48 Allowed Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.502 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 71' ' ' THR . 33.0 Cg_exo -54.92 -163.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.174 1.25 . . . . 0.0 111.219 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 30.4 ttm -107.84 -4.98 17.52 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 82.6 p -102.52 -26.75 13.12 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.429 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.87 -33.37 70.4 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.885 0.374 . . . . 0.0 110.169 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.483 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 0.7 OUTLIER -66.27 -53.37 37.51 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.443 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.4 OUTLIER -52.15 -35.43 48.54 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.475 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -68.36 -58.52 4.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.962 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -63.91 -60.47 3.23 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.834 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 p -35.24 -25.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.096 0.474 . . . . 0.0 111.686 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 79' ' ' ALA . 25.5 ttm180 -78.9 -56.31 4.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.544 0.688 . . . . 0.0 109.72 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.436 HD12 HG21 ' A' ' 82' ' ' ILE . 36.5 mt -47.88 -43.81 10.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.904 -178.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.541 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -74.23 -37.74 63.73 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 119.205 -0.998 . . . . 0.0 109.645 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -46.17 -19.05 0.06 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.94 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 83' ' ' LEU . . . 83.76 13.26 75.78 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 88' ' ' GLU . 91.6 mt-10 -103.4 -3.18 25.83 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -31.98 -32.61 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.525 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 86' ' ' GLU . 18.1 mm-40 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.337 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.497 ' CD1' ' H ' ' A' ' 13' ' ' LEU . 4.8 mp . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 120.602 0.239 . . . . 0.0 111.571 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.404 HH22 ' C ' ' A' ' 85' ' ' GLY . 61.0 mtp180 -55.38 -32.94 63.02 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.3 mm -63.23 -16.54 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.382 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.36 -16.2 17.73 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -69.99 -30.7 68.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -56.71 -44.7 81.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.235 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -42.02 -36.76 1.2 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.501 ' C ' ' H ' ' A' ' 22' ' ' LEU . 67.6 ttt-85 -65.19 -40.83 94.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.943 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.18 -4.84 0.39 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.624 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.501 ' H ' ' C ' ' A' ' 20' ' ' ARG . 16.1 mt -118.1 139.76 27.05 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.145 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -39.67 -70.95 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.927 1.751 . . . . 0.0 112.855 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -134.4 0.0 3.79 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.521 -0.631 . . . . 0.0 111.521 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.1 m -57.43 131.21 49.44 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.611 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.69 160.92 27.25 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.343 0.592 . . . . 0.0 111.808 -178.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.18 -55.81 19.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.1 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.04 8.36 8.35 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.358 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -100.32 -20.27 15.93 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 117.867 0.834 . . . . 0.0 109.932 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 45.1 tp -98.68 -23.78 15.32 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.982 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 3.9 mm? . . . . . 0 N--CA 1.467 0.411 0 CA-C-O 120.73 0.3 . . . . 0.0 110.829 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 49' ' ' GLY . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.144 0 CA-C-O 120.941 0.4 . . . . 0.0 110.149 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -61.17 71.29 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.593 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -155.08 4.98 0.24 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.454 ' CG2' ' OD2' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -123.67 176.96 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.396 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.428 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 45.2 m -119.03 161.75 19.72 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 t -55.33 -43.03 69.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.67 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 m -56.43 -26.0 52.2 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.871 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.454 ' OD2' ' CG2' ' A' ' 50' ' ' VAL . 53.1 t0 -73.87 -31.44 63.16 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.041 0.448 . . . . 0.0 110.859 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.547 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 6.3 mp -65.23 -65.01 0.73 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -53.29 -36.59 61.37 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.1 pt -78.08 -18.95 13.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.62 -38.13 89.93 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.453 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.3 mm? -75.07 -56.75 4.42 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.029 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.96 -35.31 78.15 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 93.29 -20.43 46.32 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.588 ' C ' ' H ' ' A' ' 64' ' ' GLU . 23.0 t -138.22 117.25 12.5 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.038 0.446 . . . . 0.0 111.871 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -59.34 4.06 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.686 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.588 ' H ' ' C ' ' A' ' 62' ' ' SER . 43.5 mt-10 -90.74 -45.71 8.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.194 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.65 -11.43 42.54 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.4 m -52.97 -27.44 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.035 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 19.4 p-10 -56.17 -12.61 1.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.278 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.9 mmt -106.09 -32.47 8.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.3 tp -48.45 123.59 6.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.423 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 71' ' ' THR . 47.3 p30 -48.52 -25.21 1.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.99 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.53 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 7.0 m -55.23 110.25 2.1 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.538 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 71' ' ' THR . 29.5 Cg_exo -57.14 -146.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.104 1.203 . . . . 0.0 110.948 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.432 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 33.8 ttp -123.96 -0.35 8.45 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.7 t -106.16 -27.47 11.05 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.287 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.43 -32.97 71.87 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.612 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 1.3 mm? -64.82 -49.98 68.48 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.442 ' CD ' ' N ' ' A' ' 77' ' ' LYS . 1.3 mptp? -56.67 -33.79 66.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.434 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -70.11 -58.56 3.67 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.406 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.4 -63.58 1.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.42 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 p -34.69 -24.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.904 0.383 . . . . 0.0 111.909 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 79' ' ' ALA . 17.6 ttm105 -77.29 -60.55 2.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.56 0.695 . . . . 0.0 109.965 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 39.4 mt -45.48 -41.44 3.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.209 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.561 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -76.96 -35.61 57.11 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 119.278 -0.969 . . . . 0.0 109.584 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -48.89 -20.06 0.46 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.792 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.419 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 86.66 18.46 58.38 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 88' ' ' GLU . 8.8 tp10 -112.07 1.54 16.38 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.69 0.281 . . . . 0.0 110.337 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -29.94 -39.31 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.986 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 86' ' ' GLU . 5.3 pt-20 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.95 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.558 ' H ' ' CD2' ' A' ' 13' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.334 0 CA-C-O 120.702 0.287 . . . . 0.0 111.148 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 67.7 mtt-85 -63.76 -40.78 97.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.2 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.2 mt -63.24 -11.3 7.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.457 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -103.56 -15.89 15.7 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.564 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -72.93 -28.95 62.75 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -58.2 -40.56 81.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.285 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.75 -35.53 0.2 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.495 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.511 ' C ' ' H ' ' A' ' 22' ' ' LEU . 55.5 mtp85 -65.12 -38.39 90.52 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.806 0.336 . . . . 0.0 110.404 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.53 -5.7 0.23 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.725 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.511 ' H ' ' C ' ' A' ' 20' ' ' ARG . 15.6 mt -117.46 149.84 45.51 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.919 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.05 -88.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.014 1.81 . . . . 0.0 112.474 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.72 3.25 42.11 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.537 -0.363 . . . . 0.0 112.235 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.5 m -72.43 129.36 38.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.124 0.462 . . . . 0.0 110.652 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.22 170.61 11.97 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.271 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.5 t -60.2 -57.37 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.855 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.48 5.37 10.67 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.353 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -94.17 -28.07 15.86 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 117.744 0.772 . . . . 0.0 110.276 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 tt -80.47 -17.89 50.32 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.803 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.0 tp . . . . . 0 N--CA 1.464 0.258 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.506 -179.957 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 49' ' ' GLY . 10.5 mp . . . . . 0 CA--C 1.532 0.266 0 CA-C-O 120.546 0.213 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -64.16 71.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.019 0.437 . . . . 0.0 110.443 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -152.95 7.89 0.49 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.73 177.43 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.467 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 71.8 m -118.97 165.6 13.89 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -55.97 -45.84 80.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.751 0.31 . . . . 0.0 111.241 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.8 m -53.35 -25.93 17.21 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 42.9 t0 -75.81 -31.28 59.35 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.4 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.543 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 5.7 mp -65.79 -63.33 1.11 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -54.4 -36.46 63.97 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' A' ' 61' ' ' GLY . 13.1 pt -77.6 -18.39 14.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.56 -36.72 84.01 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.6 mm? -73.99 -57.14 4.16 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.068 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.68 -34.45 72.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 114.37 -48.29 0.95 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.588 ' C ' ' H ' ' A' ' 64' ' ' GLU . 26.3 p -135.89 144.0 45.31 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.143 0.496 . . . . 0.0 111.356 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.99 9.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.836 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.603 ' OE1' ' OD1' ' A' ' 65' ' ' ASP . 5.5 tm-20 -86.6 -55.51 3.84 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.651 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.603 ' OD1' ' OE1' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -86.58 -13.09 46.8 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.031 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.0 m -49.02 -20.34 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.272 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 65' ' ' ASP . 62.9 m-20 -56.76 -33.34 66.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.132 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.428 ' C ' ' SD ' ' A' ' 68' ' ' MET . 0.0 OUTLIER -92.16 -27.86 17.44 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.786 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 71' ' ' THR . 32.5 tp -50.99 117.79 2.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.389 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -39.24 -24.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.346 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.489 ' N ' ' O ' ' A' ' 69' ' ' LEU . 2.5 m -68.27 116.18 36.88 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.56 -108.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.583 1.522 . . . . 0.0 111.643 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 24.1 ttm -150.91 2.99 0.45 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 121.094 -0.243 . . . . 0.0 110.825 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.425 ' O ' ' OD2' ' A' ' 78' ' ' ASP . 3.4 m -107.44 -23.23 12.27 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.927 0.394 . . . . 0.0 110.08 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.66 -33.09 74.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.479 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.628 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -66.36 -52.63 44.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.485 179.62 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.458 ' CD ' ' N ' ' A' ' 77' ' ' LYS . 2.6 mptp? -51.88 -36.78 49.78 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 74' ' ' SER . 4.8 m-20 -67.41 -58.76 4.18 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.18 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -63.01 -64.55 0.88 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.632 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.8 p -34.08 -24.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.59 ' N ' ' O ' ' A' ' 79' ' ' ALA . 15.1 ttm180 -76.65 -61.26 2.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.382 0.61 . . . . 0.0 110.21 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.421 HD13 HG21 ' A' ' 82' ' ' ILE . 43.7 mt -45.28 -40.2 2.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.162 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.567 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.91 -35.42 50.63 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.535 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -50.32 -20.07 0.98 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.041 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.38 11.14 69.62 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 87' ' ' ALA . 21.5 tp10 -102.4 1.18 35.04 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -31.21 -39.31 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.656 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 86' ' ' GLU . 9.5 mm-40 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.682 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -85.11 -27.25 26.39 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.7 mt -63.28 -14.95 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.405 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.4 -16.45 27.37 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.419 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 4.0 mm? -72.68 -30.71 64.47 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.9 -41.34 70.82 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.921 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -44.24 -36.37 2.69 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.407 ' C ' ' H ' ' A' ' 22' ' ' LEU . 71.0 ttt180 -66.98 -42.37 85.22 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.469 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -57.57 -8.07 0.78 Allowed 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.259 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.407 ' H ' ' C ' ' A' ' 20' ' ' ARG . 21.1 mt -113.05 147.22 36.79 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.299 -178.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.8 -73.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.168 1.912 . . . . 0.0 112.828 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -119.22 43.47 1.57 Allowed Glycine 0 N--CA 1.471 0.979 0 C-N-CA 121.503 -0.379 . . . . 0.0 112.222 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.2 m -117.89 132.88 56.37 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.869 0.334 . . . . 0.0 110.244 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.411 ' H ' ' HG1' ' A' ' 26' ' ' THR . 0.0 OUTLIER -83.45 169.14 15.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.183 0.516 . . . . 0.0 110.568 -179.685 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.9 t -60.85 -59.57 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.169 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.59 9.6 5.92 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.532 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -99.51 -12.2 20.37 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.753 0.776 . . . . 0.0 110.764 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 pp -98.15 -16.13 19.64 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.351 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 tt . . . . . 0 N--CA 1.469 0.491 0 CA-C-O 120.837 0.351 . . . . 0.0 110.765 -179.53 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 49' ' ' GLY . 10.2 mt . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.757 0.313 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -66.85 69.97 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.437 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -151.95 3.14 0.39 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.17 174.26 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.478 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 52.9 m -115.09 163.53 15.48 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 t -56.46 -42.14 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 O-C-N 123.265 0.353 . . . . 0.0 111.404 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.4 m -57.39 -25.41 59.47 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -74.44 -32.15 62.52 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.083 0.468 . . . . 0.0 110.956 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.541 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 5.7 mp -64.25 -65.59 0.66 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.503 -177.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -52.67 -37.42 58.73 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 61' ' ' GLY . 10.3 pt -79.34 -18.11 12.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.51 -41.77 96.06 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.41 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.0 mm? -73.64 -57.12 4.21 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.031 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.99 88.13 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 104.95 -34.42 5.81 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.527 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.553 ' C ' ' H ' ' A' ' 64' ' ' GLU . 22.6 t -137.24 129.6 29.69 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.106 0.479 . . . . 0.0 111.405 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -59.17 1.81 0.07 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.902 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.553 ' H ' ' C ' ' A' ' 62' ' ' SER . 42.7 mt-10 -83.02 -47.75 11.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.781 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -92.78 -7.44 46.5 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.6 m -55.72 -17.72 3.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.864 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -53.22 -31.88 45.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.286 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.8 ptm -100.27 -21.0 15.63 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 71' ' ' THR . 27.5 tp -52.17 124.09 12.21 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.256 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -41.14 -23.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.07 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 69' ' ' LEU . 2.2 m -74.73 117.94 66.34 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.954 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.41 -104.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.892 1.728 . . . . 0.0 111.785 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.471 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 31.8 ttp -153.95 1.79 0.24 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.997 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.9 m -108.27 -18.77 13.68 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.784 0.326 . . . . 0.0 110.197 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.35 -34.04 70.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.619 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.542 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -64.0 -45.92 86.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.033 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.471 ' CE ' ' O ' ' A' ' 73' ' ' MET . 1.8 mptp? -56.22 -37.83 70.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.37 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -66.75 -56.92 8.31 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.432 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -63.92 -64.27 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.677 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 76' ' ' LEU . 1.8 p -35.11 -27.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.112 0.482 . . . . 0.0 111.42 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 79' ' ' ALA . 52.6 ttm-85 -75.57 -58.92 2.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.111 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 50.1 mt -45.83 -41.71 3.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.821 -1.082 . . . . 0.0 112.656 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -79.77 -33.0 40.99 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.628 179.588 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -50.2 -21.55 1.38 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.869 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.51 17.4 55.05 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 88' ' ' GLU . 68.5 mt-10 -112.82 2.56 16.0 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -31.68 -34.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.849 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 86' ' ' GLU . 3.6 pt-20 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.686 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mp . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 -88.26 -34.06 17.86 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.2 mp -62.54 -11.36 6.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.38 -16.41 22.36 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.7 -29.01 66.33 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.62 -46.25 73.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.873 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -41.87 -36.07 0.98 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' A' ' 22' ' ' LEU . 36.9 ttt180 -65.61 -43.14 90.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.743 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.35 -6.9 0.74 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.745 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' A' ' 20' ' ' ARG . 11.7 mt -117.94 121.61 31.39 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.57 72.77 6.35 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.781 1.654 . . . . 0.0 112.604 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.83 -53.33 0.68 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.7 m -59.23 132.42 53.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.006 0.432 . . . . 0.0 111.491 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.85 173.82 9.16 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.359 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.3 t -61.61 -59.64 3.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.697 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.66 6.71 8.19 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.53 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.445 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 57.5 mt-30 -97.1 -22.81 16.55 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 117.86 0.83 . . . . 0.0 110.084 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.0 tp -90.2 -19.75 23.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.836 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 N--CA 1.466 0.357 0 CA-C-O 120.897 0.379 . . . . 0.0 110.408 -179.98 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 49' ' ' GLY . 10.3 mp . . . . . 0 N--CA 1.465 0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.67 ' NE2' ' N ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -62.06 72.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.359 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -152.76 11.61 0.61 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 51' ' ' SER . 0.3 OUTLIER -126.91 175.07 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.472 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 49.1 m -113.79 161.97 16.9 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 t -55.52 -43.46 72.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 123.196 0.31 . . . . 0.0 110.999 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.3 m -57.37 -23.95 52.27 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 16.6 t0 -75.7 -31.32 59.63 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.016 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.541 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 5.9 mp -65.31 -65.9 0.61 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.489 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -52.79 -34.98 55.88 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.8 pt -80.19 -19.78 12.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.23 -37.79 91.33 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.711 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.45 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.4 mm? -75.98 -52.61 9.88 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.284 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.66 -33.38 64.45 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.464 -0.494 . . . . 0.0 109.803 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 83.42 -9.24 62.08 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.104 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.582 ' C ' ' H ' ' A' ' 64' ' ' GLU . 3.9 t -137.75 104.24 5.24 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.924 0.392 . . . . 0.0 111.819 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -56.51 -1.24 0.05 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.701 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.582 ' H ' ' C ' ' A' ' 62' ' ' SER . 36.2 mt-10 -91.51 -41.37 10.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.3 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -92.45 -13.0 30.62 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 m -46.79 -29.8 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.622 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -52.92 -30.69 35.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.919 0.39 . . . . 0.0 110.234 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 13.2 mmt -83.96 -31.08 25.74 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.92 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.485 ' O ' ' N ' ' A' ' 71' ' ' THR . 29.7 tp -49.56 122.4 6.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.283 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 51.2 t0 -39.69 -24.9 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.021 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.485 ' N ' ' O ' ' A' ' 69' ' ' LEU . 2.8 m -65.05 122.08 77.65 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.016 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -74.71 -86.74 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.644 1.563 . . . . 0.0 112.281 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -172.13 -23.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.676 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.6 p -89.34 -14.59 35.33 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.89 -33.7 72.56 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.4 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.598 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 1.5 mm? -65.25 -47.69 75.87 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.214 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.47 ' CD ' ' N ' ' A' ' 77' ' ' LYS . 1.8 mptp? -57.95 -34.4 69.86 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.82 -58.67 3.85 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.895 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.604 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.31 -64.64 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.29 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.5 p -34.72 -23.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.961 0.41 . . . . 0.0 111.653 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.604 ' N ' ' O ' ' A' ' 79' ' ' ALA . 46.9 ttm-85 -78.71 -58.22 3.36 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.456 0.646 . . . . 0.0 109.617 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 79' ' ' ALA . 43.4 mt -47.7 -42.06 8.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.988 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.539 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -76.7 -36.65 57.1 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.564 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -48.88 -18.07 0.25 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.795 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.448 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 85.01 18.7 60.61 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 88' ' ' GLU . 24.3 tt0 -112.44 2.93 16.6 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -30.32 -34.96 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.874 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 86' ' ' GLU . 41.9 mt-10 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.677 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mp . . . . . 0 CA--C 1.534 0.328 0 CA-C-O 120.981 0.42 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 50.4 ttm-85 -86.04 -38.35 17.95 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.35 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.417 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 1.4 mp -65.29 -7.16 4.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.173 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.54 -18.91 21.72 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.74 0.305 . . . . 0.0 110.493 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -70.15 -30.35 67.49 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -57.87 -41.44 82.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.408 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 18' ' ' ALA . . . -41.28 -33.97 0.44 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.499 ' C ' ' H ' ' A' ' 22' ' ' LEU . 86.5 mtt180 -67.93 -42.24 81.33 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.224 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -57.88 -5.19 0.38 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.424 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.499 ' H ' ' C ' ' A' ' 20' ' ' ARG . 19.3 mt -115.07 148.61 40.97 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.056 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.83 -92.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.219 1.946 . . . . 0.0 112.401 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.28 46.51 1.28 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.7 m -118.21 141.73 48.2 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.827 0.346 . . . . 0.0 110.387 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.67 159.4 15.01 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.232 0.539 . . . . 0.0 110.393 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.5 t -54.84 -51.9 47.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.124 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.01 3.57 56.99 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.11 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -89.22 -20.27 24.37 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 117.597 0.699 . . . . 0.0 109.836 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.5 -27.25 15.47 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.617 0.246 . . . . 0.0 110.523 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.7 mt . . . . . 0 C--N 1.333 -0.121 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.876 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.4 mp . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -69.56 67.27 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.852 0.358 . . . . 0.0 110.424 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.71 11.15 0.36 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.77 171.78 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.47 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 31.6 m -113.66 161.72 17.12 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.07 -38.11 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 120.872 0.367 . . . . 0.0 110.415 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.6 m -59.18 -26.89 65.19 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -75.09 -30.53 60.94 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.974 0.416 . . . . 0.0 111.041 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.551 HD13 ' H ' ' A' ' 55' ' ' LEU . 5.0 mp -67.05 -62.79 1.26 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.197 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -54.01 -35.0 61.43 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.9 pt -78.96 -19.46 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.285 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.76 -33.5 84.42 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.1 mm? -77.55 -54.79 5.98 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 116.873 0.337 . . . . 0.0 110.944 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.39 -32.4 62.69 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.967 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 80.0 -4.36 66.63 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.556 ' C ' ' H ' ' A' ' 64' ' ' GLU . 13.0 t -137.12 97.53 3.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.008 0.432 . . . . 0.0 111.45 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -53.45 -6.16 0.07 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.258 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.556 ' H ' ' C ' ' A' ' 62' ' ' SER . 20.2 tp10 -86.31 -41.11 14.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.409 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -92.74 -14.77 27.49 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.7 m -49.1 -21.41 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 119.816 -0.753 . . . . 0.0 110.518 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -53.93 -34.46 59.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.226 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.5 ptp -92.59 -24.29 18.75 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.222 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.473 ' CD2' ' OG1' ' A' ' 71' ' ' THR . 21.9 tp -49.46 121.62 5.27 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -35.97 -30.26 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.598 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.473 ' OG1' ' CD2' ' A' ' 69' ' ' LEU . 2.1 m -48.92 114.46 3.77 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.578 ' C ' ' H ' ' A' ' 74' ' ' SER . 93.8 Cg_endo -80.45 19.85 1.03 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.168 1.912 . . . . 0.0 113.148 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.435 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 34.2 ttm 65.91 -12.89 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.825 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.578 ' H ' ' C ' ' A' ' 72' ' ' PRO . 30.1 t -96.49 -14.19 22.51 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.04 0.448 . . . . 0.0 110.053 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.13 -30.13 60.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.414 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.444 HD21 ' H ' ' A' ' 76' ' ' LEU . 0.7 OUTLIER -65.55 -53.15 46.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.592 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -46.66 -38.01 9.12 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.179 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -70.51 -58.24 3.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.068 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.587 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -62.72 -61.31 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.594 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 76' ' ' LEU . 2.8 p -34.85 -24.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.992 0.425 . . . . 0.0 111.745 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 79' ' ' ALA . 24.1 ttm180 -79.22 -55.7 4.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.549 0.69 . . . . 0.0 109.654 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.431 ' N ' ' O ' ' A' ' 79' ' ' ALA . 41.5 mt -49.62 -43.49 18.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.973 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.547 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -74.25 -38.07 63.58 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.484 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -45.47 -19.48 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.859 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 83' ' ' LEU . . . 83.46 14.85 72.75 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 87' ' ' ALA . 94.4 mt-10 -110.7 3.82 19.54 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -28.28 -46.19 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.839 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.126 179.784 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.551 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 3.8 mp . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.883 0.373 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -47.01 -46.54 21.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.009 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.517 ' CD1' ' N ' ' A' ' 15' ' ' ILE . 1.5 mp -63.84 -7.65 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.2 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -97.71 -15.66 20.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.275 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.01 -28.75 61.59 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -57.4 -41.98 81.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.959 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -42.67 -36.79 1.52 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.926 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.439 ' C ' ' H ' ' A' ' 22' ' ' LEU . 75.0 ttt180 -64.38 -39.17 93.34 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -60.05 -6.19 1.28 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.47 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.439 ' H ' ' C ' ' A' ' 20' ' ' ARG . 10.6 mt -121.47 109.24 34.85 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.141 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.16 66.89 7.73 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.917 1.745 . . . . 0.0 112.412 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.67 -11.68 0.45 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.001 -0.619 . . . . 0.0 111.841 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 m -113.81 137.31 51.82 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.955 0.407 . . . . 0.0 111.08 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.67 ' H ' HE21 ' A' ' 29' ' ' GLN . 0.1 OUTLIER -87.97 170.72 10.88 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.314 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.6 t -60.45 -59.69 3.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.184 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.16 11.11 4.02 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.364 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.67 HE21 ' H ' ' A' ' 26' ' ' THR . 18.2 mt-30 -98.87 -10.0 23.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.714 0.757 . . . . 0.0 110.487 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 pp -107.57 -19.18 13.64 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.3 tt . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.759 0.314 . . . . 0.0 111.631 -178.951 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.495 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 3.8 mm? . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 120.718 0.294 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -76.18 75.63 3.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.69 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.36 6.48 0.49 Allowed Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.412 HG21 ' H ' ' A' ' 51' ' ' SER . 0.3 OUTLIER -134.69 175.85 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 117.068 0.434 . . . . 0.0 110.428 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.49 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 24.0 m -111.62 164.55 12.88 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.9 t -58.25 -43.98 87.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.645 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.3 m -55.98 -25.35 43.61 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -74.85 -30.56 61.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.954 0.407 . . . . 0.0 111.468 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.529 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 6.2 mp -65.3 -64.0 0.97 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -177.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -53.66 -36.45 62.14 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 61' ' ' GLY . 8.1 pt -80.35 -21.03 11.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.97 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.75 -33.01 83.72 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.528 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 1.8 mm? -80.26 -54.73 5.46 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.42 -29.54 41.98 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.882 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 75.0 2.85 66.65 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.438 -0.887 . . . . 0.0 110.982 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 64' ' ' GLU . 9.1 t -136.37 86.78 2.25 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.886 0.374 . . . . 0.0 111.253 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -49.08 -11.23 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.72 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.524 ' H ' ' C ' ' A' ' 62' ' ' SER . 25.3 tt0 -86.07 -35.71 20.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.512 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -98.27 -14.46 20.25 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.9 m -50.16 -25.83 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.475 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -52.31 -14.44 0.46 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.589 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 67.3 mtt -104.25 -22.21 13.41 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.67 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.8 tp -51.97 120.26 5.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.2 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 44.5 t0 -39.94 -33.13 0.19 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.194 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.9 m -60.7 119.65 45.98 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.071 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.71 -156.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 121.143 1.228 . . . . 0.0 111.348 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 8.8 ptm -106.8 -16.17 14.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.789 0.328 . . . . 0.0 111.147 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.7 m -92.76 -25.17 18.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.486 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.25 -33.12 73.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.371 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.52 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 1.2 mm? -64.95 -45.62 84.98 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.303 -0.959 . . . . 0.0 108.958 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.465 ' CD ' ' N ' ' A' ' 77' ' ' LYS . 2.1 mptp? -59.97 -34.74 73.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.547 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -66.4 -58.8 4.51 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.708 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.49 -65.12 0.74 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.455 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.409 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.5 p -34.88 -27.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.05 0.452 . . . . 0.0 111.419 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.556 ' N ' ' O ' ' A' ' 79' ' ' ALA . 45.5 ttm-85 -77.3 -58.71 3.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.815 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 82' ' ' ILE . 41.9 mt -45.01 -41.64 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.291 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.575 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -78.03 -35.62 49.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.64 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -51.44 -14.9 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.646 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.443 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 81.08 19.37 67.33 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 87' ' ' ALA . 8.0 tp10 -113.0 7.63 18.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -33.6 -57.11 0.44 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.494 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.521 179.858 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 mp . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -82.07 -28.81 32.19 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.1 mt -64.3 -19.2 24.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.248 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.47 -17.94 27.7 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.337 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.3 -30.82 66.7 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.5 -43.76 75.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.13 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 18' ' ' ALA . . . -41.04 -37.36 0.82 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.524 ' C ' ' H ' ' A' ' 22' ' ' LEU . 66.2 mtp180 -68.39 -42.48 79.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.283 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.6 -5.76 0.25 Allowed 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.968 0.413 . . . . 0.0 110.275 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.524 ' H ' ' C ' ' A' ' 20' ' ' ARG . 13.9 mt -119.21 122.43 29.52 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.398 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -79.13 79.42 3.39 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.712 1.608 . . . . 0.0 112.75 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 130.17 -52.27 0.83 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.8 m -55.35 137.97 46.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.987 0.422 . . . . 0.0 111.435 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.61 171.68 9.51 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.72 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.2 t -60.25 -59.15 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.438 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.29 6.94 9.07 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.241 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.93 -20.83 17.83 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 117.283 0.542 . . . . 0.0 110.182 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 pp -90.78 -20.89 21.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.548 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.534 0.331 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.619 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 49' ' ' GLY . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 120.738 0.304 . . . . 0.0 110.393 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 84' ' ' TRP . 76.2 mt-30 -62.0 70.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.669 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -154.66 9.49 0.39 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.77 175.76 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.433 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 37.0 m -116.57 162.66 17.27 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 t -54.29 -47.83 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 123.254 0.347 . . . . 0.0 110.857 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -52.89 -25.27 11.16 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 116.365 -0.38 . . . . 0.0 112.003 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -75.43 -31.95 60.52 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.018 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.527 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 5.9 mp -66.38 -63.75 1.01 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.227 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -52.87 -34.77 56.01 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.9 pt -80.31 -19.92 11.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.022 0.439 . . . . 0.0 109.834 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.29 -38.5 91.59 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.423 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.4 mm? -76.61 -54.57 6.49 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 120.645 -0.422 . . . . 0.0 109.999 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.72 -35.06 79.23 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 118.53 -53.79 0.65 Allowed Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.673 ' C ' ' H ' ' A' ' 64' ' ' GLU . 26.8 t -140.05 152.69 46.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.995 0.426 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.34 20.89 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.891 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.673 ' H ' ' C ' ' A' ' 62' ' ' SER . 60.8 mt-10 -97.34 -59.8 1.71 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.694 0.283 . . . . 0.0 110.886 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.41 ' OD1' ' CG ' ' A' ' 68' ' ' MET . 12.4 t0 -82.45 -11.91 58.2 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 m -51.92 -28.35 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.13 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -55.92 -24.15 36.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.541 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.41 ' CG ' ' OD1' ' A' ' 65' ' ' ASP . 8.1 mmt -93.75 -36.63 12.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.521 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 71' ' ' THR . 12.7 tp -48.85 115.98 1.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.4 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -43.74 -16.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.773 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 69' ' ' LEU . 2.8 m -51.58 116.17 7.45 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.562 ' C ' ' H ' ' A' ' 74' ' ' SER . 93.0 Cg_endo -79.58 20.29 0.88 Allowed 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.319 2.013 . . . . 0.0 113.655 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 18.7 ttm 66.13 -13.42 0.16 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.633 0.254 . . . . 0.0 111.2 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.562 ' H ' ' C ' ' A' ' 72' ' ' PRO . 5.7 t -96.91 -13.6 22.32 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.063 0.459 . . . . 0.0 109.933 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.3 -31.53 64.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.904 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.455 HD21 ' H ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -67.69 -59.15 3.55 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -52.82 -15.92 0.87 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.252 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 74' ' ' SER . 8.2 m-20 -86.33 -51.96 5.92 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -69.34 -56.35 7.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.439 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.419 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.2 p -35.73 -26.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.297 0.57 . . . . 0.0 111.048 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.55 ' N ' ' O ' ' A' ' 79' ' ' ALA . 40.3 ttm-85 -76.52 -55.35 5.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.925 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 79' ' ' ALA . 53.2 mt -49.95 -42.78 19.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.463 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.568 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -79.13 -32.9 44.62 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.755 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.508 ' O ' ' NE2' ' A' ' 48' ' ' GLN . 0.6 OUTLIER -46.85 -29.64 2.08 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.44 14.9 39.65 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 88' ' ' GLU . 1.1 mp0 -110.74 0.65 17.45 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -33.07 -33.42 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.478 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 86' ' ' GLU . 56.8 mm-40 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.58 ' H ' ' CD2' ' A' ' 13' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 120.575 0.226 . . . . 0.0 111.451 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.458 ' O ' ' CG2' ' A' ' 82' ' ' ILE . 94.5 mtt-85 -42.59 -41.25 2.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.5 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.4 mm -64.44 -24.01 34.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.552 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.98 -18.76 20.01 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.99 -31.0 70.4 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -58.02 -41.53 83.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.779 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -42.38 -37.46 1.57 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.015 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.9 mtt-85 -64.06 -38.66 91.86 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.026 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.98 -7.2 0.98 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.332 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 25.3 mt -112.96 146.86 35.98 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -39.19 -71.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.196 1.931 . . . . 0.0 112.206 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -140.51 4.71 2.54 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.3 m -57.38 137.33 56.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.46 162.9 20.81 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.094 0.473 . . . . 0.0 110.806 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.1 t -61.04 -55.74 22.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.83 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.15 13.34 2.7 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.087 -0.577 . . . . 0.0 112.654 -178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -97.66 -19.31 18.36 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.018 0.909 . . . . 0.0 111.954 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.91 -17.53 20.07 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.988 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 3.0 mm? . . . . . 0 N--CA 1.471 0.618 0 CA-C-N 118.163 0.438 . . . . 0.0 110.624 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 10.2 mp . . . . . 0 N--CA 1.463 0.187 0 CA-C-O 120.8 0.333 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -81.93 65.03 6.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.935 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.13 3.15 0.76 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.52 172.73 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.453 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 60.6 m -115.43 162.28 17.38 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 t -55.41 -42.2 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 120.67 0.272 . . . . 0.0 111.058 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.3 m -58.11 -23.93 56.74 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.26 -31.98 60.94 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.995 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.542 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 5.5 mp -64.67 -65.86 0.62 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.533 -177.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -53.24 -36.13 60.72 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.538 ' O ' ' N ' ' A' ' 61' ' ' GLY . 11.6 pt -79.18 -19.02 12.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.188 0.518 . . . . 0.0 109.713 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.96 -40.02 95.14 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.011 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 1.8 mm? -75.81 -53.09 9.02 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.283 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.26 -37.03 74.82 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 119.93 -53.24 0.69 Allowed Glycine 0 N--CA 1.465 0.61 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.612 ' C ' ' H ' ' A' ' 64' ' ' GLU . 2.5 t -137.54 147.38 45.1 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.98 0.419 . . . . 0.0 110.864 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -59.99 7.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.485 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.612 ' H ' ' C ' ' A' ' 62' ' ' SER . 53.2 mm-40 -81.5 -52.51 7.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.434 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -96.79 -7.27 34.14 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.3 m -47.36 -31.32 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.786 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -52.38 -33.29 42.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 0.0 110.235 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 17.2 mtt -80.6 -21.19 41.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.395 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.0 tp -65.41 122.4 17.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.499 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -47.09 -20.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.336 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.1 m -58.12 124.46 70.29 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.59 -86.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.532 1.488 . . . . 0.0 111.976 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 18.1 ptt? -173.59 -28.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.051 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.4 m -86.05 -17.97 33.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.22 -35.78 79.95 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.96 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.46 HD21 ' H ' ' A' ' 76' ' ' LEU . 0.9 OUTLIER -66.73 -51.95 50.05 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.28 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.29 -32.41 64.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -69.52 -55.58 9.79 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.945 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -67.07 -61.94 1.68 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.439 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.413 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.7 p -35.18 -27.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.013 0.435 . . . . 0.0 111.355 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.55 ' N ' ' O ' ' A' ' 79' ' ' ALA . 47.3 ttm-85 -75.9 -59.56 2.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.149 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.458 ' CG2' ' O ' ' A' ' 14' ' ' ARG . 49.4 mt -46.04 -40.53 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.692 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.573 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -79.84 -33.09 40.53 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 119.341 -0.944 . . . . 0.0 109.527 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -52.01 -21.52 3.19 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.771 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.67 16.07 55.52 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -104.33 -1.33 27.09 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -36.0 -35.31 0.07 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.382 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.66 -179.907 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.553 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 3.5 mp . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -49.77 -46.5 50.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.152 0.501 . . . . 0.0 110.646 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.2 mt -65.17 -8.0 5.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.588 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.15 -15.0 19.11 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.651 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.38 -28.32 61.96 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -57.89 -42.83 85.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.121 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 18' ' ' ALA . . . -41.77 -33.55 0.52 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.512 ' C ' ' H ' ' A' ' 22' ' ' LEU . 37.4 ttm180 -69.7 -42.99 73.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.017 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.64 -7.49 0.43 Allowed 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.061 0.458 . . . . 0.0 110.051 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.512 ' H ' ' C ' ' A' ' 20' ' ' ARG . 14.1 mt -116.46 147.62 40.05 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.438 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -60.34 -78.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.968 1.779 . . . . 0.0 113.005 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.87 -10.5 26.39 Favored Glycine 0 N--CA 1.469 0.89 0 C-N-CA 121.409 -0.424 . . . . 0.0 112.654 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.3 m -60.48 130.57 47.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.317 0.559 . . . . 0.0 110.644 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.18 166.89 15.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.551 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.6 t -58.44 -59.59 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.739 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.13 10.55 2.45 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.702 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -101.59 -25.78 13.76 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 117.986 0.893 . . . . 0.0 110.572 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.3 tp -86.75 -27.15 23.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.902 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.9 mt . . . . . 0 N--CA 1.464 0.271 0 CA-C-O 120.677 0.275 . . . . 0.0 110.799 -179.786 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 49' ' ' GLY . 77.8 mt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.833 0.349 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 84' ' ' TRP . 70.1 mt-30 -63.16 71.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.801 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -149.7 16.04 1.08 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.84 178.39 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.467 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 67.2 m -115.98 164.23 14.74 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -57.41 -47.33 84.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.158 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.4 m -54.77 -24.69 23.65 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.457 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.94 -30.95 64.26 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.053 0.454 . . . . 0.0 110.734 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.532 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 6.6 mp -66.35 -63.35 1.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.529 -178.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -55.95 -37.93 69.67 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.0 pt -73.72 -21.4 18.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.617 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.7 -35.46 91.95 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.872 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.501 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.2 mm? -75.81 -55.48 5.59 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.899 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.29 -31.47 58.24 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.484 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 77.17 -2.36 61.5 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.098 -1.049 . . . . 0.0 111.248 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.564 ' C ' ' H ' ' A' ' 64' ' ' GLU . 22.2 t -131.03 99.37 4.87 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.921 0.391 . . . . 0.0 111.409 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -54.11 -2.73 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.036 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.564 ' H ' ' C ' ' A' ' 62' ' ' SER . 27.9 tt0 -95.5 -44.28 7.59 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.298 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.493 ' H ' ' HG ' ' A' ' 62' ' ' SER . 0.9 OUTLIER -86.79 -12.35 48.29 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.577 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.2 m -54.12 -22.4 7.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.856 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -65.19 -14.2 60.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.193 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 51.7 mtt -105.71 -18.59 14.02 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.843 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 mt -49.05 139.96 9.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.121 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 20.2 p-10 -58.27 -30.39 66.56 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.3 m -60.89 119.53 45.59 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.225 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.94 -154.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.313 1.342 . . . . 0.0 111.233 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.43 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 37.1 ttm -112.72 1.29 15.6 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.872 0.368 . . . . 0.0 110.059 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.0 m -107.1 -27.89 10.33 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.101 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.35 -35.42 75.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.548 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.511 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 0.7 OUTLIER -63.75 -49.74 71.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.448 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.458 ' CD ' ' N ' ' A' ' 77' ' ' LYS . 2.0 mptp? -54.63 -35.86 63.9 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.445 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.73 -59.4 3.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.92 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.45 -61.77 2.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.9 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -35.19 -27.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.049 0.452 . . . . 0.0 111.545 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 79' ' ' ALA . 29.0 ttm180 -78.01 -56.65 4.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.619 0.723 . . . . 0.0 109.818 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.412 HD11 HG21 ' A' ' 82' ' ' ILE . 42.8 mt -46.5 -45.09 6.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.901 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.56 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -74.49 -36.58 63.27 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.702 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.495 ' O ' ' NE2' ' A' ' 48' ' ' GLN . 0.7 OUTLIER -47.33 -19.58 0.16 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.104 -179.859 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.434 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 85.16 15.46 66.86 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 88' ' ' GLU . 25.0 tt0 -108.29 0.37 21.26 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -32.97 -31.95 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.63 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 86' ' ' GLU . 37.5 mt-10 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.707 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.565 HD13 ' H ' ' A' ' 13' ' ' LEU . 4.5 mp . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.756 0.312 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -45.72 -44.75 13.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.965 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.488 ' CD1' ' N ' ' A' ' 15' ' ' ILE . 1.8 mp -64.37 -15.72 17.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.336 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 13' ' ' LEU . . . -99.6 -17.29 17.9 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.368 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -71.74 -28.14 63.47 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -60.56 -39.98 89.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.458 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -42.93 -34.78 1.03 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.659 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.468 ' C ' ' H ' ' A' ' 22' ' ' LEU . 65.8 ttt180 -66.12 -39.05 89.6 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.884 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -59.43 -6.87 1.15 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.134 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.468 ' H ' ' C ' ' A' ' 20' ' ' ARG . 14.9 mt -119.81 117.33 32.54 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.62 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.49 70.29 7.59 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.889 1.726 . . . . 0.0 112.48 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 146.14 -52.14 0.58 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.0 m -60.47 133.0 55.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.974 0.416 . . . . 0.0 111.145 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.455 ' H ' ' HG1' ' A' ' 26' ' ' THR . 0.0 OUTLIER -87.99 168.23 13.02 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.077 179.746 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.2 t -58.77 -58.56 6.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.141 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.7 11.13 3.51 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.643 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.402 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 40.0 mm-40 -99.51 -15.26 18.73 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.952 0.876 . . . . 0.0 110.587 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.5 tp -100.75 -27.74 13.19 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.546 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 3.0 mm? . . . . . 0 N--CA 1.465 0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 110.846 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.515 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 3.0 mm? . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.04 0.448 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -70.81 72.82 0.56 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.438 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.42 5.68 0.46 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.409 ' CG2' ' OD2' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -133.82 176.12 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.953 0.376 . . . . 0.0 110.163 179.811 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.474 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 9.3 m -115.38 165.59 12.8 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 t -57.64 -49.11 81.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.31 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.4 m -53.18 -24.62 11.25 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.592 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.409 ' OD2' ' CG2' ' A' ' 50' ' ' VAL . 32.9 t0 -74.16 -31.4 62.68 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.33 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.535 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 5.9 mp -66.1 -62.26 1.58 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 -178.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -55.55 -38.98 70.03 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 61' ' ' GLY . 15.1 pt -73.77 -24.96 20.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.418 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.79 -33.06 81.43 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.943 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.499 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.0 mm? -80.19 -56.39 4.25 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.107 0.453 . . . . 0.0 111.291 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.64 -30.44 61.63 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.726 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 81.48 -13.82 32.62 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.747 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.575 ' C ' ' H ' ' A' ' 64' ' ' GLU . 2.7 p -121.67 103.76 9.12 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.918 0.39 . . . . 0.0 111.313 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.96 -0.06 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.597 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.575 ' H ' ' C ' ' A' ' 62' ' ' SER . 47.1 tt0 -96.27 -41.56 8.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.172 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -90.88 -12.11 37.18 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.7 m -54.91 -22.05 9.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.982 0.42 . . . . 0.0 111.232 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -57.73 -19.89 30.68 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.136 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 28.8 mtt -108.21 -5.16 17.02 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.553 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.84 151.11 1.28 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.283 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -67.63 -39.36 84.67 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 72' ' ' PRO . 81.9 m -61.1 112.99 6.66 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.682 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 71' ' ' THR . 50.1 Cg_exo -51.82 -164.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.594 1.53 . . . . 0.0 112.084 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.4 ptt? -105.32 -15.9 14.91 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.659 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.3 m -96.63 -19.25 19.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.243 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.44 -30.91 70.77 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.123 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.513 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 1.5 mm? -64.5 -49.6 70.68 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.444 ' CD ' ' N ' ' A' ' 77' ' ' LYS . 0.7 OUTLIER -54.45 -33.58 59.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.548 179.448 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -72.09 -59.78 2.57 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.79 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -57.05 -63.45 1.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.342 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.3 p -35.1 -27.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.923 0.392 . . . . 0.0 111.744 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 79' ' ' ALA . 46.6 ttm-85 -76.44 -60.07 2.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.534 0.683 . . . . 0.0 110.423 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.428 HD13 HG23 ' A' ' 82' ' ' ILE . 36.3 mt -43.61 -43.11 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.156 -178.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -76.65 -34.39 58.28 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 119.137 -1.025 . . . . 0.0 109.873 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -52.64 -18.03 1.58 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.676 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.56 14.67 67.61 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -102.3 1.62 35.92 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -36.78 -37.24 0.13 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.086 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.679 -179.924 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 120.685 0.279 . . . . 0.0 110.269 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 1.395 ' CD ' ' CG2' ' A' ' 82' ' ' ILE . 1.9 tmm_? -81.52 -20.6 39.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.156 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.592 HD12 ' HE ' ' A' ' 14' ' ' ARG . 7.6 mm -62.84 -26.03 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.218 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.02 -23.85 19.39 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.7 -33.62 76.38 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.19 -45.63 75.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.454 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -43.48 -36.07 1.87 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -63.43 -41.99 98.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.187 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -63.19 -7.26 5.53 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.045 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.4 mt -120.03 110.24 36.62 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.81 65.07 8.57 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.741 1.627 . . . . 0.0 112.394 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.33 -37.35 0.52 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.636 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.8 m -80.59 139.55 36.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.003 0.43 . . . . 0.0 111.432 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.43 166.79 15.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.91 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.7 t -60.52 -60.27 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.078 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.52 11.65 5.28 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.298 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.454 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 13.0 mm100 -99.0 -17.49 18.27 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.695 0.748 . . . . 0.0 110.286 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 45.8 tp -93.38 -18.28 22.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.826 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.741 0.305 . . . . 0.0 111.155 -179.797 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 49' ' ' GLY . 5.7 tp . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.65 0.262 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -64.1 70.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.169 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -153.12 7.67 0.47 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.24 175.74 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.444 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 67.0 m -119.57 164.04 16.43 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.9 t -56.45 -43.99 79.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.333 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.7 m -56.85 -23.46 44.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -75.21 -32.52 61.21 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.231 0.539 . . . . 0.0 110.837 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.539 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 6.0 mp -63.87 -66.63 0.52 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.629 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -54.25 -34.82 61.61 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.7 pt -78.58 -20.51 13.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.8 -37.03 88.16 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.858 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.454 ' CD1' ' O ' ' A' ' 29' ' ' GLN . 2.3 mm? -76.45 -53.63 7.85 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.579 -0.448 . . . . 0.0 109.902 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.56 -36.71 76.56 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 121.25 -53.23 0.71 Allowed Glycine 0 N--CA 1.466 0.668 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.688 ' C ' ' H ' ' A' ' 64' ' ' GLU . 4.1 m -139.19 150.87 46.07 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.94 0.4 . . . . 0.0 110.916 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -60.13 22.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.639 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.688 ' H ' ' C ' ' A' ' 62' ' ' SER . 27.3 mt-10 -96.62 -60.33 1.63 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.698 0.285 . . . . 0.0 110.624 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -83.4 -13.08 55.66 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.5 m -47.51 -24.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.377 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -58.95 -35.0 72.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.345 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 24.9 mmt -84.97 -33.59 22.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.653 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.4 tp -49.89 122.01 6.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 110.16 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -55.88 -25.35 42.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.666 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 72' ' ' PRO . 26.1 m -50.13 108.62 1.05 Allowed Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.226 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 71' ' ' THR . 32.5 Cg_exo -54.8 -154.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.37 1.38 . . . . 0.0 112.196 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.4 ptm -115.75 -20.89 9.88 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.565 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.4 m -90.26 -19.87 23.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.538 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.78 -34.89 79.42 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.202 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.621 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 1.3 mm? -66.49 -50.88 61.78 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.31 -31.84 64.06 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -70.9 -56.82 5.41 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.779 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -64.7 -61.25 2.3 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.433 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 p -35.87 -26.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.22 0.533 . . . . 0.0 111.21 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 79' ' ' ALA . 15.9 ttm180 -78.87 -53.54 6.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.108 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 1.395 ' CG2' ' CD ' ' A' ' 14' ' ' ARG . 46.3 mt -50.29 -44.38 23.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.138 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 1.181 ' HA ' ' CZ ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -76.38 -35.57 58.57 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.639 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.626 ' N ' HH12 ' A' ' 14' ' ' ARG . 0.6 OUTLIER -45.6 -28.0 0.88 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.249 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.862 ' H ' HH12 ' A' ' 14' ' ' ARG . . . 96.13 13.66 48.32 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 88' ' ' GLU . 27.0 tt0 -105.95 -2.91 22.36 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -33.48 -34.44 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.392 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 86' ' ' GLU . 69.3 mm-40 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.539 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.643 ' H ' ' CD2' ' A' ' 13' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -75.09 -39.98 60.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 55.1 mt -63.63 -13.04 12.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.456 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.73 -17.51 24.14 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.797 0.332 . . . . 0.0 110.771 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -70.79 -32.44 69.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.17 -44.19 74.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.291 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -41.59 -37.02 1.04 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.012 0.434 . . . . 0.0 109.969 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.436 ' C ' ' H ' ' A' ' 22' ' ' LEU . 54.8 ttm-85 -63.55 -41.72 98.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.527 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.75 -7.12 0.89 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.55 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.436 ' H ' ' C ' ' A' ' 20' ' ' ARG . 12.0 mt -119.0 114.06 35.41 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -79.35 68.94 8.13 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.657 1.571 . . . . 0.0 112.293 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.81 -49.6 0.56 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.3 m -66.79 133.77 50.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.971 0.415 . . . . 0.0 111.589 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.14 173.03 11.4 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.038 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.41 ' C ' ' H ' ' A' ' 29' ' ' GLN . 21.4 t -63.62 -63.55 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.139 0.495 . . . . 0.0 111.09 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.52 11.93 2.91 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.045 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.442 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 10.9 mm100 -99.62 -24.97 14.57 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.514 0.657 . . . . 0.0 110.607 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.7 tt -85.3 -19.8 30.98 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.926 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.3 0 CA-C-O 121.004 0.431 . . . . 0.0 109.981 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.461 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 3.7 mm? . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.753 0.311 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -84.11 69.65 10.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.938 0.399 . . . . 0.0 110.533 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.0 -2.85 0.14 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.23 172.82 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.444 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 3.5 m -115.95 161.71 18.43 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 t -53.37 -44.26 54.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 123.213 0.321 . . . . 0.0 110.985 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.6 m -58.12 -22.92 53.02 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -75.39 -31.93 60.62 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.452 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.541 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 5.8 mp -64.5 -67.57 0.42 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.42 -177.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -52.12 -34.73 45.62 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.538 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.6 pt -79.7 -19.17 12.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.71 -41.08 84.79 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.442 ' CD1' ' O ' ' A' ' 29' ' ' GLN . 2.4 mm? -73.48 -54.37 8.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.583 -0.447 . . . . 0.0 109.833 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.75 -37.06 79.11 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 118.8 -51.96 0.73 Allowed Glycine 0 N--CA 1.468 0.809 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.614 ' C ' ' H ' ' A' ' 64' ' ' GLU . 83.8 p -138.38 145.91 41.63 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.75 0.31 . . . . 0.0 110.842 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -59.92 6.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.195 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.614 ' H ' ' C ' ' A' ' 62' ' ' SER . 32.7 mt-10 -82.3 -54.72 5.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.299 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -96.74 -5.3 38.93 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 m -44.82 -26.33 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.611 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -57.04 -32.17 65.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.017 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 25.3 mmm -92.04 -7.64 48.23 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.363 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.483 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 30.1 tp -49.57 -84.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.212 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 1.3 t70 154.23 -26.78 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.408 ' OG1' ' CD2' ' A' ' 69' ' ' LEU . 3.4 m -62.4 135.12 95.17 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.018 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.6 -92.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.793 1.662 . . . . 0.0 112.28 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -172.59 -26.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.1 m -88.52 -18.9 27.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.9 -35.84 81.73 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.714 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.609 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 1.4 mm? -64.46 -49.78 70.11 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -70.15 -9.21 54.93 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.954 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -86.04 -50.4 7.07 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.577 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -70.21 -57.84 4.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.301 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.401 ' O ' ' CE3' ' A' ' 84' ' ' TRP . 1.3 p -35.22 -25.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.11 0.481 . . . . 0.0 111.167 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.577 ' N ' ' O ' ' A' ' 79' ' ' ALA . 21.4 ttm180 -78.44 -55.61 5.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.819 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.462 ' N ' ' O ' ' A' ' 79' ' ' ALA . 49.7 mt -50.72 -41.5 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.287 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.573 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.54 -35.82 52.88 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.309 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.401 ' CE3' ' O ' ' A' ' 80' ' ' VAL . 0.6 OUTLIER -45.86 -22.13 0.17 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.439 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.442 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 86.57 18.18 59.0 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 87' ' ' ALA . 85.0 mt-10 -111.29 -0.23 16.48 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.479 0.18 . . . . 0.0 110.518 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -31.86 -58.36 0.28 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.689 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.749 -179.764 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.617 ' H ' ' CD2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 120.636 0.255 . . . . 0.0 111.637 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.1 mtm-85 -50.04 -34.68 22.23 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.6 mm -64.16 -24.03 34.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.905 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.73 -19.8 22.23 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.567 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.99 -32.48 69.32 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -56.24 -43.93 79.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.329 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 18' ' ' ALA . . . -40.41 -36.36 0.54 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.46 ' C ' ' H ' ' A' ' 22' ' ' LEU . 72.8 mtt-85 -65.9 -42.51 90.12 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.342 -0.39 . . . . 0.0 109.948 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.48 -6.14 0.65 Allowed 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.345 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.46 ' H ' ' C ' ' A' ' 20' ' ' ARG . 8.7 mt -121.11 112.41 33.27 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.633 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -83.5 65.46 7.56 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.959 1.773 . . . . 0.0 112.414 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.9 -35.87 0.62 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.472 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.8 m -81.9 135.0 35.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.947 0.403 . . . . 0.0 111.333 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.77 170.47 14.13 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.015 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.4 t -61.72 -61.44 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.75 10.32 4.19 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.19 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.419 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 21.0 mm100 -99.19 -25.4 14.53 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.427 0.614 . . . . 0.0 110.574 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.7 tp -88.09 -26.17 22.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.444 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 3.4 mm? . . . . . 0 C--N 1.331 -0.239 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.513 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 3.3 mm? . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.535 0.207 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -78.06 63.9 3.13 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.388 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.64 1.34 0.6 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.16 173.62 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.469 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 36.0 m -116.0 164.8 13.9 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t -55.23 -47.71 77.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 O-C-N 123.27 0.356 . . . . 0.0 111.313 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.4 m -54.81 -24.32 22.26 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 38.1 t0 -74.74 -31.76 61.91 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.846 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.528 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 6.2 mp -65.27 -65.52 0.66 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.241 -178.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -53.63 -34.25 57.88 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.5 pt -78.77 -18.63 13.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.66 -38.79 67.49 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.419 ' CD1' ' O ' ' A' ' 29' ' ' GLN . 2.5 mm? -74.76 -55.5 5.78 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.47 -37.15 84.48 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 100.26 -28.9 13.63 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.801 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.62 ' C ' ' H ' ' A' ' 64' ' ' GLU . 14.9 p -138.2 132.42 31.82 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.386 0.612 . . . . 0.0 112.131 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -58.59 7.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.867 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.62 ' H ' ' C ' ' A' ' 62' ' ' SER . 54.2 mt-10 -93.81 -52.44 4.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.895 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -80.96 -16.28 53.93 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.3 m -50.18 -23.69 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.263 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -61.04 -30.39 70.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.425 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 37.8 mtt -91.77 -34.34 14.64 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.982 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.2 tp -49.28 108.4 0.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.944 0.402 . . . . 0.0 110.06 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -42.84 -24.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.812 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 72' ' ' PRO . 14.8 m -45.69 106.29 0.54 Allowed Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.633 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 71' ' ' THR . 52.5 Cg_exo -52.73 -168.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.311 1.341 . . . . 0.0 111.262 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 40.8 ttp -106.07 -7.55 17.96 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.2 t -100.18 -26.27 13.99 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.209 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.02 -34.5 70.11 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.036 0.445 . . . . 0.0 110.301 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.553 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -67.78 -59.66 3.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.563 0.696 . . . . 0.0 109.603 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -60.08 -10.17 4.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.205 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -87.64 -52.88 5.08 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -68.84 -56.74 7.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.182 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.424 ' O ' ' CE3' ' A' ' 84' ' ' TRP . 1.4 p -35.06 -25.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 121.219 0.533 . . . . 0.0 111.316 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 79' ' ' ALA . 39.5 ttm180 -78.75 -56.58 4.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.565 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 79' ' ' ALA . 41.8 mt -47.33 -42.48 7.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.896 -178.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.554 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.37 -36.17 53.82 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.892 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.424 ' CE3' ' O ' ' A' ' 80' ' ' VAL . 0.7 OUTLIER -46.63 -24.35 0.53 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.674 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 90.63 18.94 46.36 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 88' ' ' GLU . 45.2 mt-10 -110.15 -0.05 18.07 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -35.94 -26.58 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.358 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 86' ' ' GLU . 67.0 mm-40 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.238 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.583 ' H ' ' CD2' ' A' ' 13' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.437 0 CA-C-O 120.733 0.301 . . . . 0.0 111.329 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.513 HH21 ' CB ' ' A' ' 87' ' ' ALA . 71.9 mtp180 -43.54 -43.33 5.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.645 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 mm -63.53 -21.62 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.625 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -97.45 -17.24 19.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -69.73 -32.28 70.73 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.07 -46.03 71.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.313 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -39.7 -36.37 0.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.337 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.499 ' C ' ' H ' ' A' ' 22' ' ' LEU . 73.6 ttt-85 -64.33 -42.37 96.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.837 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.39 -4.72 0.41 Allowed 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.348 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.499 ' H ' ' C ' ' A' ' 20' ' ' ARG . 8.5 mt -122.8 111.96 30.86 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.566 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.04 67.18 8.71 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 121.713 1.609 . . . . 0.0 112.22 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.39 -43.97 0.58 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.637 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.3 m -75.2 133.43 41.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.938 0.399 . . . . 0.0 111.34 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.64 173.3 11.49 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.081 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.2 t -62.8 -62.59 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.672 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.84 11.37 3.52 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.091 -178.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.456 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 20.1 mm-40 -100.14 -24.36 14.6 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 117.487 0.644 . . . . 0.0 110.891 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.6 tt -92.79 -23.52 18.84 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.981 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.6 mt . . . . . 0 C--N 1.328 -0.34 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.87 -179.761 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.504 0.193 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -70.51 70.76 0.45 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.361 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.22 7.45 0.74 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 51' ' ' SER . 0.3 OUTLIER -130.78 175.7 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.488 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 9.0 m -113.21 163.84 14.28 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 t -56.27 -43.77 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 123.209 0.318 . . . . 0.0 111.414 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.8 m -55.33 -25.72 36.43 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -76.47 -30.94 57.49 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.912 0.387 . . . . 0.0 111.544 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.55 HD11 ' H ' ' A' ' 55' ' ' LEU . 5.6 mp -65.62 -65.09 0.72 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -50.81 -34.86 29.39 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.481 ' O ' ' N ' ' A' ' 61' ' ' GLY . 8.9 pt -83.08 -21.69 8.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.336 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.26 -38.12 95.68 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.471 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.1 mm? -74.59 -62.3 1.58 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.711 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.11 -34.17 77.04 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.325 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 86.93 -8.74 74.96 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.479 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.543 ' C ' ' H ' ' A' ' 64' ' ' GLU . 1.9 m -138.01 104.52 5.27 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 117.106 0.453 . . . . 0.0 112.022 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -54.24 -6.5 0.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.218 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.543 ' H ' ' C ' ' A' ' 62' ' ' SER . 28.3 mp0 -83.76 -45.25 13.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.719 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.06 -12.97 34.09 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.416 ' C ' ' N ' ' A' ' 68' ' ' MET . 12.9 m -50.66 -29.39 6.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.105 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -51.52 -15.12 0.38 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.48 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.416 ' N ' ' C ' ' A' ' 66' ' ' VAL . 48.6 mtt -104.45 -25.81 12.66 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.741 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.7 tp -51.86 119.26 4.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.165 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -38.99 -29.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.444 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.1 m -65.9 115.08 19.52 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.643 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.27 -156.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.261 1.307 . . . . 0.0 111.43 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -102.15 -17.58 15.94 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.823 0.344 . . . . 0.0 111.526 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.3 m -92.35 -22.96 19.4 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.702 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.61 -32.81 74.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.41 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.466 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -66.37 -48.05 71.39 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.422 -0.911 . . . . 0.0 108.922 179.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -32.34 66.51 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.48 -58.77 3.2 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.303 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -62.45 -63.25 1.29 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.403 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 p -34.56 -24.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.991 0.424 . . . . 0.0 111.673 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 79' ' ' ALA . 32.4 ttm180 -78.24 -57.53 3.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 109.82 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.41 ' N ' ' O ' ' A' ' 79' ' ' ALA . 42.0 mt -48.09 -41.44 9.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.148 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.558 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.44 -36.28 53.24 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.332 179.774 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -49.75 -15.1 0.15 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.482 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 79.46 19.53 71.22 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 88' ' ' GLU . 79.4 mt-10 -113.0 7.1 18.01 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.513 ' CB ' HH21 ' A' ' 14' ' ' ARG . . . -35.73 -26.01 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.279 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 86' ' ' GLU . 28.9 mt-10 . . . . . 0 N--CA 1.463 0.211 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.222 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 N--CA 1.465 0.278 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.631 ' HE ' ' CB ' ' A' ' 87' ' ' ALA . 15.4 ttt85 -71.54 -32.31 67.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.229 -178.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.3 mm -54.35 -16.19 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -97.75 -25.35 15.1 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.248 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.91 -38.2 84.9 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.14 -42.34 69.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.377 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -41.82 -38.89 1.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.12 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.498 ' C ' ' H ' ' A' ' 22' ' ' LEU . 39.0 ttt85 -66.08 -42.26 89.6 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.839 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.48 -5.77 0.24 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.975 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.498 ' H ' ' C ' ' A' ' 20' ' ' ARG . 8.6 mt -122.39 105.45 36.4 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.423 -178.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -80.48 78.06 3.82 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 121.562 1.508 . . . . 0.0 112.086 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.62 -30.64 1.26 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.6 m -96.18 142.7 28.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.026 0.441 . . . . 0.0 111.296 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.14 178.52 6.61 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.219 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.9 t -66.4 -65.47 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.904 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.74 13.77 3.9 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.129 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -100.33 -16.11 17.78 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.166 0.483 . . . . 0.0 110.472 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 pp -94.65 -20.81 19.24 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.469 0.515 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.249 -179.78 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.0 tp . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.825 0.345 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -85.52 71.73 10.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.512 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.34 7.44 0.84 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 120.949 -0.644 . . . . 0.0 111.643 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.436 HG21 ' H ' ' A' ' 51' ' ' SER . 0.3 OUTLIER -128.1 177.92 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.676 0.274 . . . . 0.0 110.361 -179.801 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.48 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 33.7 m -112.78 162.46 15.75 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t -57.2 -44.32 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 120.667 0.27 . . . . 0.0 111.139 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.9 m -56.88 -22.07 34.34 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -77.25 -30.59 54.51 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.211 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.548 HD13 ' H ' ' A' ' 55' ' ' LEU . 5.9 mp -65.93 -64.47 0.85 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.211 -177.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -52.99 -34.13 54.74 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 61' ' ' GLY . 7.4 pt -83.38 -18.86 10.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.668 0.271 . . . . 0.0 110.948 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.29 -33.22 86.66 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.5 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 1.8 mm? -79.23 -57.25 3.81 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.578 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.58 -32.78 64.3 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.125 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 84.75 -5.11 83.3 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.538 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.55 ' C ' ' H ' ' A' ' 64' ' ' GLU . 69.0 m -137.9 99.22 3.84 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.942 0.401 . . . . 0.0 111.635 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 63' ' ' GLU . 0.1 OUTLIER -50.88 -8.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.72 179.246 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.55 ' H ' ' C ' ' A' ' 62' ' ' SER . 32.6 tt0 -87.62 -41.31 13.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.835 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -89.8 -18.17 26.78 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.6 m -46.74 -23.07 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.967 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 67' ' ' ASP . 56.1 t0 -50.72 -34.57 27.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.46 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 68' ' ' MET . 0.0 OUTLIER -82.5 -32.83 28.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.637 179.761 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.3 tp -49.91 116.22 1.72 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.114 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -42.45 -26.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.89 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.7 m -62.15 112.51 6.47 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 119.343 -0.36 . . . . 0.0 110.699 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.47 -157.58 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.345 1.364 . . . . 0.0 111.748 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.7 ttm -103.72 -10.85 18.01 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.557 0.217 . . . . 0.0 110.776 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.2 m -94.51 -23.2 17.79 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.881 0.372 . . . . 0.0 110.39 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.93 -36.24 83.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.517 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -67.55 -47.26 70.34 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.654 -0.818 . . . . 0.0 109.092 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -26.03 61.06 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.48 -57.88 3.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.721 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.21 -64.69 0.86 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.06 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.2 p -34.89 -27.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.3 0.571 . . . . 0.0 111.146 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.564 ' N ' ' O ' ' A' ' 79' ' ' ALA . 23.7 ttm180 -78.47 -55.84 4.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.654 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.475 ' N ' ' O ' ' A' ' 79' ' ' ALA . 33.7 mt -47.68 -41.53 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.22 -178.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.55 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -78.16 -34.99 49.37 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.714 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -52.49 -14.26 0.47 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.744 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 83' ' ' LEU . . . 81.12 17.71 71.32 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 87' ' ' ALA . 52.0 mt-10 -114.05 8.84 17.17 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.631 ' CB ' ' HE ' ' A' ' 14' ' ' ARG . . . -31.89 -48.81 0.16 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.776 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.67 -179.872 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.569 ' H ' ' CD2' ' A' ' 13' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 120.743 0.306 . . . . 0.0 111.518 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -44.42 -48.9 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.973 0.416 . . . . 0.0 110.992 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.2 mm -65.39 -15.47 18.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.586 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.73 -16.68 17.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.093 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -71.62 -30.14 65.45 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -59.38 -42.04 90.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.512 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 18' ' ' ALA . . . -40.35 -33.44 0.25 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.502 ' C ' ' H ' ' A' ' 22' ' ' LEU . 56.7 ttt-85 -69.26 -42.48 75.51 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.294 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.73 -7.65 0.47 Allowed 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.078 0.466 . . . . 0.0 110.207 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.502 ' H ' ' C ' ' A' ' 20' ' ' ARG . 14.0 mt -113.91 149.69 42.27 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.855 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.18 -88.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.094 1.863 . . . . 0.0 112.552 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.34 -7.03 52.65 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.455 -0.403 . . . . 0.0 112.303 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.9 m -60.84 137.51 58.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.149 0.474 . . . . 0.0 110.628 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.16 164.34 13.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.985 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.0 t -55.2 -53.27 36.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.659 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.82 5.37 24.6 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.451 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -97.23 -24.34 15.75 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.74 0.77 . . . . 0.0 110.305 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 pp -84.12 -24.72 30.15 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.352 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.6 tp . . . . . 0 N--CA 1.463 0.203 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.882 -179.879 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 49' ' ' GLY . 1.3 tt . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -61.41 70.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.514 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -151.9 13.56 0.75 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -128.63 173.05 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.471 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 40.3 m -112.75 161.59 16.71 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -55.62 -39.93 57.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 120.798 0.332 . . . . 0.0 110.546 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 m -58.62 -25.11 62.32 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.053 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -75.47 -31.64 60.33 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.183 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.553 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 4.9 mp -66.45 -60.85 2.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.439 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -56.91 -36.04 69.71 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 61' ' ' GLY . 15.6 pt -75.93 -29.66 20.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.62 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.26 -27.49 39.76 Favored Glycine 0 CA--C 1.517 0.195 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mt -83.27 -64.15 1.22 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.805 -0.697 . . . . 0.0 112.433 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.76 -20.93 60.36 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.169 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 70.83 -0.61 27.81 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.399 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.535 ' C ' ' H ' ' A' ' 64' ' ' GLU . 15.0 t -136.0 95.69 3.26 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.929 0.395 . . . . 0.0 111.437 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -54.29 -6.41 0.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.707 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.535 ' H ' ' C ' ' A' ' 62' ' ' SER . 28.8 mt-10 -90.23 -32.49 16.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.732 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -101.53 -11.64 19.12 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 m -52.82 -25.46 8.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.443 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -53.74 -23.33 11.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.208 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 7.0 mmt -94.83 -31.11 13.87 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.663 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.476 ' CD2' ' OG1' ' A' ' 71' ' ' THR . 30.4 tp -49.67 127.47 15.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.219 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -39.74 -31.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.391 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.476 ' OG1' ' CD2' ' A' ' 69' ' ' LEU . 1.4 m -48.57 110.28 1.42 Allowed Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.647 ' C ' ' H ' ' A' ' 74' ' ' SER . 91.5 Cg_endo -80.23 29.48 0.51 Allowed 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.321 2.014 . . . . 0.0 113.507 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.468 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 19.4 ttp 55.78 -7.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.647 ' H ' ' C ' ' A' ' 72' ' ' PRO . 22.8 t -100.82 -16.14 17.38 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.165 0.507 . . . . 0.0 109.91 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.02 -31.22 62.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.264 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.577 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 1.1 mm? -65.9 -51.8 55.58 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.55 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.5 OUTLIER -48.25 -36.97 15.02 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.254 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.63 -59.05 3.05 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.375 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.573 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.5 -62.86 1.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.482 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.455 ' N ' ' O ' ' A' ' 76' ' ' LEU . 2.1 p -35.26 -25.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.007 0.432 . . . . 0.0 111.475 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 79' ' ' ALA . 28.1 ttm180 -78.3 -56.47 4.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.635 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 79' ' ' ALA . 44.7 mt -47.78 -43.81 10.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.849 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.557 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -75.48 -36.51 60.62 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 119.253 -0.979 . . . . 0.0 109.751 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -46.9 -22.08 0.28 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.836 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.419 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 88.18 13.87 63.25 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 87' ' ' ALA . 5.5 tp10 -109.28 2.54 20.89 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -28.96 -42.68 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.996 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.772 -179.854 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.459 ' CD1' ' H ' ' A' ' 13' ' ' LEU . 5.9 mp . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 46.3 mtt85 -78.27 -32.08 49.34 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 63.9 mt -66.11 -16.14 20.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.75 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.36 -17.28 21.72 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.275 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -73.25 -30.42 63.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.37 -42.22 73.64 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.096 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -41.12 -36.3 0.7 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.171 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.5 ' C ' ' H ' ' A' ' 22' ' ' LEU . 70.9 mtp180 -63.68 -40.3 96.46 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.58 -4.32 0.4 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.443 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.5 ' H ' ' C ' ' A' ' 20' ' ' ARG . 10.2 mt -122.89 115.55 29.26 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -82.01 64.02 8.38 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.814 1.676 . . . . 0.0 112.437 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.57 -48.84 0.48 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.56 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.2 m -68.41 133.46 48.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.959 0.409 . . . . 0.0 111.225 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.479 ' H ' ' HG1' ' A' ' 26' ' ' THR . 0.1 OUTLIER -85.22 171.45 11.94 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.025 179.668 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -60.93 -60.38 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.431 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.1 9.32 7.01 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.595 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.48 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 28.0 mm100 -99.61 -18.95 17.08 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 117.948 0.874 . . . . 0.0 110.411 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.5 tp -93.36 -19.64 21.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.063 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 21.6 mt . . . . . 0 N--CA 1.465 0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 110.849 -179.874 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.881 0.372 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -75.97 73.89 2.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.816 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -157.66 14.56 0.29 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -124.96 174.19 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.415 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 14.1 m -115.33 160.13 20.2 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t -53.32 -37.82 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 120.788 0.328 . . . . 0.0 110.494 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 m -61.09 -25.28 66.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.998 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 11.2 t0 -74.56 -30.55 61.78 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.64 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.542 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 5.9 mp -66.67 -66.53 0.54 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -51.39 -34.79 36.02 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 61' ' ' GLY . 9.6 pt -82.03 -17.36 11.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.28 -41.27 79.53 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.808 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.48 ' CD1' ' O ' ' A' ' 29' ' ' GLN . 1.9 mm? -74.93 -52.41 11.27 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.789 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.39 -37.93 74.59 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 116.81 -51.57 0.72 Allowed Glycine 0 N--CA 1.468 0.833 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.544 ' C ' ' H ' ' A' ' 64' ' ' GLU . 46.0 p -135.63 141.23 45.02 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.089 0.471 . . . . 0.0 111.116 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -57.91 1.15 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.347 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.544 ' H ' ' C ' ' A' ' 62' ' ' SER . 72.2 mm-40 -75.92 -53.88 7.74 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.422 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -93.24 -9.01 40.63 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -177.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.4 m -50.16 -24.2 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.517 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.26 -15.32 2.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.616 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 52.6 mtp -99.37 -34.76 10.16 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.62 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.7 tp -51.07 124.57 11.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.228 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -61.38 -22.97 65.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.345 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.1 m -49.68 107.65 0.83 Allowed Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.413 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.95 -171.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.224 1.283 . . . . 0.0 111.808 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.3 ptm -98.17 -22.02 16.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.724 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.9 t -89.06 -25.38 21.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.437 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.48 -33.47 69.82 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.302 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.44 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -67.39 -52.96 33.6 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.429 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -65.09 -9.44 22.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.466 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -87.61 -52.18 5.48 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -70.04 -57.79 4.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.587 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 79' ' ' ALA . 1.5 p -34.8 -28.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.287 0.565 . . . . 0.0 110.943 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 79' ' ' ALA . 20.4 ttm105 -74.04 -62.12 1.61 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.807 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 55.5 mt -45.44 -39.94 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.897 -178.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -81.42 -28.52 34.23 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.472 179.306 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -64.89 2.87 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.481 -0.488 . . . . 0.0 109.793 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 83' ' ' LEU . . . 65.93 22.16 70.15 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -107.26 2.23 24.48 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.921 0.391 . . . . 0.0 110.157 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -40.03 -68.88 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.956 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.723 -179.877 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.81 0.338 . . . . 0.0 110.474 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 71.3 mtm180 -84.63 -36.41 22.01 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.44 ' CD1' ' N ' ' A' ' 15' ' ' ILE . 1.2 mp -65.35 -8.92 6.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.257 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.18 -16.81 25.75 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.806 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.34 -30.5 63.38 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.94 -44.99 74.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.732 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -40.91 -36.16 0.61 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.98 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.463 ' C ' ' H ' ' A' ' 22' ' ' LEU . 57.1 mtp85 -68.1 -40.56 82.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.162 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.08 -6.8 0.65 Allowed 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 120.945 0.402 . . . . 0.0 110.496 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.463 ' H ' ' C ' ' A' ' 20' ' ' ARG . 11.4 mt -118.75 120.3 31.72 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.814 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.3 71.31 7.1 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.879 1.72 . . . . 0.0 112.557 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.42 -54.75 0.6 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.6 m -59.63 128.33 36.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.923 0.392 . . . . 0.0 110.949 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.442 ' H ' ' HG1' ' A' ' 26' ' ' THR . 0.0 OUTLIER -86.82 178.19 7.07 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.29 0.567 . . . . 0.0 110.875 -179.777 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.8 t -61.8 -58.77 6.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.904 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.421 ' C ' ' NE2' ' A' ' 29' ' ' GLN . . . -66.43 2.89 3.9 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.675 -178.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.646 ' N ' ' NE2' ' A' ' 29' ' ' GLN . 1.1 mp0 -100.38 -30.46 11.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.575 0.688 . . . . 0.0 111.236 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 pp -88.37 -27.45 21.6 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 120.718 0.294 . . . . 0.0 110.733 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.625 0.25 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -75.41 52.14 0.6 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.324 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -136.0 15.87 3.99 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 51' ' ' SER . 0.3 OUTLIER -128.42 177.96 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.437 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 20.3 m -119.05 164.01 16.14 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -56.55 -47.19 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.177 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.4 m -54.15 -24.18 16.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -74.59 -31.72 62.13 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.074 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.531 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 6.2 mp -64.96 -64.96 0.74 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.404 -178.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -54.75 -39.53 68.4 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.7 pt -71.52 -23.72 22.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.316 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.75 -30.8 78.74 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 121.164 -0.541 . . . . 0.0 111.756 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.53 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.1 mm? -79.51 -52.96 7.36 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.294 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.5 -30.19 33.35 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.603 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 74.21 4.85 69.69 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.266 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 64' ' ' GLU . 10.2 t -135.95 93.44 2.93 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.824 0.345 . . . . 0.0 111.307 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -48.57 -10.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.762 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.531 ' H ' ' C ' ' A' ' 62' ' ' SER . 30.9 tt0 -88.66 -42.61 11.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.714 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.17 -15.02 34.75 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.1 m -49.75 -28.96 4.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.77 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -55.47 -27.65 49.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.925 0.393 . . . . 0.0 110.244 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 48.8 mtm -92.33 -24.31 18.97 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.766 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.4 tp -53.37 123.0 10.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.931 0.396 . . . . 0.0 110.076 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -40.65 -38.56 0.91 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.661 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.1 m -52.66 107.76 0.92 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.973 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.12 -162.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.161 1.24 . . . . 0.0 111.423 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.467 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 32.4 ttm -109.11 -6.44 15.61 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 61.3 m -100.78 -20.83 15.38 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.138 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.57 -34.06 76.28 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.822 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.513 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 0.9 OUTLIER -64.08 -45.92 86.6 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.83 179.379 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.467 ' CE ' ' O ' ' A' ' 73' ' ' MET . 1.1 mptp? -55.83 -34.87 65.79 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.312 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.03 -59.93 2.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.495 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -59.03 -62.99 1.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.432 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 p -35.37 -25.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.917 0.389 . . . . 0.0 111.721 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.568 ' N ' ' O ' ' A' ' 79' ' ' ALA . 28.3 ttm180 -77.56 -57.35 3.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.668 0.747 . . . . 0.0 110.074 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.4 HD13 HG22 ' A' ' 82' ' ' ILE . 41.4 mt -47.79 -43.74 10.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.929 -178.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.558 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -75.03 -36.64 61.87 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.557 179.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -47.38 -18.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.457 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 83.1 15.52 72.03 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 88' ' ' GLU . 50.2 mm-40 -105.57 -0.63 25.58 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -36.7 -26.0 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.088 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 86' ' ' GLU . 2.7 mp0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.9 ptt? . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.8 p -166.79 -9.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.368 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.1 m 59.26 74.65 0.57 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.37 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.55 121.92 4.86 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.408 2.072 . . . . 0.0 111.966 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.9 p -82.24 -34.92 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.57 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -147.03 164.84 31.72 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.307 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -75.57 -37.01 60.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.78 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.7 m -119.72 139.41 52.32 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.342 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.606 ' O ' ' N ' ' A' ' 12' ' ' ALA . 35.2 ptt180 -70.64 -34.21 71.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -48.35 -31.46 6.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.434 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.3 m -71.19 -24.65 62.27 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.606 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -82.81 -70.16 0.57 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 113.613 -1.631 . . . . 0.0 109.893 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.47 ' CD1' ' H ' ' A' ' 13' ' ' LEU . 5.5 mp -37.02 -31.65 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.808 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 30.8 mtm105 -80.65 -39.49 27.24 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 54.7 mt -62.8 -14.68 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.446 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.35 -15.71 17.9 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -72.73 -31.91 65.32 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.6 -42.87 75.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.218 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 18' ' ' ALA . . . -39.9 -34.36 0.27 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.52 ' C ' ' H ' ' A' ' 22' ' ' LEU . 75.9 ttt-85 -67.23 -41.66 85.32 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.227 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -55.32 -6.73 0.18 Allowed 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.465 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.52 ' H ' ' C ' ' A' ' 20' ' ' ARG . 9.5 mt -116.23 149.33 43.34 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.27 -80.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 121.881 1.721 . . . . 0.0 112.548 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -116.24 7.89 18.48 Favored Glycine 0 N--CA 1.47 0.908 0 C-N-CA 121.44 -0.409 . . . . 0.0 112.467 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.0 m -73.97 126.84 31.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.43 0.615 . . . . 0.0 110.13 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.07 168.11 20.39 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.985 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -61.72 -61.15 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.23 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.91 10.64 4.11 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.085 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -98.57 -25.27 14.79 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 117.44 0.62 . . . . 0.0 110.391 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.2 tt -95.5 -17.8 21.16 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.588 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 tt -89.51 -47.24 8.12 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.965 0.412 . . . . 0.0 110.785 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -43.89 -24.75 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.384 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.2 mm -49.39 -33.2 6.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.452 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.7 tp -56.11 -15.14 3.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.985 0.421 . . . . 0.0 110.029 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.67 ' CD2' ' H ' ' A' ' 36' ' ' GLN . 5.2 t60 62.9 -127.66 0.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.435 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.67 ' H ' ' CD2' ' A' ' 35' ' ' HIS . 15.9 mm100 53.06 105.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.89 0.376 . . . . 0.0 110.435 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -49.22 -63.67 1.03 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.9 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.9 tt -46.51 144.15 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.813 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -79.75 -76.2 0.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.017 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.4 161.34 2.74 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.41 128.52 11.22 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.647 2.231 . . . . 0.0 111.99 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.528 ' N ' ' CD2' ' A' ' 42' ' ' LEU . 3.5 mm? -86.84 94.48 9.57 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.985 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 p -81.81 -176.06 5.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.018 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -75.51 -26.04 57.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.417 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -82.19 -33.93 29.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.482 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.0 m -55.7 -46.73 77.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.548 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.5 mt -61.08 -36.17 78.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.696 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -80.36 71.63 7.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.453 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -153.43 -0.28 0.2 Allowed Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.36 175.98 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.449 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 55.7 m -117.03 162.96 16.96 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 t -56.01 -43.71 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.905 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -56.52 -25.16 50.92 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.2 -31.76 62.78 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.08 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.545 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 5.8 mp -64.92 -65.36 0.68 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.378 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -53.58 -37.21 62.72 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.54 ' O ' ' N ' ' A' ' 61' ' ' GLY . 11.3 pt -77.95 -18.23 13.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.121 0.486 . . . . 0.0 109.994 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.72 -38.64 93.29 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.0 mm? -73.68 -56.94 4.37 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.242 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.42 -35.68 73.56 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 103.99 -33.86 6.24 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.798 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.55 ' C ' ' H ' ' A' ' 64' ' ' GLU . 68.8 m -136.3 127.68 28.43 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.037 0.446 . . . . 0.0 111.192 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -58.68 -0.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.453 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.55 ' H ' ' C ' ' A' ' 62' ' ' SER . 33.7 mt-10 -79.44 -45.22 19.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 67' ' ' ASP . 16.7 m-20 -99.05 -7.85 26.18 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.0 m -49.23 -27.24 2.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.62 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 17.8 p-10 -51.67 -35.36 42.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.012 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.22 -19.21 43.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.861 0.362 . . . . 0.0 110.61 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.5 tp -64.84 125.9 26.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.496 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -51.68 -22.82 3.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.048 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 m -64.49 115.94 24.35 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.232 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.68 -154.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.375 1.384 . . . . 0.0 111.126 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.439 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 29.7 ttm -112.66 1.82 15.88 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.2 t -109.58 -18.53 13.47 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.521 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.46 -33.46 71.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.822 0.344 . . . . 0.0 110.345 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.534 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -65.74 -47.14 76.28 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.447 ' CD ' ' N ' ' A' ' 77' ' ' LYS . 1.6 mptp? -55.96 -35.75 67.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.37 -58.84 3.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.852 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -63.23 -62.7 1.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.679 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.1 p -35.24 -26.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 120.922 0.392 . . . . 0.0 111.429 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.556 ' N ' ' O ' ' A' ' 79' ' ' ALA . 50.4 ttm-85 -75.98 -58.1 3.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.603 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 52.1 mt -47.49 -41.22 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.622 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.584 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -80.02 -32.08 39.61 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.587 179.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -49.12 -27.92 3.85 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.956 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.22 13.04 50.31 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 88' ' ' GLU . 74.8 mt-10 -113.88 8.69 17.36 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -28.08 -37.5 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.194 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 86' ' ' GLU . 5.8 pt-20 -66.33 142.26 57.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.835 0.35 . . . . 0.0 110.46 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.43 153.12 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.858 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -84.58 -142.75 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.66 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 61.6 p -65.08 -172.61 0.09 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.78 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.55 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 3.1 mm? -81.39 150.52 67.48 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.177 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -37.59 -68.93 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 122.285 1.99 . . . . 0.0 112.542 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -60.37 150.83 71.45 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.604 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.98 113.69 3.85 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.303 2.002 . . . . 0.0 111.828 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.518 179.937 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.0 mtp . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -163.35 -14.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.206 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.5 m -155.82 59.65 2.17 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.311 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.06 98.05 0.97 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.669 2.246 . . . . 0.0 111.854 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.4 m -82.2 32.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.816 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 6' ' ' ASN . 11.8 p30 -41.59 97.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.964 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.9 ' HE3' HD11 ' A' ' 42' ' ' LEU . 31.8 mtt -64.51 143.67 57.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.453 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.3 m -87.66 -149.84 0.17 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 12' ' ' ALA . 30.0 ptt180 -143.35 -54.57 0.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -43.16 -23.88 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.026 0.441 . . . . 0.0 109.841 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 9' ' ' ARG . 10.0 m -74.51 -50.95 16.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -59.56 -72.14 0.11 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.917 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.523 ' CD1' ' H ' ' A' ' 13' ' ' LEU . 5.6 mp -30.27 -51.75 0.14 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.062 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.42 ' O ' ' CG2' ' A' ' 82' ' ' ILE . 20.3 mmt85 -56.03 -30.38 61.8 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.7 mm -65.11 -18.21 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.369 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.66 -18.24 16.63 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.31 -28.57 65.28 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -57.77 -42.75 84.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.424 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 18' ' ' ALA . . . -40.48 -33.4 0.26 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.541 ' C ' ' H ' ' A' ' 22' ' ' LEU . 50.3 ttt85 -69.16 -42.59 75.72 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.23 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.13 -6.11 0.23 Allowed 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.243 0.544 . . . . 0.0 110.082 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.541 ' H ' ' C ' ' A' ' 20' ' ' ARG . 13.2 mt -117.0 149.52 44.32 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.177 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.43 -88.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.037 1.825 . . . . 0.0 112.485 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.12 -8.92 49.71 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.48 -0.391 . . . . 0.0 112.293 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.4 m -59.54 132.28 53.5 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.474 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.507 ' H ' ' NE2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -90.74 165.53 13.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.202 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.0 t -57.44 -55.88 18.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.149 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.18 8.36 8.89 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.808 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.507 ' NE2' ' H ' ' A' ' 26' ' ' THR . 19.2 mt-30 -96.82 -18.87 19.28 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.008 0.904 . . . . 0.0 110.753 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.4 tp -85.47 -37.93 19.18 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.526 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 33' ' ' ILE . 2.9 pp -78.25 -32.72 49.82 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.991 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -35.3 -27.72 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.765 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 31' ' ' LEU . 16.1 tt -56.05 -41.18 67.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.769 0.319 . . . . 0.0 110.842 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.7 tp -80.13 -78.14 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.506 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.673 ' CD2' ' H ' ' A' ' 36' ' ' GLN . 63.9 t60 60.01 -133.01 0.85 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.559 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.673 ' H ' ' CD2' ' A' ' 35' ' ' HIS . 32.6 mt-30 52.33 179.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.961 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -72.06 137.94 47.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.411 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.9 pt -57.12 127.41 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.503 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.427 ' OE2' ' O ' ' A' ' 39' ' ' GLU . 1.8 tm-20 -72.15 -42.07 66.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.306 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.16 -84.45 0.08 OUTLIER Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.87 141.38 53.67 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.45 2.1 . . . . 0.0 111.629 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.9 HD11 ' HE3' ' A' ' 7' ' ' MET . 0.6 OUTLIER -139.43 33.98 2.06 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.017 0.437 . . . . 0.0 110.535 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.461 ' OG1' ' OE2' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -98.21 177.15 5.48 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.93 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.518 ' CD ' ' N ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -55.23 -33.69 63.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.4 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.484 ' HG3' ' OE2' ' A' ' 44' ' ' GLU . 81.0 mt-10 -59.6 -37.44 78.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.628 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.4 t -64.41 -33.51 76.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.014 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.3 mp -70.94 -33.23 70.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.777 0.322 . . . . 0.0 110.502 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -73.0 67.17 0.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.456 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.68 15.03 0.81 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.469 ' CG2' ' OD2' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -127.61 177.38 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.445 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 5.2 m -119.23 164.01 16.25 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t -57.22 -45.49 84.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.751 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.4 m -54.3 -25.22 22.51 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.665 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.469 ' OD2' ' CG2' ' A' ' 50' ' ' VAL . 42.6 t0 -74.74 -31.1 61.72 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.916 0.388 . . . . 0.0 111.296 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.543 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 6.2 mp -65.94 -63.38 1.1 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -54.54 -36.29 64.13 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.1 pt -77.38 -19.22 14.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.035 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.63 -34.83 88.71 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.2 mm? -76.52 -57.07 4.07 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.658 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.81 -32.97 68.13 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.481 -0.487 . . . . 0.0 109.947 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 85.51 -9.13 68.79 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.535 ' C ' ' H ' ' A' ' 64' ' ' GLU . 3.2 m -137.87 107.53 6.23 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.101 0.477 . . . . 0.0 112.243 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -56.39 -4.6 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.016 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.535 ' H ' ' C ' ' A' ' 62' ' ' SER . 19.0 mm-40 -86.35 -43.48 12.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.762 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -92.47 -11.91 33.42 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.2 m -50.9 -26.65 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 119.689 -0.805 . . . . 0.0 110.283 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -56.25 -17.07 6.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.399 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 43.7 mtt -101.93 -32.47 10.19 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.529 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.5 tp -49.57 131.95 21.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.221 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 9.6 p-10 -57.05 -32.49 66.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.395 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 72' ' ' PRO . 10.7 m -46.45 105.45 0.48 Allowed Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.502 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 71' ' ' THR . 33.0 Cg_exo -54.92 -163.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.174 1.25 . . . . 0.0 111.219 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 30.4 ttm -107.84 -4.98 17.52 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 82.6 p -102.52 -26.75 13.12 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.429 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.87 -33.37 70.4 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.885 0.374 . . . . 0.0 110.169 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.483 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 0.7 OUTLIER -66.27 -53.37 37.51 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.443 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.4 OUTLIER -52.15 -35.43 48.54 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.475 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -68.36 -58.52 4.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.962 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -63.91 -60.47 3.23 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.834 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 p -35.24 -25.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.096 0.474 . . . . 0.0 111.686 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 79' ' ' ALA . 25.5 ttm180 -78.9 -56.31 4.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.544 0.688 . . . . 0.0 109.72 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.436 HD12 HG21 ' A' ' 82' ' ' ILE . 36.5 mt -47.88 -43.81 10.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.904 -178.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.541 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -74.23 -37.74 63.73 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 119.205 -0.998 . . . . 0.0 109.645 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -46.17 -19.05 0.06 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.94 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 83' ' ' LEU . . . 83.76 13.26 75.78 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 88' ' ' GLU . 91.6 mt-10 -103.4 -3.18 25.83 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -31.98 -32.61 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.525 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 86' ' ' GLU . 18.1 mm-40 -42.2 -51.65 4.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.337 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.0 m -54.38 130.57 16.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.814 0.34 . . . . 0.0 110.629 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' A' ' 91' ' ' SER . 3.5 p-10 -81.93 -108.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.519 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.455 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 98.9 p -76.45 172.47 12.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.937 0.398 . . . . 0.0 110.454 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.545 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 3.2 mm? -77.52 150.46 79.5 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.904 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -36.99 -66.7 0.12 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.214 1.942 . . . . 0.0 112.186 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.424 ' O ' ' O ' ' A' ' 95' ' ' PRO . 3.0 pt20 -61.05 152.27 71.76 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.056 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 94' ' ' GLN . 75.4 Cg_exo -37.18 160.94 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.32 2.013 . . . . 0.0 112.374 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.9 t . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.627 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 mtt . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.434 ' O ' ' OG1' ' A' ' 3' ' ' THR . 8.0 p -163.94 -30.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.496 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 2' ' ' VAL . 6.5 p 59.05 148.09 0.07 OUTLIER Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.373 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.19 -12.46 25.54 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.002 1.801 . . . . 0.0 111.87 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -164.42 138.54 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.593 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -164.84 166.93 19.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.606 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 32.3 mtm 59.81 58.08 2.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.603 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.9 m -82.86 178.4 8.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.297 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 12' ' ' ALA . 44.2 ptt85 -79.67 -39.87 30.38 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.45 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -43.06 -28.11 0.25 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.905 0.383 . . . . 0.0 110.598 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.3 m -76.88 -50.01 14.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -51.63 -69.94 0.1 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.362 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.497 ' CD1' ' H ' ' A' ' 13' ' ' LEU . 4.8 mp -34.11 -50.16 0.38 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.571 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.404 HH22 ' C ' ' A' ' 85' ' ' GLY . 61.0 mtp180 -55.38 -32.94 63.02 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 12' ' ' ALA . 28.3 mm -63.23 -16.54 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.382 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.36 -16.2 17.73 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -69.99 -30.7 68.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -56.71 -44.7 81.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.235 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -42.02 -36.76 1.2 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.501 ' C ' ' H ' ' A' ' 22' ' ' LEU . 67.6 ttt-85 -65.19 -40.83 94.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.943 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.18 -4.84 0.39 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.624 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.501 ' H ' ' C ' ' A' ' 20' ' ' ARG . 16.1 mt -118.1 139.76 27.05 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.145 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -39.67 -70.95 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.927 1.751 . . . . 0.0 112.855 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -134.4 0.0 3.79 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.521 -0.631 . . . . 0.0 111.521 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.1 m -57.43 131.21 49.44 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.611 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.69 160.92 27.25 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.343 0.592 . . . . 0.0 111.808 -178.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.18 -55.81 19.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.1 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.04 8.36 8.35 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.358 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -100.32 -20.27 15.93 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 117.867 0.834 . . . . 0.0 109.932 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 45.1 tp -98.68 -23.78 15.32 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.982 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 33' ' ' ILE . 3.9 mm? -92.33 -46.75 7.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.73 0.3 . . . . 0.0 110.829 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.475 ' C ' ' H ' ' A' ' 34' ' ' LEU . 45.4 tt0 -39.15 -25.26 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.404 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.474 ' N ' ' O ' ' A' ' 31' ' ' LEU . 31.1 pt -47.61 -13.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.926 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.475 ' H ' ' C ' ' A' ' 32' ' ' GLU . 7.8 tp -72.04 -50.4 28.78 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.144 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 63.08 103.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.954 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -152.17 171.44 17.92 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.351 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -158.22 -56.27 0.07 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.945 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.8 mm -47.24 -66.06 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.506 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -87.78 -157.41 0.4 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.269 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.66 65.72 0.09 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.12 168.37 11.98 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.921 2.414 . . . . 0.0 111.769 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 tt -169.74 77.36 0.09 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.035 0.445 . . . . 0.0 110.297 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.429 ' OG1' ' OG ' ' A' ' 46' ' ' SER . 33.2 p -127.09 160.38 31.36 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.497 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -78.27 -21.54 49.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.202 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -80.68 -43.88 19.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.079 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.429 ' OG ' ' OG1' ' A' ' 43' ' ' THR . 50.3 m -56.74 -34.73 67.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.289 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 49' ' ' GLY . 0.2 OUTLIER -60.51 -38.48 84.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.941 0.4 . . . . 0.0 110.149 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -61.17 71.29 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.593 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -155.08 4.98 0.24 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.454 ' CG2' ' OD2' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -123.67 176.96 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.396 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.428 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 45.2 m -119.03 161.75 19.72 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 t -55.33 -43.03 69.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.67 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 m -56.43 -26.0 52.2 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.871 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.454 ' OD2' ' CG2' ' A' ' 50' ' ' VAL . 53.1 t0 -73.87 -31.44 63.16 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.041 0.448 . . . . 0.0 110.859 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.547 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 6.3 mp -65.23 -65.01 0.73 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -53.29 -36.59 61.37 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.1 pt -78.08 -18.95 13.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.62 -38.13 89.93 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.453 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.3 mm? -75.07 -56.75 4.42 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.029 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.96 -35.31 78.15 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 93.29 -20.43 46.32 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.588 ' C ' ' H ' ' A' ' 64' ' ' GLU . 23.0 t -138.22 117.25 12.5 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.038 0.446 . . . . 0.0 111.871 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -59.34 4.06 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.686 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.588 ' H ' ' C ' ' A' ' 62' ' ' SER . 43.5 mt-10 -90.74 -45.71 8.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.194 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.65 -11.43 42.54 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.4 m -52.97 -27.44 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.035 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 19.4 p-10 -56.17 -12.61 1.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.278 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.9 mmt -106.09 -32.47 8.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.3 tp -48.45 123.59 6.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.423 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 71' ' ' THR . 47.3 p30 -48.52 -25.21 1.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.99 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.53 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 7.0 m -55.23 110.25 2.1 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.538 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 71' ' ' THR . 29.5 Cg_exo -57.14 -146.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.104 1.203 . . . . 0.0 110.948 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.432 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 33.8 ttp -123.96 -0.35 8.45 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.7 t -106.16 -27.47 11.05 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.287 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.43 -32.97 71.87 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.612 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 1.3 mm? -64.82 -49.98 68.48 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.442 ' CD ' ' N ' ' A' ' 77' ' ' LYS . 1.3 mptp? -56.67 -33.79 66.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.434 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -70.11 -58.56 3.67 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.406 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.4 -63.58 1.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.42 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 p -34.69 -24.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.904 0.383 . . . . 0.0 111.909 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 79' ' ' ALA . 17.6 ttm105 -77.29 -60.55 2.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.56 0.695 . . . . 0.0 109.965 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 39.4 mt -45.48 -41.44 3.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.209 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.561 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -76.96 -35.61 57.11 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 119.278 -0.969 . . . . 0.0 109.584 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -48.89 -20.06 0.46 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.792 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.419 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 86.66 18.46 58.38 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 88' ' ' GLU . 8.8 tp10 -112.07 1.54 16.38 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.69 0.281 . . . . 0.0 110.337 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -29.94 -39.31 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.986 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 86' ' ' GLU . 5.3 pt-20 -75.93 59.86 1.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.95 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.0 p -85.57 143.57 11.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.33 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -57.23 123.89 16.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.584 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.1 m -62.35 165.66 5.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.609 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.547 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 3.0 mm? -83.48 150.13 59.35 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.043 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.11 27.51 0.3 Allowed 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.162 1.908 . . . . 0.0 111.895 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' A' ' 92' ' ' LEU . 4.9 pt20 -55.16 151.93 16.27 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.279 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -36.09 152.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 122.45 2.1 . . . . 0.0 112.412 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.0 m . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.541 179.989 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.5 mtt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.8 t 41.48 90.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.767 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 63.59 155.63 0.12 Allowed Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.236 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.11 -175.6 0.53 Allowed 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.422 2.081 . . . . 0.0 111.59 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 t -145.38 148.08 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.449 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -77.96 125.6 29.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.811 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.6 tpt 63.13 159.49 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.196 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.481 ' OG ' ' N ' ' A' ' 9' ' ' ARG . 26.2 t -89.04 -174.11 4.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.242 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 12' ' ' ALA . 21.1 ptt180 -83.86 -28.47 27.97 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -45.76 -25.85 0.56 Allowed 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.175 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -78.51 -42.28 29.98 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -53.29 -71.29 0.07 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.28 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.558 ' H ' ' CD2' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -43.4 -42.15 4.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.148 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 67.7 mtt-85 -63.76 -40.78 97.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.2 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.2 mt -63.24 -11.3 7.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.457 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -103.56 -15.89 15.7 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.564 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -72.93 -28.95 62.75 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -58.2 -40.56 81.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.285 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.75 -35.53 0.2 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.495 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.511 ' C ' ' H ' ' A' ' 22' ' ' LEU . 55.5 mtp85 -65.12 -38.39 90.52 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.806 0.336 . . . . 0.0 110.404 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.53 -5.7 0.23 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.725 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.511 ' H ' ' C ' ' A' ' 20' ' ' ARG . 15.6 mt -117.46 149.84 45.51 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.919 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.05 -88.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.014 1.81 . . . . 0.0 112.474 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.72 3.25 42.11 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.537 -0.363 . . . . 0.0 112.235 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.5 m -72.43 129.36 38.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.124 0.462 . . . . 0.0 110.652 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.22 170.61 11.97 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.271 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.5 t -60.2 -57.37 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.855 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.48 5.37 10.67 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.353 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -94.17 -28.07 15.86 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 117.744 0.772 . . . . 0.0 110.276 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 tt -80.47 -17.89 50.32 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.803 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 33' ' ' ILE . 13.0 tp -89.82 -37.2 14.64 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.506 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -38.85 -21.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.681 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 1.084 HD13 ' OD1' ' A' ' 54' ' ' ASP . 12.8 tt -51.2 -25.28 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.694 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 80.5 mt -82.17 -81.0 0.15 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.673 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 56.61 78.78 0.2 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.405 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -159.77 -165.0 1.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.027 0.441 . . . . 0.0 110.923 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -70.09 79.01 0.5 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.182 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.503 ' N ' ' CD1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -57.07 -177.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.391 179.598 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -166.3 -18.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.728 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -157.79 174.65 35.15 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -73.32 -6.33 18.66 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.839 2.36 . . . . 0.0 111.903 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.3 mt 61.0 115.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.62 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.9 p -83.6 160.34 21.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.988 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -50.43 -24.64 3.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.671 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -82.14 -39.65 22.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.502 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.1 p -57.9 -34.63 70.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.779 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 49' ' ' GLY . 10.5 mp -66.67 -29.28 69.25 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.507 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -64.16 71.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.019 0.437 . . . . 0.0 110.443 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -152.95 7.89 0.49 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.73 177.43 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.467 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 71.8 m -118.97 165.6 13.89 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 t -55.97 -45.84 80.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.751 0.31 . . . . 0.0 111.241 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.8 m -53.35 -25.93 17.21 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 1.084 ' OD1' HD13 ' A' ' 33' ' ' ILE . 42.9 t0 -75.81 -31.28 59.35 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.4 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.543 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 5.7 mp -65.79 -63.33 1.11 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -54.4 -36.46 63.97 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' A' ' 61' ' ' GLY . 13.1 pt -77.6 -18.39 14.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.56 -36.72 84.01 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.6 mm? -73.99 -57.14 4.16 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.068 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.68 -34.45 72.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 114.37 -48.29 0.95 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.588 ' C ' ' H ' ' A' ' 64' ' ' GLU . 26.3 p -135.89 144.0 45.31 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.143 0.496 . . . . 0.0 111.356 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.99 9.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.836 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.603 ' OE1' ' OD1' ' A' ' 65' ' ' ASP . 5.5 tm-20 -86.6 -55.51 3.84 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.651 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.603 ' OD1' ' OE1' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -86.58 -13.09 46.8 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.031 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.0 m -49.02 -20.34 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.272 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 65' ' ' ASP . 62.9 m-20 -56.76 -33.34 66.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.132 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.428 ' C ' ' SD ' ' A' ' 68' ' ' MET . 0.0 OUTLIER -92.16 -27.86 17.44 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.786 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 71' ' ' THR . 32.5 tp -50.99 117.79 2.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.389 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -39.24 -24.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.346 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.489 ' N ' ' O ' ' A' ' 69' ' ' LEU . 2.5 m -68.27 116.18 36.88 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.56 -108.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.583 1.522 . . . . 0.0 111.643 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 24.1 ttm -150.91 2.99 0.45 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 121.094 -0.243 . . . . 0.0 110.825 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.425 ' O ' ' OD2' ' A' ' 78' ' ' ASP . 3.4 m -107.44 -23.23 12.27 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.927 0.394 . . . . 0.0 110.08 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.66 -33.09 74.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.479 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.628 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -66.36 -52.63 44.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.485 179.62 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.458 ' CD ' ' N ' ' A' ' 77' ' ' LYS . 2.6 mptp? -51.88 -36.78 49.78 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 74' ' ' SER . 4.8 m-20 -67.41 -58.76 4.18 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.18 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -63.01 -64.55 0.88 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.632 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.8 p -34.08 -24.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.59 ' N ' ' O ' ' A' ' 79' ' ' ALA . 15.1 ttm180 -76.65 -61.26 2.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.382 0.61 . . . . 0.0 110.21 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.421 HD13 HG21 ' A' ' 82' ' ' ILE . 43.7 mt -45.28 -40.2 2.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.162 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.567 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.91 -35.42 50.63 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.535 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -50.32 -20.07 0.98 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.041 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.38 11.14 69.62 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 87' ' ' ALA . 21.5 tp10 -102.4 1.18 35.04 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -31.21 -39.31 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.656 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 86' ' ' GLU . 9.5 mm-40 -49.9 161.31 0.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.682 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.0 t -72.17 142.7 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.443 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -79.22 -171.51 2.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.046 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.5 m -62.38 -176.3 0.1 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.728 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.547 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 3.1 mm? -83.07 148.79 57.48 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.023 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -38.9 119.25 0.42 Allowed 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.137 1.892 . . . . 0.0 112.287 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -70.83 151.17 95.22 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -36.81 142.14 0.14 Allowed 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.291 1.994 . . . . 0.0 112.339 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.569 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ptp . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.6 m -90.79 24.52 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.45 ' H ' ' HG1' ' A' ' 3' ' ' THR . 0.0 OUTLIER -55.35 -61.96 5.2 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.221 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.96 126.85 15.88 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.138 1.892 . . . . 0.0 111.638 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 1.365 HG22 ' CG ' ' A' ' 41' ' ' PRO . 6.3 p -163.19 156.22 2.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.561 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 1.036 ' CA ' ' HB3' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -149.19 140.71 23.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.237 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.502 ' N ' ' CB ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -70.3 -72.31 0.21 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.471 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.672 ' HG ' ' H ' ' A' ' 9' ' ' ARG . 5.0 t -118.18 -144.58 0.37 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.344 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.672 ' H ' ' HG ' ' A' ' 8' ' ' SER . 27.5 ptt-85 -142.46 -52.6 0.4 Allowed 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -40.0 -25.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.172 0.51 . . . . 0.0 110.714 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 9' ' ' ARG . 13.0 m -82.98 -39.4 21.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.925 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -82.35 8.05 12.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.027 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mp -109.01 -35.68 6.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.224 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -85.11 -27.25 26.39 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.7 mt -63.28 -14.95 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.405 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.4 -16.45 27.37 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.419 ' N ' ' CD2' ' A' ' 17' ' ' LEU . 4.0 mm? -72.68 -30.71 64.47 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.9 -41.34 70.82 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.921 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -44.24 -36.37 2.69 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.407 ' C ' ' H ' ' A' ' 22' ' ' LEU . 71.0 ttt180 -66.98 -42.37 85.22 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.469 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -57.57 -8.07 0.78 Allowed 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.259 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.407 ' H ' ' C ' ' A' ' 20' ' ' ARG . 21.1 mt -113.05 147.22 36.79 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.299 -178.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.8 -73.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.168 1.912 . . . . 0.0 112.828 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -119.22 43.47 1.57 Allowed Glycine 0 N--CA 1.471 0.979 0 C-N-CA 121.503 -0.379 . . . . 0.0 112.222 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.2 m -117.89 132.88 56.37 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.869 0.334 . . . . 0.0 110.244 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.411 ' H ' ' HG1' ' A' ' 26' ' ' THR . 0.0 OUTLIER -83.45 169.14 15.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.183 0.516 . . . . 0.0 110.568 -179.685 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.9 t -60.85 -59.57 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.169 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.59 9.6 5.92 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.532 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -99.51 -12.2 20.37 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.753 0.776 . . . . 0.0 110.764 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 pp -98.15 -16.13 19.64 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.351 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 33' ' ' ILE . 1.6 tt -110.35 -58.31 2.09 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.837 0.351 . . . . 0.0 110.765 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -36.9 -26.18 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.768 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.539 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 1.4 mp -66.87 -47.86 81.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 31' ' ' LEU . 9.4 tp -67.46 -57.44 6.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.689 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.578 ' HD1' ' N ' ' A' ' 36' ' ' GLN . 2.0 t-80 46.37 -120.71 1.03 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.855 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.578 ' N ' ' HD1' ' A' ' 35' ' ' HIS . 51.1 tt0 58.26 -79.51 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 35' ' ' HIS . 5.9 tpp180 -57.37 138.81 54.48 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 40' ' ' GLY . 18.3 tt -159.91 -14.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.829 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -45.42 90.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.74 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 38' ' ' ILE . . . 76.37 -177.52 50.88 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 1.365 ' CG ' HG22 ' A' ' 5' ' ' VAL . 60.1 Cg_exo -50.0 124.1 12.04 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.602 2.201 . . . . 0.0 112.038 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.469 ' N ' ' CD2' ' A' ' 42' ' ' LEU . 3.7 mm? -58.02 99.25 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 p -79.86 177.99 8.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.058 0.456 . . . . 0.0 111.19 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -68.92 -23.23 64.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.41 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.513 ' HA ' HE21 ' A' ' 48' ' ' GLN . 61.2 tt0 -71.99 -40.17 68.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.335 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.0 t -54.36 -38.87 66.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.363 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 49' ' ' GLY . 10.2 mt -66.28 -47.28 74.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.74 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.513 HE21 ' HA ' ' A' ' 45' ' ' GLU . 32.7 mt-30 -66.85 69.97 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.437 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -151.95 3.14 0.39 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.17 174.26 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.478 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 52.9 m -115.09 163.53 15.48 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 t -56.46 -42.14 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 O-C-N 123.265 0.353 . . . . 0.0 111.404 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.4 m -57.39 -25.41 59.47 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -74.44 -32.15 62.52 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.083 0.468 . . . . 0.0 110.956 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.541 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 5.7 mp -64.25 -65.59 0.66 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.503 -177.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -52.67 -37.42 58.73 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 61' ' ' GLY . 10.3 pt -79.34 -18.11 12.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.51 -41.77 96.06 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.41 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.0 mm? -73.64 -57.12 4.21 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.031 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.99 88.13 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 104.95 -34.42 5.81 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.527 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.553 ' C ' ' H ' ' A' ' 64' ' ' GLU . 22.6 t -137.24 129.6 29.69 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.106 0.479 . . . . 0.0 111.405 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -59.17 1.81 0.07 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.902 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.553 ' H ' ' C ' ' A' ' 62' ' ' SER . 42.7 mt-10 -83.02 -47.75 11.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.781 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -92.78 -7.44 46.5 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.6 m -55.72 -17.72 3.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.864 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -53.22 -31.88 45.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.286 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.8 ptm -100.27 -21.0 15.63 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 71' ' ' THR . 27.5 tp -52.17 124.09 12.21 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.256 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -41.14 -23.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.07 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 69' ' ' LEU . 2.2 m -74.73 117.94 66.34 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.954 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.41 -104.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.892 1.728 . . . . 0.0 111.785 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.471 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 31.8 ttp -153.95 1.79 0.24 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.997 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.9 m -108.27 -18.77 13.68 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.784 0.326 . . . . 0.0 110.197 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.35 -34.04 70.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.619 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.542 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -64.0 -45.92 86.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.033 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.471 ' CE ' ' O ' ' A' ' 73' ' ' MET . 1.8 mptp? -56.22 -37.83 70.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.37 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -66.75 -56.92 8.31 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.432 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -63.92 -64.27 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.677 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 76' ' ' LEU . 1.8 p -35.11 -27.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.112 0.482 . . . . 0.0 111.42 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 79' ' ' ALA . 52.6 ttm-85 -75.57 -58.92 2.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.111 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 50.1 mt -45.83 -41.71 3.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.821 -1.082 . . . . 0.0 112.656 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -79.77 -33.0 40.99 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.628 179.588 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -50.2 -21.55 1.38 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.869 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.51 17.4 55.05 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 88' ' ' GLU . 68.5 mt-10 -112.82 2.56 16.0 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -31.68 -34.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.849 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 86' ' ' GLU . 3.6 pt-20 -58.66 -105.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.686 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.406 ' H ' ' CG ' ' A' ' 88' ' ' GLU . 16.0 m -56.2 140.98 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.603 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -85.47 -143.33 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.703 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.2 m -63.34 -139.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.797 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.562 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 3.0 mm? -82.45 150.4 63.41 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.17 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.34 -165.51 0.22 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.259 1.973 . . . . 0.0 112.044 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -60.58 132.89 91.28 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.2 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.94 96.31 1.01 Allowed 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.917 1.744 . . . . 0.0 111.858 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 25.6 m . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.529 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.9 mtt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.0 t -76.23 -36.97 31.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.64 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.5 m -155.76 74.15 5.19 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.541 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -50.81 -64.19 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.498 2.132 . . . . 0.0 111.578 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.4 p -173.7 146.02 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.001 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -140.24 -85.96 0.21 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.659 0.266 . . . . 0.0 110.632 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 85.7 mtp -47.05 151.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.87 0.367 . . . . 0.0 110.506 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.4 t -63.2 -149.36 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.642 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 11' ' ' THR . 5.7 ptm85 -136.79 -59.47 0.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.438 ' H ' ' CG ' ' A' ' 9' ' ' ARG . 10.9 pt-20 -39.8 -24.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.157 0.503 . . . . 0.0 110.489 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 9' ' ' ARG . 23.4 m -81.52 -52.53 7.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.445 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -68.51 4.75 1.24 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.508 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.505 ' H ' ' C ' ' A' ' 11' ' ' THR . 3.1 mp -109.12 -41.7 4.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.248 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 -88.26 -34.06 17.86 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.2 mp -62.54 -11.36 6.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.38 -16.41 22.36 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.7 -29.01 66.33 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.62 -46.25 73.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.873 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -41.87 -36.07 0.98 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' A' ' 22' ' ' LEU . 36.9 ttt180 -65.61 -43.14 90.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.743 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.35 -6.9 0.74 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.745 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' A' ' 20' ' ' ARG . 11.7 mt -117.94 121.61 31.39 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.57 72.77 6.35 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.781 1.654 . . . . 0.0 112.604 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.83 -53.33 0.68 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.7 m -59.23 132.42 53.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.006 0.432 . . . . 0.0 111.491 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.85 173.82 9.16 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.359 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.3 t -61.61 -59.64 3.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.697 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.66 6.71 8.19 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.53 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.445 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 57.5 mt-30 -97.1 -22.81 16.55 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 117.86 0.83 . . . . 0.0 110.084 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.0 tp -90.2 -19.75 23.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.836 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 33' ' ' ILE . 10.9 mp -100.16 -50.33 4.0 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.897 0.379 . . . . 0.0 110.408 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -44.71 -15.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.053 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 31' ' ' LEU . 7.2 pt -71.78 -39.86 68.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.742 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 36' ' ' GLN . 14.2 mt -91.98 9.25 33.93 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.781 0.324 . . . . 0.0 110.461 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -44.5 89.82 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.887 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 34' ' ' LEU . 49.9 tt0 -171.05 137.66 1.2 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.577 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.422 ' O ' ' CD2' ' A' ' 42' ' ' LEU . 0.6 OUTLIER 56.8 36.7 28.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.758 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.716 ' HA ' HD22 ' A' ' 42' ' ' LEU . 14.4 pt -88.06 -38.03 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.712 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -46.9 99.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 0.0 110.538 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.9 179.9 28.81 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.58 46.43 1.22 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.699 2.266 . . . . 0.0 111.66 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.716 HD22 ' HA ' ' A' ' 38' ' ' ILE . 9.6 mp -80.67 121.66 26.14 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.596 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.36 -175.86 2.78 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.515 ' O ' ' NE2' ' A' ' 48' ' ' GLN . 22.1 pt-20 -49.45 -36.68 23.24 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -56.95 -36.49 70.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.358 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.449 ' HG ' ' N ' ' A' ' 47' ' ' LEU . 24.7 p -65.13 -29.4 70.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.779 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 49' ' ' GLY . 10.3 mp -71.59 -31.58 67.1 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 110.576 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.67 ' NE2' ' N ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -62.06 72.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.359 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -152.76 11.61 0.61 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 51' ' ' SER . 0.3 OUTLIER -126.91 175.07 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.472 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 49.1 m -113.79 161.97 16.9 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 t -55.52 -43.46 72.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 123.196 0.31 . . . . 0.0 110.999 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.3 m -57.37 -23.95 52.27 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 16.6 t0 -75.7 -31.32 59.63 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.016 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.541 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 5.9 mp -65.31 -65.9 0.61 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.489 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -52.79 -34.98 55.88 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.8 pt -80.19 -19.78 12.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.23 -37.79 91.33 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.711 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.45 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.4 mm? -75.98 -52.61 9.88 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.284 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.66 -33.38 64.45 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.464 -0.494 . . . . 0.0 109.803 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 83.42 -9.24 62.08 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.104 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.582 ' C ' ' H ' ' A' ' 64' ' ' GLU . 3.9 t -137.75 104.24 5.24 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.924 0.392 . . . . 0.0 111.819 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -56.51 -1.24 0.05 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.701 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.582 ' H ' ' C ' ' A' ' 62' ' ' SER . 36.2 mt-10 -91.51 -41.37 10.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.3 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -92.45 -13.0 30.62 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 m -46.79 -29.8 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.622 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -52.92 -30.69 35.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.919 0.39 . . . . 0.0 110.234 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 13.2 mmt -83.96 -31.08 25.74 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.92 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.485 ' O ' ' N ' ' A' ' 71' ' ' THR . 29.7 tp -49.56 122.4 6.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.283 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 51.2 t0 -39.69 -24.9 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.021 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.485 ' N ' ' O ' ' A' ' 69' ' ' LEU . 2.8 m -65.05 122.08 77.65 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.016 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -74.71 -86.74 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.644 1.563 . . . . 0.0 112.281 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -172.13 -23.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.676 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.6 p -89.34 -14.59 35.33 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.89 -33.7 72.56 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.4 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.598 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 1.5 mm? -65.25 -47.69 75.87 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.214 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.47 ' CD ' ' N ' ' A' ' 77' ' ' LYS . 1.8 mptp? -57.95 -34.4 69.86 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.82 -58.67 3.85 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.895 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.604 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.31 -64.64 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.29 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.5 p -34.72 -23.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.961 0.41 . . . . 0.0 111.653 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.604 ' N ' ' O ' ' A' ' 79' ' ' ALA . 46.9 ttm-85 -78.71 -58.22 3.36 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.456 0.646 . . . . 0.0 109.617 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 79' ' ' ALA . 43.4 mt -47.7 -42.06 8.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.988 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.539 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -76.7 -36.65 57.1 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.564 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -48.88 -18.07 0.25 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.795 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.448 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 85.01 18.7 60.61 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 88' ' ' GLU . 24.3 tt0 -112.44 2.93 16.6 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -30.32 -34.96 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.874 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 86' ' ' GLU . 41.9 mt-10 -47.24 114.29 0.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.677 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 91' ' ' SER . 3.9 t -60.63 -11.13 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.641 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -61.49 73.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.461 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 89' ' ' VAL . 69.0 m -75.02 -170.19 1.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.6 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.546 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 3.1 mm? -79.73 150.16 72.2 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.793 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.4 179.23 4.74 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.192 1.928 . . . . 0.0 111.887 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -74.02 150.57 88.07 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.314 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -37.88 149.97 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.265 0 C-N-CA 122.149 1.899 . . . . 0.0 112.156 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.527 179.854 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.0 mtt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.4 t -81.27 86.29 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.933 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -159.91 151.19 16.19 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.737 -179.536 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 3' ' ' THR . 77.6 Cg_exo -38.11 163.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 122.38 2.053 . . . . 0.0 112.391 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 t -82.1 105.35 11.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.344 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -136.9 164.31 28.61 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.962 0.41 . . . . 0.0 110.371 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.53 145.29 52.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.661 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.23 133.72 52.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.593 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 11' ' ' THR . 7.4 ptt180 -69.64 -38.08 77.04 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -41.78 -22.45 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.257 0.551 . . . . 0.0 110.198 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.545 ' C ' ' H ' ' A' ' 13' ' ' LEU . 8.3 m -83.86 -49.33 9.13 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -66.36 2.34 1.27 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.132 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.545 ' H ' ' C ' ' A' ' 11' ' ' THR . 3.6 mp -111.07 -41.38 4.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.025 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 50.4 ttm-85 -86.04 -38.35 17.95 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.35 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.417 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 1.4 mp -65.29 -7.16 4.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.173 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.54 -18.91 21.72 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.74 0.305 . . . . 0.0 110.493 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -70.15 -30.35 67.49 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -57.87 -41.44 82.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.408 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 18' ' ' ALA . . . -41.28 -33.97 0.44 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.499 ' C ' ' H ' ' A' ' 22' ' ' LEU . 86.5 mtt180 -67.93 -42.24 81.33 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.224 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -57.88 -5.19 0.38 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.424 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.499 ' H ' ' C ' ' A' ' 20' ' ' ARG . 19.3 mt -115.07 148.61 40.97 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.056 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.83 -92.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.219 1.946 . . . . 0.0 112.401 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.28 46.51 1.28 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.7 m -118.21 141.73 48.2 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.827 0.346 . . . . 0.0 110.387 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.67 159.4 15.01 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.232 0.539 . . . . 0.0 110.393 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.5 t -54.84 -51.9 47.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.124 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.01 3.57 56.99 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.11 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -89.22 -20.27 24.37 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 117.597 0.699 . . . . 0.0 109.836 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.5 -27.25 15.47 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.617 0.246 . . . . 0.0 110.523 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 33' ' ' ILE . 24.7 mt -83.01 -41.19 18.99 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.876 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.4 ' C ' ' N ' ' A' ' 34' ' ' LEU . 10.4 pt-20 -48.47 -13.36 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.826 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.482 ' H ' ' C ' ' A' ' 31' ' ' LEU . 10.1 tt -49.33 -16.9 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.609 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 35' ' ' HIS . 96.7 mt -61.86 -94.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.519 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.446 ' N ' ' HD1' ' A' ' 35' ' ' HIS . 0.3 OUTLIER 47.73 98.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.487 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' A' ' 37' ' ' ARG . 6.2 pt20 -177.12 33.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.948 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 36' ' ' GLN . 69.1 mtt-85 54.74 165.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.78 0.324 . . . . 0.0 110.543 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.7 mt 40.04 71.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.921 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.479 ' CD ' ' H ' ' A' ' 39' ' ' GLU . 1.0 OUTLIER -80.56 112.55 18.02 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.853 0.358 . . . . 0.0 110.097 179.687 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.17 -178.13 45.9 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.32 174.53 12.35 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.62 2.213 . . . . 0.0 111.974 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.566 ' N ' ' CD2' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -166.57 133.22 2.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.599 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.489 ' N ' ' OG ' ' A' ' 46' ' ' SER . 1.1 p -128.97 -176.52 3.88 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.559 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.548 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 1.8 pm0 -50.61 -26.48 5.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.651 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.452 ' CG ' ' N ' ' A' ' 46' ' ' SER . 10.2 pt-20 -86.3 -43.38 12.96 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.933 0.397 . . . . 0.0 111.223 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.489 ' OG ' ' N ' ' A' ' 43' ' ' THR . 87.7 p -54.0 -45.71 71.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.264 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.4 mp -56.96 -33.2 66.81 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.379 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -69.56 67.27 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.852 0.358 . . . . 0.0 110.424 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.71 11.15 0.36 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.77 171.78 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.47 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 31.6 m -113.66 161.72 17.12 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.07 -38.11 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 120.872 0.367 . . . . 0.0 110.415 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.6 m -59.18 -26.89 65.19 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -75.09 -30.53 60.94 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.974 0.416 . . . . 0.0 111.041 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.551 HD13 ' H ' ' A' ' 55' ' ' LEU . 5.0 mp -67.05 -62.79 1.26 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.197 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -54.01 -35.0 61.43 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.9 pt -78.96 -19.46 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.285 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.76 -33.5 84.42 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.1 mm? -77.55 -54.79 5.98 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 116.873 0.337 . . . . 0.0 110.944 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.39 -32.4 62.69 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.967 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 80.0 -4.36 66.63 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.556 ' C ' ' H ' ' A' ' 64' ' ' GLU . 13.0 t -137.12 97.53 3.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.008 0.432 . . . . 0.0 111.45 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -53.45 -6.16 0.07 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.258 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.556 ' H ' ' C ' ' A' ' 62' ' ' SER . 20.2 tp10 -86.31 -41.11 14.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.409 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -92.74 -14.77 27.49 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.7 m -49.1 -21.41 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 119.816 -0.753 . . . . 0.0 110.518 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -53.93 -34.46 59.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.226 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.5 ptp -92.59 -24.29 18.75 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.222 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.473 ' CD2' ' OG1' ' A' ' 71' ' ' THR . 21.9 tp -49.46 121.62 5.27 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -35.97 -30.26 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.598 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.473 ' OG1' ' CD2' ' A' ' 69' ' ' LEU . 2.1 m -48.92 114.46 3.77 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.578 ' C ' ' H ' ' A' ' 74' ' ' SER . 93.8 Cg_endo -80.45 19.85 1.03 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.168 1.912 . . . . 0.0 113.148 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.435 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 34.2 ttm 65.91 -12.89 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.825 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.578 ' H ' ' C ' ' A' ' 72' ' ' PRO . 30.1 t -96.49 -14.19 22.51 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.04 0.448 . . . . 0.0 110.053 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.13 -30.13 60.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.414 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.444 HD21 ' H ' ' A' ' 76' ' ' LEU . 0.7 OUTLIER -65.55 -53.15 46.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.592 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -46.66 -38.01 9.12 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.179 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -70.51 -58.24 3.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.068 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.587 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -62.72 -61.31 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.594 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 76' ' ' LEU . 2.8 p -34.85 -24.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.992 0.425 . . . . 0.0 111.745 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 79' ' ' ALA . 24.1 ttm180 -79.22 -55.7 4.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.549 0.69 . . . . 0.0 109.654 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.431 ' N ' ' O ' ' A' ' 79' ' ' ALA . 41.5 mt -49.62 -43.49 18.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.973 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.547 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -74.25 -38.07 63.58 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.484 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -45.47 -19.48 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.859 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 83' ' ' LEU . . . 83.46 14.85 72.75 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 87' ' ' ALA . 94.4 mt-10 -110.7 3.82 19.54 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -28.28 -46.19 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.839 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.444 ' C ' ' H ' ' A' ' 90' ' ' ASP . 65.2 mm-40 -49.15 167.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.126 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.491 ' C ' ' H ' ' A' ' 91' ' ' SER . 16.9 m -77.94 36.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.593 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 88' ' ' GLU . 28.4 t70 -74.18 39.54 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.464 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.491 ' H ' ' C ' ' A' ' 89' ' ' VAL . 83.5 p -73.21 -149.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.567 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.549 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 3.1 mm? -77.18 150.31 80.38 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.899 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -36.96 -36.1 0.25 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.285 1.99 . . . . 0.0 112.3 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -70.6 151.05 95.51 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.081 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -72.27 176.92 7.91 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.232 1.955 . . . . 0.0 111.793 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 t . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.643 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 mtt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.4 m -56.79 -15.77 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.393 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 40.2 p -40.6 104.46 0.34 Allowed Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.861 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -44.86 106.07 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.896 1.73 . . . . 0.0 111.964 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.6 m -51.12 172.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.827 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.457 ' OD1' ' SD ' ' A' ' 7' ' ' MET . 0.7 OUTLIER -155.98 -45.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.157 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.457 ' SD ' ' OD1' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -75.04 -178.33 3.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.3 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.2 m -69.28 -148.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.672 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 56.8 ttt-85 -148.3 -30.32 0.29 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.32 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.525 ' H ' ' CD ' ' A' ' 10' ' ' GLU . 1.4 pm0 -101.3 -31.4 10.99 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 14' ' ' ARG . 8.8 m -78.46 -62.59 1.63 Allowed 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 11' ' ' THR . . . -28.84 -50.77 0.09 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.358 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.551 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 3.8 mp -53.31 -42.88 67.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.028 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 11' ' ' THR . 36.4 ttt180 -47.01 -46.54 21.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.009 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.517 ' CD1' ' N ' ' A' ' 15' ' ' ILE . 1.5 mp -63.84 -7.65 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.2 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -97.71 -15.66 20.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.275 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.01 -28.75 61.59 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -57.4 -41.98 81.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.959 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -42.67 -36.79 1.52 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.926 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.439 ' C ' ' H ' ' A' ' 22' ' ' LEU . 75.0 ttt180 -64.38 -39.17 93.34 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -60.05 -6.19 1.28 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.47 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.439 ' H ' ' C ' ' A' ' 20' ' ' ARG . 10.6 mt -121.47 109.24 34.85 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.141 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.16 66.89 7.73 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.917 1.745 . . . . 0.0 112.412 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.67 -11.68 0.45 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.001 -0.619 . . . . 0.0 111.841 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 m -113.81 137.31 51.82 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.955 0.407 . . . . 0.0 111.08 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.67 ' H ' HE21 ' A' ' 29' ' ' GLN . 0.1 OUTLIER -87.97 170.72 10.88 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.314 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.6 t -60.45 -59.69 3.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.184 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.432 ' O ' ' OE1' ' A' ' 32' ' ' GLU . . . -72.16 11.11 4.02 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.364 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.67 HE21 ' H ' ' A' ' 26' ' ' THR . 18.2 mt-30 -98.87 -10.0 23.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.714 0.757 . . . . 0.0 110.487 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 pp -107.57 -19.18 13.64 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.535 ' C ' ' H ' ' A' ' 33' ' ' ILE . 2.3 tt -91.63 -47.68 7.26 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.759 0.314 . . . . 0.0 111.631 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.561 ' N ' ' OE1' ' A' ' 32' ' ' GLU . 4.4 pm0 -47.08 -10.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.473 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.535 ' H ' ' C ' ' A' ' 31' ' ' LEU . 37.4 mm -77.79 -60.25 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.837 0.351 . . . . 0.0 110.366 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.548 ' O ' ' CD2' ' A' ' 35' ' ' HIS . 9.7 mp -48.8 -54.4 15.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.868 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.548 ' CD2' ' O ' ' A' ' 34' ' ' LEU . 1.3 p80 57.9 142.0 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.4 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -167.84 143.73 3.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.623 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -159.49 88.4 0.86 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.814 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.6 tt -175.97 -33.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.397 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -82.47 -106.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.283 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.14 -76.83 0.1 OUTLIER Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.61 103.49 1.76 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.652 2.235 . . . . 0.0 112.023 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.3 mt -85.38 69.14 10.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.04 0.448 . . . . 0.0 110.138 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.8 p -68.3 172.68 5.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.477 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -55.05 -23.7 21.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.67 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -75.62 -35.42 60.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.494 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.1 p -54.81 -32.14 59.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.149 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.495 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 3.8 mm? -64.64 -22.88 67.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.774 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -76.18 75.63 3.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.69 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.36 6.48 0.49 Allowed Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.412 HG21 ' H ' ' A' ' 51' ' ' SER . 0.3 OUTLIER -134.69 175.85 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 117.068 0.434 . . . . 0.0 110.428 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.49 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 24.0 m -111.62 164.55 12.88 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.9 t -58.25 -43.98 87.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.645 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.3 m -55.98 -25.35 43.61 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -74.85 -30.56 61.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.954 0.407 . . . . 0.0 111.468 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.529 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 6.2 mp -65.3 -64.0 0.97 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -177.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -53.66 -36.45 62.14 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 61' ' ' GLY . 8.1 pt -80.35 -21.03 11.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.97 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.75 -33.01 83.72 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.528 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 1.8 mm? -80.26 -54.73 5.46 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.42 -29.54 41.98 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.882 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 75.0 2.85 66.65 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.438 -0.887 . . . . 0.0 110.982 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 64' ' ' GLU . 9.1 t -136.37 86.78 2.25 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.886 0.374 . . . . 0.0 111.253 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -49.08 -11.23 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.72 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.524 ' H ' ' C ' ' A' ' 62' ' ' SER . 25.3 tt0 -86.07 -35.71 20.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.512 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -98.27 -14.46 20.25 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.9 m -50.16 -25.83 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.475 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -52.31 -14.44 0.46 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.589 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 67.3 mtt -104.25 -22.21 13.41 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.67 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.8 tp -51.97 120.26 5.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.2 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 44.5 t0 -39.94 -33.13 0.19 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.194 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.9 m -60.7 119.65 45.98 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.071 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.71 -156.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 121.143 1.228 . . . . 0.0 111.348 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 8.8 ptm -106.8 -16.17 14.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.789 0.328 . . . . 0.0 111.147 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.7 m -92.76 -25.17 18.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.486 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.25 -33.12 73.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.371 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.52 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 1.2 mm? -64.95 -45.62 84.98 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.303 -0.959 . . . . 0.0 108.958 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.465 ' CD ' ' N ' ' A' ' 77' ' ' LYS . 2.1 mptp? -59.97 -34.74 73.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.547 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -66.4 -58.8 4.51 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.708 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.49 -65.12 0.74 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.455 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.409 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.5 p -34.88 -27.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.05 0.452 . . . . 0.0 111.419 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.556 ' N ' ' O ' ' A' ' 79' ' ' ALA . 45.5 ttm-85 -77.3 -58.71 3.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.815 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 82' ' ' ILE . 41.9 mt -45.01 -41.64 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.291 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.575 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -78.03 -35.62 49.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.64 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -51.44 -14.9 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.646 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.443 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 81.08 19.37 67.33 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 87' ' ' ALA . 8.0 tp10 -113.0 7.63 18.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -33.6 -57.11 0.44 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.494 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -53.3 140.3 27.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.521 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.8 p -83.2 142.36 13.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.608 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.08 -98.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.62 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.5 t -63.12 179.35 0.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.604 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 3.0 mm? -78.01 150.13 77.59 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.721 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.5 123.22 9.66 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.065 1.843 . . . . 0.0 111.798 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -74.37 151.74 87.69 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.252 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.77 164.78 34.57 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.211 1.941 . . . . 0.0 111.873 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.577 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.3 p -75.78 151.84 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.584 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.4 p -63.0 150.32 88.51 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.442 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.2 73.31 3.25 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.144 1.896 . . . . 0.0 111.781 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.506 ' C ' ' H ' ' A' ' 7' ' ' MET . 16.2 m -61.31 -169.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.595 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.6 t30 55.15 7.22 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.493 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.506 ' H ' ' C ' ' A' ' 5' ' ' VAL . 18.2 ttm -172.59 60.33 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.405 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.0 m -82.45 148.53 28.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.537 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' A' ' 12' ' ' ALA . 4.2 ptp180 -65.54 -41.77 92.69 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.319 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -41.73 -27.42 0.11 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.924 0.393 . . . . 0.0 110.774 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.403 ' N ' ' O ' ' A' ' 9' ' ' ARG . 87.9 m -83.59 -37.08 23.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.327 0.584 . . . . 0.0 109.53 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -82.78 8.44 12.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.265 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 mp -109.66 -35.47 6.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.176 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -82.07 -28.81 32.19 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.1 mt -64.3 -19.2 24.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.248 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.47 -17.94 27.7 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.337 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.3 -30.82 66.7 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.5 -43.76 75.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.13 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 18' ' ' ALA . . . -41.04 -37.36 0.82 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.524 ' C ' ' H ' ' A' ' 22' ' ' LEU . 66.2 mtp180 -68.39 -42.48 79.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.283 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.6 -5.76 0.25 Allowed 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.968 0.413 . . . . 0.0 110.275 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.524 ' H ' ' C ' ' A' ' 20' ' ' ARG . 13.9 mt -119.21 122.43 29.52 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.398 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -79.13 79.42 3.39 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.712 1.608 . . . . 0.0 112.75 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 130.17 -52.27 0.83 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.8 m -55.35 137.97 46.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.987 0.422 . . . . 0.0 111.435 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.61 171.68 9.51 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.72 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.2 t -60.25 -59.15 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.438 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.29 6.94 9.07 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.241 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 1.091 ' NE2' ' OE2' ' A' ' 32' ' ' GLU . 1.0 OUTLIER -96.93 -20.83 17.83 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 117.283 0.542 . . . . 0.0 110.182 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 pp -90.78 -20.89 21.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.548 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -91.72 -39.13 11.99 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.619 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 1.091 ' OE2' ' NE2' ' A' ' 29' ' ' GLN . 16.3 pt-20 -35.25 -25.67 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.999 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.55 ' N ' ' O ' ' A' ' 31' ' ' LEU . 78.7 mt -49.61 -36.22 10.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.684 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.7 tp -83.39 -7.28 59.59 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.941 0.4 . . . . 0.0 110.292 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.414 ' N ' ' O ' ' A' ' 32' ' ' GLU . 14.6 m-70 58.58 102.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.099 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -82.08 19.12 1.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.817 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.402 ' H ' ' C ' ' A' ' 35' ' ' HIS . 52.5 ttm-85 -49.54 -75.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.774 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.4 tt -90.15 136.72 23.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.396 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -48.24 130.25 15.97 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -153.64 -167.09 15.45 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -46.15 174.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.669 2.246 . . . . 0.0 112.164 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.6 tp -172.16 53.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.803 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 35.8 p -120.28 172.91 7.46 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.123 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.89 -25.97 40.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.042 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -78.31 -37.75 43.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.0 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.3 t -53.91 -39.65 66.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.639 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 49' ' ' GLY . 0.2 OUTLIER -64.79 -40.52 95.37 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.393 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 84' ' ' TRP . 76.2 mt-30 -62.0 70.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.669 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -154.66 9.49 0.39 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.77 175.76 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.433 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 37.0 m -116.57 162.66 17.27 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 t -54.29 -47.83 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 123.254 0.347 . . . . 0.0 110.857 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -52.89 -25.27 11.16 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 116.365 -0.38 . . . . 0.0 112.003 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -75.43 -31.95 60.52 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.018 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.527 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 5.9 mp -66.38 -63.75 1.01 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.227 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -52.87 -34.77 56.01 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.9 pt -80.31 -19.92 11.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.022 0.439 . . . . 0.0 109.834 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.29 -38.5 91.59 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.423 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.4 mm? -76.61 -54.57 6.49 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 120.645 -0.422 . . . . 0.0 109.999 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.72 -35.06 79.23 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 118.53 -53.79 0.65 Allowed Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.673 ' C ' ' H ' ' A' ' 64' ' ' GLU . 26.8 t -140.05 152.69 46.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.995 0.426 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.34 20.89 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.891 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.673 ' H ' ' C ' ' A' ' 62' ' ' SER . 60.8 mt-10 -97.34 -59.8 1.71 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.694 0.283 . . . . 0.0 110.886 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.41 ' OD1' ' CG ' ' A' ' 68' ' ' MET . 12.4 t0 -82.45 -11.91 58.2 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 m -51.92 -28.35 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.13 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -55.92 -24.15 36.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.541 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.41 ' CG ' ' OD1' ' A' ' 65' ' ' ASP . 8.1 mmt -93.75 -36.63 12.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.521 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 71' ' ' THR . 12.7 tp -48.85 115.98 1.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.4 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -43.74 -16.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.773 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 69' ' ' LEU . 2.8 m -51.58 116.17 7.45 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.562 ' C ' ' H ' ' A' ' 74' ' ' SER . 93.0 Cg_endo -79.58 20.29 0.88 Allowed 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.319 2.013 . . . . 0.0 113.655 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 18.7 ttm 66.13 -13.42 0.16 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.633 0.254 . . . . 0.0 111.2 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.562 ' H ' ' C ' ' A' ' 72' ' ' PRO . 5.7 t -96.91 -13.6 22.32 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.063 0.459 . . . . 0.0 109.933 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -73.3 -31.53 64.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.904 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.455 HD21 ' H ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -67.69 -59.15 3.55 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -52.82 -15.92 0.87 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.252 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 74' ' ' SER . 8.2 m-20 -86.33 -51.96 5.92 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -69.34 -56.35 7.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.439 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.419 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.2 p -35.73 -26.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.297 0.57 . . . . 0.0 111.048 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.55 ' N ' ' O ' ' A' ' 79' ' ' ALA . 40.3 ttm-85 -76.52 -55.35 5.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.925 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 79' ' ' ALA . 53.2 mt -49.95 -42.78 19.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.463 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.568 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -79.13 -32.9 44.62 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.755 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.508 ' O ' ' NE2' ' A' ' 48' ' ' GLN . 0.6 OUTLIER -46.85 -29.64 2.08 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.44 14.9 39.65 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 88' ' ' GLU . 1.1 mp0 -110.74 0.65 17.45 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -33.07 -33.42 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.478 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 86' ' ' GLU . 56.8 mm-40 -47.46 -45.26 25.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.9 t -59.74 109.84 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.466 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -79.59 148.58 31.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.649 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.2 m -71.97 -143.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.458 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.554 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 3.1 mm? -86.48 149.94 50.23 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.947 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.03 35.97 0.36 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.159 1.906 . . . . 0.0 111.843 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.446 ' H ' ' C ' ' A' ' 92' ' ' LEU . 6.6 pt20 -66.43 151.3 96.28 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.277 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.3 128.78 15.05 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.195 1.93 . . . . 0.0 111.866 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.6 m . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.511 -179.98 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 ptt? . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.5 t -80.72 101.28 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.568 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.5 m -160.66 60.33 1.32 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.708 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -76.7 92.62 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.777 2.318 . . . . 0.0 111.831 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.5 p -161.15 -18.95 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.598 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.494 ' CG ' ' H ' ' A' ' 7' ' ' MET . 8.8 t-20 -157.05 -176.8 6.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.859 0.362 . . . . 0.0 110.718 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.494 ' H ' ' CG ' ' A' ' 6' ' ' ASN . 3.1 ttt -161.93 -135.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.466 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.453 ' H ' ' CG ' ' A' ' 7' ' ' MET . 48.1 t -86.7 138.14 31.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.331 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 12' ' ' ALA . 10.4 ptt180 -51.92 -56.12 16.05 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.075 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.436 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 14.2 pt-20 -44.36 -34.64 2.05 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 83.4 m -72.0 -19.71 61.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.339 0.59 . . . . 0.0 109.877 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -91.39 -72.15 0.6 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.236 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.58 ' H ' ' CD2' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -39.83 -55.54 1.95 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.451 -178.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.458 ' O ' ' CG2' ' A' ' 82' ' ' ILE . 94.5 mtt-85 -42.59 -41.25 2.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.5 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.4 mm -64.44 -24.01 34.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.552 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.98 -18.76 20.01 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.99 -31.0 70.4 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -58.02 -41.53 83.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.779 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -42.38 -37.46 1.57 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.015 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.9 mtt-85 -64.06 -38.66 91.86 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.026 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.98 -7.2 0.98 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.332 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 25.3 mt -112.96 146.86 35.98 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -39.19 -71.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.196 1.931 . . . . 0.0 112.206 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -140.51 4.71 2.54 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.3 m -57.38 137.33 56.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.46 162.9 20.81 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.094 0.473 . . . . 0.0 110.806 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.1 t -61.04 -55.74 22.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.83 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.15 13.34 2.7 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.087 -0.577 . . . . 0.0 112.654 -178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -97.66 -19.31 18.36 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.018 0.909 . . . . 0.0 111.954 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.91 -17.53 20.07 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.988 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 3.0 mm? -96.3 -49.13 5.33 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.163 0.438 . . . . 0.0 110.624 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -35.48 -28.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.303 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 31' ' ' LEU . 14.4 tt -76.17 -51.57 19.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.516 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 pp -87.6 -4.92 58.94 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.74 0.305 . . . . 0.0 110.728 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 1.083 ' HE1' HD23 ' A' ' 42' ' ' LEU . 25.6 t60 -132.85 105.47 7.15 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.564 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -140.12 137.59 34.6 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.301 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 39' ' ' GLU . 39.8 mmm-85 52.69 -159.25 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.297 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' A' ' 39' ' ' GLU . 66.7 mt 57.34 -83.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.168 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 37' ' ' ARG . 35.7 mt-10 60.15 124.04 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.225 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.2 -65.45 0.13 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.89 -71.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.52 2.146 . . . . 0.0 112.082 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 1.083 HD23 ' HE1' ' A' ' 35' ' ' HIS . 6.4 mt 47.83 29.32 1.58 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.363 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.3 p -76.05 170.03 17.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.989 0.423 . . . . 0.0 111.014 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -68.29 -22.09 64.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.965 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -85.97 -30.98 22.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.639 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.0 p -56.26 -45.89 79.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 10.2 mp -64.15 -22.24 66.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.8 0.333 . . . . 0.0 110.481 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -81.93 65.03 6.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.935 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.13 3.15 0.76 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.52 172.73 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.453 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 60.6 m -115.43 162.28 17.38 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 t -55.41 -42.2 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 120.67 0.272 . . . . 0.0 111.058 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.3 m -58.11 -23.93 56.74 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.26 -31.98 60.94 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.995 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.542 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 5.5 mp -64.67 -65.86 0.62 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.533 -177.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -53.24 -36.13 60.72 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.538 ' O ' ' N ' ' A' ' 61' ' ' GLY . 11.6 pt -79.18 -19.02 12.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.188 0.518 . . . . 0.0 109.713 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.96 -40.02 95.14 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.011 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 1.8 mm? -75.81 -53.09 9.02 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.283 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.26 -37.03 74.82 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 119.93 -53.24 0.69 Allowed Glycine 0 N--CA 1.465 0.61 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.612 ' C ' ' H ' ' A' ' 64' ' ' GLU . 2.5 t -137.54 147.38 45.1 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.98 0.419 . . . . 0.0 110.864 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -59.99 7.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.485 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.612 ' H ' ' C ' ' A' ' 62' ' ' SER . 53.2 mm-40 -81.5 -52.51 7.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.434 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -96.79 -7.27 34.14 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.3 m -47.36 -31.32 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.786 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -52.38 -33.29 42.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 0.0 110.235 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 17.2 mtt -80.6 -21.19 41.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.395 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.0 tp -65.41 122.4 17.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.499 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -47.09 -20.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.336 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.1 m -58.12 124.46 70.29 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.59 -86.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.532 1.488 . . . . 0.0 111.976 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 18.1 ptt? -173.59 -28.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.051 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.4 m -86.05 -17.97 33.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.22 -35.78 79.95 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.96 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.46 HD21 ' H ' ' A' ' 76' ' ' LEU . 0.9 OUTLIER -66.73 -51.95 50.05 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.28 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.29 -32.41 64.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -69.52 -55.58 9.79 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.945 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -67.07 -61.94 1.68 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.439 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.413 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.7 p -35.18 -27.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.013 0.435 . . . . 0.0 111.355 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.55 ' N ' ' O ' ' A' ' 79' ' ' ALA . 47.3 ttm-85 -75.9 -59.56 2.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.149 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.458 ' CG2' ' O ' ' A' ' 14' ' ' ARG . 49.4 mt -46.04 -40.53 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.692 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.573 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -79.84 -33.09 40.53 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 119.341 -0.944 . . . . 0.0 109.527 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -52.01 -21.52 3.19 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.771 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.67 16.07 55.52 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -104.33 -1.33 27.09 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -36.0 -35.31 0.07 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.382 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -47.6 -73.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.66 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 92.6 t -81.42 128.15 38.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.803 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.525 ' CG ' ' H ' ' A' ' 91' ' ' SER . 25.8 t0 -87.03 -175.6 5.41 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.457 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.525 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 79.7 p -62.0 -173.53 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.89 0.376 . . . . 0.0 110.5 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.553 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 3.1 mm? -81.49 150.47 67.05 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.109 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.34 107.22 2.43 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.077 1.851 . . . . 0.0 111.392 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -54.89 151.21 16.3 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.376 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -36.06 -56.77 0.61 Allowed 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 122.573 2.182 . . . . 0.0 112.458 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.3 m . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.624 -179.924 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 mmt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.9 m -75.41 162.39 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.532 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.428 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -178.69 -50.93 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.302 179.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 3' ' ' THR . 61.1 Cg_endo -87.51 62.69 3.84 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.532 2.155 . . . . 0.0 112.371 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 7' ' ' MET . 14.9 p -169.46 -37.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.908 0.385 . . . . 0.0 110.884 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -54.63 84.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.71 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.498 ' N ' ' O ' ' A' ' 5' ' ' VAL . 39.1 mtt 51.97 -176.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.254 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 7' ' ' MET . 16.2 m -58.29 -155.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.322 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -142.23 -34.95 0.44 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.276 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -101.99 -33.6 9.67 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.869 0.366 . . . . 0.0 110.064 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.534 ' O ' ' N ' ' A' ' 14' ' ' ARG . 5.7 m -75.65 -62.19 1.67 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 11' ' ' THR . . . -28.38 -51.38 0.08 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.01 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.553 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 3.5 mp -56.69 -42.32 78.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.624 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' THR . 98.2 mtt180 -49.77 -46.5 50.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.152 0.501 . . . . 0.0 110.646 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.2 mt -65.17 -8.0 5.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.588 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.15 -15.0 19.11 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.651 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.38 -28.32 61.96 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -57.89 -42.83 85.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.121 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 18' ' ' ALA . . . -41.77 -33.55 0.52 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.512 ' C ' ' H ' ' A' ' 22' ' ' LEU . 37.4 ttm180 -69.7 -42.99 73.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.017 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.64 -7.49 0.43 Allowed 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.061 0.458 . . . . 0.0 110.051 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.512 ' H ' ' C ' ' A' ' 20' ' ' ARG . 14.1 mt -116.46 147.62 40.05 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.438 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -60.34 -78.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.968 1.779 . . . . 0.0 113.005 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.87 -10.5 26.39 Favored Glycine 0 N--CA 1.469 0.89 0 C-N-CA 121.409 -0.424 . . . . 0.0 112.654 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.3 m -60.48 130.57 47.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.317 0.559 . . . . 0.0 110.644 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.18 166.89 15.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.551 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.6 t -58.44 -59.59 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.739 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.13 10.55 2.45 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.702 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -101.59 -25.78 13.76 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 117.986 0.893 . . . . 0.0 110.572 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.3 tp -86.75 -27.15 23.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.902 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.538 ' O ' ' N ' ' A' ' 33' ' ' ILE . 4.9 mt -86.88 -41.22 14.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.677 0.275 . . . . 0.0 110.799 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -34.44 -27.36 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.017 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 31' ' ' LEU . 58.4 mt -46.76 -44.51 6.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.566 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' A' ' 34' ' ' LEU . 3.9 mm? -63.3 -76.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.244 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 1.402 ' HD1' ' N ' ' A' ' 36' ' ' GLN . 0.8 OUTLIER 54.33 165.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.663 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 1.402 ' N ' ' HD1' ' A' ' 35' ' ' HIS . 37.4 mt-30 47.9 -123.47 1.6 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.67 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.421 ' O ' ' O ' ' A' ' 36' ' ' GLN . 14.7 mmt180 58.61 135.21 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.095 0.474 . . . . 0.0 110.893 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 39' ' ' GLU . 3.6 mm -67.83 -19.47 24.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.974 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 38' ' ' ILE . 27.7 mm-40 -46.12 175.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.058 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.404 ' H ' ' HD2' ' A' ' 41' ' ' PRO . . . -141.09 -66.12 0.03 OUTLIER Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.404 ' HD2' ' H ' ' A' ' 40' ' ' GLY . 97.0 Cg_endo -78.41 100.14 1.34 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.845 2.363 . . . . 0.0 112.53 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.499 ' N ' ' CD2' ' A' ' 42' ' ' LEU . 3.5 mm? -81.37 64.88 6.28 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.8 p -61.35 174.63 0.68 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.282 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -76.11 -21.7 56.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.204 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -87.89 -41.37 13.25 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.693 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.2 m -53.1 -32.9 49.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.856 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 49' ' ' GLY . 77.8 mt -60.8 -28.57 68.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.638 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 84' ' ' TRP . 70.1 mt-30 -63.16 71.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.801 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -149.7 16.04 1.08 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.84 178.39 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.467 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 67.2 m -115.98 164.23 14.74 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -57.41 -47.33 84.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.158 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.4 m -54.77 -24.69 23.65 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.457 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.94 -30.95 64.26 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.053 0.454 . . . . 0.0 110.734 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.532 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 6.6 mp -66.35 -63.35 1.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.529 -178.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -55.95 -37.93 69.67 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.0 pt -73.72 -21.4 18.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.617 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.7 -35.46 91.95 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.872 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.501 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.2 mm? -75.81 -55.48 5.59 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.899 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.29 -31.47 58.24 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.484 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 77.17 -2.36 61.5 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.098 -1.049 . . . . 0.0 111.248 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.564 ' C ' ' H ' ' A' ' 64' ' ' GLU . 22.2 t -131.03 99.37 4.87 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.921 0.391 . . . . 0.0 111.409 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -54.11 -2.73 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.036 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.564 ' H ' ' C ' ' A' ' 62' ' ' SER . 27.9 tt0 -95.5 -44.28 7.59 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.298 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.493 ' H ' ' HG ' ' A' ' 62' ' ' SER . 0.9 OUTLIER -86.79 -12.35 48.29 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.577 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.2 m -54.12 -22.4 7.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.856 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -65.19 -14.2 60.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.193 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 51.7 mtt -105.71 -18.59 14.02 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.843 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 mt -49.05 139.96 9.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.121 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 20.2 p-10 -58.27 -30.39 66.56 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.3 m -60.89 119.53 45.59 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.225 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.94 -154.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.313 1.342 . . . . 0.0 111.233 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.43 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 37.1 ttm -112.72 1.29 15.6 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.872 0.368 . . . . 0.0 110.059 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.0 m -107.1 -27.89 10.33 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.101 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.35 -35.42 75.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.548 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.511 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 0.7 OUTLIER -63.75 -49.74 71.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.448 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.458 ' CD ' ' N ' ' A' ' 77' ' ' LYS . 2.0 mptp? -54.63 -35.86 63.9 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.445 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.73 -59.4 3.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.92 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.45 -61.77 2.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.9 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -35.19 -27.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.049 0.452 . . . . 0.0 111.545 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 79' ' ' ALA . 29.0 ttm180 -78.01 -56.65 4.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.619 0.723 . . . . 0.0 109.818 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.412 HD11 HG21 ' A' ' 82' ' ' ILE . 42.8 mt -46.5 -45.09 6.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.901 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.56 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -74.49 -36.58 63.27 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.702 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.495 ' O ' ' NE2' ' A' ' 48' ' ' GLN . 0.7 OUTLIER -47.33 -19.58 0.16 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.104 -179.859 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.434 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 85.16 15.46 66.86 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 88' ' ' GLU . 25.0 tt0 -108.29 0.37 21.26 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -32.97 -31.95 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.63 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 86' ' ' GLU . 37.5 mt-10 -53.36 125.19 16.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.707 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 66.0 t -84.3 118.94 32.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.497 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -82.0 -81.2 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.647 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.8 m -76.33 -178.92 4.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.724 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.554 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 3.2 mm? -76.8 150.82 81.93 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.849 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -36.61 -41.86 0.67 Allowed 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.297 1.998 . . . . 0.0 112.362 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -64.68 151.03 93.22 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.146 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -72.39 -52.56 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.186 1.924 . . . . 0.0 111.862 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 64.4 t . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.536 -179.968 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.412 ' CG2' ' H ' ' A' ' 3' ' ' THR . 1.8 m -56.77 -104.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.192 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.412 ' H ' ' CG2' ' A' ' 2' ' ' VAL . 36.8 p -137.67 63.6 40.45 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.623 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -77.85 8.15 3.58 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.64 2.227 . . . . 0.0 111.646 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.8 t -67.72 -71.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.458 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 7' ' ' MET . 63.5 m-80 52.06 -173.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.796 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' A' ' 7' ' ' MET . 0.6 OUTLIER 57.52 141.51 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.952 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -71.41 -152.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.128 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.2 ptt85 -144.33 -31.47 0.44 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.383 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -102.84 -34.2 9.07 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 14' ' ' ARG . 10.1 m -78.09 -62.03 1.81 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 11' ' ' THR . . . -28.57 -51.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.139 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.565 HD13 ' H ' ' A' ' 13' ' ' LEU . 4.5 mp -49.42 -44.82 45.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.884 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 11' ' ' THR . 53.2 mtp180 -45.72 -44.75 13.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.965 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.488 ' CD1' ' N ' ' A' ' 15' ' ' ILE . 1.8 mp -64.37 -15.72 17.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.336 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 13' ' ' LEU . . . -99.6 -17.29 17.9 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.368 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -71.74 -28.14 63.47 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -60.56 -39.98 89.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.458 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -42.93 -34.78 1.03 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.659 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.468 ' C ' ' H ' ' A' ' 22' ' ' LEU . 65.8 ttt180 -66.12 -39.05 89.6 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.884 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -59.43 -6.87 1.15 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.134 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.468 ' H ' ' C ' ' A' ' 20' ' ' ARG . 14.9 mt -119.81 117.33 32.54 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.62 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.49 70.29 7.59 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.889 1.726 . . . . 0.0 112.48 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 146.14 -52.14 0.58 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.0 m -60.47 133.0 55.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.974 0.416 . . . . 0.0 111.145 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.455 ' H ' ' HG1' ' A' ' 26' ' ' THR . 0.0 OUTLIER -87.99 168.23 13.02 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.077 179.746 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.2 t -58.77 -58.56 6.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.141 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.7 11.13 3.51 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.643 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.402 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 40.0 mm-40 -99.51 -15.26 18.73 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.952 0.876 . . . . 0.0 110.587 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.5 tp -100.75 -27.74 13.19 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.546 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 3.0 mm? -90.28 -46.43 8.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 110.846 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -36.89 -25.78 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.737 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.517 ' N ' ' O ' ' A' ' 31' ' ' LEU . 1.8 mp -86.08 -42.26 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.631 0.253 . . . . 0.0 110.494 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 31' ' ' LEU . 17.2 tp -52.94 -81.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.613 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.402 ' O ' ' OE1' ' A' ' 36' ' ' GLN . 16.6 p80 -70.13 158.14 36.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.357 . . . . 0.0 110.532 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.402 ' OE1' ' O ' ' A' ' 35' ' ' HIS . 13.9 mm100 -128.89 -113.35 0.26 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.613 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -69.09 -137.79 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.863 0.363 . . . . 0.0 110.801 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 tp -41.68 143.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.942 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -162.13 -178.06 6.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.265 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.58 -69.24 0.02 OUTLIER Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -41.47 143.01 0.99 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.516 2.144 . . . . 0.0 111.89 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.536 ' N ' ' CD2' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -161.07 14.72 0.1 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.239 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 p -81.0 160.63 24.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.225 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -48.13 -23.35 0.82 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.687 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -76.09 -39.91 54.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.096 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.9 m -53.86 -34.45 59.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.899 0.381 . . . . 0.0 110.432 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.515 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 3.0 mm? -61.43 -35.62 78.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.961 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -70.81 72.82 0.56 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.438 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.42 5.68 0.46 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.409 ' CG2' ' OD2' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -133.82 176.12 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.953 0.376 . . . . 0.0 110.163 179.811 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.474 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 9.3 m -115.38 165.59 12.8 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.5 t -57.64 -49.11 81.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.31 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.4 m -53.18 -24.62 11.25 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.592 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.409 ' OD2' ' CG2' ' A' ' 50' ' ' VAL . 32.9 t0 -74.16 -31.4 62.68 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.33 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.535 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 5.9 mp -66.1 -62.26 1.58 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 -178.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -55.55 -38.98 70.03 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 61' ' ' GLY . 15.1 pt -73.77 -24.96 20.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.418 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.79 -33.06 81.43 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.943 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.499 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.0 mm? -80.19 -56.39 4.25 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.107 0.453 . . . . 0.0 111.291 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.64 -30.44 61.63 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.726 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 81.48 -13.82 32.62 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.747 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.575 ' C ' ' H ' ' A' ' 64' ' ' GLU . 2.7 p -121.67 103.76 9.12 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.918 0.39 . . . . 0.0 111.313 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.96 -0.06 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.597 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.575 ' H ' ' C ' ' A' ' 62' ' ' SER . 47.1 tt0 -96.27 -41.56 8.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.172 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -90.88 -12.11 37.18 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.7 m -54.91 -22.05 9.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.982 0.42 . . . . 0.0 111.232 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -57.73 -19.89 30.68 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.136 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 28.8 mtt -108.21 -5.16 17.02 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.553 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.84 151.11 1.28 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.283 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -67.63 -39.36 84.67 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 72' ' ' PRO . 81.9 m -61.1 112.99 6.66 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.682 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 71' ' ' THR . 50.1 Cg_exo -51.82 -164.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.594 1.53 . . . . 0.0 112.084 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.4 ptt? -105.32 -15.9 14.91 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.659 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.3 m -96.63 -19.25 19.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.243 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.44 -30.91 70.77 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.123 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.513 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 1.5 mm? -64.5 -49.6 70.68 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.444 ' CD ' ' N ' ' A' ' 77' ' ' LYS . 0.7 OUTLIER -54.45 -33.58 59.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.548 179.448 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -72.09 -59.78 2.57 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.79 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -57.05 -63.45 1.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.342 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.3 p -35.1 -27.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.923 0.392 . . . . 0.0 111.744 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 79' ' ' ALA . 46.6 ttm-85 -76.44 -60.07 2.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.534 0.683 . . . . 0.0 110.423 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.428 HD13 HG23 ' A' ' 82' ' ' ILE . 36.3 mt -43.61 -43.11 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.156 -178.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -76.65 -34.39 58.28 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 119.137 -1.025 . . . . 0.0 109.873 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -52.64 -18.03 1.58 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.676 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.56 14.67 67.61 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -102.3 1.62 35.92 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -36.78 -37.24 0.13 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.086 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.52 70.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.679 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.5 p -79.74 135.57 25.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.636 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 18.4 p-10 -76.02 -170.32 1.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.535 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.2 t -74.23 158.04 34.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.481 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.545 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 3.2 mm? -75.4 150.22 84.71 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.861 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -37.68 -50.54 1.87 Allowed 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 122.18 1.92 . . . . 0.0 112.228 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -81.12 150.96 69.33 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.375 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.03 178.59 5.76 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.115 1.877 . . . . 0.0 111.699 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.1 m . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.617 -179.979 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.58 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 63.5 t -66.94 -71.29 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.746 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.594 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 2.7 m -80.59 -36.58 0.94 Allowed Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.355 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 3' ' ' THR . 64.2 Cg_endo -91.05 94.77 0.23 Allowed 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.324 2.016 . . . . 0.0 111.849 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.8 p -82.49 144.86 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.475 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.49 ' N ' ' ND2' ' A' ' 6' ' ' ASN . 0.1 OUTLIER -148.02 171.78 15.28 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.367 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.403 ' C ' ' O ' ' A' ' 6' ' ' ASN . 6.8 ptt? 32.13 91.64 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.643 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.497 ' OG ' ' N ' ' A' ' 9' ' ' ARG . 3.8 t -117.2 179.29 4.08 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.213 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 12' ' ' ALA . 24.6 ptt180 -70.66 -35.39 72.83 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -40.71 -28.89 0.08 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.645 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 93.0 m -86.22 -28.21 24.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.043 0.449 . . . . 0.0 110.679 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -84.43 8.89 14.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.056 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.79 -27.36 10.31 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 120.685 0.279 . . . . 0.0 110.269 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 1.395 ' CD ' ' CG2' ' A' ' 82' ' ' ILE . 1.9 tmm_? -81.52 -20.6 39.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.156 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.592 HD12 ' HE ' ' A' ' 14' ' ' ARG . 7.6 mm -62.84 -26.03 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.218 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.02 -23.85 19.39 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.7 -33.62 76.38 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.19 -45.63 75.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.454 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -43.48 -36.07 1.87 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -63.43 -41.99 98.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.187 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -63.19 -7.26 5.53 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.045 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.4 mt -120.03 110.24 36.62 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.81 65.07 8.57 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.741 1.627 . . . . 0.0 112.394 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.33 -37.35 0.52 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.636 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.8 m -80.59 139.55 36.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.003 0.43 . . . . 0.0 111.432 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.43 166.79 15.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.91 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.7 t -60.52 -60.27 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.078 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.52 11.65 5.28 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.298 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.454 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 13.0 mm100 -99.0 -17.49 18.27 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.695 0.748 . . . . 0.0 110.286 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 45.8 tp -93.38 -18.28 22.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.826 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 33' ' ' ILE . 12.0 mt -83.84 -39.74 19.56 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.741 0.305 . . . . 0.0 111.155 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -41.36 -22.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.253 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 31' ' ' LEU . 28.8 pt -52.14 -32.86 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.563 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.62 -41.9 59.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.759 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.4 ' O ' ' O ' ' A' ' 36' ' ' GLN . 19.6 t60 58.39 73.33 0.48 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.509 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.4 ' O ' ' O ' ' A' ' 35' ' ' HIS . 17.5 pt20 -57.45 -157.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.757 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -169.38 -14.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.759 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.466 ' CG1' ' N ' ' A' ' 39' ' ' GLU . 8.5 tt -157.28 161.67 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.468 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.466 ' N ' ' CG1' ' A' ' 38' ' ' ILE . 3.8 mp0 -61.27 138.36 58.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.407 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 175.96 172.73 41.01 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -72.93 171.48 17.39 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.71 2.273 . . . . 0.0 111.86 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.4 tp -159.48 59.12 0.39 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.118 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 p -68.94 -177.42 1.02 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.743 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -76.42 -26.03 55.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.313 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -72.51 -33.72 67.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.812 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.3 m -69.79 -32.78 71.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.59 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 49' ' ' GLY . 5.7 tp -71.03 -28.73 64.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.699 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -64.1 70.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.169 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -153.12 7.67 0.47 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.24 175.74 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.444 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 67.0 m -119.57 164.04 16.43 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.9 t -56.45 -43.99 79.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.333 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.7 m -56.85 -23.46 44.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -75.21 -32.52 61.21 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.231 0.539 . . . . 0.0 110.837 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.539 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 6.0 mp -63.87 -66.63 0.52 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.629 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -54.25 -34.82 61.61 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.7 pt -78.58 -20.51 13.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.8 -37.03 88.16 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.858 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.454 ' CD1' ' O ' ' A' ' 29' ' ' GLN . 2.3 mm? -76.45 -53.63 7.85 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.579 -0.448 . . . . 0.0 109.902 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.56 -36.71 76.56 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 121.25 -53.23 0.71 Allowed Glycine 0 N--CA 1.466 0.668 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.688 ' C ' ' H ' ' A' ' 64' ' ' GLU . 4.1 m -139.19 150.87 46.07 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.94 0.4 . . . . 0.0 110.916 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -60.13 22.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.639 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.688 ' H ' ' C ' ' A' ' 62' ' ' SER . 27.3 mt-10 -96.62 -60.33 1.63 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.698 0.285 . . . . 0.0 110.624 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -83.4 -13.08 55.66 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.5 m -47.51 -24.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.377 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -58.95 -35.0 72.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.345 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 24.9 mmt -84.97 -33.59 22.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.653 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.4 tp -49.89 122.01 6.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 110.16 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -55.88 -25.35 42.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.666 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 72' ' ' PRO . 26.1 m -50.13 108.62 1.05 Allowed Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.226 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 71' ' ' THR . 32.5 Cg_exo -54.8 -154.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.37 1.38 . . . . 0.0 112.196 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.4 ptm -115.75 -20.89 9.88 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.565 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.4 m -90.26 -19.87 23.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.538 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.78 -34.89 79.42 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.202 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.621 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 1.3 mm? -66.49 -50.88 61.78 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.31 -31.84 64.06 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -70.9 -56.82 5.41 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.779 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -64.7 -61.25 2.3 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.433 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.4 p -35.87 -26.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.22 0.533 . . . . 0.0 111.21 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 79' ' ' ALA . 15.9 ttm180 -78.87 -53.54 6.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.108 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 1.395 ' CG2' ' CD ' ' A' ' 14' ' ' ARG . 46.3 mt -50.29 -44.38 23.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.138 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 1.181 ' HA ' ' CZ ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -76.38 -35.57 58.57 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.639 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.626 ' N ' HH12 ' A' ' 14' ' ' ARG . 0.6 OUTLIER -45.6 -28.0 0.88 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.249 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.862 ' H ' HH12 ' A' ' 14' ' ' ARG . . . 96.13 13.66 48.32 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 88' ' ' GLU . 27.0 tt0 -105.95 -2.91 22.36 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -33.48 -34.44 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.392 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 86' ' ' GLU . 69.3 mm-40 -45.44 -47.99 13.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.539 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 99.5 t -61.38 93.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.681 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -82.83 132.71 35.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.433 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 85.8 p -62.37 172.59 1.46 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.934 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.55 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 3.0 mm? -82.47 150.52 63.62 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.88 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.34 119.2 6.1 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.269 1.979 . . . . 0.0 111.755 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -64.44 147.84 96.91 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.232 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.06 113.91 3.21 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.078 1.852 . . . . 0.0 111.825 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.498 -179.975 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.517 ' C ' ' H ' ' A' ' 3' ' ' THR . 37.9 mtt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.5 t 62.33 -1.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.528 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.517 ' H ' ' C ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -176.07 63.7 0.22 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.987 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.31 -44.12 0.33 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.512 2.142 . . . . 0.0 111.675 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.5 t 58.44 115.13 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.797 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.417 ' ND2' ' N ' ' A' ' 7' ' ' MET . 4.3 p-10 40.84 -155.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.216 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.417 ' N ' ' ND2' ' A' ' 6' ' ' ASN . 6.7 tpt 73.13 30.53 1.58 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.714 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.5 t -61.37 133.33 55.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.346 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.548 ' O ' ' N ' ' A' ' 12' ' ' ALA . 0.5 OUTLIER -49.03 -56.55 8.65 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.476 ' O ' ' NE ' ' A' ' 14' ' ' ARG . 21.6 pt-20 -43.81 -31.38 0.82 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.431 ' O ' ' CD1' ' A' ' 15' ' ' ILE . 61.0 m -76.39 -23.59 54.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.49 0.662 . . . . 0.0 109.776 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -85.92 -74.61 0.41 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.937 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.643 ' H ' ' CD2' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -42.59 -27.92 0.19 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.661 -178.628 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.476 ' NE ' ' O ' ' A' ' 10' ' ' GLU . 29.4 mtm180 -75.09 -39.98 60.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.431 ' CD1' ' O ' ' A' ' 11' ' ' THR . 55.1 mt -63.63 -13.04 12.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.456 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.73 -17.51 24.14 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.797 0.332 . . . . 0.0 110.771 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -70.79 -32.44 69.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.17 -44.19 74.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.291 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -41.59 -37.02 1.04 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.012 0.434 . . . . 0.0 109.969 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.436 ' C ' ' H ' ' A' ' 22' ' ' LEU . 54.8 ttm-85 -63.55 -41.72 98.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.527 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.75 -7.12 0.89 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.55 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.436 ' H ' ' C ' ' A' ' 20' ' ' ARG . 12.0 mt -119.0 114.06 35.41 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -79.35 68.94 8.13 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.657 1.571 . . . . 0.0 112.293 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.81 -49.6 0.56 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.3 m -66.79 133.77 50.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.971 0.415 . . . . 0.0 111.589 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.14 173.03 11.4 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.038 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.41 ' C ' ' H ' ' A' ' 29' ' ' GLN . 21.4 t -63.62 -63.55 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.139 0.495 . . . . 0.0 111.09 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.52 11.93 2.91 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.045 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.442 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 10.9 mm100 -99.62 -24.97 14.57 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.514 0.657 . . . . 0.0 110.607 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.7 tt -85.3 -19.8 30.98 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.926 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -93.96 -44.9 7.85 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.004 0.431 . . . . 0.0 109.981 179.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.463 ' C ' ' H ' ' A' ' 34' ' ' LEU . 84.2 mt-10 -56.45 -4.87 0.16 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.952 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.488 ' H ' ' C ' ' A' ' 31' ' ' LEU . 27.5 pt -52.13 -12.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.942 0.401 . . . . 0.0 110.515 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.463 ' H ' ' C ' ' A' ' 32' ' ' GLU . 33.9 mt -83.05 -22.15 33.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.825 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 58.22 174.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.221 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 60.53 109.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.284 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -51.01 146.6 5.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.478 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.8 tt -173.38 -23.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.735 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 52.71 -103.54 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.17 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.36 171.84 33.53 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.21 -174.08 1.1 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.755 2.303 . . . . 0.0 111.717 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 tp -157.48 99.27 1.74 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.082 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.9 p -101.64 179.82 4.23 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -75.53 -23.23 56.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.995 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -84.34 -31.53 24.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.426 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.2 t -53.1 -54.44 35.58 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.732 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.461 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 3.7 mm? -57.15 -30.37 64.39 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.343 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -84.11 69.65 10.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.938 0.399 . . . . 0.0 110.533 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.0 -2.85 0.14 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.23 172.82 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.444 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 3.5 m -115.95 161.71 18.43 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 t -53.37 -44.26 54.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 123.213 0.321 . . . . 0.0 110.985 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.6 m -58.12 -22.92 53.02 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -75.39 -31.93 60.62 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.452 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.541 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 5.8 mp -64.5 -67.57 0.42 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.42 -177.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -52.12 -34.73 45.62 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.538 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.6 pt -79.7 -19.17 12.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.71 -41.08 84.79 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.442 ' CD1' ' O ' ' A' ' 29' ' ' GLN . 2.4 mm? -73.48 -54.37 8.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.583 -0.447 . . . . 0.0 109.833 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.75 -37.06 79.11 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 118.8 -51.96 0.73 Allowed Glycine 0 N--CA 1.468 0.809 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.614 ' C ' ' H ' ' A' ' 64' ' ' GLU . 83.8 p -138.38 145.91 41.63 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.75 0.31 . . . . 0.0 110.842 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -59.92 6.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.195 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.614 ' H ' ' C ' ' A' ' 62' ' ' SER . 32.7 mt-10 -82.3 -54.72 5.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.299 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -96.74 -5.3 38.93 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 m -44.82 -26.33 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.611 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -57.04 -32.17 65.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.017 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 25.3 mmm -92.04 -7.64 48.23 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.363 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.483 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 30.1 tp -49.57 -84.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.212 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 1.3 t70 154.23 -26.78 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.408 ' OG1' ' CD2' ' A' ' 69' ' ' LEU . 3.4 m -62.4 135.12 95.17 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.018 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.6 -92.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.793 1.662 . . . . 0.0 112.28 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -172.59 -26.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.1 m -88.52 -18.9 27.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.9 -35.84 81.73 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.714 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.609 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 1.4 mm? -64.46 -49.78 70.11 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -70.15 -9.21 54.93 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.954 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -86.04 -50.4 7.07 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.577 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -70.21 -57.84 4.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.301 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.401 ' O ' ' CE3' ' A' ' 84' ' ' TRP . 1.3 p -35.22 -25.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.11 0.481 . . . . 0.0 111.167 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.577 ' N ' ' O ' ' A' ' 79' ' ' ALA . 21.4 ttm180 -78.44 -55.61 5.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.819 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.462 ' N ' ' O ' ' A' ' 79' ' ' ALA . 49.7 mt -50.72 -41.5 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.287 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.573 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.54 -35.82 52.88 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.309 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.401 ' CE3' ' O ' ' A' ' 80' ' ' VAL . 0.6 OUTLIER -45.86 -22.13 0.17 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.439 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.442 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 86.57 18.18 59.0 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 89' ' ' VAL . 85.0 mt-10 -111.29 -0.23 16.48 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.479 0.18 . . . . 0.0 110.518 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -31.86 -58.36 0.28 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.689 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -47.53 -40.45 18.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.749 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.499 ' N ' ' O ' ' A' ' 86' ' ' GLU . 48.0 t -72.52 78.58 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.342 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.481 ' CG ' ' H ' ' A' ' 91' ' ' SER . 7.5 p-10 -89.3 -56.63 3.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.799 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.481 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 93.5 p -71.5 166.86 20.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.653 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 3.2 mm? -70.61 150.16 95.45 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.33 -38.17 2.15 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.132 1.888 . . . . 0.0 111.861 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -65.12 151.99 92.46 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.223 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -71.67 122.96 9.03 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.234 1.956 . . . . 0.0 111.947 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.0 t . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.589 -179.998 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.443 ' O ' ' OG1' ' A' ' 3' ' ' THR . 12.5 t -98.57 84.95 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.555 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 2' ' ' VAL . 15.5 p 58.07 148.47 0.06 OUTLIER Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.659 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.482 ' O ' ' N ' ' A' ' 6' ' ' ASN . 73.1 Cg_exo -37.23 -62.46 0.28 Allowed 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.357 2.038 . . . . 0.0 112.61 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.2 t -61.99 74.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.95 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 4' ' ' PRO . 30.0 m120 -80.63 50.81 1.38 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.884 0.374 . . . . 0.0 110.267 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 17.3 ptp -167.63 157.87 10.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.302 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.3 m -92.47 123.2 35.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.958 0.409 . . . . 0.0 111.149 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 12' ' ' ALA . 6.4 ptm180 -55.25 -50.94 68.18 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.259 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -45.25 -30.41 1.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 m -75.43 -21.46 58.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.546 0.689 . . . . 0.0 109.532 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -86.47 -72.74 0.49 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.251 -1.341 . . . . 0.0 111.642 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.617 ' H ' ' CD2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -35.25 -51.26 0.57 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.637 -178.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.1 mtm-85 -50.04 -34.68 22.23 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.6 mm -64.16 -24.03 34.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.905 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.73 -19.8 22.23 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.567 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.99 -32.48 69.32 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -56.24 -43.93 79.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.329 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 18' ' ' ALA . . . -40.41 -36.36 0.54 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.46 ' C ' ' H ' ' A' ' 22' ' ' LEU . 72.8 mtt-85 -65.9 -42.51 90.12 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.342 -0.39 . . . . 0.0 109.948 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.48 -6.14 0.65 Allowed 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.345 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.46 ' H ' ' C ' ' A' ' 20' ' ' ARG . 8.7 mt -121.11 112.41 33.27 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.633 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -83.5 65.46 7.56 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.959 1.773 . . . . 0.0 112.414 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.9 -35.87 0.62 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.472 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.8 m -81.9 135.0 35.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.947 0.403 . . . . 0.0 111.333 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.77 170.47 14.13 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.015 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.4 t -61.72 -61.44 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.75 10.32 4.19 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.19 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.419 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 21.0 mm100 -99.19 -25.4 14.53 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.427 0.614 . . . . 0.0 110.574 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.7 tp -88.09 -26.17 22.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.444 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 3.4 mm? -82.72 -38.75 22.88 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.669 ' O ' ' HD2' ' A' ' 35' ' ' HIS . 26.0 tt0 -32.86 -32.08 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.772 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 31' ' ' LEU . 1.7 mp -51.99 -47.27 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' A' ' 35' ' ' HIS . 5.1 tp -64.29 -8.0 11.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.9 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.669 ' HD2' ' O ' ' A' ' 32' ' ' GLU . 52.7 m170 57.12 116.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.022 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.48 ' C ' ' H ' ' A' ' 38' ' ' ILE . 5.8 pt20 -177.86 50.63 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.58 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -59.4 -3.69 0.47 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.834 0.35 . . . . 0.0 110.67 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.48 ' H ' ' C ' ' A' ' 36' ' ' GLN . 10.1 pt -146.4 68.46 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.938 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 38' ' ' ILE . 15.6 mp0 55.33 163.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.285 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 161.75 -167.44 36.51 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -46.05 150.34 1.94 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.82 2.347 . . . . 0.0 112.232 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.1 tp -172.27 33.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.622 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 34.4 p -80.43 172.39 13.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.746 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -68.12 -26.7 65.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.891 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.451 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 3.9 mp0 -85.9 -29.04 23.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.491 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.5 t -53.67 -47.47 70.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.115 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.513 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 3.3 mm? -65.22 -34.7 78.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.677 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -78.06 63.9 3.13 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.388 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.64 1.34 0.6 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.16 173.62 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.469 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 36.0 m -116.0 164.8 13.9 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t -55.23 -47.71 77.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 O-C-N 123.27 0.356 . . . . 0.0 111.313 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.4 m -54.81 -24.32 22.26 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 38.1 t0 -74.74 -31.76 61.91 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.846 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.528 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 6.2 mp -65.27 -65.52 0.66 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.241 -178.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -53.63 -34.25 57.88 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.5 pt -78.77 -18.63 13.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.66 -38.79 67.49 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.419 ' CD1' ' O ' ' A' ' 29' ' ' GLN . 2.5 mm? -74.76 -55.5 5.78 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.47 -37.15 84.48 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 100.26 -28.9 13.63 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.801 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.62 ' C ' ' H ' ' A' ' 64' ' ' GLU . 14.9 p -138.2 132.42 31.82 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.386 0.612 . . . . 0.0 112.131 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -58.59 7.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.867 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.62 ' H ' ' C ' ' A' ' 62' ' ' SER . 54.2 mt-10 -93.81 -52.44 4.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.895 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -80.96 -16.28 53.93 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.3 m -50.18 -23.69 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.263 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -61.04 -30.39 70.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.425 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 37.8 mtt -91.77 -34.34 14.64 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.982 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.2 tp -49.28 108.4 0.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.944 0.402 . . . . 0.0 110.06 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -42.84 -24.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.812 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 72' ' ' PRO . 14.8 m -45.69 106.29 0.54 Allowed Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.633 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 71' ' ' THR . 52.5 Cg_exo -52.73 -168.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.311 1.341 . . . . 0.0 111.262 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 40.8 ttp -106.07 -7.55 17.96 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.2 t -100.18 -26.27 13.99 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.209 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.02 -34.5 70.11 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.036 0.445 . . . . 0.0 110.301 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.553 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -67.78 -59.66 3.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.563 0.696 . . . . 0.0 109.603 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -60.08 -10.17 4.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.205 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -87.64 -52.88 5.08 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -68.84 -56.74 7.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.182 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.424 ' O ' ' CE3' ' A' ' 84' ' ' TRP . 1.4 p -35.06 -25.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 121.219 0.533 . . . . 0.0 111.316 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 79' ' ' ALA . 39.5 ttm180 -78.75 -56.58 4.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.565 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 79' ' ' ALA . 41.8 mt -47.33 -42.48 7.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.896 -178.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.554 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.37 -36.17 53.82 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.892 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.424 ' CE3' ' O ' ' A' ' 80' ' ' VAL . 0.7 OUTLIER -46.63 -24.35 0.53 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.674 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 90.63 18.94 46.36 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 88' ' ' GLU . 45.2 mt-10 -110.15 -0.05 18.07 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -35.94 -26.58 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.358 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 86' ' ' GLU . 67.0 mm-40 -52.01 -60.84 2.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.238 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.0 m -74.74 40.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.026 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 88' ' ' GLU . 14.3 t70 -87.7 102.84 15.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.782 0.325 . . . . 0.0 110.362 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.0 t -75.51 158.61 32.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.232 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.554 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 3.0 mm? -78.87 149.68 74.25 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.015 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -37.68 -44.09 1.53 Allowed 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 122.141 1.894 . . . . 0.0 112.192 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -75.01 153.2 86.64 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.111 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.46 101.14 1.1 Allowed 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.199 1.932 . . . . 0.0 111.835 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.536 -179.899 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.544 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.8 mpt? . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.2 m -72.12 -178.23 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.511 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.5 m 49.3 68.26 3.68 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.472 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -46.07 169.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.881 2.388 . . . . 0.0 112.196 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.0 m -152.35 -165.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.239 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 51.29 94.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.465 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.44 ' O ' ' SD ' ' A' ' 7' ' ' MET . 0.0 OUTLIER -165.49 15.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.734 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.2 m -68.35 179.07 1.72 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.613 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 12' ' ' ALA . 9.6 ptp180 -50.58 -57.5 8.02 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.652 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -43.95 -35.59 2.1 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.6 m -72.18 -19.46 61.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.549 0.69 . . . . 0.0 109.724 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -90.04 -71.36 0.62 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.469 -1.242 . . . . 0.0 111.844 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.583 ' H ' ' CD2' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -40.99 -51.53 3.24 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.329 -178.685 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.513 HH21 ' CB ' ' A' ' 87' ' ' ALA . 71.9 mtp180 -43.54 -43.33 5.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.645 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 mm -63.53 -21.62 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.625 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -97.45 -17.24 19.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -69.73 -32.28 70.73 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.07 -46.03 71.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.313 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -39.7 -36.37 0.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.337 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.499 ' C ' ' H ' ' A' ' 22' ' ' LEU . 73.6 ttt-85 -64.33 -42.37 96.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.837 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.39 -4.72 0.41 Allowed 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.348 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.499 ' H ' ' C ' ' A' ' 20' ' ' ARG . 8.5 mt -122.8 111.96 30.86 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.566 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.04 67.18 8.71 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 121.713 1.609 . . . . 0.0 112.22 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.39 -43.97 0.58 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.637 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.3 m -75.2 133.43 41.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.938 0.399 . . . . 0.0 111.34 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.64 173.3 11.49 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.081 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.2 t -62.8 -62.59 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.672 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.84 11.37 3.52 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.091 -178.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.456 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 20.1 mm-40 -100.14 -24.36 14.6 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 117.487 0.644 . . . . 0.0 110.891 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 1.071 ' O ' HD11 ' A' ' 33' ' ' ILE . 6.6 tt -92.79 -23.52 18.84 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.981 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 33' ' ' ILE . 25.6 mt -76.22 -37.37 57.84 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.87 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.401 ' CD ' HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -36.16 -25.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.917 -179.309 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 1.071 HD11 ' O ' ' A' ' 30' ' ' LEU . 1.9 mp -48.13 -68.87 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.556 -0.458 . . . . 0.0 109.963 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.9 tt -68.14 -61.32 1.91 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.498 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -44.5 153.5 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.95 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.478 ' C ' ' H ' ' A' ' 38' ' ' ILE . 5.2 mt-30 60.16 160.74 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.704 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 66.22 -3.06 0.86 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.481 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.478 ' H ' ' C ' ' A' ' 36' ' ' GLN . 9.0 tp -163.01 -41.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.821 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 38' ' ' ILE . 95.0 mt-10 54.71 163.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.852 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.14 -161.63 28.97 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -47.11 168.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.292 1.994 . . . . 0.0 111.763 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.59 ' CD1' ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -139.39 27.57 2.3 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.881 0.372 . . . . 0.0 110.378 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.0 p -72.94 167.99 19.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.597 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -73.51 -22.57 60.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.245 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -87.44 -32.3 19.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.317 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.4 t -53.44 -46.2 69.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.224 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -50.22 -21.23 1.26 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.936 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -70.51 70.76 0.45 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.361 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.22 7.45 0.74 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 51' ' ' SER . 0.3 OUTLIER -130.78 175.7 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.488 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 9.0 m -113.21 163.84 14.28 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 t -56.27 -43.77 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 123.209 0.318 . . . . 0.0 111.414 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.8 m -55.33 -25.72 36.43 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -76.47 -30.94 57.49 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.912 0.387 . . . . 0.0 111.544 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.55 HD11 ' H ' ' A' ' 55' ' ' LEU . 5.6 mp -65.62 -65.09 0.72 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -50.81 -34.86 29.39 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.481 ' O ' ' N ' ' A' ' 61' ' ' GLY . 8.9 pt -83.08 -21.69 8.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.336 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.26 -38.12 95.68 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.471 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.1 mm? -74.59 -62.3 1.58 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.711 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.11 -34.17 77.04 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.325 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 86.93 -8.74 74.96 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.479 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.543 ' C ' ' H ' ' A' ' 64' ' ' GLU . 1.9 m -138.01 104.52 5.27 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 117.106 0.453 . . . . 0.0 112.022 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -54.24 -6.5 0.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.218 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.543 ' H ' ' C ' ' A' ' 62' ' ' SER . 28.3 mp0 -83.76 -45.25 13.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.719 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.06 -12.97 34.09 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.416 ' C ' ' N ' ' A' ' 68' ' ' MET . 12.9 m -50.66 -29.39 6.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.105 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -51.52 -15.12 0.38 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.48 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.416 ' N ' ' C ' ' A' ' 66' ' ' VAL . 48.6 mtt -104.45 -25.81 12.66 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.741 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.7 tp -51.86 119.26 4.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.165 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -38.99 -29.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.444 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.1 m -65.9 115.08 19.52 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.643 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.27 -156.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.261 1.307 . . . . 0.0 111.43 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -102.15 -17.58 15.94 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.823 0.344 . . . . 0.0 111.526 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.3 m -92.35 -22.96 19.4 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.702 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.61 -32.81 74.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.41 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.466 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -66.37 -48.05 71.39 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.422 -0.911 . . . . 0.0 108.922 179.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -32.34 66.51 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.48 -58.77 3.2 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.303 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -62.45 -63.25 1.29 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.403 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 p -34.56 -24.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.991 0.424 . . . . 0.0 111.673 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 79' ' ' ALA . 32.4 ttm180 -78.24 -57.53 3.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 109.82 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.41 ' N ' ' O ' ' A' ' 79' ' ' ALA . 42.0 mt -48.09 -41.44 9.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.148 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.558 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.44 -36.28 53.24 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.332 179.774 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -49.75 -15.1 0.15 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.482 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 79.46 19.53 71.22 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 88' ' ' GLU . 79.4 mt-10 -113.0 7.1 18.01 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.513 ' CB ' HH21 ' A' ' 14' ' ' ARG . . . -35.73 -26.01 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.279 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 86' ' ' GLU . 28.9 mt-10 -37.48 -69.25 0.12 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.222 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.5 t -60.77 75.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.426 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 88' ' ' GLU . 46.3 t0 -91.9 140.53 29.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.556 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 85.4 p -62.89 153.96 31.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.285 0.564 . . . . 0.0 110.552 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.499 ' N ' ' CD1' ' A' ' 92' ' ' LEU . 6.8 mp -88.7 154.78 50.66 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.276 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -35.14 95.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 122.49 2.127 . . . . 0.0 112.243 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -53.91 129.67 56.93 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.223 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.22 121.43 6.49 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.759 1.639 . . . . 0.0 111.826 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.533 -179.959 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.7 mtt . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.8 m -80.64 138.54 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.676 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.3 m -158.52 63.57 2.56 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.371 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -42.19 160.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.739 2.293 . . . . 0.0 112.388 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.3 p -161.32 153.06 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.339 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.42 ' CG ' ' H ' ' A' ' 7' ' ' MET . 8.2 p30 -170.01 -106.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.341 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.42 ' H ' ' CG ' ' A' ' 6' ' ' ASN . 23.7 ttt -46.82 115.9 1.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.793 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.699 ' HG ' ' H ' ' A' ' 9' ' ' ARG . 4.2 t -83.36 -156.26 0.19 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.822 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.699 ' H ' ' HG ' ' A' ' 8' ' ' SER . 12.6 tpt180 -136.83 -28.3 0.97 Allowed 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 116.713 -0.222 . . . . 0.0 111.208 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.426 ' H ' ' CD ' ' A' ' 10' ' ' GLU . 1.2 pm0 -95.23 -27.14 15.66 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.33 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.597 ' C ' ' H ' ' A' ' 13' ' ' LEU . 22.2 m -84.88 -44.95 12.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.43 0.633 . . . . 0.0 110.155 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.55 14.44 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.538 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.597 ' H ' ' C ' ' A' ' 11' ' ' THR . 7.0 mp -117.13 -35.51 4.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.932 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.631 ' HE ' ' CB ' ' A' ' 87' ' ' ALA . 15.4 ttt85 -71.54 -32.31 67.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.229 -178.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.3 mm -54.35 -16.19 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -97.75 -25.35 15.1 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.248 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.91 -38.2 84.9 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.14 -42.34 69.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.377 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -41.82 -38.89 1.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.12 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.498 ' C ' ' H ' ' A' ' 22' ' ' LEU . 39.0 ttt85 -66.08 -42.26 89.6 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.839 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.48 -5.77 0.24 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.975 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.498 ' H ' ' C ' ' A' ' 20' ' ' ARG . 8.6 mt -122.39 105.45 36.4 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.423 -178.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -80.48 78.06 3.82 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 121.562 1.508 . . . . 0.0 112.086 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.62 -30.64 1.26 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.6 m -96.18 142.7 28.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.026 0.441 . . . . 0.0 111.296 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.14 178.52 6.61 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.219 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.9 t -66.4 -65.47 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.904 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.74 13.77 3.9 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.129 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -100.33 -16.11 17.78 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.166 0.483 . . . . 0.0 110.472 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 pp -94.65 -20.81 19.24 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 pp -99.95 -39.59 8.08 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.249 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -55.47 -8.22 0.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.0 mt -43.72 -51.32 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.779 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.516 ' O ' ' CG ' ' A' ' 35' ' ' HIS . 8.0 mp -64.66 -61.72 2.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.268 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.516 ' CG ' ' O ' ' A' ' 34' ' ' LEU . 68.5 m80 -157.74 -112.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.353 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.417 ' CG ' ' H ' ' A' ' 37' ' ' ARG . 22.3 tt0 -161.96 -134.93 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.756 0.312 . . . . 0.0 110.462 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.417 ' H ' ' CG ' ' A' ' 36' ' ' GLN . 66.2 ttt180 -97.4 79.42 2.77 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.748 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.9 mt -83.39 -74.14 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.377 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.23 -170.57 2.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.409 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.33 176.45 3.62 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.61 -176.36 3.21 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.838 2.359 . . . . 0.0 112.129 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 tt -159.15 82.11 0.77 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.955 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 p -94.31 159.66 15.02 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.577 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -53.65 -21.64 7.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.427 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -81.67 -34.37 30.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.007 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.4 t -59.93 -32.44 70.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.374 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.0 tp -69.65 -5.12 22.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.825 0.345 . . . . 0.0 110.75 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -85.52 71.73 10.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.512 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.34 7.44 0.84 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 120.949 -0.644 . . . . 0.0 111.643 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.436 HG21 ' H ' ' A' ' 51' ' ' SER . 0.3 OUTLIER -128.1 177.92 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.676 0.274 . . . . 0.0 110.361 -179.801 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.48 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 33.7 m -112.78 162.46 15.75 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t -57.2 -44.32 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 120.667 0.27 . . . . 0.0 111.139 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.9 m -56.88 -22.07 34.34 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -77.25 -30.59 54.51 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.211 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.548 HD13 ' H ' ' A' ' 55' ' ' LEU . 5.9 mp -65.93 -64.47 0.85 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.211 -177.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -52.99 -34.13 54.74 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 61' ' ' GLY . 7.4 pt -83.38 -18.86 10.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.668 0.271 . . . . 0.0 110.948 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.29 -33.22 86.66 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.5 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 1.8 mm? -79.23 -57.25 3.81 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.578 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.58 -32.78 64.3 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.125 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 84.75 -5.11 83.3 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.538 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.55 ' C ' ' H ' ' A' ' 64' ' ' GLU . 69.0 m -137.9 99.22 3.84 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.942 0.401 . . . . 0.0 111.635 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 63' ' ' GLU . 0.1 OUTLIER -50.88 -8.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.72 179.246 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.55 ' H ' ' C ' ' A' ' 62' ' ' SER . 32.6 tt0 -87.62 -41.31 13.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.835 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -89.8 -18.17 26.78 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.6 m -46.74 -23.07 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.967 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 67' ' ' ASP . 56.1 t0 -50.72 -34.57 27.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.46 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 68' ' ' MET . 0.0 OUTLIER -82.5 -32.83 28.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.637 179.761 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.3 tp -49.91 116.22 1.72 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.114 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -42.45 -26.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.89 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.7 m -62.15 112.51 6.47 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 119.343 -0.36 . . . . 0.0 110.699 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.47 -157.58 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.345 1.364 . . . . 0.0 111.748 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.7 ttm -103.72 -10.85 18.01 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.557 0.217 . . . . 0.0 110.776 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.2 m -94.51 -23.2 17.79 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.881 0.372 . . . . 0.0 110.39 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.93 -36.24 83.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.517 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -67.55 -47.26 70.34 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.654 -0.818 . . . . 0.0 109.092 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -26.03 61.06 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.48 -57.88 3.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.721 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.21 -64.69 0.86 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.06 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.2 p -34.89 -27.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.3 0.571 . . . . 0.0 111.146 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.564 ' N ' ' O ' ' A' ' 79' ' ' ALA . 23.7 ttm180 -78.47 -55.84 4.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.654 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.475 ' N ' ' O ' ' A' ' 79' ' ' ALA . 33.7 mt -47.68 -41.53 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.22 -178.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.55 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -78.16 -34.99 49.37 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.714 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -52.49 -14.26 0.47 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.744 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 83' ' ' LEU . . . 81.12 17.71 71.32 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 87' ' ' ALA . 52.0 mt-10 -114.05 8.84 17.17 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.631 ' CB ' ' HE ' ' A' ' 14' ' ' ARG . . . -31.89 -48.81 0.16 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.776 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -55.83 139.5 45.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.67 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.5 m -85.92 179.07 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.744 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -95.55 -95.39 0.18 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.793 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.0 t -62.05 -179.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.736 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.542 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 3.0 mm? -81.08 150.23 67.99 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.012 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -37.75 108.78 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 122.156 1.904 . . . . 0.0 112.259 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.621 ' N ' ' CD ' ' A' ' 95' ' ' PRO . 6.0 tm0? -78.67 -36.11 1.18 Allowed Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.265 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 94' ' ' GLN . 32.1 Cg_exo -57.49 171.83 1.22 Allowed 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.176 1.917 . . . . 0.0 111.987 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.912 -1.042 . . . . 0.0 110.506 179.877 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 mtt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.78 151.59 9.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.468 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.3 m -148.11 84.24 6.91 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.335 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.96 151.03 4.19 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.513 2.142 . . . . 0.0 112.262 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.82 -4.01 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.131 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -51.19 -17.84 0.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.54 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -171.39 54.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.589 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.443 ' OG ' ' N ' ' A' ' 9' ' ' ARG . 26.5 t -61.0 179.91 0.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.259 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.48 ' O ' ' N ' ' A' ' 12' ' ' ALA . 14.5 ptt85 -50.29 -56.03 12.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.558 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.466 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 19.4 pt-20 -45.68 -35.15 3.95 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.4 m -71.7 -16.78 62.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.445 0.641 . . . . 0.0 109.672 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -94.03 -71.14 0.67 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.955 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.569 ' H ' ' CD2' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -50.2 -49.85 51.34 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.518 -178.382 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -44.42 -48.9 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.973 0.416 . . . . 0.0 110.992 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.2 mm -65.39 -15.47 18.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.586 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.73 -16.68 17.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.093 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -71.62 -30.14 65.45 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -59.38 -42.04 90.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.512 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 18' ' ' ALA . . . -40.35 -33.44 0.25 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.502 ' C ' ' H ' ' A' ' 22' ' ' LEU . 56.7 ttt-85 -69.26 -42.48 75.51 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.294 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.73 -7.65 0.47 Allowed 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.078 0.466 . . . . 0.0 110.207 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.502 ' H ' ' C ' ' A' ' 20' ' ' ARG . 14.0 mt -113.91 149.69 42.27 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.855 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.18 -88.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.094 1.863 . . . . 0.0 112.552 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.34 -7.03 52.65 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.455 -0.403 . . . . 0.0 112.303 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.9 m -60.84 137.51 58.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.149 0.474 . . . . 0.0 110.628 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.16 164.34 13.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.985 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.0 t -55.2 -53.27 36.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.659 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.82 5.37 24.6 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.451 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -97.23 -24.34 15.75 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.74 0.77 . . . . 0.0 110.305 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 pp -84.12 -24.72 30.15 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.352 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 34' ' ' LEU . 6.6 tp -91.59 -34.82 14.57 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.882 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 31' ' ' LEU . 78.7 tt0 -34.29 -49.99 0.4 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.777 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.3 tt -65.47 -37.43 80.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.426 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 31' ' ' LEU . 19.5 mt -82.93 -3.09 56.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.646 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.616 ' O ' HG21 ' A' ' 38' ' ' ILE . 10.8 t-80 -64.6 -0.01 1.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.126 0.489 . . . . 0.0 110.04 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 1.338 ' HG3' ' NH2' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -90.81 171.53 9.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.596 -180.0 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 1.338 ' NH2' ' HG3' ' A' ' 36' ' ' GLN . 23.3 mtm-85 45.48 15.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.872 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.616 HG21 ' O ' ' A' ' 35' ' ' HIS . 19.3 tt -110.23 159.21 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.238 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 40' ' ' GLY . 78.6 mt-10 -145.63 -109.33 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.928 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 39' ' ' GLU . . . -56.7 -160.2 0.02 OUTLIER Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.69 81.87 2.5 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.429 2.086 . . . . 0.0 112.326 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.29 159.13 15.71 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.826 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 p -87.7 157.54 19.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.606 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -60.23 -21.89 62.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.686 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -68.36 -44.65 74.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.662 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.4 t -55.97 -36.79 68.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.627 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 49' ' ' GLY . 1.3 tt -45.65 -41.02 9.8 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.049 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -61.41 70.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.514 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -151.9 13.56 0.75 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -128.63 173.05 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.471 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 40.3 m -112.75 161.59 16.71 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -55.62 -39.93 57.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 120.798 0.332 . . . . 0.0 110.546 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 m -58.62 -25.11 62.32 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.053 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -75.47 -31.64 60.33 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.183 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.553 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 4.9 mp -66.45 -60.85 2.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.439 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -56.91 -36.04 69.71 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 61' ' ' GLY . 15.6 pt -75.93 -29.66 20.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.62 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.26 -27.49 39.76 Favored Glycine 0 CA--C 1.517 0.195 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mt -83.27 -64.15 1.22 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.805 -0.697 . . . . 0.0 112.433 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.76 -20.93 60.36 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.169 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 70.83 -0.61 27.81 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.399 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.535 ' C ' ' H ' ' A' ' 64' ' ' GLU . 15.0 t -136.0 95.69 3.26 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.929 0.395 . . . . 0.0 111.437 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -54.29 -6.41 0.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.707 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.535 ' H ' ' C ' ' A' ' 62' ' ' SER . 28.8 mt-10 -90.23 -32.49 16.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.732 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -101.53 -11.64 19.12 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 m -52.82 -25.46 8.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.443 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -53.74 -23.33 11.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.208 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 7.0 mmt -94.83 -31.11 13.87 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.663 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.476 ' CD2' ' OG1' ' A' ' 71' ' ' THR . 30.4 tp -49.67 127.47 15.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.219 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -39.74 -31.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.391 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.476 ' OG1' ' CD2' ' A' ' 69' ' ' LEU . 1.4 m -48.57 110.28 1.42 Allowed Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.647 ' C ' ' H ' ' A' ' 74' ' ' SER . 91.5 Cg_endo -80.23 29.48 0.51 Allowed 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.321 2.014 . . . . 0.0 113.507 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.468 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 19.4 ttp 55.78 -7.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.647 ' H ' ' C ' ' A' ' 72' ' ' PRO . 22.8 t -100.82 -16.14 17.38 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.165 0.507 . . . . 0.0 109.91 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.02 -31.22 62.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.264 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.577 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 1.1 mm? -65.9 -51.8 55.58 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.55 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.5 OUTLIER -48.25 -36.97 15.02 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.254 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.63 -59.05 3.05 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.375 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.573 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.5 -62.86 1.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.482 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.455 ' N ' ' O ' ' A' ' 76' ' ' LEU . 2.1 p -35.26 -25.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.007 0.432 . . . . 0.0 111.475 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 79' ' ' ALA . 28.1 ttm180 -78.3 -56.47 4.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.635 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 79' ' ' ALA . 44.7 mt -47.78 -43.81 10.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.849 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.557 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -75.48 -36.51 60.62 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 119.253 -0.979 . . . . 0.0 109.751 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -46.9 -22.08 0.28 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.836 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.419 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 88.18 13.87 63.25 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 87' ' ' ALA . 5.5 tp10 -109.28 2.54 20.89 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -28.96 -42.68 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.996 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -56.05 135.8 52.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.772 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.7 p -84.28 128.0 39.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.269 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -84.77 -75.78 0.34 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.6 m -72.11 -155.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.75 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.549 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 3.1 mm? -77.2 149.59 79.5 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.922 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.18 -91.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.059 1.839 . . . . 0.0 111.829 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -74.35 152.02 87.8 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.21 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.91 104.31 1.61 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.216 1.944 . . . . 0.0 111.785 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.571 -179.951 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.6 mtt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.429 ' O ' ' OG1' ' A' ' 3' ' ' THR . 7.4 p -64.45 116.04 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.037 0.446 . . . . 0.0 110.495 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 2' ' ' VAL . 22.6 m -167.5 65.8 0.77 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.237 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.12 159.32 37.35 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.587 2.191 . . . . 0.0 112.144 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.411 ' O ' ' O ' ' A' ' 6' ' ' ASN . 11.7 t -143.51 -57.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.272 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.495 ' CG ' ' H ' ' A' ' 7' ' ' MET . 1.3 p30 -56.07 -111.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.765 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.495 ' H ' ' CG ' ' A' ' 6' ' ' ASN . 11.6 mmt -138.33 -60.97 0.61 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.646 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.494 ' HG ' ' H ' ' A' ' 10' ' ' GLU . 30.9 t -120.46 158.39 27.33 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.107 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.575 ' O ' ' N ' ' A' ' 12' ' ' ALA . 4.1 ptm85 -79.61 -25.76 41.39 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.096 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.494 ' H ' ' HG ' ' A' ' 8' ' ' SER . 0.9 OUTLIER -50.39 -29.57 10.38 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.818 179.467 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.466 ' O ' ' CD1' ' A' ' 15' ' ' ILE . 83.3 m -71.09 -25.4 62.6 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.575 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -81.76 -71.19 0.49 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.688 -1.596 . . . . 0.0 110.801 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.459 ' CD1' ' H ' ' A' ' 13' ' ' LEU . 5.9 mp -32.62 -40.77 0.05 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.162 -0.926 . . . . 0.0 113.017 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 46.3 mtt85 -78.27 -32.08 49.34 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.466 ' CD1' ' O ' ' A' ' 11' ' ' THR . 63.9 mt -66.11 -16.14 20.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.75 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.36 -17.28 21.72 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.275 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -73.25 -30.42 63.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.37 -42.22 73.64 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.096 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -41.12 -36.3 0.7 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.171 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.5 ' C ' ' H ' ' A' ' 22' ' ' LEU . 70.9 mtp180 -63.68 -40.3 96.46 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.58 -4.32 0.4 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.443 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.5 ' H ' ' C ' ' A' ' 20' ' ' ARG . 10.2 mt -122.89 115.55 29.26 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -82.01 64.02 8.38 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.814 1.676 . . . . 0.0 112.437 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.57 -48.84 0.48 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.56 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.2 m -68.41 133.46 48.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.959 0.409 . . . . 0.0 111.225 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.479 ' H ' ' HG1' ' A' ' 26' ' ' THR . 0.1 OUTLIER -85.22 171.45 11.94 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.025 179.668 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -60.93 -60.38 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.431 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.1 9.32 7.01 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.595 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.48 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 28.0 mm100 -99.61 -18.95 17.08 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 117.948 0.874 . . . . 0.0 110.411 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.5 tp -93.36 -19.64 21.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.063 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 21.6 mt -95.12 -42.54 8.54 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 110.849 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -54.73 -20.72 8.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.042 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.3 pp -49.16 -17.93 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.998 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.4 mt -60.6 -89.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.393 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.406 ' HD1' ' C ' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -168.17 -135.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.29 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -46.35 167.7 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.813 0.339 . . . . 0.0 110.384 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -83.03 -76.41 0.28 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.532 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 39' ' ' GLU . 40.1 pt -44.48 140.38 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.869 0.366 . . . . 0.0 110.768 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.438 ' O ' ' O ' ' A' ' 38' ' ' ILE . 0.6 OUTLIER 55.59 113.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.64 -76.88 0.2 Allowed Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.28 69.2 1.95 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.656 2.238 . . . . 0.0 111.526 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.1 mt -84.53 -107.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.05 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.01 169.53 11.12 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.772 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' A' ' 83' ' ' LEU . 32.0 tt0 -62.76 -27.17 69.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.494 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -64.3 -39.2 93.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.568 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.3 p -59.8 -43.81 94.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.494 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.9 mp -59.45 -33.66 71.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.881 0.372 . . . . 0.0 110.334 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -75.97 73.89 2.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.816 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -157.66 14.56 0.29 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -124.96 174.19 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.415 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 14.1 m -115.33 160.13 20.2 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t -53.32 -37.82 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 120.788 0.328 . . . . 0.0 110.494 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 m -61.09 -25.28 66.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.998 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 11.2 t0 -74.56 -30.55 61.78 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.64 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.542 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 5.9 mp -66.67 -66.53 0.54 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -51.39 -34.79 36.02 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 61' ' ' GLY . 9.6 pt -82.03 -17.36 11.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.28 -41.27 79.53 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.808 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.48 ' CD1' ' O ' ' A' ' 29' ' ' GLN . 1.9 mm? -74.93 -52.41 11.27 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.789 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.39 -37.93 74.59 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 116.81 -51.57 0.72 Allowed Glycine 0 N--CA 1.468 0.833 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.544 ' C ' ' H ' ' A' ' 64' ' ' GLU . 46.0 p -135.63 141.23 45.02 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.089 0.471 . . . . 0.0 111.116 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -57.91 1.15 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.347 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.544 ' H ' ' C ' ' A' ' 62' ' ' SER . 72.2 mm-40 -75.92 -53.88 7.74 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.422 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -93.24 -9.01 40.63 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -177.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.4 m -50.16 -24.2 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.517 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.26 -15.32 2.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.616 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 52.6 mtp -99.37 -34.76 10.16 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.62 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.7 tp -51.07 124.57 11.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.228 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -61.38 -22.97 65.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.345 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.1 m -49.68 107.65 0.83 Allowed Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.413 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.95 -171.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.224 1.283 . . . . 0.0 111.808 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.3 ptm -98.17 -22.02 16.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.724 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.9 t -89.06 -25.38 21.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.437 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.48 -33.47 69.82 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.302 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.44 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -67.39 -52.96 33.6 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.429 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -65.09 -9.44 22.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.466 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -87.61 -52.18 5.48 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -70.04 -57.79 4.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.587 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 79' ' ' ALA . 1.5 p -34.8 -28.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.287 0.565 . . . . 0.0 110.943 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 79' ' ' ALA . 20.4 ttm105 -74.04 -62.12 1.61 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.807 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 55.5 mt -45.44 -39.94 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.897 -178.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -81.42 -28.52 34.23 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.472 179.306 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -64.89 2.87 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.481 -0.488 . . . . 0.0 109.793 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 83' ' ' LEU . . . 65.93 22.16 70.15 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -107.26 2.23 24.48 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.921 0.391 . . . . 0.0 110.157 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -40.03 -68.88 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.956 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -50.24 -34.66 23.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.723 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.5 t -77.94 84.41 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.814 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 31.0 p-10 -95.56 150.56 20.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.555 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.1 t -68.29 171.01 7.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.551 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.551 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 3.1 mm? -76.15 149.74 82.49 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.817 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.35 -40.87 1.42 Allowed 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.102 1.868 . . . . 0.0 112.026 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -71.52 129.33 88.82 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.213 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -76.21 80.67 2.64 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.737 1.625 . . . . 0.0 111.845 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.3 t . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.676 -179.956 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 mtm . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.9 p -161.66 15.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.094 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.3 p -137.79 69.32 51.43 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.045 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -47.83 119.88 4.22 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.676 2.251 . . . . 0.0 112.367 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.4 p -54.46 142.43 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.208 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -160.75 113.63 2.0 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.641 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 39.4 mtm -130.05 175.04 9.21 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.219 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.5 m -88.3 119.14 28.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.596 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.596 ' O ' ' N ' ' A' ' 12' ' ' ALA . 10.6 ptm180 -51.5 -57.06 10.07 Favored 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.442 ' H ' ' CG ' ' A' ' 9' ' ' ARG . 87.5 tt0 -35.39 -28.21 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 9' ' ' ARG . 50.9 m -84.62 -31.41 24.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.197 0.522 . . . . 0.0 110.51 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.596 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -84.23 4.65 29.85 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.634 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -115.42 -36.9 4.16 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 120.81 0.338 . . . . 0.0 110.474 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 71.3 mtm180 -84.63 -36.41 22.01 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.44 ' CD1' ' N ' ' A' ' 15' ' ' ILE . 1.2 mp -65.35 -8.92 6.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.257 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.18 -16.81 25.75 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.806 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.34 -30.5 63.38 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.94 -44.99 74.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.732 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -40.91 -36.16 0.61 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.98 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.463 ' C ' ' H ' ' A' ' 22' ' ' LEU . 57.1 mtp85 -68.1 -40.56 82.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.162 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.08 -6.8 0.65 Allowed 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 120.945 0.402 . . . . 0.0 110.496 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.463 ' H ' ' C ' ' A' ' 20' ' ' ARG . 11.4 mt -118.75 120.3 31.72 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.814 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.3 71.31 7.1 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.879 1.72 . . . . 0.0 112.557 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.42 -54.75 0.6 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.6 m -59.63 128.33 36.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.923 0.392 . . . . 0.0 110.949 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.442 ' H ' ' HG1' ' A' ' 26' ' ' THR . 0.0 OUTLIER -86.82 178.19 7.07 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.29 0.567 . . . . 0.0 110.875 -179.777 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.8 t -61.8 -58.77 6.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.904 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.421 ' C ' ' NE2' ' A' ' 29' ' ' GLN . . . -66.43 2.89 3.9 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.675 -178.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.646 ' N ' ' NE2' ' A' ' 29' ' ' GLN . 1.1 mp0 -100.38 -30.46 11.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.575 0.688 . . . . 0.0 111.236 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 pp -88.37 -27.45 21.6 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -85.71 -41.18 15.37 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.718 0.294 . . . . 0.0 110.733 -179.234 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 34' ' ' LEU . 35.0 tp10 -41.41 -26.52 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.296 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.404 ' N ' ' O ' ' A' ' 31' ' ' LEU . 28.4 pt -45.62 -12.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.311 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.601 HD22 HD23 ' A' ' 42' ' ' LEU . 39.5 tp -64.7 -26.47 68.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.258 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.0 m170 55.28 -132.36 1.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.611 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.434 ' O ' ' CG ' ' A' ' 36' ' ' GLN . 3.6 pt20 -40.16 111.64 0.21 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.029 0.443 . . . . 0.0 110.936 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -72.66 82.89 1.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.551 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.46 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 14.3 tt -65.89 116.02 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.177 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.435 ' O ' ' O ' ' A' ' 38' ' ' ILE . 10.4 mm-40 56.18 158.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.523 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.86 -82.52 0.09 OUTLIER Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.194 -0.527 . . . . 0.0 111.858 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -34.22 146.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.842 2.361 . . . . 0.0 113.029 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.601 HD23 HD22 ' A' ' 34' ' ' LEU . 8.0 tp -167.28 93.16 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.877 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.31 166.53 12.25 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.231 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.21 -23.71 56.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.478 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.456 ' HA ' HE21 ' A' ' 48' ' ' GLN . 33.0 mt-10 -61.01 -47.99 83.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.239 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.5 t -59.27 -47.51 85.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.92 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -44.8 -25.48 0.3 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.42 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.456 HE21 ' HA ' ' A' ' 45' ' ' GLU . 34.9 mt-30 -75.41 52.14 0.6 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.324 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -136.0 15.87 3.99 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 51' ' ' SER . 0.3 OUTLIER -128.42 177.96 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.437 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 20.3 m -119.05 164.01 16.14 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -56.55 -47.19 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.177 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.4 m -54.15 -24.18 16.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -74.59 -31.72 62.13 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.074 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.531 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 6.2 mp -64.96 -64.96 0.74 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.404 -178.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -54.75 -39.53 68.4 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.7 pt -71.52 -23.72 22.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.316 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.75 -30.8 78.74 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 121.164 -0.541 . . . . 0.0 111.756 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.53 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.1 mm? -79.51 -52.96 7.36 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.294 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.5 -30.19 33.35 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.603 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 74.21 4.85 69.69 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.266 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 64' ' ' GLU . 10.2 t -135.95 93.44 2.93 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.824 0.345 . . . . 0.0 111.307 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -48.57 -10.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.762 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.531 ' H ' ' C ' ' A' ' 62' ' ' SER . 30.9 tt0 -88.66 -42.61 11.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.714 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.17 -15.02 34.75 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.1 m -49.75 -28.96 4.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.77 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -55.47 -27.65 49.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.925 0.393 . . . . 0.0 110.244 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 48.8 mtm -92.33 -24.31 18.97 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.766 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.4 tp -53.37 123.0 10.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.931 0.396 . . . . 0.0 110.076 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -40.65 -38.56 0.91 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.661 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.1 m -52.66 107.76 0.92 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.973 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.12 -162.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.161 1.24 . . . . 0.0 111.423 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.467 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 32.4 ttm -109.11 -6.44 15.61 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 61.3 m -100.78 -20.83 15.38 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.138 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.57 -34.06 76.28 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.822 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.513 ' CD2' ' H ' ' A' ' 76' ' ' LEU . 0.9 OUTLIER -64.08 -45.92 86.6 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.83 179.379 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.467 ' CE ' ' O ' ' A' ' 73' ' ' MET . 1.1 mptp? -55.83 -34.87 65.79 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.312 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.03 -59.93 2.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.495 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -59.03 -62.99 1.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.432 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 p -35.37 -25.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.917 0.389 . . . . 0.0 111.721 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.568 ' N ' ' O ' ' A' ' 79' ' ' ALA . 28.3 ttm180 -77.56 -57.35 3.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.668 0.747 . . . . 0.0 110.074 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.4 HD13 HG22 ' A' ' 82' ' ' ILE . 41.4 mt -47.79 -43.74 10.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.929 -178.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.558 ' CD1' ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -75.03 -36.64 61.87 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.557 179.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -47.38 -18.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.457 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 83.1 15.52 72.03 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 88' ' ' GLU . 50.2 mm-40 -105.57 -0.63 25.58 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -36.7 -26.0 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.088 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 86' ' ' GLU . 2.7 mp0 -53.31 -78.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.1 m -73.81 58.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.906 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -77.36 -33.46 55.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.523 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 65.5 m -70.56 158.81 35.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.691 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.551 ' CD2' ' N ' ' A' ' 92' ' ' LEU . 3.1 mm? -78.61 150.39 76.05 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.828 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.99 87.37 0.86 Allowed 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.167 1.911 . . . . 0.0 111.975 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -57.59 152.09 36.88 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.206 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.31 -170.56 0.59 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.333 2.022 . . . . 0.0 111.917 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.524 -179.948 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.52 ' O ' HD23 ' A' ' 17' ' ' LEU . 5.5 mp . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 30.8 mtm105 -80.65 -39.49 27.24 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.438 ' O ' HG22 ' A' ' 15' ' ' ILE . 54.7 mt -62.8 -14.68 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.446 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.35 -15.71 17.9 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 13' ' ' LEU . 1.2 mm? -72.73 -31.91 65.32 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.6 -42.87 75.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.218 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.712 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -39.9 -34.36 0.27 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.504 ' C ' ' H ' ' A' ' 22' ' ' LEU . 75.9 ttt-85 -67.23 -41.66 85.32 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.227 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -55.32 -6.73 0.18 Allowed 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.465 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.504 ' H ' ' C ' ' A' ' 20' ' ' ARG . 9.5 mt -116.23 149.33 43.34 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.27 -80.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 121.881 1.721 . . . . 0.0 112.548 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -116.24 7.89 18.48 Favored Glycine 0 N--CA 1.47 0.908 0 C-N-CA 121.44 -0.409 . . . . 0.0 112.467 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.0 m -73.97 126.84 31.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.43 0.615 . . . . 0.0 110.13 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.07 168.11 20.39 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.985 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.712 HG22 ' HB2' ' A' ' 19' ' ' ALA . 21.2 t -61.72 -61.15 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.23 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.91 10.64 4.11 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.085 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -98.57 -25.27 14.79 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 117.44 0.62 . . . . 0.0 110.391 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.2 tt -95.5 -17.8 21.16 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.588 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 31' ' ' LEU . 1.8 tt . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 120.965 0.412 . . . . 0.0 110.785 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.5 mt . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.722 0.296 . . . . 0.0 110.696 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -80.36 71.63 7.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.453 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -153.43 -0.28 0.2 Allowed Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.433 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -123.36 175.98 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.449 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 55.7 m -117.03 162.96 16.96 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.481 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.3 t -56.01 -43.71 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.905 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 57' ' ' ILE . 3.2 m -56.52 -25.16 50.92 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.433 ' CB ' HG22 ' A' ' 50' ' ' VAL . 12.5 t70 -74.2 -31.76 62.78 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.08 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.725 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.8 mp -64.92 -65.36 0.68 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.378 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -53.58 -37.21 62.72 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.54 ' O ' ' N ' ' A' ' 61' ' ' GLY . 11.3 pt -77.95 -18.23 13.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.121 0.486 . . . . 0.0 109.994 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.72 -38.64 93.29 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.761 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.0 mm? -73.68 -56.94 4.37 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.242 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.42 -35.68 73.56 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 103.99 -33.86 6.24 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.798 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.521 ' C ' ' H ' ' A' ' 64' ' ' GLU . 68.8 m -136.3 127.68 28.43 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.037 0.446 . . . . 0.0 111.192 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -58.68 -0.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.453 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.521 ' H ' ' C ' ' A' ' 62' ' ' SER . 33.7 mt-10 -79.44 -45.22 19.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 67' ' ' ASP . 16.7 m-20 -99.05 -7.85 26.18 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.0 m -49.23 -27.24 2.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.62 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 17.8 p-10 -51.67 -35.36 42.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.012 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.22 -19.21 43.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.861 0.362 . . . . 0.0 110.61 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.445 ' HG ' ' H ' ' A' ' 71' ' ' THR . 20.5 tp -64.84 125.9 26.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.496 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -51.68 -22.82 3.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.048 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.445 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 3.3 m -64.49 115.94 24.35 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.232 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.449 ' O ' HD21 ' A' ' 76' ' ' LEU . 74.4 Cg_endo -73.68 -154.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.375 1.384 . . . . 0.0 111.126 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.439 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 29.7 ttm -112.66 1.82 15.88 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.2 t -109.58 -18.53 13.47 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.521 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.46 -33.46 71.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.822 0.344 . . . . 0.0 110.345 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.93 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -65.74 -47.14 76.28 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.507 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 1.6 mptp? -55.96 -35.75 67.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.37 -58.84 3.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.852 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -63.23 -62.7 1.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.679 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.431 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 3.1 p -35.24 -26.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 120.922 0.392 . . . . 0.0 111.429 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.556 ' N ' ' O ' ' A' ' 79' ' ' ALA . 50.4 ttm-85 -75.98 -58.1 3.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.603 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 52.1 mt -47.49 -41.22 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.622 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.88 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -80.02 -32.08 39.61 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.587 179.596 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -49.12 -27.92 3.85 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.956 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.22 13.04 50.31 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 88' ' ' GLU . 74.8 mt-10 -113.88 8.69 17.36 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -28.08 -37.5 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.194 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 86' ' ' GLU . 5.8 pt-20 . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 120.835 0.35 . . . . 0.0 110.46 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.472 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 5.6 mp . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 120.927 0.394 . . . . 0.0 112.062 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.42 ' O ' ' CG2' ' A' ' 82' ' ' ILE . 20.3 mmt85 -56.03 -30.38 61.8 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.7 mm -65.11 -18.21 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.369 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.66 -18.24 16.63 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.31 -28.57 65.28 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -57.77 -42.75 84.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.424 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.693 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -40.48 -33.4 0.26 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.529 ' C ' ' H ' ' A' ' 22' ' ' LEU . 50.3 ttt85 -69.16 -42.59 75.72 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.23 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.13 -6.11 0.23 Allowed 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.243 0.544 . . . . 0.0 110.082 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.529 ' H ' ' C ' ' A' ' 20' ' ' ARG . 13.2 mt -117.0 149.52 44.32 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.177 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.43 -88.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.037 1.825 . . . . 0.0 112.485 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.12 -8.92 49.71 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.48 -0.391 . . . . 0.0 112.293 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.4 m -59.54 132.28 53.5 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.474 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.74 165.53 13.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.202 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.693 HG22 ' HB2' ' A' ' 19' ' ' ALA . 18.0 t -57.44 -55.88 18.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.149 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.18 8.36 8.89 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.808 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -96.82 -18.87 19.28 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.008 0.904 . . . . 0.0 110.753 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.4 tp -85.47 -37.93 19.18 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.526 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 pp . . . . . 0 N--CA 1.463 0.223 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.991 -179.643 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 47' ' ' LEU . 10.3 mp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.777 0.322 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -73.0 67.17 0.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.456 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.68 15.03 0.81 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.469 ' CG2' ' OD2' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -127.61 177.38 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.445 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 5.2 m -119.23 164.01 16.25 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.469 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.9 t -57.22 -45.49 84.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.751 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.4 m -54.3 -25.22 22.51 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.665 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.469 ' OD2' ' CG2' ' A' ' 50' ' ' VAL . 42.6 t0 -74.74 -31.1 61.72 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.916 0.388 . . . . 0.0 111.296 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.72 ' N ' HD12 ' A' ' 55' ' ' LEU . 6.2 mp -65.94 -63.38 1.1 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -54.54 -36.29 64.13 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.446 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.1 pt -77.38 -19.22 14.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.035 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.63 -34.83 88.71 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.743 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.2 mm? -76.52 -57.07 4.07 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.658 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.81 -32.97 68.13 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.481 -0.487 . . . . 0.0 109.947 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 85.51 -9.13 68.79 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.506 ' C ' ' H ' ' A' ' 64' ' ' GLU . 3.2 m -137.87 107.53 6.23 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.101 0.477 . . . . 0.0 112.243 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -56.39 -4.6 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.016 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' A' ' 62' ' ' SER . 19.0 mm-40 -86.35 -43.48 12.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.762 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -92.47 -11.91 33.42 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.2 m -50.9 -26.65 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 119.689 -0.805 . . . . 0.0 110.283 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -56.25 -17.07 6.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.399 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 43.7 mtt -101.93 -32.47 10.19 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.529 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.419 ' HG ' ' H ' ' A' ' 71' ' ' THR . 25.5 tp -49.57 131.95 21.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.221 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 9.6 p-10 -57.05 -32.49 66.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.395 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 72' ' ' PRO . 10.7 m -46.45 105.45 0.48 Allowed Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.502 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 71' ' ' THR . 33.0 Cg_exo -54.92 -163.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.174 1.25 . . . . 0.0 111.219 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 30.4 ttm -107.84 -4.98 17.52 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 82.6 p -102.52 -26.75 13.12 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.429 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.87 -33.37 70.4 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.885 0.374 . . . . 0.0 110.169 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.886 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -66.27 -53.37 37.51 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.453 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.528 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.4 OUTLIER -52.15 -35.43 48.54 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.475 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -68.36 -58.52 4.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.962 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -63.91 -60.47 3.23 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.834 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.425 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 2.4 p -35.24 -25.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.096 0.474 . . . . 0.0 111.686 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 79' ' ' ALA . 25.5 ttm180 -78.9 -56.31 4.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.544 0.688 . . . . 0.0 109.72 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.549 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 36.5 mt -47.88 -43.81 10.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.904 -178.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.849 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -74.23 -37.74 63.73 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 119.205 -0.998 . . . . 0.0 109.645 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -46.17 -19.05 0.06 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.94 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 83' ' ' LEU . . . 83.76 13.26 75.78 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 88' ' ' GLU . 91.6 mt-10 -103.4 -3.18 25.83 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.549 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -31.98 -32.61 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.525 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 86' ' ' GLU . 18.1 mm-40 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.337 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 4.8 mp . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 120.602 0.239 . . . . 0.0 111.571 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.417 HH22 ' C ' ' A' ' 85' ' ' GLY . 61.0 mtp180 -55.38 -32.94 63.02 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.3 mm -63.23 -16.54 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.382 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.36 -16.2 17.73 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.4 ' HA ' HD13 ' A' ' 17' ' ' LEU . 3.9 mm? -69.99 -30.7 68.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -56.71 -44.7 81.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.235 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.672 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -42.02 -36.76 1.2 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.487 ' C ' ' H ' ' A' ' 22' ' ' LEU . 67.6 ttt-85 -65.19 -40.83 94.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.943 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.18 -4.84 0.39 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.624 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.487 ' H ' ' C ' ' A' ' 20' ' ' ARG . 16.1 mt -118.1 139.76 27.05 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.145 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -39.67 -70.95 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.927 1.751 . . . . 0.0 112.855 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -134.4 0.0 3.79 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.521 -0.631 . . . . 0.0 111.521 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.1 m -57.43 131.21 49.44 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.611 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.69 160.92 27.25 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.343 0.592 . . . . 0.0 111.808 -178.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 19' ' ' ALA . 21.5 t -58.18 -55.81 19.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.1 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.04 8.36 8.35 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.358 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -100.32 -20.27 15.93 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 117.867 0.834 . . . . 0.0 109.932 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.404 HD22 HD11 ' A' ' 22' ' ' LEU . 45.1 tp -98.68 -23.78 15.32 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.982 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 31' ' ' LEU . 3.9 mm? . . . . . 0 N--CA 1.467 0.411 0 CA-C-O 120.73 0.3 . . . . 0.0 110.829 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.604 ' O ' HD13 ' A' ' 47' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.144 0 CA-C-O 120.941 0.4 . . . . 0.0 110.149 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -61.17 71.29 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.593 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -155.08 4.98 0.24 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.454 ' CG2' ' OD2' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -123.67 176.96 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.396 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.428 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 45.2 m -119.03 161.75 19.72 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.467 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.4 t -55.33 -43.03 69.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.67 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 m -56.43 -26.0 52.2 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.871 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.454 ' OD2' ' CG2' ' A' ' 50' ' ' VAL . 53.1 t0 -73.87 -31.44 63.16 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.041 0.448 . . . . 0.0 110.859 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.728 ' N ' HD12 ' A' ' 55' ' ' LEU . 6.3 mp -65.23 -65.01 0.73 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -53.29 -36.59 61.37 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.1 pt -78.08 -18.95 13.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.62 -38.13 89.93 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.705 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.3 mm? -75.07 -56.75 4.42 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.029 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.96 -35.31 78.15 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 93.29 -20.43 46.32 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.553 ' C ' ' H ' ' A' ' 64' ' ' GLU . 23.0 t -138.22 117.25 12.5 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.038 0.446 . . . . 0.0 111.871 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -59.34 4.06 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.686 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.553 ' H ' ' C ' ' A' ' 62' ' ' SER . 43.5 mt-10 -90.74 -45.71 8.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.194 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.65 -11.43 42.54 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.4 m -52.97 -27.44 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.035 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 19.4 p-10 -56.17 -12.61 1.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.278 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.9 mmt -106.09 -32.47 8.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.406 ' HG ' ' H ' ' A' ' 71' ' ' THR . 20.3 tp -48.45 123.59 6.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.423 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 71' ' ' THR . 47.3 p30 -48.52 -25.21 1.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.99 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.53 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 7.0 m -55.23 110.25 2.1 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.538 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 71' ' ' THR . 29.5 Cg_exo -57.14 -146.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.104 1.203 . . . . 0.0 110.948 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.432 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 33.8 ttp -123.96 -0.35 8.45 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.7 t -106.16 -27.47 11.05 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.287 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.43 -32.97 71.87 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.975 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.3 mm? -64.82 -49.98 68.48 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.516 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 1.3 mptp? -56.67 -33.79 66.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.434 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -70.11 -58.56 3.67 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.406 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.4 -63.58 1.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.42 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.408 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 3.0 p -34.69 -24.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.904 0.383 . . . . 0.0 111.909 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 79' ' ' ALA . 17.6 ttm105 -77.29 -60.55 2.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.56 0.695 . . . . 0.0 109.965 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.449 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 39.4 mt -45.48 -41.44 3.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.209 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.834 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -76.96 -35.61 57.11 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 119.278 -0.969 . . . . 0.0 109.584 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -48.89 -20.06 0.46 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.792 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.419 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 86.66 18.46 58.38 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 88' ' ' GLU . 8.8 tp10 -112.07 1.54 16.38 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.69 0.281 . . . . 0.0 110.337 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.449 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -29.94 -39.31 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.986 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 86' ' ' GLU . 5.3 pt-20 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.95 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.524 ' N ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.334 0 CA-C-O 120.702 0.287 . . . . 0.0 111.148 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 67.7 mtt-85 -63.76 -40.78 97.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.2 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.436 ' O ' HG22 ' A' ' 15' ' ' ILE . 29.2 mt -63.24 -11.3 7.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.457 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -103.56 -15.89 15.7 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.564 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' A' ' 17' ' ' LEU . 1.3 mm? -72.93 -28.95 62.75 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -58.2 -40.56 81.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.285 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.737 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -38.75 -35.53 0.2 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.495 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.501 ' C ' ' H ' ' A' ' 22' ' ' LEU . 55.5 mtp85 -65.12 -38.39 90.52 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.806 0.336 . . . . 0.0 110.404 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.53 -5.7 0.23 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.725 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.501 ' H ' ' C ' ' A' ' 20' ' ' ARG . 15.6 mt -117.46 149.84 45.51 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.919 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.05 -88.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.014 1.81 . . . . 0.0 112.474 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.72 3.25 42.11 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.537 -0.363 . . . . 0.0 112.235 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.5 m -72.43 129.36 38.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.124 0.462 . . . . 0.0 110.652 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.22 170.61 11.97 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.271 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.737 HG22 ' HB2' ' A' ' 19' ' ' ALA . 16.5 t -60.2 -57.37 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.855 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.48 5.37 10.67 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.353 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -94.17 -28.07 15.86 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 117.744 0.772 . . . . 0.0 110.276 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 tt -80.47 -17.89 50.32 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.803 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.0 tp . . . . . 0 N--CA 1.464 0.258 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.506 -179.957 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 49' ' ' GLY . 10.5 mp . . . . . 0 CA--C 1.532 0.266 0 CA-C-O 120.546 0.213 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -64.16 71.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.019 0.437 . . . . 0.0 110.443 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -152.95 7.89 0.49 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.401 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -130.73 177.43 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.467 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 71.8 m -118.97 165.6 13.89 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.467 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.8 t -55.97 -45.84 80.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.751 0.31 . . . . 0.0 111.241 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 57' ' ' ILE . 1.8 m -53.35 -25.93 17.21 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 42.9 t0 -75.81 -31.28 59.35 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.4 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.728 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.7 mp -65.79 -63.33 1.11 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -54.4 -36.46 63.97 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 61' ' ' GLY . 13.1 pt -77.6 -18.39 14.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.56 -36.72 84.01 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.692 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.6 mm? -73.99 -57.14 4.16 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.068 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.68 -34.45 72.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 114.37 -48.29 0.95 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.562 ' C ' ' H ' ' A' ' 64' ' ' GLU . 26.3 p -135.89 144.0 45.31 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.143 0.496 . . . . 0.0 111.356 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.99 9.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.836 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.603 ' OE1' ' OD1' ' A' ' 65' ' ' ASP . 5.5 tm-20 -86.6 -55.51 3.84 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.651 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.603 ' OD1' ' OE1' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -86.58 -13.09 46.8 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.031 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.0 m -49.02 -20.34 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.272 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 65' ' ' ASP . 62.9 m-20 -56.76 -33.34 66.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.132 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.428 ' C ' ' SD ' ' A' ' 68' ' ' MET . 0.0 OUTLIER -92.16 -27.86 17.44 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.786 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 71' ' ' THR . 32.5 tp -50.99 117.79 2.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.389 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -39.24 -24.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.346 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.489 ' N ' ' O ' ' A' ' 69' ' ' LEU . 2.5 m -68.27 116.18 36.88 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.56 -108.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.583 1.522 . . . . 0.0 111.643 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 24.1 ttm -150.91 2.99 0.45 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 121.094 -0.243 . . . . 0.0 110.825 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.425 ' O ' ' OD2' ' A' ' 78' ' ' ASP . 3.4 m -107.44 -23.23 12.27 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.927 0.394 . . . . 0.0 110.08 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -66.66 -33.09 74.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.479 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.986 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.0 OUTLIER -66.36 -52.63 44.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.485 179.62 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.539 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 2.6 mptp? -51.88 -36.78 49.78 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 74' ' ' SER . 4.8 m-20 -67.41 -58.76 4.18 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.18 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -63.01 -64.55 0.88 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.632 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.404 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 2.8 p -34.08 -24.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.59 ' N ' ' O ' ' A' ' 79' ' ' ALA . 15.1 ttm180 -76.65 -61.26 2.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.382 0.61 . . . . 0.0 110.21 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.485 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 43.7 mt -45.28 -40.2 2.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.162 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.83 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.91 -35.42 50.63 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.535 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -50.32 -20.07 0.98 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.041 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.38 11.14 69.62 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 87' ' ' ALA . 21.5 tp10 -102.4 1.18 35.04 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.485 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -31.21 -39.31 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.656 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 86' ' ' GLU . 9.5 mm-40 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.682 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -85.11 -27.25 26.39 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.414 ' O ' HG22 ' A' ' 15' ' ' ILE . 60.7 mt -63.28 -14.95 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.405 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.407 ' HA ' HG13 ' A' ' 27' ' ' VAL . . . -91.4 -16.45 27.37 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.427 ' N ' HD22 ' A' ' 17' ' ' LEU . 4.0 mm? -72.68 -30.71 64.47 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.9 -41.34 70.82 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.921 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.676 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -44.24 -36.37 2.69 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -66.98 -42.37 85.22 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.469 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -57.57 -8.07 0.78 Allowed 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.259 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 21.1 mt -113.05 147.22 36.79 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.299 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.8 -73.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.168 1.912 . . . . 0.0 112.828 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -119.22 43.47 1.57 Allowed Glycine 0 N--CA 1.471 0.979 0 C-N-CA 121.503 -0.379 . . . . 0.0 112.222 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.2 m -117.89 132.88 56.37 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.869 0.334 . . . . 0.0 110.244 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.45 169.14 15.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.183 0.516 . . . . 0.0 110.568 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.676 HG22 ' HB2' ' A' ' 19' ' ' ALA . 27.9 t -60.85 -59.57 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.169 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.59 9.6 5.92 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.532 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -99.51 -12.2 20.37 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.753 0.776 . . . . 0.0 110.764 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 pp -98.15 -16.13 19.64 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.351 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 31' ' ' LEU . 1.6 tt . . . . . 0 N--CA 1.469 0.491 0 CA-C-O 120.837 0.351 . . . . 0.0 110.765 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 49' ' ' GLY . 10.2 mt . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.757 0.313 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -66.85 69.97 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.437 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -151.95 3.14 0.39 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.17 174.26 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.478 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 52.9 m -115.09 163.53 15.48 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.515 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.4 t -56.46 -42.14 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 O-C-N 123.265 0.353 . . . . 0.0 111.404 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.4 m -57.39 -25.41 59.47 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -74.44 -32.15 62.52 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.083 0.468 . . . . 0.0 110.956 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.735 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.7 mp -64.25 -65.59 0.66 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.503 -177.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -52.67 -37.42 58.73 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 61' ' ' GLY . 10.3 pt -79.34 -18.11 12.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.51 -41.77 96.06 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.41 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.749 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.0 mm? -73.64 -57.12 4.21 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.031 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.99 88.13 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 104.95 -34.42 5.81 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.527 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.519 ' C ' ' H ' ' A' ' 64' ' ' GLU . 22.6 t -137.24 129.6 29.69 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.106 0.479 . . . . 0.0 111.405 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -59.17 1.81 0.07 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.902 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.519 ' H ' ' C ' ' A' ' 62' ' ' SER . 42.7 mt-10 -83.02 -47.75 11.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.781 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -92.78 -7.44 46.5 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.6 m -55.72 -17.72 3.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.864 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -53.22 -31.88 45.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.286 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.8 ptm -100.27 -21.0 15.63 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.485 ' HG ' ' H ' ' A' ' 71' ' ' THR . 27.5 tp -52.17 124.09 12.21 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.256 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -41.14 -23.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.07 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.485 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 2.2 m -74.73 117.94 66.34 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.954 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.41 -104.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.892 1.728 . . . . 0.0 111.785 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.471 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 31.8 ttp -153.95 1.79 0.24 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.997 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.9 m -108.27 -18.77 13.68 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.784 0.326 . . . . 0.0 110.197 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.35 -34.04 70.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.619 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.958 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -64.0 -45.92 86.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.033 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.502 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 1.8 mptp? -56.22 -37.83 70.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.37 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -66.75 -56.92 8.31 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.432 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -63.92 -64.27 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.677 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.437 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.8 p -35.11 -27.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.112 0.482 . . . . 0.0 111.42 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 79' ' ' ALA . 52.6 ttm-85 -75.57 -58.92 2.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.111 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.473 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 50.1 mt -45.83 -41.71 3.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.821 -1.082 . . . . 0.0 112.656 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.884 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -79.77 -33.0 40.99 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.628 179.588 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -50.2 -21.55 1.38 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.869 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.51 17.4 55.05 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 88' ' ' GLU . 68.5 mt-10 -112.82 2.56 16.0 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -31.68 -34.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.849 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 86' ' ' GLU . 3.6 pt-20 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.686 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mp . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 -88.26 -34.06 17.86 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.2 mp -62.54 -11.36 6.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.38 -16.41 22.36 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.7 -29.01 66.33 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.62 -46.25 73.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.873 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.637 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.87 -36.07 0.98 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 22' ' ' LEU . 36.9 ttt180 -65.61 -43.14 90.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.743 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.35 -6.9 0.74 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.745 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.409 ' H ' ' C ' ' A' ' 20' ' ' ARG . 11.7 mt -117.94 121.61 31.39 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.57 72.77 6.35 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.781 1.654 . . . . 0.0 112.604 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.83 -53.33 0.68 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.7 m -59.23 132.42 53.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.006 0.432 . . . . 0.0 111.491 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.85 173.82 9.16 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.359 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.637 HG22 ' HB2' ' A' ' 19' ' ' ALA . 15.3 t -61.61 -59.64 3.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.697 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.66 6.71 8.19 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.53 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.445 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 57.5 mt-30 -97.1 -22.81 16.55 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 117.86 0.83 . . . . 0.0 110.084 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.0 tp -90.2 -19.75 23.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.836 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.441 ' N ' HD12 ' A' ' 31' ' ' LEU . 10.9 mp . . . . . 0 N--CA 1.466 0.357 0 CA-C-O 120.897 0.379 . . . . 0.0 110.408 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 49' ' ' GLY . 10.3 mp . . . . . 0 N--CA 1.465 0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.52 ' OE1' ' N ' ' A' ' 48' ' ' GLN . 0.9 OUTLIER -62.06 72.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.359 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -152.76 11.61 0.61 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.91 175.07 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.472 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 49.1 m -113.79 161.97 16.9 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.496 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.2 t -55.52 -43.46 72.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 123.196 0.31 . . . . 0.0 110.999 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.3 m -57.37 -23.95 52.27 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 16.6 t0 -75.7 -31.32 59.63 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.016 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.735 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.9 mp -65.31 -65.9 0.61 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.489 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -52.79 -34.98 55.88 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.8 pt -80.19 -19.78 12.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.23 -37.79 91.33 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.711 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.699 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.4 mm? -75.98 -52.61 9.88 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.284 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.66 -33.38 64.45 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.464 -0.494 . . . . 0.0 109.803 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 83.42 -9.24 62.08 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.104 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.528 ' C ' ' H ' ' A' ' 64' ' ' GLU . 3.9 t -137.75 104.24 5.24 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.924 0.392 . . . . 0.0 111.819 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -56.51 -1.24 0.05 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.701 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.528 ' H ' ' C ' ' A' ' 62' ' ' SER . 36.2 mt-10 -91.51 -41.37 10.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.3 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -92.45 -13.0 30.62 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 m -46.79 -29.8 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.622 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -52.92 -30.69 35.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.919 0.39 . . . . 0.0 110.234 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 13.2 mmt -83.96 -31.08 25.74 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.92 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.485 ' O ' ' N ' ' A' ' 71' ' ' THR . 29.7 tp -49.56 122.4 6.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.283 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 51.2 t0 -39.69 -24.9 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.021 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.485 ' N ' ' O ' ' A' ' 69' ' ' LEU . 2.8 m -65.05 122.08 77.65 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.016 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -74.71 -86.74 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.644 1.563 . . . . 0.0 112.281 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -172.13 -23.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.676 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.6 p -89.34 -14.59 35.33 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.476 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -69.89 -33.7 72.56 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.4 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.915 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.5 mm? -65.25 -47.69 75.87 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.214 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.497 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 1.8 mptp? -57.95 -34.4 69.86 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.82 -58.67 3.85 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.895 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.604 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.31 -64.64 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.29 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.5 p -34.72 -23.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.961 0.41 . . . . 0.0 111.653 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.604 ' N ' ' O ' ' A' ' 79' ' ' ALA . 46.9 ttm-85 -78.71 -58.22 3.36 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.456 0.646 . . . . 0.0 109.617 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.462 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 43.4 mt -47.7 -42.06 8.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.988 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.82 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -76.7 -36.65 57.1 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.564 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -48.88 -18.07 0.25 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.795 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.448 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 85.01 18.7 60.61 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 88' ' ' GLU . 24.3 tt0 -112.44 2.93 16.6 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.462 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -30.32 -34.96 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.874 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 86' ' ' GLU . 41.9 mt-10 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.677 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mp . . . . . 0 CA--C 1.534 0.328 0 CA-C-O 120.981 0.42 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 50.4 ttm-85 -86.04 -38.35 17.95 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.35 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.417 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 1.4 mp -65.29 -7.16 4.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.173 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.54 -18.91 21.72 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.74 0.305 . . . . 0.0 110.493 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -70.15 -30.35 67.49 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -57.87 -41.44 82.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.408 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.696 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.28 -33.97 0.44 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.486 ' C ' ' H ' ' A' ' 22' ' ' LEU . 86.5 mtt180 -67.93 -42.24 81.33 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.224 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -57.88 -5.19 0.38 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.424 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 20' ' ' ARG . 19.3 mt -115.07 148.61 40.97 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.056 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.83 -92.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.219 1.946 . . . . 0.0 112.401 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.28 46.51 1.28 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.7 m -118.21 141.73 48.2 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.827 0.346 . . . . 0.0 110.387 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.67 159.4 15.01 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.232 0.539 . . . . 0.0 110.393 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.696 HG22 ' HB2' ' A' ' 19' ' ' ALA . 23.5 t -54.84 -51.9 47.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.124 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.01 3.57 56.99 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.11 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -89.22 -20.27 24.37 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 117.597 0.699 . . . . 0.0 109.836 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.578 HD23 ' O ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -95.5 -27.25 15.47 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.617 0.246 . . . . 0.0 110.523 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.7 mt . . . . . 0 C--N 1.333 -0.121 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.876 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.4 mp . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -69.56 67.27 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.852 0.358 . . . . 0.0 110.424 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.71 11.15 0.36 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.77 171.78 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.47 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 31.6 m -113.66 161.72 17.12 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.545 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.3 t -55.07 -38.11 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 120.872 0.367 . . . . 0.0 110.415 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.6 m -59.18 -26.89 65.19 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -75.09 -30.53 60.94 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.974 0.416 . . . . 0.0 111.041 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.753 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.0 mp -67.05 -62.79 1.26 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.197 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -54.01 -35.0 61.43 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.42 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.9 pt -78.96 -19.46 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.285 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.76 -33.5 84.42 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.757 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.1 mm? -77.55 -54.79 5.98 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 116.873 0.337 . . . . 0.0 110.944 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.39 -32.4 62.69 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.967 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 80.0 -4.36 66.63 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 64' ' ' GLU . 13.0 t -137.12 97.53 3.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.008 0.432 . . . . 0.0 111.45 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -53.45 -6.16 0.07 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.258 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.531 ' H ' ' C ' ' A' ' 62' ' ' SER . 20.2 tp10 -86.31 -41.11 14.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.409 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -92.74 -14.77 27.49 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.7 m -49.1 -21.41 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 119.816 -0.753 . . . . 0.0 110.518 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -53.93 -34.46 59.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.226 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.5 ptp -92.59 -24.29 18.75 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.222 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.473 ' CD2' ' OG1' ' A' ' 71' ' ' THR . 21.9 tp -49.46 121.62 5.27 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -35.97 -30.26 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.598 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.473 ' OG1' ' CD2' ' A' ' 69' ' ' LEU . 2.1 m -48.92 114.46 3.77 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.547 ' C ' ' H ' ' A' ' 74' ' ' SER . 93.8 Cg_endo -80.45 19.85 1.03 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.168 1.912 . . . . 0.0 113.148 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.435 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 34.2 ttm 65.91 -12.89 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.825 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 72' ' ' PRO . 30.1 t -96.49 -14.19 22.51 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.04 0.448 . . . . 0.0 110.053 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.13 -30.13 60.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.414 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.568 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -65.55 -53.15 46.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.856 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.67 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -46.66 -38.01 9.12 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.179 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -70.51 -58.24 3.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.068 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.587 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -62.72 -61.31 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.594 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.407 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 2.8 p -34.85 -24.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.992 0.425 . . . . 0.0 111.745 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 79' ' ' ALA . 24.1 ttm180 -79.22 -55.7 4.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.549 0.69 . . . . 0.0 109.654 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.46 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 41.5 mt -49.62 -43.49 18.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.973 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.842 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -74.25 -38.07 63.58 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.484 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -45.47 -19.48 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.859 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 83' ' ' LEU . . . 83.46 14.85 72.75 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 87' ' ' ALA . 94.4 mt-10 -110.7 3.82 19.54 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.46 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -28.28 -46.19 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.839 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.126 179.784 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.551 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 3.8 mp . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.883 0.373 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.514 ' NH2' ' HB3' ' A' ' 87' ' ' ALA . 36.4 ttt180 -47.01 -46.54 21.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.009 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.607 HD12 ' N ' ' A' ' 15' ' ' ILE . 1.5 mp -63.84 -7.65 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.2 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 13' ' ' LEU . . . -97.71 -15.66 20.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.275 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.01 -28.75 61.59 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -57.4 -41.98 81.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.959 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.679 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -42.67 -36.79 1.52 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.926 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.415 ' C ' ' H ' ' A' ' 22' ' ' LEU . 75.0 ttt180 -64.38 -39.17 93.34 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -60.05 -6.19 1.28 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.47 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 20' ' ' ARG . 10.6 mt -121.47 109.24 34.85 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.141 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.16 66.89 7.73 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.917 1.745 . . . . 0.0 112.412 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.67 -11.68 0.45 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.001 -0.619 . . . . 0.0 111.841 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 m -113.81 137.31 51.82 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.955 0.407 . . . . 0.0 111.08 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.97 170.72 10.88 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.314 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.679 HG22 ' HB2' ' A' ' 19' ' ' ALA . 17.6 t -60.45 -59.69 3.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.184 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.16 11.11 4.02 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.364 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -98.87 -10.0 23.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.714 0.757 . . . . 0.0 110.487 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 pp -107.57 -19.18 13.64 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.609 HD23 ' O ' ' A' ' 31' ' ' LEU . 2.3 tt . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.759 0.314 . . . . 0.0 111.631 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.546 HD22 ' N ' ' A' ' 47' ' ' LEU . 3.8 mm? . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 120.718 0.294 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -76.18 75.63 3.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.69 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.36 6.48 0.49 Allowed Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.69 175.85 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 117.068 0.434 . . . . 0.0 110.428 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.49 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 24.0 m -111.62 164.55 12.88 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.519 ' HA ' HD13 ' A' ' 55' ' ' LEU . 4.9 t -58.25 -43.98 87.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.645 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.3 m -55.98 -25.35 43.61 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -74.85 -30.56 61.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.954 0.407 . . . . 0.0 111.468 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.722 ' N ' HD12 ' A' ' 55' ' ' LEU . 6.2 mp -65.3 -64.0 0.97 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -177.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -53.66 -36.45 62.14 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 61' ' ' GLY . 8.1 pt -80.35 -21.03 11.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.97 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.75 -33.01 83.72 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.78 ' N ' HD22 ' A' ' 59' ' ' LEU . 1.8 mm? -80.26 -54.73 5.46 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.483 ' HB3' HG12 ' A' ' 66' ' ' VAL . . . -79.42 -29.54 41.98 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.882 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 75.0 2.85 66.65 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.438 -0.887 . . . . 0.0 110.982 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.494 ' C ' ' H ' ' A' ' 64' ' ' GLU . 9.1 t -136.37 86.78 2.25 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.886 0.374 . . . . 0.0 111.253 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -49.08 -11.23 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.72 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.494 ' H ' ' C ' ' A' ' 62' ' ' SER . 25.3 tt0 -86.07 -35.71 20.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.512 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -98.27 -14.46 20.25 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.483 HG12 ' HB3' ' A' ' 60' ' ' ALA . 17.9 m -50.16 -25.83 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.475 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -52.31 -14.44 0.46 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.589 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 67.3 mtt -104.25 -22.21 13.41 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.67 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.448 ' HG ' ' H ' ' A' ' 71' ' ' THR . 37.8 tp -51.97 120.26 5.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.2 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 44.5 t0 -39.94 -33.13 0.19 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.194 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.448 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 62.9 m -60.7 119.65 45.98 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.071 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.439 ' O ' HD21 ' A' ' 76' ' ' LEU . 56.1 Cg_endo -69.71 -156.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 121.143 1.228 . . . . 0.0 111.348 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 8.8 ptm -106.8 -16.17 14.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.789 0.328 . . . . 0.0 111.147 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.7 m -92.76 -25.17 18.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.486 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.52 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -61.25 -33.12 73.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.371 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.908 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.2 mm? -64.95 -45.62 84.98 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.303 -0.959 . . . . 0.0 108.958 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.472 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 2.1 mptp? -59.97 -34.74 73.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.547 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -66.4 -58.8 4.51 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.708 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.49 -65.12 0.74 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.455 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.444 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.5 p -34.88 -27.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.05 0.452 . . . . 0.0 111.419 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.556 ' N ' ' O ' ' A' ' 79' ' ' ALA . 45.5 ttm-85 -77.3 -58.71 3.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.815 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.9 mt -45.01 -41.64 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.291 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.863 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -78.03 -35.62 49.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.64 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -51.44 -14.9 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.646 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.443 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 81.08 19.37 67.33 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 87' ' ' ALA . 8.0 tp10 -113.0 7.63 18.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.514 ' HB3' ' NH2' ' A' ' 14' ' ' ARG . . . -33.6 -57.11 0.44 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.494 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.521 179.858 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 mp . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -82.07 -28.81 32.19 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.1 mt -64.3 -19.2 24.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.248 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.421 ' HA ' HG13 ' A' ' 27' ' ' VAL . . . -89.47 -17.94 27.7 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.337 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.3 -30.82 66.7 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.5 -43.76 75.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.13 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.66 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.04 -37.36 0.82 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.487 ' C ' ' H ' ' A' ' 22' ' ' LEU . 66.2 mtp180 -68.39 -42.48 79.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.283 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.6 -5.76 0.25 Allowed 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.968 0.413 . . . . 0.0 110.275 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.487 ' H ' ' C ' ' A' ' 20' ' ' ARG . 13.9 mt -119.21 122.43 29.52 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.398 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -79.13 79.42 3.39 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.712 1.608 . . . . 0.0 112.75 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 130.17 -52.27 0.83 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.8 m -55.35 137.97 46.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.987 0.422 . . . . 0.0 111.435 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.61 171.68 9.51 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.72 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.66 HG22 ' HB2' ' A' ' 19' ' ' ALA . 20.2 t -60.25 -59.15 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.438 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.29 6.94 9.07 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.241 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -96.93 -20.83 17.83 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 117.283 0.542 . . . . 0.0 110.182 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 pp -90.78 -20.89 21.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.548 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 31' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.534 0.331 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.619 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.545 ' O ' HD13 ' A' ' 47' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 120.738 0.304 . . . . 0.0 110.393 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 84' ' ' TRP . 76.2 mt-30 -62.0 70.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.669 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -154.66 9.49 0.39 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.404 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -127.77 175.76 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.433 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 37.0 m -116.57 162.66 17.27 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.455 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.1 t -54.29 -47.83 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 123.254 0.347 . . . . 0.0 110.857 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -52.89 -25.27 11.16 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 116.365 -0.38 . . . . 0.0 112.003 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.404 ' CB ' HG22 ' A' ' 50' ' ' VAL . 13.2 t0 -75.43 -31.95 60.52 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.018 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.711 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.9 mp -66.38 -63.75 1.01 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.227 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.418 ' HB2' HD21 ' A' ' 76' ' ' LEU . 26.0 ttpt -52.87 -34.77 56.01 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.9 pt -80.31 -19.92 11.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.022 0.439 . . . . 0.0 109.834 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.29 -38.5 91.59 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.668 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.4 mm? -76.61 -54.57 6.49 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 120.645 -0.422 . . . . 0.0 109.999 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.72 -35.06 79.23 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 118.53 -53.79 0.65 Allowed Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.651 ' C ' ' H ' ' A' ' 64' ' ' GLU . 26.8 t -140.05 152.69 46.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.995 0.426 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.34 20.89 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.891 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.651 ' H ' ' C ' ' A' ' 62' ' ' SER . 60.8 mt-10 -97.34 -59.8 1.71 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.694 0.283 . . . . 0.0 110.886 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.41 ' OD1' ' CG ' ' A' ' 68' ' ' MET . 12.4 t0 -82.45 -11.91 58.2 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 m -51.92 -28.35 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.13 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -55.92 -24.15 36.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.541 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.41 ' CG ' ' OD1' ' A' ' 65' ' ' ASP . 8.1 mmt -93.75 -36.63 12.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.521 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.519 HD23 ' OG1' ' A' ' 71' ' ' THR . 12.7 tp -48.85 115.98 1.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.4 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -43.74 -16.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.773 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.519 ' OG1' HD23 ' A' ' 69' ' ' LEU . 2.8 m -51.58 116.17 7.45 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.535 ' C ' ' H ' ' A' ' 74' ' ' SER . 93.0 Cg_endo -79.58 20.29 0.88 Allowed 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.319 2.013 . . . . 0.0 113.655 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 18.7 ttm 66.13 -13.42 0.16 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.633 0.254 . . . . 0.0 111.2 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.535 ' H ' ' C ' ' A' ' 72' ' ' PRO . 5.7 t -96.91 -13.6 22.32 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.063 0.459 . . . . 0.0 109.933 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.426 ' HB1' HD23 ' A' ' 22' ' ' LEU . . . -73.3 -31.53 64.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.904 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.567 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -67.69 -59.15 3.55 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.886 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -52.82 -15.92 0.87 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.252 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 74' ' ' SER . 8.2 m-20 -86.33 -51.96 5.92 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -69.34 -56.35 7.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.439 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.447 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.2 p -35.73 -26.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.297 0.57 . . . . 0.0 111.048 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.55 ' N ' ' O ' ' A' ' 79' ' ' ALA . 40.3 ttm-85 -76.52 -55.35 5.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.925 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.567 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 53.2 mt -49.95 -42.78 19.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.463 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.887 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -79.13 -32.9 44.62 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.755 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.508 ' O ' ' NE2' ' A' ' 48' ' ' GLN . 0.6 OUTLIER -46.85 -29.64 2.08 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.44 14.9 39.65 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 88' ' ' GLU . 1.1 mp0 -110.74 0.65 17.45 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -33.07 -33.42 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.478 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 86' ' ' GLU . 56.8 mm-40 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.592 ' N ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 120.575 0.226 . . . . 0.0 111.451 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.458 ' O ' ' CG2' ' A' ' 82' ' ' ILE . 94.5 mtt-85 -42.59 -41.25 2.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.5 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.4 mm -64.44 -24.01 34.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.552 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.98 -18.76 20.01 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.99 -31.0 70.4 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -58.02 -41.53 83.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.779 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.711 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -42.38 -37.46 1.57 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.015 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.9 mtt-85 -64.06 -38.66 91.86 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.026 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.98 -7.2 0.98 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.332 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.43 HD23 ' HB1' ' A' ' 75' ' ' ALA . 25.3 mt -112.96 146.86 35.98 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -39.19 -71.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.196 1.931 . . . . 0.0 112.206 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -140.51 4.71 2.54 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.3 m -57.38 137.33 56.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.46 162.9 20.81 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.094 0.473 . . . . 0.0 110.806 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.711 HG22 ' HB2' ' A' ' 19' ' ' ALA . 22.1 t -61.04 -55.74 22.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.83 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.15 13.34 2.7 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.087 -0.577 . . . . 0.0 112.654 -178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -97.66 -19.31 18.36 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.018 0.909 . . . . 0.0 111.954 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.91 -17.53 20.07 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.988 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.686 HD22 ' N ' ' A' ' 31' ' ' LEU . 3.0 mm? . . . . . 0 N--CA 1.471 0.618 0 CA-C-N 118.163 0.438 . . . . 0.0 110.624 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 47' ' ' LEU . 10.2 mp . . . . . 0 N--CA 1.463 0.187 0 CA-C-O 120.8 0.333 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -81.93 65.03 6.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.935 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.13 3.15 0.76 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.52 172.73 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.453 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 60.6 m -115.43 162.28 17.38 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.507 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.7 t -55.41 -42.2 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 120.67 0.272 . . . . 0.0 111.058 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.3 m -58.11 -23.93 56.74 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.26 -31.98 60.94 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.995 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.737 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.5 mp -64.67 -65.86 0.62 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.533 -177.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -53.24 -36.13 60.72 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.538 ' O ' ' N ' ' A' ' 61' ' ' GLY . 11.6 pt -79.18 -19.02 12.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.188 0.518 . . . . 0.0 109.713 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.96 -40.02 95.14 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.011 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.781 ' N ' HD22 ' A' ' 59' ' ' LEU . 1.8 mm? -75.81 -53.09 9.02 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.283 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.26 -37.03 74.82 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 119.93 -53.24 0.69 Allowed Glycine 0 N--CA 1.465 0.61 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.582 ' C ' ' H ' ' A' ' 64' ' ' GLU . 2.5 t -137.54 147.38 45.1 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.98 0.419 . . . . 0.0 110.864 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -59.99 7.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.485 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.582 ' H ' ' C ' ' A' ' 62' ' ' SER . 53.2 mm-40 -81.5 -52.51 7.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.434 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -96.79 -7.27 34.14 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.3 m -47.36 -31.32 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.786 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -52.38 -33.29 42.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 0.0 110.235 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 17.2 mtt -80.6 -21.19 41.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.395 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.424 ' HG ' ' H ' ' A' ' 71' ' ' THR . 23.0 tp -65.41 122.4 17.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.499 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -47.09 -20.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.336 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.424 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 4.1 m -58.12 124.46 70.29 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.59 -86.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.532 1.488 . . . . 0.0 111.976 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 18.1 ptt? -173.59 -28.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.051 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.4 m -86.05 -17.97 33.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HB1' HD23 ' A' ' 22' ' ' LEU . . . -62.22 -35.78 79.95 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.96 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.714 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -66.73 -51.95 50.05 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.28 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.29 -32.41 64.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -69.52 -55.58 9.79 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.945 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -67.07 -61.94 1.68 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.439 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.447 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.7 p -35.18 -27.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.013 0.435 . . . . 0.0 111.355 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.55 ' N ' ' O ' ' A' ' 79' ' ' ALA . 47.3 ttm-85 -75.9 -59.56 2.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.149 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.515 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 49.4 mt -46.04 -40.53 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.692 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.88 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -79.84 -33.09 40.53 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 119.341 -0.944 . . . . 0.0 109.527 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -52.01 -21.52 3.19 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.771 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.67 16.07 55.52 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -104.33 -1.33 27.09 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.515 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -36.0 -35.31 0.07 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.382 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.66 -179.907 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.553 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 3.5 mp . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -49.77 -46.5 50.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.152 0.501 . . . . 0.0 110.646 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.466 ' O ' HG22 ' A' ' 15' ' ' ILE . 25.2 mt -65.17 -8.0 5.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.588 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 13' ' ' LEU . . . -99.15 -15.0 19.11 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.651 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.38 -28.32 61.96 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -57.89 -42.83 85.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.121 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.673 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.77 -33.55 0.52 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.49 ' C ' ' H ' ' A' ' 22' ' ' LEU . 37.4 ttm180 -69.7 -42.99 73.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.017 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.64 -7.49 0.43 Allowed 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.061 0.458 . . . . 0.0 110.051 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' A' ' 20' ' ' ARG . 14.1 mt -116.46 147.62 40.05 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.438 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -60.34 -78.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.968 1.779 . . . . 0.0 113.005 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.87 -10.5 26.39 Favored Glycine 0 N--CA 1.469 0.89 0 C-N-CA 121.409 -0.424 . . . . 0.0 112.654 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.3 m -60.48 130.57 47.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.317 0.559 . . . . 0.0 110.644 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.18 166.89 15.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.551 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.673 HG22 ' HB2' ' A' ' 19' ' ' ALA . 21.6 t -58.44 -59.59 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.739 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.13 10.55 2.45 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.702 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -101.59 -25.78 13.76 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 117.986 0.893 . . . . 0.0 110.572 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.3 tp -86.75 -27.15 23.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.902 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.9 mt . . . . . 0 N--CA 1.464 0.271 0 CA-C-O 120.677 0.275 . . . . 0.0 110.799 -179.786 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 49' ' ' GLY . 77.8 mt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.833 0.349 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 84' ' ' TRP . 70.1 mt-30 -63.16 71.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.801 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -149.7 16.04 1.08 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.461 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -134.84 178.39 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.467 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 67.2 m -115.98 164.23 14.74 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.472 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.6 t -57.41 -47.33 84.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.158 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 57' ' ' ILE . 3.4 m -54.77 -24.69 23.65 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.457 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.461 ' CB ' HG22 ' A' ' 50' ' ' VAL . 9.8 t70 -72.94 -30.95 64.26 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.053 0.454 . . . . 0.0 110.734 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.708 ' N ' HD12 ' A' ' 55' ' ' LEU . 6.6 mp -66.35 -63.35 1.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.529 -178.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -55.95 -37.93 69.67 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.0 pt -73.72 -21.4 18.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.617 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.7 -35.46 91.95 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.872 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.746 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.2 mm? -75.81 -55.48 5.59 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.899 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.551 ' HB2' ' CD1' ' A' ' 69' ' ' LEU . . . -76.29 -31.47 58.24 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.484 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 77.17 -2.36 61.5 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.098 -1.049 . . . . 0.0 111.248 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.526 ' C ' ' H ' ' A' ' 64' ' ' GLU . 22.2 t -131.03 99.37 4.87 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.921 0.391 . . . . 0.0 111.409 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -54.11 -2.73 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.036 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 62' ' ' SER . 27.9 tt0 -95.5 -44.28 7.59 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.298 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.79 -12.35 48.29 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 62' ' ' SER . 15.2 m -54.12 -22.4 7.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.856 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -65.19 -14.2 60.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.193 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 51.7 mtt -105.71 -18.59 14.02 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.843 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.551 ' CD1' ' HB2' ' A' ' 60' ' ' ALA . 1.2 mt -49.05 139.96 9.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.121 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 20.2 p-10 -58.27 -30.39 66.56 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.3 m -60.89 119.53 45.59 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.225 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.41 ' O ' HD21 ' A' ' 76' ' ' LEU . 72.2 Cg_endo -72.94 -154.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.313 1.342 . . . . 0.0 111.233 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.43 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 37.1 ttm -112.72 1.29 15.6 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.872 0.368 . . . . 0.0 110.059 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.0 m -107.1 -27.89 10.33 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.101 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.453 ' HB1' HD23 ' A' ' 22' ' ' LEU . . . -60.35 -35.42 75.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.548 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.905 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -63.75 -49.74 71.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.448 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.522 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 2.0 mptp? -54.63 -35.86 63.9 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.445 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.73 -59.4 3.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.92 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.45 -61.77 2.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.9 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.438 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 2.7 p -35.19 -27.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.049 0.452 . . . . 0.0 111.545 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 79' ' ' ALA . 29.0 ttm180 -78.01 -56.65 4.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.619 0.723 . . . . 0.0 109.818 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.544 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 42.8 mt -46.5 -45.09 6.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.901 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.866 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -74.49 -36.58 63.27 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.702 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.495 ' O ' ' NE2' ' A' ' 48' ' ' GLN . 0.7 OUTLIER -47.33 -19.58 0.16 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.104 -179.859 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.434 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 85.16 15.46 66.86 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 88' ' ' GLU . 25.0 tt0 -108.29 0.37 21.26 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.544 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -32.97 -31.95 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.63 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 86' ' ' GLU . 37.5 mt-10 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.707 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 4.5 mp . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.756 0.312 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.471 HH21 ' HB3' ' A' ' 87' ' ' ALA . 53.2 mtp180 -45.72 -44.75 13.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.965 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.666 HD12 ' N ' ' A' ' 15' ' ' ILE . 1.8 mp -64.37 -15.72 17.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.336 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 13' ' ' LEU . . . -99.6 -17.29 17.9 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.368 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -71.74 -28.14 63.47 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -60.56 -39.98 89.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.458 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.701 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -42.93 -34.78 1.03 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.659 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.437 ' C ' ' H ' ' A' ' 22' ' ' LEU . 65.8 ttt180 -66.12 -39.05 89.6 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.884 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -59.43 -6.87 1.15 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.134 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.437 ' H ' ' C ' ' A' ' 20' ' ' ARG . 14.9 mt -119.81 117.33 32.54 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.62 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.49 70.29 7.59 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.889 1.726 . . . . 0.0 112.48 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 146.14 -52.14 0.58 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.0 m -60.47 133.0 55.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.974 0.416 . . . . 0.0 111.145 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.99 168.23 13.02 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.077 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.701 HG22 ' HB2' ' A' ' 19' ' ' ALA . 18.2 t -58.77 -58.56 6.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.141 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.7 11.13 3.51 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.643 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.402 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 40.0 mm-40 -99.51 -15.26 18.73 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.952 0.876 . . . . 0.0 110.587 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.5 tp -100.75 -27.74 13.19 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.66 HD22 ' N ' ' A' ' 31' ' ' LEU . 3.0 mm? . . . . . 0 N--CA 1.465 0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 110.846 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.515 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 3.0 mm? . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.04 0.448 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -70.81 72.82 0.56 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.438 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.42 5.68 0.46 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.447 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -133.82 176.12 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.953 0.376 . . . . 0.0 110.163 179.811 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.474 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 9.3 m -115.38 165.59 12.8 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.462 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.5 t -57.64 -49.11 81.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.31 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.4 m -53.18 -24.62 11.25 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.592 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.447 ' CB ' HG22 ' A' ' 50' ' ' VAL . 32.9 t0 -74.16 -31.4 62.68 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.33 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.712 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.9 mp -66.1 -62.26 1.58 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 -178.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -55.55 -38.98 70.03 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 61' ' ' GLY . 15.1 pt -73.77 -24.96 20.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.418 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.79 -33.06 81.43 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.943 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.755 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.0 mm? -80.19 -56.39 4.25 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.107 0.453 . . . . 0.0 111.291 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.64 -30.44 61.63 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.726 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 81.48 -13.82 32.62 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.747 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.542 ' O ' HG13 ' A' ' 66' ' ' VAL . 2.7 p -121.67 103.76 9.12 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.918 0.39 . . . . 0.0 111.313 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.96 -0.06 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.597 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.536 ' H ' ' C ' ' A' ' 62' ' ' SER . 47.1 tt0 -96.27 -41.56 8.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.172 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -90.88 -12.11 37.18 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 62' ' ' SER . 13.7 m -54.91 -22.05 9.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.982 0.42 . . . . 0.0 111.232 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -57.73 -19.89 30.68 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.136 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 28.8 mtt -108.21 -5.16 17.02 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.553 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.498 HD23 ' H ' ' A' ' 70' ' ' ASP . 0.5 OUTLIER -48.84 151.11 1.28 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.283 -179.472 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.498 ' H ' HD23 ' A' ' 69' ' ' LEU . 8.4 t70 -67.63 -39.36 84.67 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 72' ' ' PRO . 81.9 m -61.1 112.99 6.66 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.682 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 71' ' ' THR . 50.1 Cg_exo -51.82 -164.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.594 1.53 . . . . 0.0 112.084 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.4 ptt? -105.32 -15.9 14.91 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.659 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.3 m -96.63 -19.25 19.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.243 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.436 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -67.44 -30.91 70.77 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.123 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.886 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.5 mm? -64.5 -49.6 70.68 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.526 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.7 OUTLIER -54.45 -33.58 59.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.548 179.448 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -72.09 -59.78 2.57 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.79 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -57.05 -63.45 1.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.342 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.425 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 2.3 p -35.1 -27.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.923 0.392 . . . . 0.0 111.744 -178.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 79' ' ' ALA . 46.6 ttm-85 -76.44 -60.07 2.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.534 0.683 . . . . 0.0 110.423 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.487 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 36.3 mt -43.61 -43.11 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.156 -178.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.877 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -76.65 -34.39 58.28 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 119.137 -1.025 . . . . 0.0 109.873 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -52.64 -18.03 1.58 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.676 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.56 14.67 67.61 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -102.3 1.62 35.92 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.487 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -36.78 -37.24 0.13 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.086 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.679 -179.924 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 120.685 0.279 . . . . 0.0 110.269 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 1.395 ' CD ' ' CG2' ' A' ' 82' ' ' ILE . 1.9 tmm_? -81.52 -20.6 39.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.156 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.503 HD13 ' HE ' ' A' ' 14' ' ' ARG . 7.6 mm -62.84 -26.03 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.218 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.02 -23.85 19.39 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.7 -33.62 76.38 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.19 -45.63 75.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.454 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.67 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -43.48 -36.07 1.87 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -63.43 -41.99 98.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.187 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -63.19 -7.26 5.53 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.045 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.4 mt -120.03 110.24 36.62 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.81 65.07 8.57 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.741 1.627 . . . . 0.0 112.394 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.33 -37.35 0.52 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.636 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.8 m -80.59 139.55 36.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.003 0.43 . . . . 0.0 111.432 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.43 166.79 15.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.91 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.67 HG22 ' HB2' ' A' ' 19' ' ' ALA . 25.7 t -60.52 -60.27 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.078 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.52 11.65 5.28 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.298 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.454 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 13.0 mm100 -99.0 -17.49 18.27 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.695 0.748 . . . . 0.0 110.286 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 45.8 tp -93.38 -18.28 22.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.826 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.741 0.305 . . . . 0.0 111.155 -179.797 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 49' ' ' GLY . 5.7 tp . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.65 0.262 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -64.1 70.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.169 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -153.12 7.67 0.47 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.413 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -124.24 175.74 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.444 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 67.0 m -119.57 164.04 16.43 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.479 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.9 t -56.45 -43.99 79.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.333 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.7 m -56.85 -23.46 44.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.413 ' CB ' HG22 ' A' ' 50' ' ' VAL . 11.8 t70 -75.21 -32.52 61.21 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.231 0.539 . . . . 0.0 110.837 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.724 ' N ' HD12 ' A' ' 55' ' ' LEU . 6.0 mp -63.87 -66.63 0.52 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.629 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -54.25 -34.82 61.61 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.7 pt -78.58 -20.51 13.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.8 -37.03 88.16 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.858 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.704 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.3 mm? -76.45 -53.63 7.85 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.579 -0.448 . . . . 0.0 109.902 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.56 -36.71 76.56 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 121.25 -53.23 0.71 Allowed Glycine 0 N--CA 1.466 0.668 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.663 ' C ' ' H ' ' A' ' 64' ' ' GLU . 4.1 m -139.19 150.87 46.07 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.94 0.4 . . . . 0.0 110.916 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -60.13 22.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.639 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.663 ' H ' ' C ' ' A' ' 62' ' ' SER . 27.3 mt-10 -96.62 -60.33 1.63 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.698 0.285 . . . . 0.0 110.624 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -83.4 -13.08 55.66 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.5 m -47.51 -24.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.377 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -58.95 -35.0 72.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.345 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 24.9 mmt -84.97 -33.59 22.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.653 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.4 tp -49.89 122.01 6.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 110.16 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -55.88 -25.35 42.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.666 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 72' ' ' PRO . 26.1 m -50.13 108.62 1.05 Allowed Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.226 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 71' ' ' THR . 32.5 Cg_exo -54.8 -154.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.37 1.38 . . . . 0.0 112.196 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.4 ptm -115.75 -20.89 9.88 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.565 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.4 m -90.26 -19.87 23.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.538 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -64.78 -34.89 79.42 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.202 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.932 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.3 mm? -66.49 -50.88 61.78 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.31 -31.84 64.06 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -70.9 -56.82 5.41 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.779 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -64.7 -61.25 2.3 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.433 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.426 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 2.4 p -35.87 -26.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.22 0.533 . . . . 0.0 111.21 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 79' ' ' ALA . 15.9 ttm180 -78.87 -53.54 6.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.108 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 1.395 ' CG2' ' CD ' ' A' ' 14' ' ' ARG . 46.3 mt -50.29 -44.38 23.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.138 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 1.146 ' HA ' ' CZ ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -76.38 -35.57 58.57 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.639 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.636 ' N ' HH12 ' A' ' 14' ' ' ARG . 0.6 OUTLIER -45.6 -28.0 0.88 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.249 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.833 ' H ' HH12 ' A' ' 14' ' ' ARG . . . 96.13 13.66 48.32 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 88' ' ' GLU . 27.0 tt0 -105.95 -2.91 22.36 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.581 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -33.48 -34.44 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.392 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 86' ' ' GLU . 69.3 mm-40 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.539 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.566 ' N ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -75.09 -39.98 60.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.445 ' O ' HG22 ' A' ' 15' ' ' ILE . 55.1 mt -63.63 -13.04 12.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.456 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.73 -17.51 24.14 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.797 0.332 . . . . 0.0 110.771 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -70.79 -32.44 69.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.17 -44.19 74.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.291 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.691 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.59 -37.02 1.04 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.012 0.434 . . . . 0.0 109.969 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.405 ' C ' ' H ' ' A' ' 22' ' ' LEU . 54.8 ttm-85 -63.55 -41.72 98.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.527 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.75 -7.12 0.89 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.55 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 20' ' ' ARG . 12.0 mt -119.0 114.06 35.41 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -79.35 68.94 8.13 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.657 1.571 . . . . 0.0 112.293 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.81 -49.6 0.56 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.3 m -66.79 133.77 50.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.971 0.415 . . . . 0.0 111.589 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.14 173.03 11.4 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.038 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.691 HG22 ' HB2' ' A' ' 19' ' ' ALA . 21.4 t -63.62 -63.55 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.139 0.495 . . . . 0.0 111.09 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.52 11.93 2.91 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.045 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.442 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 10.9 mm100 -99.62 -24.97 14.57 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.514 0.657 . . . . 0.0 110.607 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.7 tt -85.3 -19.8 30.98 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.926 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.508 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.3 0 CA-C-O 121.004 0.431 . . . . 0.0 109.981 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.473 HD22 ' N ' ' A' ' 47' ' ' LEU . 3.7 mm? . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.753 0.311 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -84.11 69.65 10.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.938 0.399 . . . . 0.0 110.533 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.0 -2.85 0.14 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.458 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -123.23 172.82 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.637 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.444 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 3.5 m -115.95 161.71 18.43 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.459 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.4 t -53.37 -44.26 54.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 123.213 0.321 . . . . 0.0 110.985 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 57' ' ' ILE . 3.6 m -58.12 -22.92 53.02 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.458 ' CB ' HG22 ' A' ' 50' ' ' VAL . 9.6 t0 -75.39 -31.93 60.62 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.452 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.726 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.8 mp -64.5 -67.57 0.42 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.42 -177.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -52.12 -34.73 45.62 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.6 pt -79.7 -19.17 12.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.71 -41.08 84.79 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.681 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.4 mm? -73.48 -54.37 8.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.583 -0.447 . . . . 0.0 109.833 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.75 -37.06 79.11 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 118.8 -51.96 0.73 Allowed Glycine 0 N--CA 1.468 0.809 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.593 ' C ' ' H ' ' A' ' 64' ' ' GLU . 83.8 p -138.38 145.91 41.63 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.75 0.31 . . . . 0.0 110.842 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -59.92 6.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.195 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.593 ' H ' ' C ' ' A' ' 62' ' ' SER . 32.7 mt-10 -82.3 -54.72 5.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.299 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -96.74 -5.3 38.93 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 m -44.82 -26.33 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.611 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -57.04 -32.17 65.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.017 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 25.3 mmm -92.04 -7.64 48.23 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.363 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.483 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 30.1 tp -49.57 -84.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.212 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 1.3 t70 154.23 -26.78 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.408 ' OG1' ' CD2' ' A' ' 69' ' ' LEU . 3.4 m -62.4 135.12 95.17 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.018 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.6 -92.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.793 1.662 . . . . 0.0 112.28 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -172.59 -26.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.1 m -88.52 -18.9 27.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.9 -35.84 81.73 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.714 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.944 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.4 mm? -64.46 -49.78 70.11 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -70.15 -9.21 54.93 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.954 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -86.04 -50.4 7.07 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.577 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -70.21 -57.84 4.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.301 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.411 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.3 p -35.22 -25.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.11 0.481 . . . . 0.0 111.167 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.577 ' N ' ' O ' ' A' ' 79' ' ' ALA . 21.4 ttm180 -78.44 -55.61 5.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.819 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.517 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 49.7 mt -50.72 -41.5 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.287 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.858 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.54 -35.82 52.88 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.309 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.401 ' CE3' ' O ' ' A' ' 80' ' ' VAL . 0.6 OUTLIER -45.86 -22.13 0.17 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.439 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.442 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 86.57 18.18 59.0 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 87' ' ' ALA . 85.0 mt-10 -111.29 -0.23 16.48 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.479 0.18 . . . . 0.0 110.518 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.517 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -31.86 -58.36 0.28 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.689 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.749 -179.764 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.595 ' N ' HD23 ' A' ' 13' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 120.636 0.255 . . . . 0.0 111.637 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.1 mtm-85 -50.04 -34.68 22.23 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.6 mm -64.16 -24.03 34.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.905 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.73 -19.8 22.23 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.567 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.99 -32.48 69.32 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -56.24 -43.93 79.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.329 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.688 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -40.41 -36.36 0.54 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.435 ' C ' ' H ' ' A' ' 22' ' ' LEU . 72.8 mtt-85 -65.9 -42.51 90.12 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.342 -0.39 . . . . 0.0 109.948 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.48 -6.14 0.65 Allowed 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.345 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.435 ' H ' ' C ' ' A' ' 20' ' ' ARG . 8.7 mt -121.11 112.41 33.27 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.633 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -83.5 65.46 7.56 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.959 1.773 . . . . 0.0 112.414 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.9 -35.87 0.62 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.472 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.8 m -81.9 135.0 35.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.947 0.403 . . . . 0.0 111.333 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.77 170.47 14.13 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.015 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.688 HG22 ' HB2' ' A' ' 19' ' ' ALA . 23.4 t -61.72 -61.44 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.75 10.32 4.19 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.19 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.419 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 21.0 mm100 -99.19 -25.4 14.53 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.427 0.614 . . . . 0.0 110.574 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.7 tp -88.09 -26.17 22.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.444 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 31' ' ' LEU . 3.4 mm? . . . . . 0 C--N 1.331 -0.239 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.527 HD22 ' N ' ' A' ' 47' ' ' LEU . 3.3 mm? . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.535 0.207 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -78.06 63.9 3.13 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.388 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.64 1.34 0.6 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.457 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -130.16 173.62 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.469 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 36.0 m -116.0 164.8 13.9 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.463 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.2 t -55.23 -47.71 77.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 O-C-N 123.27 0.356 . . . . 0.0 111.313 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.4 m -54.81 -24.32 22.26 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.457 ' CB ' HG22 ' A' ' 50' ' ' VAL . 38.1 t0 -74.74 -31.76 61.91 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.846 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.719 ' N ' HD12 ' A' ' 55' ' ' LEU . 6.2 mp -65.27 -65.52 0.66 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.241 -178.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -53.63 -34.25 57.88 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.5 pt -78.77 -18.63 13.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.66 -38.79 67.49 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.656 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.5 mm? -74.76 -55.5 5.78 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.47 -37.15 84.48 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 100.26 -28.9 13.63 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.801 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.597 ' C ' ' H ' ' A' ' 64' ' ' GLU . 14.9 p -138.2 132.42 31.82 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.386 0.612 . . . . 0.0 112.131 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.434 ' HG3' ' H ' ' A' ' 63' ' ' GLU . 2.2 mt-10 -58.59 7.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.867 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.597 ' H ' ' C ' ' A' ' 62' ' ' SER . 54.2 mt-10 -93.81 -52.44 4.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.895 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -80.96 -16.28 53.93 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.3 m -50.18 -23.69 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.263 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -61.04 -30.39 70.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.425 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 37.8 mtt -91.77 -34.34 14.64 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.982 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.2 tp -49.28 108.4 0.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.944 0.402 . . . . 0.0 110.06 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -42.84 -24.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.812 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 72' ' ' PRO . 14.8 m -45.69 106.29 0.54 Allowed Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.633 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.447 ' O ' HD21 ' A' ' 76' ' ' LEU . 52.5 Cg_exo -52.73 -168.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.311 1.341 . . . . 0.0 111.262 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 40.8 ttp -106.07 -7.55 17.96 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.2 t -100.18 -26.27 13.99 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.209 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.02 -34.5 70.11 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.036 0.445 . . . . 0.0 110.301 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.915 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -67.78 -59.66 3.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.563 0.696 . . . . 0.0 109.603 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -60.08 -10.17 4.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.205 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -87.64 -52.88 5.08 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -68.84 -56.74 7.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.182 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.424 ' O ' ' CE3' ' A' ' 84' ' ' TRP . 1.4 p -35.06 -25.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 121.219 0.533 . . . . 0.0 111.316 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 79' ' ' ALA . 39.5 ttm180 -78.75 -56.58 4.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.565 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.557 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 41.8 mt -47.33 -42.48 7.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.896 -178.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.845 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.37 -36.17 53.82 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.892 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.424 ' CE3' ' O ' ' A' ' 80' ' ' VAL . 0.7 OUTLIER -46.63 -24.35 0.53 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.674 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 90.63 18.94 46.36 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 88' ' ' GLU . 45.2 mt-10 -110.15 -0.05 18.07 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.557 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -35.94 -26.58 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.358 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 86' ' ' GLU . 67.0 mm-40 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.238 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.596 ' N ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.437 0 CA-C-O 120.733 0.301 . . . . 0.0 111.329 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.752 HH21 ' HB3' ' A' ' 87' ' ' ALA . 71.9 mtp180 -43.54 -43.33 5.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.645 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 mm -63.53 -21.62 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.625 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -97.45 -17.24 19.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -69.73 -32.28 70.73 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.07 -46.03 71.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.313 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.66 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -39.7 -36.37 0.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.337 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.481 ' C ' ' H ' ' A' ' 22' ' ' LEU . 73.6 ttt-85 -64.33 -42.37 96.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.837 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.39 -4.72 0.41 Allowed 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.348 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 20' ' ' ARG . 8.5 mt -122.8 111.96 30.86 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.566 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.04 67.18 8.71 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 121.713 1.609 . . . . 0.0 112.22 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.39 -43.97 0.58 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.637 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.3 m -75.2 133.43 41.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.938 0.399 . . . . 0.0 111.34 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.64 173.3 11.49 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.081 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.66 HG22 ' HB2' ' A' ' 19' ' ' ALA . 22.2 t -62.8 -62.59 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.672 -179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.84 11.37 3.52 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.091 -178.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.456 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 20.1 mm-40 -100.14 -24.36 14.6 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 117.487 0.644 . . . . 0.0 110.891 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.6 tt -92.79 -23.52 18.84 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.981 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.6 mt . . . . . 0 C--N 1.328 -0.34 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.87 -179.761 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.504 0.193 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -70.51 70.76 0.45 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.361 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.22 7.45 0.74 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.78 175.7 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.488 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 9.0 m -113.21 163.84 14.28 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.503 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.4 t -56.27 -43.77 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 123.209 0.318 . . . . 0.0 111.414 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.8 m -55.33 -25.72 36.43 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -76.47 -30.94 57.49 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.912 0.387 . . . . 0.0 111.544 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.737 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.6 mp -65.62 -65.09 0.72 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -50.81 -34.86 29.39 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 61' ' ' GLY . 8.9 pt -83.08 -21.69 8.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.336 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.26 -38.12 95.68 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.727 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.1 mm? -74.59 -62.3 1.58 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.711 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.11 -34.17 77.04 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.325 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 86.93 -8.74 74.96 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.479 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.506 ' C ' ' H ' ' A' ' 64' ' ' GLU . 1.9 m -138.01 104.52 5.27 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 117.106 0.453 . . . . 0.0 112.022 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -54.24 -6.5 0.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.218 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' A' ' 62' ' ' SER . 28.3 mp0 -83.76 -45.25 13.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.719 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.06 -12.97 34.09 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.416 ' C ' ' N ' ' A' ' 68' ' ' MET . 12.9 m -50.66 -29.39 6.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.105 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -51.52 -15.12 0.38 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.48 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.416 ' N ' ' C ' ' A' ' 66' ' ' VAL . 48.6 mtt -104.45 -25.81 12.66 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.741 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.463 ' HG ' ' H ' ' A' ' 71' ' ' THR . 38.7 tp -51.86 119.26 4.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.165 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -38.99 -29.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.444 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.463 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 33.1 m -65.9 115.08 19.52 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.643 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.487 ' O ' HD21 ' A' ' 76' ' ' LEU . 60.4 Cg_endo -71.27 -156.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.261 1.307 . . . . 0.0 111.43 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -102.15 -17.58 15.94 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.823 0.344 . . . . 0.0 111.526 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.3 m -92.35 -22.96 19.4 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.702 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -63.61 -32.81 74.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.41 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.862 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.0 OUTLIER -66.37 -48.05 71.39 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.422 -0.911 . . . . 0.0 108.922 179.754 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -32.34 66.51 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.48 -58.77 3.2 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.303 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -62.45 -63.25 1.29 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.403 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 p -34.56 -24.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.991 0.424 . . . . 0.0 111.673 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 79' ' ' ALA . 32.4 ttm180 -78.24 -57.53 3.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 109.82 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.464 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 42.0 mt -48.09 -41.44 9.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.148 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.824 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.44 -36.28 53.24 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.332 179.774 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -49.75 -15.1 0.15 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.482 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 79.46 19.53 71.22 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 88' ' ' GLU . 79.4 mt-10 -113.0 7.1 18.01 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.752 ' HB3' HH21 ' A' ' 14' ' ' ARG . . . -35.73 -26.01 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.279 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 86' ' ' GLU . 28.9 mt-10 . . . . . 0 N--CA 1.463 0.211 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.222 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 N--CA 1.465 0.278 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.664 ' HE ' ' CB ' ' A' ' 87' ' ' ALA . 15.4 ttt85 -71.54 -32.31 67.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.229 -178.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.3 mm -54.35 -16.19 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.476 ' HA ' HG13 ' A' ' 27' ' ' VAL . . . -97.75 -25.35 15.1 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.248 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.91 -38.2 84.9 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.14 -42.34 69.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.377 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.679 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.82 -38.89 1.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.12 178.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.453 ' C ' ' H ' ' A' ' 22' ' ' LEU . 39.0 ttt85 -66.08 -42.26 89.6 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.839 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.48 -5.77 0.24 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.975 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 20' ' ' ARG . 8.6 mt -122.39 105.45 36.4 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.423 -178.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -80.48 78.06 3.82 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 121.562 1.508 . . . . 0.0 112.086 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.62 -30.64 1.26 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.6 m -96.18 142.7 28.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.026 0.441 . . . . 0.0 111.296 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.14 178.52 6.61 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.219 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.679 HG22 ' HB2' ' A' ' 19' ' ' ALA . 22.9 t -66.4 -65.47 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.904 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.74 13.77 3.9 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.129 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -100.33 -16.11 17.78 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.166 0.483 . . . . 0.0 110.472 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 pp -94.65 -20.81 19.24 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.469 0.515 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.249 -179.78 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.0 tp . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.825 0.345 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -85.52 71.73 10.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.512 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.34 7.44 0.84 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 120.949 -0.644 . . . . 0.0 111.643 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.1 177.92 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.676 0.274 . . . . 0.0 110.361 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.48 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 33.7 m -112.78 162.46 15.75 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.505 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.9 t -57.2 -44.32 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 120.667 0.27 . . . . 0.0 111.139 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.9 m -56.88 -22.07 34.34 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -77.25 -30.59 54.51 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.211 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.73 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.9 mp -65.93 -64.47 0.85 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.211 -177.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -52.99 -34.13 54.74 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 61' ' ' GLY . 7.4 pt -83.38 -18.86 10.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.668 0.271 . . . . 0.0 110.948 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.29 -33.22 86.66 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.757 ' N ' HD22 ' A' ' 59' ' ' LEU . 1.8 mm? -79.23 -57.25 3.81 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.578 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.58 -32.78 64.3 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.125 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 84.75 -5.11 83.3 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.538 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.511 ' C ' ' H ' ' A' ' 64' ' ' GLU . 69.0 m -137.9 99.22 3.84 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.942 0.401 . . . . 0.0 111.635 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 63' ' ' GLU . 0.1 OUTLIER -50.88 -8.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.72 179.246 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.511 ' H ' ' C ' ' A' ' 62' ' ' SER . 32.6 tt0 -87.62 -41.31 13.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.835 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -89.8 -18.17 26.78 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.6 m -46.74 -23.07 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.967 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 67' ' ' ASP . 56.1 t0 -50.72 -34.57 27.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.46 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 68' ' ' MET . 0.0 OUTLIER -82.5 -32.83 28.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.637 179.761 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.403 ' HG ' ' H ' ' A' ' 71' ' ' THR . 25.3 tp -49.91 116.22 1.72 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.114 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -42.45 -26.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.89 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.403 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 6.7 m -62.15 112.51 6.47 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 119.343 -0.36 . . . . 0.0 110.699 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.517 ' O ' HD21 ' A' ' 76' ' ' LEU . 72.5 Cg_endo -73.47 -157.58 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.345 1.364 . . . . 0.0 111.748 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.7 ttm -103.72 -10.85 18.01 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.557 0.217 . . . . 0.0 110.776 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.2 m -94.51 -23.2 17.79 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.881 0.372 . . . . 0.0 110.39 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -63.93 -36.24 83.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.921 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -67.55 -47.26 70.34 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.654 -0.818 . . . . 0.0 109.092 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -26.03 61.06 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.48 -57.88 3.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.721 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.21 -64.69 0.86 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.06 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.427 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.2 p -34.89 -27.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.3 0.571 . . . . 0.0 111.146 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.564 ' N ' ' O ' ' A' ' 79' ' ' ALA . 23.7 ttm180 -78.47 -55.84 4.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.654 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.475 ' N ' ' O ' ' A' ' 79' ' ' ALA . 33.7 mt -47.68 -41.53 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.22 -178.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.854 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -78.16 -34.99 49.37 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.714 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -52.49 -14.26 0.47 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.744 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.429 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 81.12 17.71 71.32 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 87' ' ' ALA . 52.0 mt-10 -114.05 8.84 17.17 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.664 ' CB ' ' HE ' ' A' ' 14' ' ' ARG . . . -31.89 -48.81 0.16 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.776 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.67 -179.872 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.55 ' N ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 120.743 0.306 . . . . 0.0 111.518 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -44.42 -48.9 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.973 0.416 . . . . 0.0 110.992 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.2 mm -65.39 -15.47 18.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.586 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.73 -16.68 17.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.093 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -71.62 -30.14 65.45 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -59.38 -42.04 90.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.512 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.694 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -40.35 -33.44 0.25 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.461 ' C ' ' H ' ' A' ' 22' ' ' LEU . 56.7 ttt-85 -69.26 -42.48 75.51 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.294 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.73 -7.65 0.47 Allowed 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.078 0.466 . . . . 0.0 110.207 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' ' 79' ' ' ALA . 14.0 mt -113.91 149.69 42.27 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.855 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.18 -88.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.094 1.863 . . . . 0.0 112.552 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.34 -7.03 52.65 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.455 -0.403 . . . . 0.0 112.303 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.9 m -60.84 137.51 58.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.149 0.474 . . . . 0.0 110.628 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.16 164.34 13.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.985 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.694 HG22 ' HB2' ' A' ' 19' ' ' ALA . 17.0 t -55.2 -53.27 36.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.659 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.82 5.37 24.6 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.451 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -97.23 -24.34 15.75 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.74 0.77 . . . . 0.0 110.305 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 pp -84.12 -24.72 30.15 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.352 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.6 tp . . . . . 0 N--CA 1.463 0.203 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.882 -179.879 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 49' ' ' GLY . 1.3 tt . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 84' ' ' TRP . 71.9 mt-30 -61.41 70.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.514 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -151.9 13.56 0.75 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -128.63 173.05 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.471 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 40.3 m -112.75 161.59 16.71 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.512 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.6 t -55.62 -39.93 57.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 120.798 0.332 . . . . 0.0 110.546 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 m -58.62 -25.11 62.32 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.053 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -75.47 -31.64 60.33 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.183 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.758 ' N ' HD12 ' A' ' 55' ' ' LEU . 4.9 mp -66.45 -60.85 2.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.439 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -56.91 -36.04 69.71 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 61' ' ' GLY . 15.6 pt -75.93 -29.66 20.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.62 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.26 -27.49 39.76 Favored Glycine 0 CA--C 1.517 0.195 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.5 HD23 ' N ' ' A' ' 59' ' ' LEU . 3.8 mt -83.27 -64.15 1.22 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.805 -0.697 . . . . 0.0 112.433 -176.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.76 -20.93 60.36 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.169 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 70.83 -0.61 27.81 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.399 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.488 ' C ' ' H ' ' A' ' 64' ' ' GLU . 15.0 t -136.0 95.69 3.26 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.929 0.395 . . . . 0.0 111.437 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -54.29 -6.41 0.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.707 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.488 ' H ' ' C ' ' A' ' 62' ' ' SER . 28.8 mt-10 -90.23 -32.49 16.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.732 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -101.53 -11.64 19.12 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 m -52.82 -25.46 8.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.443 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -53.74 -23.33 11.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.208 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 7.0 mmt -94.83 -31.11 13.87 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.663 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.476 ' CD2' ' OG1' ' A' ' 71' ' ' THR . 30.4 tp -49.67 127.47 15.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.219 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -39.74 -31.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.391 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.476 ' OG1' ' CD2' ' A' ' 69' ' ' LEU . 1.4 m -48.57 110.28 1.42 Allowed Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.616 ' C ' ' H ' ' A' ' 74' ' ' SER . 91.5 Cg_endo -80.23 29.48 0.51 Allowed 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.321 2.014 . . . . 0.0 113.507 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.468 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 19.4 ttp 55.78 -7.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.616 ' H ' ' C ' ' A' ' 72' ' ' PRO . 22.8 t -100.82 -16.14 17.38 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.165 0.507 . . . . 0.0 109.91 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -74.02 -31.22 62.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.264 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.921 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.1 mm? -65.9 -51.8 55.58 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.63 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.5 OUTLIER -48.25 -36.97 15.02 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.254 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.63 -59.05 3.05 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.375 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.573 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.5 -62.86 1.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.482 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.455 ' N ' ' O ' ' A' ' 76' ' ' LEU . 2.1 p -35.26 -25.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.007 0.432 . . . . 0.0 111.475 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 79' ' ' ALA . 28.1 ttm180 -78.3 -56.47 4.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.635 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.488 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 44.7 mt -47.78 -43.81 10.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.849 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.854 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -75.48 -36.51 60.62 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 119.253 -0.979 . . . . 0.0 109.751 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.49 ' O ' ' NE2' ' A' ' 48' ' ' GLN . 0.7 OUTLIER -46.9 -22.08 0.28 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.836 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.419 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 88.18 13.87 63.25 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 87' ' ' ALA . 5.5 tp10 -109.28 2.54 20.89 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -28.96 -42.68 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.996 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.772 -179.854 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 5.9 mp . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 46.3 mtt85 -78.27 -32.08 49.34 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 15' ' ' ILE . 63.9 mt -66.11 -16.14 20.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.75 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.36 -17.28 21.72 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.275 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.435 HD23 ' O ' ' A' ' 13' ' ' LEU . 1.9 mm? -73.25 -30.42 63.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.37 -42.22 73.64 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.096 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.687 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.12 -36.3 0.7 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.171 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 22' ' ' LEU . 70.9 mtp180 -63.68 -40.3 96.46 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.58 -4.32 0.4 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.443 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.48 ' H ' ' C ' ' A' ' 20' ' ' ARG . 10.2 mt -122.89 115.55 29.26 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -82.01 64.02 8.38 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.814 1.676 . . . . 0.0 112.437 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.57 -48.84 0.48 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.56 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.2 m -68.41 133.46 48.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.959 0.409 . . . . 0.0 111.225 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.22 171.45 11.94 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.025 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.687 HG22 ' HB2' ' A' ' 19' ' ' ALA . 21.7 t -60.93 -60.38 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.431 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.1 9.32 7.01 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.595 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.48 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 28.0 mm100 -99.61 -18.95 17.08 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 117.948 0.874 . . . . 0.0 110.411 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.5 tp -93.36 -19.64 21.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.063 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 21.6 mt . . . . . 0 N--CA 1.465 0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 110.849 -179.874 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.492 ' N ' HD12 ' A' ' 47' ' ' LEU . 10.9 mp . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.881 0.372 . . . . 0.0 110.334 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -75.97 73.89 2.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.816 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -157.66 14.56 0.29 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.447 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.4 OUTLIER -124.96 174.19 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.686 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.441 ' N ' HG13 ' A' ' 50' ' ' VAL . 14.1 m -115.33 160.13 20.2 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.479 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.2 t -53.32 -37.82 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 120.788 0.328 . . . . 0.0 110.494 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 m -61.09 -25.28 66.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.998 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.447 ' CB ' HG22 ' A' ' 50' ' ' VAL . 11.2 t0 -74.56 -30.55 61.78 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.64 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.749 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.9 mp -66.67 -66.53 0.54 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -51.39 -34.79 36.02 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 61' ' ' GLY . 9.6 pt -82.03 -17.36 11.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.28 -41.27 79.53 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.808 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.727 ' N ' HD22 ' A' ' 59' ' ' LEU . 1.9 mm? -74.93 -52.41 11.27 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.789 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.39 -37.93 74.59 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 116.81 -51.57 0.72 Allowed Glycine 0 N--CA 1.468 0.833 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.504 ' C ' ' H ' ' A' ' 64' ' ' GLU . 46.0 p -135.63 141.23 45.02 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.089 0.471 . . . . 0.0 111.116 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -57.91 1.15 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.347 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.504 ' H ' ' C ' ' A' ' 62' ' ' SER . 72.2 mm-40 -75.92 -53.88 7.74 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.422 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -93.24 -9.01 40.63 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -177.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.4 m -50.16 -24.2 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.517 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.26 -15.32 2.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.616 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 52.6 mtp -99.37 -34.76 10.16 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.62 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.7 tp -51.07 124.57 11.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.228 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -61.38 -22.97 65.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.345 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.1 m -49.68 107.65 0.83 Allowed Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.413 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.95 -171.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.224 1.283 . . . . 0.0 111.808 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.3 ptm -98.17 -22.02 16.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.724 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.9 t -89.06 -25.38 21.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.437 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.48 -33.47 69.82 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.302 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.595 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -67.39 -52.96 33.6 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.429 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -65.09 -9.44 22.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.466 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -87.61 -52.18 5.48 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -70.04 -57.79 4.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.587 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.409 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.5 p -34.8 -28.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.287 0.565 . . . . 0.0 110.943 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 79' ' ' ALA . 20.4 ttm105 -74.04 -62.12 1.61 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.807 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.435 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 55.5 mt -45.44 -39.94 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.897 -178.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.883 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -81.42 -28.52 34.23 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.472 179.306 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -64.89 2.87 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.481 -0.488 . . . . 0.0 109.793 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 83' ' ' LEU . . . 65.93 22.16 70.15 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -107.26 2.23 24.48 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.921 0.391 . . . . 0.0 110.157 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.435 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -40.03 -68.88 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.956 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.723 -179.877 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.81 0.338 . . . . 0.0 110.474 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 71.3 mtm180 -84.63 -36.41 22.01 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.44 ' CD1' ' N ' ' A' ' 15' ' ' ILE . 1.2 mp -65.35 -8.92 6.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.257 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.18 -16.81 25.75 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.806 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.34 -30.5 63.38 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.94 -44.99 74.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.732 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.622 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -40.91 -36.16 0.61 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.98 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.443 ' C ' ' H ' ' A' ' 22' ' ' LEU . 57.1 mtp85 -68.1 -40.56 82.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.162 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.08 -6.8 0.65 Allowed 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 120.945 0.402 . . . . 0.0 110.496 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.443 ' H ' ' C ' ' A' ' 20' ' ' ARG . 11.4 mt -118.75 120.3 31.72 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.814 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.3 71.31 7.1 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.879 1.72 . . . . 0.0 112.557 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.42 -54.75 0.6 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.6 m -59.63 128.33 36.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.923 0.392 . . . . 0.0 110.949 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.82 178.19 7.07 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.29 0.567 . . . . 0.0 110.875 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.622 HG22 ' HB2' ' A' ' 19' ' ' ALA . 11.8 t -61.8 -58.77 6.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.904 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.43 2.89 3.9 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.675 -178.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.507 ' OE1' ' N ' ' A' ' 29' ' ' GLN . 3.9 mp0 -100.38 -30.46 11.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.575 0.688 . . . . 0.0 111.236 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 pp -88.37 -27.45 21.6 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.537 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 120.718 0.294 . . . . 0.0 110.733 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.625 0.25 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -75.41 52.14 0.6 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.324 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -136.0 15.87 3.99 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.432 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -128.42 177.96 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.437 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 20.3 m -119.05 164.01 16.14 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.452 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.6 t -56.55 -47.19 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.177 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 57' ' ' ILE . 3.4 m -54.15 -24.18 16.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -178.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.432 ' CB ' HG22 ' A' ' 50' ' ' VAL . 9.7 t70 -74.59 -31.72 62.13 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.074 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.714 ' N ' HD12 ' A' ' 55' ' ' LEU . 6.2 mp -64.96 -64.96 0.74 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.404 -178.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -54.75 -39.53 68.4 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.7 pt -71.52 -23.72 22.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.316 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.75 -30.8 78.74 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 121.164 -0.541 . . . . 0.0 111.756 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.777 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.1 mm? -79.51 -52.96 7.36 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.294 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.5 -30.19 33.35 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.603 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 74.21 4.85 69.69 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.266 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.509 ' C ' ' H ' ' A' ' 64' ' ' GLU . 10.2 t -135.95 93.44 2.93 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.824 0.345 . . . . 0.0 111.307 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -48.57 -10.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.762 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.509 ' H ' ' C ' ' A' ' 62' ' ' SER . 30.9 tt0 -88.66 -42.61 11.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.714 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.17 -15.02 34.75 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.1 m -49.75 -28.96 4.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.77 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -55.47 -27.65 49.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.925 0.393 . . . . 0.0 110.244 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 48.8 mtm -92.33 -24.31 18.97 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.766 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.424 ' HG ' ' H ' ' A' ' 71' ' ' THR . 60.4 tp -53.37 123.0 10.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.931 0.396 . . . . 0.0 110.076 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -40.65 -38.56 0.91 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.661 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.424 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 20.1 m -52.66 107.76 0.92 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.973 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.12 -162.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.161 1.24 . . . . 0.0 111.423 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.467 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 32.4 ttm -109.11 -6.44 15.61 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 61.3 m -100.78 -20.83 15.38 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.138 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.57 -34.06 76.28 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.822 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.933 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -64.08 -45.92 86.6 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.83 179.379 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.531 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 1.1 mptp? -55.83 -34.87 65.79 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.312 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.03 -59.93 2.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.495 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -59.03 -62.99 1.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.432 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.429 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 3.0 p -35.37 -25.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.917 0.389 . . . . 0.0 111.721 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.568 ' N ' ' O ' ' A' ' 79' ' ' ALA . 28.3 ttm180 -77.56 -57.35 3.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.668 0.747 . . . . 0.0 110.074 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.572 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 41.4 mt -47.79 -43.74 10.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.929 -178.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.853 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -75.03 -36.64 61.87 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.557 179.871 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -47.38 -18.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.457 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 83.1 15.52 72.03 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 88' ' ' GLU . 50.2 mm-40 -105.57 -0.63 25.58 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.572 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -36.7 -26.0 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.088 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.587 ' H ' ' CD ' ' A' ' 88' ' ' GLU . 2.7 mp0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.9 ptt? . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.497 ' O ' HG22 ' A' ' 2' ' ' VAL . 4.8 p -166.79 -9.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.368 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.426 ' H ' ' H ' ' A' ' 2' ' ' VAL . 13.1 m 59.26 74.65 0.57 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.37 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.55 121.92 4.86 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.408 2.072 . . . . 0.0 111.966 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.9 p -82.24 -34.92 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.57 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -147.03 164.84 31.72 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.307 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -75.57 -37.01 60.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.78 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.7 m -119.72 139.41 52.32 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.342 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.606 ' O ' ' N ' ' A' ' 12' ' ' ALA . 35.2 ptt180 -70.64 -34.21 71.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -48.35 -31.46 6.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.434 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.3 m -71.19 -24.65 62.27 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.606 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -82.81 -70.16 0.57 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 113.613 -1.631 . . . . 0.0 109.893 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.547 ' CD1' ' H ' ' A' ' 13' ' ' LEU . 5.5 mp -37.02 -31.65 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.808 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 30.8 mtm105 -80.65 -39.49 27.24 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.438 ' O ' HG22 ' A' ' 15' ' ' ILE . 54.7 mt -62.8 -14.68 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.446 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.35 -15.71 17.9 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 13' ' ' LEU . 1.2 mm? -72.73 -31.91 65.32 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.6 -42.87 75.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.218 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.712 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -39.9 -34.36 0.27 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.504 ' C ' ' H ' ' A' ' 22' ' ' LEU . 75.9 ttt-85 -67.23 -41.66 85.32 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.227 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -55.32 -6.73 0.18 Allowed 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.465 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.504 ' H ' ' C ' ' A' ' 20' ' ' ARG . 9.5 mt -116.23 149.33 43.34 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.27 -80.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 121.881 1.721 . . . . 0.0 112.548 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -116.24 7.89 18.48 Favored Glycine 0 N--CA 1.47 0.908 0 C-N-CA 121.44 -0.409 . . . . 0.0 112.467 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.0 m -73.97 126.84 31.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.43 0.615 . . . . 0.0 110.13 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.07 168.11 20.39 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.985 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.712 HG22 ' HB2' ' A' ' 19' ' ' ALA . 21.2 t -61.72 -61.15 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.23 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.91 10.64 4.11 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.085 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -98.57 -25.27 14.79 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 117.44 0.62 . . . . 0.0 110.391 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.2 tt -95.5 -17.8 21.16 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.588 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 31' ' ' LEU . 1.8 tt -89.51 -47.24 8.12 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.965 0.412 . . . . 0.0 110.785 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -43.89 -24.75 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.384 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.2 mm -49.39 -33.2 6.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.452 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.7 tp -56.11 -15.14 3.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.985 0.421 . . . . 0.0 110.029 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.458 ' CG ' ' H ' ' A' ' 36' ' ' GLN . 40.5 t-80 62.9 -127.66 0.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.435 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.458 ' H ' ' CG ' ' A' ' 35' ' ' HIS . 15.9 mm100 53.06 105.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.89 0.376 . . . . 0.0 110.435 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -49.22 -63.67 1.03 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.9 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.9 tt -46.51 144.15 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.813 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -79.75 -76.2 0.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.017 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.4 161.34 2.74 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.41 128.52 11.22 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.647 2.231 . . . . 0.0 111.99 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.57 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.5 mm? -86.84 94.48 9.57 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.985 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 p -81.81 -176.06 5.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.018 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -75.51 -26.04 57.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.417 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -82.19 -33.93 29.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.482 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.0 m -55.7 -46.73 77.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.548 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.5 mt -61.08 -36.17 78.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.696 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -80.36 71.63 7.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.453 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -153.43 -0.28 0.2 Allowed Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.433 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -123.36 175.98 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.449 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 55.7 m -117.03 162.96 16.96 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.481 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.3 t -56.01 -43.71 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.905 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 57' ' ' ILE . 3.2 m -56.52 -25.16 50.92 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.433 ' CB ' HG22 ' A' ' 50' ' ' VAL . 12.5 t70 -74.2 -31.76 62.78 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.08 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.725 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.8 mp -64.92 -65.36 0.68 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.378 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -53.58 -37.21 62.72 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.54 ' O ' ' N ' ' A' ' 61' ' ' GLY . 11.3 pt -77.95 -18.23 13.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.121 0.486 . . . . 0.0 109.994 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.72 -38.64 93.29 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.761 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.0 mm? -73.68 -56.94 4.37 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.242 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.42 -35.68 73.56 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 103.99 -33.86 6.24 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.798 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.521 ' C ' ' H ' ' A' ' 64' ' ' GLU . 68.8 m -136.3 127.68 28.43 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.037 0.446 . . . . 0.0 111.192 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -58.68 -0.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.453 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.521 ' H ' ' C ' ' A' ' 62' ' ' SER . 33.7 mt-10 -79.44 -45.22 19.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 67' ' ' ASP . 16.7 m-20 -99.05 -7.85 26.18 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.0 m -49.23 -27.24 2.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.62 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 17.8 p-10 -51.67 -35.36 42.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.012 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.22 -19.21 43.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.861 0.362 . . . . 0.0 110.61 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.445 ' HG ' ' H ' ' A' ' 71' ' ' THR . 20.5 tp -64.84 125.9 26.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.496 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -51.68 -22.82 3.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.048 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.445 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 3.3 m -64.49 115.94 24.35 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.232 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.449 ' O ' HD21 ' A' ' 76' ' ' LEU . 74.4 Cg_endo -73.68 -154.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.375 1.384 . . . . 0.0 111.126 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.439 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 29.7 ttm -112.66 1.82 15.88 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.2 t -109.58 -18.53 13.47 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.521 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.46 -33.46 71.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.822 0.344 . . . . 0.0 110.345 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.93 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -65.74 -47.14 76.28 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.507 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 1.6 mptp? -55.96 -35.75 67.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.37 -58.84 3.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.852 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -63.23 -62.7 1.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.679 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.431 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 3.1 p -35.24 -26.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 120.922 0.392 . . . . 0.0 111.429 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.556 ' N ' ' O ' ' A' ' 79' ' ' ALA . 50.4 ttm-85 -75.98 -58.1 3.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.603 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 52.1 mt -47.49 -41.22 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.622 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.88 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -80.02 -32.08 39.61 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.587 179.596 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -49.12 -27.92 3.85 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.956 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.22 13.04 50.31 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 88' ' ' GLU . 74.8 mt-10 -113.88 8.69 17.36 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -28.08 -37.5 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.194 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 86' ' ' GLU . 5.8 pt-20 -66.33 142.26 57.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.835 0.35 . . . . 0.0 110.46 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' ' 90' ' ' ASP . 62.1 t -68.43 153.12 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.858 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.404 ' N ' HG12 ' A' ' 89' ' ' VAL . 21.4 p-10 -84.58 -142.75 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.66 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 61.6 p -65.08 -172.61 0.09 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.78 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.639 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.1 mm? -81.39 150.52 67.48 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.177 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -37.59 -68.93 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 122.285 1.99 . . . . 0.0 112.542 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.4 ' HG2' ' H ' ' A' ' 94' ' ' GLN . 7.2 pt20 -60.37 150.83 71.45 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.604 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.98 113.69 3.85 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.303 2.002 . . . . 0.0 111.828 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.518 179.937 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.0 mtp . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.424 ' O ' HG22 ' A' ' 2' ' ' VAL . 7.7 p -163.35 -14.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.206 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.41 ' H ' ' H ' ' A' ' 2' ' ' VAL . 7.5 m -155.82 59.65 2.17 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.311 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.06 98.05 0.97 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.669 2.246 . . . . 0.0 111.854 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.4 m -82.2 32.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.816 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 6' ' ' ASN . 11.8 p30 -41.59 97.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.964 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.44 ' CE ' HD11 ' A' ' 42' ' ' LEU . 31.8 mtt -64.51 143.67 57.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.453 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.3 m -87.66 -149.84 0.17 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 12' ' ' ALA . 30.0 ptt180 -143.35 -54.57 0.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -43.16 -23.88 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.026 0.441 . . . . 0.0 109.841 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 9' ' ' ARG . 10.0 m -74.51 -50.95 16.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -59.56 -72.14 0.11 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.917 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.597 ' CD1' ' H ' ' A' ' 13' ' ' LEU . 5.6 mp -30.27 -51.75 0.14 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.062 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.42 ' O ' ' CG2' ' A' ' 82' ' ' ILE . 20.3 mmt85 -56.03 -30.38 61.8 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.7 mm -65.11 -18.21 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.369 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.66 -18.24 16.63 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.31 -28.57 65.28 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -57.77 -42.75 84.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.424 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.693 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -40.48 -33.4 0.26 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.529 ' C ' ' H ' ' A' ' 22' ' ' LEU . 50.3 ttt85 -69.16 -42.59 75.72 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.23 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.13 -6.11 0.23 Allowed 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.243 0.544 . . . . 0.0 110.082 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.529 ' H ' ' C ' ' A' ' 20' ' ' ARG . 13.2 mt -117.0 149.52 44.32 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.177 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.43 -88.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.037 1.825 . . . . 0.0 112.485 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.12 -8.92 49.71 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.48 -0.391 . . . . 0.0 112.293 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.4 m -59.54 132.28 53.5 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.474 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.74 165.53 13.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.202 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.693 HG22 ' HB2' ' A' ' 19' ' ' ALA . 18.0 t -57.44 -55.88 18.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.149 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.18 8.36 8.89 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.808 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -96.82 -18.87 19.28 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.008 0.904 . . . . 0.0 110.753 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.4 tp -85.47 -37.93 19.18 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.526 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 33' ' ' ILE . 2.9 pp -78.25 -32.72 49.82 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.991 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -35.3 -27.72 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.765 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 31' ' ' LEU . 16.1 tt -56.05 -41.18 67.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.769 0.319 . . . . 0.0 110.842 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.479 ' N ' HG23 ' A' ' 33' ' ' ILE . 29.7 tp -80.13 -78.14 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.506 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.619 ' CG ' ' H ' ' A' ' 36' ' ' GLN . 20.9 t-80 60.01 -133.01 0.85 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.559 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.619 ' H ' ' CG ' ' A' ' 35' ' ' HIS . 32.6 mt-30 52.33 179.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.961 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -72.06 137.94 47.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.411 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.9 pt -57.12 127.41 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.503 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.427 ' OE2' ' O ' ' A' ' 39' ' ' GLU . 1.8 tm-20 -72.15 -42.07 66.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.306 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.16 -84.45 0.08 OUTLIER Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.87 141.38 53.67 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.45 2.1 . . . . 0.0 111.629 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.44 HD11 ' CE ' ' A' ' 7' ' ' MET . 0.6 OUTLIER -139.43 33.98 2.06 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.017 0.437 . . . . 0.0 110.535 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.404 ' OG1' ' OE2' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -98.21 177.15 5.48 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.93 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.538 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -55.23 -33.69 63.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.4 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.481 ' HG3' ' OE2' ' A' ' 44' ' ' GLU . 81.0 mt-10 -59.6 -37.44 78.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.628 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.4 t -64.41 -33.51 76.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.014 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 47' ' ' LEU . 10.3 mp -70.94 -33.23 70.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.777 0.322 . . . . 0.0 110.502 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -73.0 67.17 0.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.456 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.68 15.03 0.81 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.469 ' CG2' ' OD2' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -127.61 177.38 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.445 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 5.2 m -119.23 164.01 16.25 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.469 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.9 t -57.22 -45.49 84.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.751 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.4 m -54.3 -25.22 22.51 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.665 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.469 ' OD2' ' CG2' ' A' ' 50' ' ' VAL . 42.6 t0 -74.74 -31.1 61.72 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.916 0.388 . . . . 0.0 111.296 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.72 ' N ' HD12 ' A' ' 55' ' ' LEU . 6.2 mp -65.94 -63.38 1.1 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -54.54 -36.29 64.13 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.446 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.1 pt -77.38 -19.22 14.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.035 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.63 -34.83 88.71 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.743 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.2 mm? -76.52 -57.07 4.07 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.658 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.81 -32.97 68.13 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.481 -0.487 . . . . 0.0 109.947 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 85.51 -9.13 68.79 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.506 ' C ' ' H ' ' A' ' 64' ' ' GLU . 3.2 m -137.87 107.53 6.23 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.101 0.477 . . . . 0.0 112.243 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -56.39 -4.6 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.016 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' A' ' 62' ' ' SER . 19.0 mm-40 -86.35 -43.48 12.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.762 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -92.47 -11.91 33.42 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.2 m -50.9 -26.65 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 119.689 -0.805 . . . . 0.0 110.283 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -56.25 -17.07 6.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.399 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 43.7 mtt -101.93 -32.47 10.19 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.529 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.419 ' HG ' ' H ' ' A' ' 71' ' ' THR . 25.5 tp -49.57 131.95 21.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.221 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 9.6 p-10 -57.05 -32.49 66.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.395 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 72' ' ' PRO . 10.7 m -46.45 105.45 0.48 Allowed Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.502 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 71' ' ' THR . 33.0 Cg_exo -54.92 -163.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.174 1.25 . . . . 0.0 111.219 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 30.4 ttm -107.84 -4.98 17.52 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 82.6 p -102.52 -26.75 13.12 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.429 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.87 -33.37 70.4 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.885 0.374 . . . . 0.0 110.169 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.886 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -66.27 -53.37 37.51 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.453 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.528 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.4 OUTLIER -52.15 -35.43 48.54 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.475 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -68.36 -58.52 4.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.962 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -63.91 -60.47 3.23 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.834 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.425 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 2.4 p -35.24 -25.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.096 0.474 . . . . 0.0 111.686 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 79' ' ' ALA . 25.5 ttm180 -78.9 -56.31 4.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.544 0.688 . . . . 0.0 109.72 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.549 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 36.5 mt -47.88 -43.81 10.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.904 -178.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.849 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -74.23 -37.74 63.73 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 119.205 -0.998 . . . . 0.0 109.645 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -46.17 -19.05 0.06 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.94 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 83' ' ' LEU . . . 83.76 13.26 75.78 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 88' ' ' GLU . 91.6 mt-10 -103.4 -3.18 25.83 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.549 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -31.98 -32.61 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.525 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 86' ' ' GLU . 18.1 mm-40 -42.2 -51.65 4.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.337 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 89' ' ' VAL . 9.0 m -54.38 130.57 16.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.814 0.34 . . . . 0.0 110.629 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' A' ' 91' ' ' SER . 3.5 p-10 -81.93 -108.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.519 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.4 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 98.9 p -76.45 172.47 12.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.937 0.398 . . . . 0.0 110.454 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.647 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.2 mm? -77.52 150.46 79.5 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.904 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -36.99 -66.7 0.12 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.214 1.942 . . . . 0.0 112.186 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.424 ' O ' ' O ' ' A' ' 95' ' ' PRO . 3.0 pt20 -61.05 152.27 71.76 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.056 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 94' ' ' GLN . 75.4 Cg_exo -37.18 160.94 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.32 2.013 . . . . 0.0 112.374 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.9 t . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.627 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 mtt . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 3' ' ' THR . 8.0 p -163.94 -30.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.496 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.431 ' O ' ' O ' ' A' ' 2' ' ' VAL . 6.5 p 59.05 148.09 0.07 OUTLIER Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.373 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.19 -12.46 25.54 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.002 1.801 . . . . 0.0 111.87 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -164.42 138.54 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.593 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -164.84 166.93 19.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.606 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 32.3 mtm 59.81 58.08 2.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.603 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.9 m -82.86 178.4 8.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.297 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 12' ' ' ALA . 44.2 ptt85 -79.67 -39.87 30.38 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.45 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -43.06 -28.11 0.25 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.905 0.383 . . . . 0.0 110.598 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.3 m -76.88 -50.01 14.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -51.63 -69.94 0.1 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.362 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.569 ' CD1' ' H ' ' A' ' 13' ' ' LEU . 4.8 mp -34.11 -50.16 0.38 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.571 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.417 HH22 ' C ' ' A' ' 85' ' ' GLY . 61.0 mtp180 -55.38 -32.94 63.02 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.407 ' N ' ' O ' ' A' ' 12' ' ' ALA . 28.3 mm -63.23 -16.54 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.382 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.36 -16.2 17.73 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.4 ' HA ' HD13 ' A' ' 17' ' ' LEU . 3.9 mm? -69.99 -30.7 68.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -56.71 -44.7 81.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.235 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.672 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -42.02 -36.76 1.2 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.487 ' C ' ' H ' ' A' ' 22' ' ' LEU . 67.6 ttt-85 -65.19 -40.83 94.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.943 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.18 -4.84 0.39 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.624 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.487 ' H ' ' C ' ' A' ' 20' ' ' ARG . 16.1 mt -118.1 139.76 27.05 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.145 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -39.67 -70.95 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.927 1.751 . . . . 0.0 112.855 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -134.4 0.0 3.79 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.521 -0.631 . . . . 0.0 111.521 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.1 m -57.43 131.21 49.44 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.611 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.69 160.92 27.25 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.343 0.592 . . . . 0.0 111.808 -178.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 19' ' ' ALA . 21.5 t -58.18 -55.81 19.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.1 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.04 8.36 8.35 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.358 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -100.32 -20.27 15.93 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 117.867 0.834 . . . . 0.0 109.932 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.404 HD22 HD11 ' A' ' 22' ' ' LEU . 45.1 tp -98.68 -23.78 15.32 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.982 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 31' ' ' LEU . 3.9 mm? -92.33 -46.75 7.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.73 0.3 . . . . 0.0 110.829 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' A' ' 34' ' ' LEU . 45.4 tt0 -39.15 -25.26 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.404 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.474 ' N ' ' O ' ' A' ' 31' ' ' LEU . 31.1 pt -47.61 -13.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.926 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 32' ' ' GLU . 7.8 tp -72.04 -50.4 28.78 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.144 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 63.08 103.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.954 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -152.17 171.44 17.92 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.351 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -158.22 -56.27 0.07 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.945 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.8 mm -47.24 -66.06 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.506 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -87.78 -157.41 0.4 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.269 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.66 65.72 0.09 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.12 168.37 11.98 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.921 2.414 . . . . 0.0 111.769 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.411 ' C ' HD23 ' A' ' 42' ' ' LEU . 1.8 tt -169.74 77.36 0.09 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.035 0.445 . . . . 0.0 110.297 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 33.2 p -127.09 160.38 31.36 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.497 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -78.27 -21.54 49.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.202 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -80.68 -43.88 19.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.079 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.3 m -56.74 -34.73 67.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.289 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.604 ' O ' HD13 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -60.51 -38.48 84.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.941 0.4 . . . . 0.0 110.149 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -61.17 71.29 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.593 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -155.08 4.98 0.24 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.454 ' CG2' ' OD2' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -123.67 176.96 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.396 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.428 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 45.2 m -119.03 161.75 19.72 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.467 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.4 t -55.33 -43.03 69.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.67 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 m -56.43 -26.0 52.2 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.871 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.454 ' OD2' ' CG2' ' A' ' 50' ' ' VAL . 53.1 t0 -73.87 -31.44 63.16 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.041 0.448 . . . . 0.0 110.859 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.728 ' N ' HD12 ' A' ' 55' ' ' LEU . 6.3 mp -65.23 -65.01 0.73 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -53.29 -36.59 61.37 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.1 pt -78.08 -18.95 13.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.62 -38.13 89.93 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.705 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.3 mm? -75.07 -56.75 4.42 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.029 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.96 -35.31 78.15 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 93.29 -20.43 46.32 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.553 ' C ' ' H ' ' A' ' 64' ' ' GLU . 23.0 t -138.22 117.25 12.5 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.038 0.446 . . . . 0.0 111.871 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -59.34 4.06 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.686 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.553 ' H ' ' C ' ' A' ' 62' ' ' SER . 43.5 mt-10 -90.74 -45.71 8.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.194 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.65 -11.43 42.54 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.4 m -52.97 -27.44 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.035 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 19.4 p-10 -56.17 -12.61 1.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.278 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.9 mmt -106.09 -32.47 8.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.406 ' HG ' ' H ' ' A' ' 71' ' ' THR . 20.3 tp -48.45 123.59 6.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.423 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 71' ' ' THR . 47.3 p30 -48.52 -25.21 1.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.99 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.53 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 7.0 m -55.23 110.25 2.1 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.538 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 71' ' ' THR . 29.5 Cg_exo -57.14 -146.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.104 1.203 . . . . 0.0 110.948 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.432 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 33.8 ttp -123.96 -0.35 8.45 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.7 t -106.16 -27.47 11.05 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.287 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.43 -32.97 71.87 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.975 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.3 mm? -64.82 -49.98 68.48 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.516 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 1.3 mptp? -56.67 -33.79 66.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.434 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -70.11 -58.56 3.67 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.406 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.4 -63.58 1.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.42 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.408 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 3.0 p -34.69 -24.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.904 0.383 . . . . 0.0 111.909 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 79' ' ' ALA . 17.6 ttm105 -77.29 -60.55 2.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.56 0.695 . . . . 0.0 109.965 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.449 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 39.4 mt -45.48 -41.44 3.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.209 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.834 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -76.96 -35.61 57.11 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 119.278 -0.969 . . . . 0.0 109.584 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -48.89 -20.06 0.46 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.792 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.419 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 86.66 18.46 58.38 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 88' ' ' GLU . 8.8 tp10 -112.07 1.54 16.38 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.69 0.281 . . . . 0.0 110.337 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.449 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -29.94 -39.31 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.986 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 86' ' ' GLU . 5.3 pt-20 -75.93 59.86 1.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.95 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.0 p -85.57 143.57 11.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.33 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -57.23 123.89 16.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.584 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.1 m -62.35 165.66 5.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.609 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.669 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.0 mm? -83.48 150.13 59.35 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.043 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.11 27.51 0.3 Allowed 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.162 1.908 . . . . 0.0 111.895 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.432 ' H ' ' C ' ' A' ' 92' ' ' LEU . 4.9 pt20 -55.16 151.93 16.27 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.279 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -36.09 152.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 122.45 2.1 . . . . 0.0 112.412 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.0 m . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.541 179.989 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.5 mtt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.8 t 41.48 90.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.767 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 63.59 155.63 0.12 Allowed Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.236 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.11 -175.6 0.53 Allowed 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.422 2.081 . . . . 0.0 111.59 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 t -145.38 148.08 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.449 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.401 ' ND2' ' H ' ' A' ' 6' ' ' ASN . 3.6 p30 -77.96 125.6 29.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.811 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.6 tpt 63.13 159.49 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.196 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.481 ' OG ' ' N ' ' A' ' 9' ' ' ARG . 26.2 t -89.04 -174.11 4.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.242 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 12' ' ' ALA . 21.1 ptt180 -83.86 -28.47 27.97 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -45.76 -25.85 0.56 Allowed 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.175 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -78.51 -42.28 29.98 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -53.29 -71.29 0.07 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.28 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.655 HD23 ' H ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -43.4 -42.15 4.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.148 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 67.7 mtt-85 -63.76 -40.78 97.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.2 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.436 ' O ' HG22 ' A' ' 15' ' ' ILE . 29.2 mt -63.24 -11.3 7.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.457 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -103.56 -15.89 15.7 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.564 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' A' ' 17' ' ' LEU . 1.3 mm? -72.93 -28.95 62.75 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -58.2 -40.56 81.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.285 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.737 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -38.75 -35.53 0.2 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.495 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.501 ' C ' ' H ' ' A' ' 22' ' ' LEU . 55.5 mtp85 -65.12 -38.39 90.52 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.806 0.336 . . . . 0.0 110.404 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.53 -5.7 0.23 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.725 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.501 ' H ' ' C ' ' A' ' 20' ' ' ARG . 15.6 mt -117.46 149.84 45.51 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.919 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.05 -88.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.014 1.81 . . . . 0.0 112.474 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.72 3.25 42.11 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.537 -0.363 . . . . 0.0 112.235 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.5 m -72.43 129.36 38.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.124 0.462 . . . . 0.0 110.652 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.22 170.61 11.97 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.271 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.737 HG22 ' HB2' ' A' ' 19' ' ' ALA . 16.5 t -60.2 -57.37 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.855 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.48 5.37 10.67 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.353 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -94.17 -28.07 15.86 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 117.744 0.772 . . . . 0.0 110.276 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 tt -80.47 -17.89 50.32 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.803 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 33' ' ' ILE . 13.0 tp -89.82 -37.2 14.64 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.506 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -38.85 -21.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.681 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.173 HD11 ' OD1' ' A' ' 54' ' ' ASP . 12.8 tt -51.2 -25.28 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.694 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 80.5 mt -82.17 -81.0 0.15 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.673 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 56.61 78.78 0.2 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.405 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -159.77 -165.0 1.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.027 0.441 . . . . 0.0 110.923 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -70.09 79.01 0.5 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.182 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.54 ' N ' HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -57.07 -177.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.391 179.598 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -166.3 -18.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.728 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -157.79 174.65 35.15 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -73.32 -6.33 18.66 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.839 2.36 . . . . 0.0 111.903 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.3 mt 61.0 115.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.62 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.9 p -83.6 160.34 21.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.988 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -50.43 -24.64 3.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.671 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -82.14 -39.65 22.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.502 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.1 p -57.9 -34.63 70.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.779 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 49' ' ' GLY . 10.5 mp -66.67 -29.28 69.25 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.507 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -64.16 71.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.019 0.437 . . . . 0.0 110.443 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -152.95 7.89 0.49 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.401 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -130.73 177.43 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.467 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 71.8 m -118.97 165.6 13.89 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.467 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.8 t -55.97 -45.84 80.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.751 0.31 . . . . 0.0 111.241 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 57' ' ' ILE . 1.8 m -53.35 -25.93 17.21 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 1.173 ' OD1' HD11 ' A' ' 33' ' ' ILE . 42.9 t0 -75.81 -31.28 59.35 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.4 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.728 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.7 mp -65.79 -63.33 1.11 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -54.4 -36.46 63.97 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 61' ' ' GLY . 13.1 pt -77.6 -18.39 14.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.56 -36.72 84.01 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.692 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.6 mm? -73.99 -57.14 4.16 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.068 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.68 -34.45 72.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 114.37 -48.29 0.95 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.562 ' C ' ' H ' ' A' ' 64' ' ' GLU . 26.3 p -135.89 144.0 45.31 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.143 0.496 . . . . 0.0 111.356 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.99 9.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.836 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.603 ' OE1' ' OD1' ' A' ' 65' ' ' ASP . 5.5 tm-20 -86.6 -55.51 3.84 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.651 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.603 ' OD1' ' OE1' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -86.58 -13.09 46.8 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.031 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.0 m -49.02 -20.34 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.272 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 65' ' ' ASP . 62.9 m-20 -56.76 -33.34 66.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.132 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.428 ' C ' ' SD ' ' A' ' 68' ' ' MET . 0.0 OUTLIER -92.16 -27.86 17.44 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.786 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 71' ' ' THR . 32.5 tp -50.99 117.79 2.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.389 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -39.24 -24.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.346 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.489 ' N ' ' O ' ' A' ' 69' ' ' LEU . 2.5 m -68.27 116.18 36.88 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.56 -108.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.583 1.522 . . . . 0.0 111.643 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 24.1 ttm -150.91 2.99 0.45 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 121.094 -0.243 . . . . 0.0 110.825 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.425 ' O ' ' OD2' ' A' ' 78' ' ' ASP . 3.4 m -107.44 -23.23 12.27 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.927 0.394 . . . . 0.0 110.08 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -66.66 -33.09 74.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.479 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.986 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.0 OUTLIER -66.36 -52.63 44.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.485 179.62 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.539 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 2.6 mptp? -51.88 -36.78 49.78 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 74' ' ' SER . 4.8 m-20 -67.41 -58.76 4.18 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.18 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -63.01 -64.55 0.88 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.632 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.404 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 2.8 p -34.08 -24.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.59 ' N ' ' O ' ' A' ' 79' ' ' ALA . 15.1 ttm180 -76.65 -61.26 2.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.382 0.61 . . . . 0.0 110.21 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.485 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 43.7 mt -45.28 -40.2 2.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.162 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.83 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.91 -35.42 50.63 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.535 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -50.32 -20.07 0.98 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.041 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.38 11.14 69.62 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 87' ' ' ALA . 21.5 tp10 -102.4 1.18 35.04 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.485 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -31.21 -39.31 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.656 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 86' ' ' GLU . 9.5 mm-40 -49.9 161.31 0.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.682 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.0 t -72.17 142.7 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.443 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -79.22 -171.51 2.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.046 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.5 m -62.38 -176.3 0.1 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.728 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.65 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.1 mm? -83.07 148.79 57.48 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.023 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -38.9 119.25 0.42 Allowed 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.137 1.892 . . . . 0.0 112.287 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -70.83 151.17 95.22 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -36.81 142.14 0.14 Allowed 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.291 1.994 . . . . 0.0 112.339 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.569 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ptp . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.6 m -90.79 24.52 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -61.96 5.2 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.221 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.96 126.85 15.88 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.138 1.892 . . . . 0.0 111.638 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.317 HG22 ' CG ' ' A' ' 41' ' ' PRO . 6.3 p -163.19 156.22 2.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.561 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 1.037 ' CA ' ' HB3' ' A' ' 41' ' ' PRO . 18.5 p-10 -149.19 140.71 23.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.237 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.502 ' N ' ' CB ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -70.3 -72.31 0.21 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.471 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 t -118.18 -144.58 0.37 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.344 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.573 ' O ' ' N ' ' A' ' 12' ' ' ALA . 27.5 ptt-85 -142.46 -52.6 0.4 Allowed 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -40.0 -25.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.172 0.51 . . . . 0.0 110.714 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 9' ' ' ARG . 13.0 m -82.98 -39.4 21.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.925 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -82.35 8.05 12.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.027 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mp -109.01 -35.68 6.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.224 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -85.11 -27.25 26.39 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.414 ' O ' HG22 ' A' ' 15' ' ' ILE . 60.7 mt -63.28 -14.95 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.405 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.407 ' HA ' HG13 ' A' ' 27' ' ' VAL . . . -91.4 -16.45 27.37 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.427 ' N ' HD22 ' A' ' 17' ' ' LEU . 4.0 mm? -72.68 -30.71 64.47 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.9 -41.34 70.82 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.921 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.676 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -44.24 -36.37 2.69 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -66.98 -42.37 85.22 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.469 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -57.57 -8.07 0.78 Allowed 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.259 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 21.1 mt -113.05 147.22 36.79 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.299 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.8 -73.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.168 1.912 . . . . 0.0 112.828 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -119.22 43.47 1.57 Allowed Glycine 0 N--CA 1.471 0.979 0 C-N-CA 121.503 -0.379 . . . . 0.0 112.222 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.2 m -117.89 132.88 56.37 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.869 0.334 . . . . 0.0 110.244 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.45 169.14 15.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.183 0.516 . . . . 0.0 110.568 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.676 HG22 ' HB2' ' A' ' 19' ' ' ALA . 27.9 t -60.85 -59.57 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.169 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.59 9.6 5.92 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.532 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.445 ' O ' HD13 ' A' ' 33' ' ' ILE . 48.7 mt-30 -99.51 -12.2 20.37 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.753 0.776 . . . . 0.0 110.764 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 pp -98.15 -16.13 19.64 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.351 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 33' ' ' ILE . 1.6 tt -110.35 -58.31 2.09 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.837 0.351 . . . . 0.0 110.765 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -36.9 -26.18 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.768 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.595 ' N ' HD12 ' A' ' 33' ' ' ILE . 1.4 mp -66.87 -47.86 81.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 31' ' ' LEU . 9.4 tp -67.46 -57.44 6.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.689 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.56 ' ND1' ' N ' ' A' ' 36' ' ' GLN . 2.0 t-80 46.37 -120.71 1.03 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.855 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.56 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 51.1 tt0 58.26 -79.51 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 35' ' ' HIS . 5.9 tpp180 -57.37 138.81 54.48 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 40' ' ' GLY . 18.3 tt -159.91 -14.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.829 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.419 ' H ' ' H ' ' A' ' 38' ' ' ILE . 38.2 mt-10 -45.42 90.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.74 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 38' ' ' ILE . . . 76.37 -177.52 50.88 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 1.317 ' CG ' HG22 ' A' ' 5' ' ' VAL . 60.1 Cg_exo -50.0 124.1 12.04 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.602 2.201 . . . . 0.0 112.038 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.589 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.7 mm? -58.02 99.25 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.423 ' H ' HG23 ' A' ' 43' ' ' THR . 1.5 p -79.86 177.99 8.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.058 0.456 . . . . 0.0 111.19 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -68.92 -23.23 64.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.41 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -71.99 -40.17 68.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.335 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.0 t -54.36 -38.87 66.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.363 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 49' ' ' GLY . 10.2 mt -66.28 -47.28 74.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.74 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -66.85 69.97 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.437 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -151.95 3.14 0.39 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.17 174.26 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.478 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 52.9 m -115.09 163.53 15.48 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.515 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.4 t -56.46 -42.14 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 O-C-N 123.265 0.353 . . . . 0.0 111.404 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.4 m -57.39 -25.41 59.47 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -74.44 -32.15 62.52 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.083 0.468 . . . . 0.0 110.956 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.735 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.7 mp -64.25 -65.59 0.66 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.503 -177.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -52.67 -37.42 58.73 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 61' ' ' GLY . 10.3 pt -79.34 -18.11 12.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.51 -41.77 96.06 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.41 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.749 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.0 mm? -73.64 -57.12 4.21 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.031 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.99 88.13 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 104.95 -34.42 5.81 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.527 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.519 ' C ' ' H ' ' A' ' 64' ' ' GLU . 22.6 t -137.24 129.6 29.69 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.106 0.479 . . . . 0.0 111.405 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -59.17 1.81 0.07 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.902 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.519 ' H ' ' C ' ' A' ' 62' ' ' SER . 42.7 mt-10 -83.02 -47.75 11.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.781 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -92.78 -7.44 46.5 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.6 m -55.72 -17.72 3.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.864 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -53.22 -31.88 45.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.286 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.8 ptm -100.27 -21.0 15.63 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.485 ' HG ' ' H ' ' A' ' 71' ' ' THR . 27.5 tp -52.17 124.09 12.21 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.256 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -41.14 -23.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.07 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.485 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 2.2 m -74.73 117.94 66.34 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.954 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.41 -104.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.892 1.728 . . . . 0.0 111.785 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.471 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 31.8 ttp -153.95 1.79 0.24 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.997 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.9 m -108.27 -18.77 13.68 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.784 0.326 . . . . 0.0 110.197 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.35 -34.04 70.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.619 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.958 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -64.0 -45.92 86.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.033 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.502 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 1.8 mptp? -56.22 -37.83 70.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.37 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -66.75 -56.92 8.31 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.432 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -63.92 -64.27 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.677 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.437 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.8 p -35.11 -27.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.112 0.482 . . . . 0.0 111.42 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 79' ' ' ALA . 52.6 ttm-85 -75.57 -58.92 2.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.111 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.473 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 50.1 mt -45.83 -41.71 3.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.821 -1.082 . . . . 0.0 112.656 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.884 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -79.77 -33.0 40.99 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.628 179.588 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -50.2 -21.55 1.38 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.869 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.51 17.4 55.05 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 88' ' ' GLU . 68.5 mt-10 -112.82 2.56 16.0 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -31.68 -34.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.849 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 86' ' ' GLU . 3.6 pt-20 -58.66 -105.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.686 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.0 m -56.2 140.98 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.603 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -85.47 -143.33 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.703 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.2 m -63.34 -139.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.797 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.656 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.0 mm? -82.45 150.4 63.41 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.17 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.34 -165.51 0.22 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.259 1.973 . . . . 0.0 112.044 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -60.58 132.89 91.28 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.2 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.94 96.31 1.01 Allowed 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.917 1.744 . . . . 0.0 111.858 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 25.6 m . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.529 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.9 mtt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.0 t -76.23 -36.97 31.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.64 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.5 m -155.76 74.15 5.19 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.541 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -50.81 -64.19 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.498 2.132 . . . . 0.0 111.578 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.4 p -173.7 146.02 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.001 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -140.24 -85.96 0.21 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.659 0.266 . . . . 0.0 110.632 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 85.7 mtp -47.05 151.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.87 0.367 . . . . 0.0 110.506 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.4 t -63.2 -149.36 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.642 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 11' ' ' THR . 5.7 ptm85 -136.79 -59.47 0.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 9' ' ' ARG . 10.9 pt-20 -39.8 -24.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.157 0.503 . . . . 0.0 110.489 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 9' ' ' ARG . 23.4 m -81.52 -52.53 7.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.445 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -68.51 4.75 1.24 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.508 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.479 ' H ' ' C ' ' A' ' 11' ' ' THR . 3.1 mp -109.12 -41.7 4.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.248 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 -88.26 -34.06 17.86 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.2 mp -62.54 -11.36 6.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.38 -16.41 22.36 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.7 -29.01 66.33 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.62 -46.25 73.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.873 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.637 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.87 -36.07 0.98 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 22' ' ' LEU . 36.9 ttt180 -65.61 -43.14 90.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.743 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.35 -6.9 0.74 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.745 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.409 ' H ' ' C ' ' A' ' 20' ' ' ARG . 11.7 mt -117.94 121.61 31.39 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.57 72.77 6.35 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.781 1.654 . . . . 0.0 112.604 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.83 -53.33 0.68 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.7 m -59.23 132.42 53.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.006 0.432 . . . . 0.0 111.491 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.85 173.82 9.16 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.359 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.637 HG22 ' HB2' ' A' ' 19' ' ' ALA . 15.3 t -61.61 -59.64 3.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.697 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.66 6.71 8.19 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.53 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.445 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 57.5 mt-30 -97.1 -22.81 16.55 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 117.86 0.83 . . . . 0.0 110.084 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.0 tp -90.2 -19.75 23.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.836 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 33' ' ' ILE . 10.9 mp -100.16 -50.33 4.0 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.897 0.379 . . . . 0.0 110.408 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -44.71 -15.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.053 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 31' ' ' LEU . 7.2 pt -71.78 -39.86 68.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.742 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 36' ' ' GLN . 14.2 mt -91.98 9.25 33.93 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.781 0.324 . . . . 0.0 110.461 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -44.5 89.82 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.887 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 34' ' ' LEU . 49.9 tt0 -171.05 137.66 1.2 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.577 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.422 ' O ' ' CD2' ' A' ' 42' ' ' LEU . 0.6 OUTLIER 56.8 36.7 28.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.758 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.767 ' HA ' HD22 ' A' ' 42' ' ' LEU . 14.4 pt -88.06 -38.03 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.712 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -46.9 99.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 0.0 110.538 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.9 179.9 28.81 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.58 46.43 1.22 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.699 2.266 . . . . 0.0 111.66 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.767 HD22 ' HA ' ' A' ' 38' ' ' ILE . 9.6 mp -80.67 121.66 26.14 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.596 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.36 -175.86 2.78 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.515 ' O ' ' NE2' ' A' ' 48' ' ' GLN . 22.1 pt-20 -49.45 -36.68 23.24 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -56.95 -36.49 70.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.358 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.7 p -65.13 -29.4 70.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.779 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 49' ' ' GLY . 10.3 mp -71.59 -31.58 67.1 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 110.576 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.67 ' NE2' ' N ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -62.06 72.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.359 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -152.76 11.61 0.61 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.91 175.07 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.472 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 49.1 m -113.79 161.97 16.9 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.496 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.2 t -55.52 -43.46 72.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 123.196 0.31 . . . . 0.0 110.999 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.3 m -57.37 -23.95 52.27 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 16.6 t0 -75.7 -31.32 59.63 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.016 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.735 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.9 mp -65.31 -65.9 0.61 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.489 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -52.79 -34.98 55.88 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.8 pt -80.19 -19.78 12.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.23 -37.79 91.33 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.711 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.699 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.4 mm? -75.98 -52.61 9.88 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.284 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.66 -33.38 64.45 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.464 -0.494 . . . . 0.0 109.803 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 83.42 -9.24 62.08 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.104 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.528 ' C ' ' H ' ' A' ' 64' ' ' GLU . 3.9 t -137.75 104.24 5.24 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.924 0.392 . . . . 0.0 111.819 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -56.51 -1.24 0.05 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.701 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.528 ' H ' ' C ' ' A' ' 62' ' ' SER . 36.2 mt-10 -91.51 -41.37 10.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.3 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -92.45 -13.0 30.62 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 m -46.79 -29.8 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.622 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -52.92 -30.69 35.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.919 0.39 . . . . 0.0 110.234 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 13.2 mmt -83.96 -31.08 25.74 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.92 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.485 ' O ' ' N ' ' A' ' 71' ' ' THR . 29.7 tp -49.56 122.4 6.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.283 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 51.2 t0 -39.69 -24.9 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.021 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.485 ' N ' ' O ' ' A' ' 69' ' ' LEU . 2.8 m -65.05 122.08 77.65 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.016 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -74.71 -86.74 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.644 1.563 . . . . 0.0 112.281 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -172.13 -23.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.676 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.6 p -89.34 -14.59 35.33 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.476 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -69.89 -33.7 72.56 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.4 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.915 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.5 mm? -65.25 -47.69 75.87 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.214 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.497 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 1.8 mptp? -57.95 -34.4 69.86 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.82 -58.67 3.85 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.895 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.604 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.31 -64.64 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.29 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.5 p -34.72 -23.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.961 0.41 . . . . 0.0 111.653 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.604 ' N ' ' O ' ' A' ' 79' ' ' ALA . 46.9 ttm-85 -78.71 -58.22 3.36 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.456 0.646 . . . . 0.0 109.617 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.462 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 43.4 mt -47.7 -42.06 8.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.988 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.82 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -76.7 -36.65 57.1 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.564 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -48.88 -18.07 0.25 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.795 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.448 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 85.01 18.7 60.61 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 88' ' ' GLU . 24.3 tt0 -112.44 2.93 16.6 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.462 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -30.32 -34.96 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.874 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 86' ' ' GLU . 41.9 mt-10 -47.24 114.29 0.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.677 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 91' ' ' SER . 3.9 t -60.63 -11.13 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.641 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -61.49 73.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.461 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 89' ' ' VAL . 69.0 m -75.02 -170.19 1.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.6 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.656 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.1 mm? -79.73 150.16 72.2 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.793 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.4 179.23 4.74 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.192 1.928 . . . . 0.0 111.887 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -74.02 150.57 88.07 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.314 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -37.88 149.97 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.265 0 C-N-CA 122.149 1.899 . . . . 0.0 112.156 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.527 179.854 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.0 mtt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.4 t -81.27 86.29 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.933 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -159.91 151.19 16.19 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.737 -179.536 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 3' ' ' THR . 77.6 Cg_exo -38.11 163.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 122.38 2.053 . . . . 0.0 112.391 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 t -82.1 105.35 11.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.344 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -136.9 164.31 28.61 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.962 0.41 . . . . 0.0 110.371 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.53 145.29 52.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.661 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.23 133.72 52.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.593 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 11' ' ' THR . 7.4 ptt180 -69.64 -38.08 77.04 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -41.78 -22.45 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.257 0.551 . . . . 0.0 110.198 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.532 ' N ' ' O ' ' A' ' 9' ' ' ARG . 8.3 m -83.86 -49.33 9.13 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -66.36 2.34 1.27 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.132 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.495 ' H ' ' C ' ' A' ' 11' ' ' THR . 3.6 mp -111.07 -41.38 4.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.025 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 50.4 ttm-85 -86.04 -38.35 17.95 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.35 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.417 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 1.4 mp -65.29 -7.16 4.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.173 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.54 -18.91 21.72 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.74 0.305 . . . . 0.0 110.493 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -70.15 -30.35 67.49 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -57.87 -41.44 82.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.408 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.696 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.28 -33.97 0.44 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.486 ' C ' ' H ' ' A' ' 22' ' ' LEU . 86.5 mtt180 -67.93 -42.24 81.33 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.224 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -57.88 -5.19 0.38 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.424 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 20' ' ' ARG . 19.3 mt -115.07 148.61 40.97 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.056 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.83 -92.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.219 1.946 . . . . 0.0 112.401 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.28 46.51 1.28 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.7 m -118.21 141.73 48.2 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.827 0.346 . . . . 0.0 110.387 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.67 159.4 15.01 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.232 0.539 . . . . 0.0 110.393 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.696 HG22 ' HB2' ' A' ' 19' ' ' ALA . 23.5 t -54.84 -51.9 47.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.124 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.01 3.57 56.99 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.11 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -89.22 -20.27 24.37 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 117.597 0.699 . . . . 0.0 109.836 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.578 HD23 ' O ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -95.5 -27.25 15.47 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.617 0.246 . . . . 0.0 110.523 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.453 ' C ' ' N ' ' A' ' 33' ' ' ILE . 24.7 mt -83.01 -41.19 18.99 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.876 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.4 ' C ' ' N ' ' A' ' 34' ' ' LEU . 10.4 pt-20 -48.47 -13.36 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.826 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.453 ' N ' ' C ' ' A' ' 31' ' ' LEU . 10.1 tt -49.33 -16.9 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.609 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 35' ' ' HIS . 96.7 mt -61.86 -94.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.519 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER 47.73 98.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.487 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' A' ' 37' ' ' ARG . 6.2 pt20 -177.12 33.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.948 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 36' ' ' GLN . 69.1 mtt-85 54.74 165.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.78 0.324 . . . . 0.0 110.543 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 38' ' ' ILE . 17.7 mt 40.04 71.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.921 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 39' ' ' GLU . 1.0 OUTLIER -80.56 112.55 18.02 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.853 0.358 . . . . 0.0 110.097 179.687 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.17 -178.13 45.9 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.32 174.53 12.35 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.62 2.213 . . . . 0.0 111.974 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.696 HD23 ' N ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -166.57 133.22 2.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.599 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.489 ' N ' ' OG ' ' A' ' 46' ' ' SER . 1.1 p -128.97 -176.52 3.88 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.559 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.629 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 1.8 pm0 -50.61 -26.48 5.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.651 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.452 ' CG ' ' N ' ' A' ' 46' ' ' SER . 10.2 pt-20 -86.3 -43.38 12.96 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.933 0.397 . . . . 0.0 111.223 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.489 ' OG ' ' N ' ' A' ' 43' ' ' THR . 87.7 p -54.0 -45.71 71.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.264 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.4 mp -56.96 -33.2 66.81 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.379 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -69.56 67.27 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.852 0.358 . . . . 0.0 110.424 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.71 11.15 0.36 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.77 171.78 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.47 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 31.6 m -113.66 161.72 17.12 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.545 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.3 t -55.07 -38.11 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 120.872 0.367 . . . . 0.0 110.415 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.6 m -59.18 -26.89 65.19 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -75.09 -30.53 60.94 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.974 0.416 . . . . 0.0 111.041 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.753 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.0 mp -67.05 -62.79 1.26 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.197 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -54.01 -35.0 61.43 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.42 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.9 pt -78.96 -19.46 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.285 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.76 -33.5 84.42 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.757 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.1 mm? -77.55 -54.79 5.98 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 116.873 0.337 . . . . 0.0 110.944 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.39 -32.4 62.69 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.967 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 80.0 -4.36 66.63 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 64' ' ' GLU . 13.0 t -137.12 97.53 3.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.008 0.432 . . . . 0.0 111.45 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -53.45 -6.16 0.07 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.258 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.531 ' H ' ' C ' ' A' ' 62' ' ' SER . 20.2 tp10 -86.31 -41.11 14.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.409 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -92.74 -14.77 27.49 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.7 m -49.1 -21.41 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 119.816 -0.753 . . . . 0.0 110.518 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -53.93 -34.46 59.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.226 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.5 ptp -92.59 -24.29 18.75 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.222 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.473 ' CD2' ' OG1' ' A' ' 71' ' ' THR . 21.9 tp -49.46 121.62 5.27 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -35.97 -30.26 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.598 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.473 ' OG1' ' CD2' ' A' ' 69' ' ' LEU . 2.1 m -48.92 114.46 3.77 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.547 ' C ' ' H ' ' A' ' 74' ' ' SER . 93.8 Cg_endo -80.45 19.85 1.03 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.168 1.912 . . . . 0.0 113.148 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.435 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 34.2 ttm 65.91 -12.89 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.825 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 72' ' ' PRO . 30.1 t -96.49 -14.19 22.51 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.04 0.448 . . . . 0.0 110.053 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.13 -30.13 60.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.414 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.568 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -65.55 -53.15 46.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.856 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.67 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -46.66 -38.01 9.12 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.179 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -70.51 -58.24 3.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.068 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.587 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -62.72 -61.31 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.594 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.407 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 2.8 p -34.85 -24.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.992 0.425 . . . . 0.0 111.745 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 79' ' ' ALA . 24.1 ttm180 -79.22 -55.7 4.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.549 0.69 . . . . 0.0 109.654 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.46 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 41.5 mt -49.62 -43.49 18.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.973 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.842 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -74.25 -38.07 63.58 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.484 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -45.47 -19.48 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.859 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 83' ' ' LEU . . . 83.46 14.85 72.75 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 87' ' ' ALA . 94.4 mt-10 -110.7 3.82 19.54 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.46 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -28.28 -46.19 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.839 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.417 ' C ' ' H ' ' A' ' 90' ' ' ASP . 65.2 mm-40 -49.15 167.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.126 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 91' ' ' SER . 16.9 m -77.94 36.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.593 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 88' ' ' GLU . 28.4 t70 -74.18 39.54 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.464 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.447 ' H ' ' C ' ' A' ' 89' ' ' VAL . 83.5 p -73.21 -149.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.567 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.674 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.1 mm? -77.18 150.31 80.38 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.899 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -36.96 -36.1 0.25 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.285 1.99 . . . . 0.0 112.3 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -70.6 151.05 95.51 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.081 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -72.27 176.92 7.91 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.232 1.955 . . . . 0.0 111.793 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 t . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.643 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 mtt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.4 m -56.79 -15.77 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.393 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 40.2 p -40.6 104.46 0.34 Allowed Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.861 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -44.86 106.07 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.896 1.73 . . . . 0.0 111.964 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.6 m -51.12 172.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.827 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.61 ' ND2' ' SD ' ' A' ' 7' ' ' MET . 6.1 p-10 -155.98 -45.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.157 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.61 ' SD ' ' ND2' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -75.04 -178.33 3.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.3 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.2 m -69.28 -148.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.672 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.471 ' O ' HD13 ' A' ' 13' ' ' LEU . 56.8 ttt-85 -148.3 -30.32 0.29 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.32 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.568 ' H ' ' CD ' ' A' ' 10' ' ' GLU . 1.4 pm0 -101.3 -31.4 10.99 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 14' ' ' ARG . 8.8 m -78.46 -62.59 1.63 Allowed 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 11' ' ' THR . . . -28.84 -50.77 0.09 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.358 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.551 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 3.8 mp -53.31 -42.88 67.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.028 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 11' ' ' THR . 36.4 ttt180 -47.01 -46.54 21.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.009 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.607 HD12 ' N ' ' A' ' 15' ' ' ILE . 1.5 mp -63.84 -7.65 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.2 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 13' ' ' LEU . . . -97.71 -15.66 20.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.275 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.01 -28.75 61.59 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -57.4 -41.98 81.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.959 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.679 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -42.67 -36.79 1.52 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.926 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.415 ' C ' ' H ' ' A' ' 22' ' ' LEU . 75.0 ttt180 -64.38 -39.17 93.34 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -60.05 -6.19 1.28 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.47 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 20' ' ' ARG . 10.6 mt -121.47 109.24 34.85 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.141 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.16 66.89 7.73 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.917 1.745 . . . . 0.0 112.412 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.67 -11.68 0.45 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.001 -0.619 . . . . 0.0 111.841 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 m -113.81 137.31 51.82 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.955 0.407 . . . . 0.0 111.08 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.97 170.72 10.88 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.314 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.679 HG22 ' HB2' ' A' ' 19' ' ' ALA . 17.6 t -60.45 -59.69 3.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.184 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.432 ' O ' ' OE1' ' A' ' 32' ' ' GLU . . . -72.16 11.11 4.02 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.364 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.451 ' O ' ' OE2' ' A' ' 32' ' ' GLU . 54.3 mt-30 -98.87 -10.0 23.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.714 0.757 . . . . 0.0 110.487 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 pp -107.57 -19.18 13.64 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.609 HD23 ' O ' ' A' ' 31' ' ' LEU . 2.3 tt -91.63 -47.68 7.26 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.759 0.314 . . . . 0.0 111.631 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.561 ' N ' ' OE1' ' A' ' 32' ' ' GLU . 4.4 pm0 -47.08 -10.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.473 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.523 ' N ' ' O ' ' A' ' 31' ' ' LEU . 37.4 mm -77.79 -60.25 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.837 0.351 . . . . 0.0 110.366 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.577 ' N ' HD12 ' A' ' 34' ' ' LEU . 9.7 mp -48.8 -54.4 15.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.868 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.548 ' CD2' ' O ' ' A' ' 34' ' ' LEU . 1.3 p80 57.9 142.0 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.4 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -167.84 143.73 3.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.623 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -159.49 88.4 0.86 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.814 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.6 tt -175.97 -33.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.397 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -82.47 -106.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.283 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.14 -76.83 0.1 OUTLIER Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.61 103.49 1.76 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.652 2.235 . . . . 0.0 112.023 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.3 mt -85.38 69.14 10.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.04 0.448 . . . . 0.0 110.138 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.8 p -68.3 172.68 5.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.477 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -55.05 -23.7 21.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.67 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -75.62 -35.42 60.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.494 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.1 p -54.81 -32.14 59.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.149 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.546 HD22 ' N ' ' A' ' 47' ' ' LEU . 3.8 mm? -64.64 -22.88 67.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.774 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -76.18 75.63 3.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.69 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.36 6.48 0.49 Allowed Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.69 175.85 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 117.068 0.434 . . . . 0.0 110.428 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.49 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 24.0 m -111.62 164.55 12.88 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.519 ' HA ' HD13 ' A' ' 55' ' ' LEU . 4.9 t -58.25 -43.98 87.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.645 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.3 m -55.98 -25.35 43.61 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -74.85 -30.56 61.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.954 0.407 . . . . 0.0 111.468 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.722 ' N ' HD12 ' A' ' 55' ' ' LEU . 6.2 mp -65.3 -64.0 0.97 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -177.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -53.66 -36.45 62.14 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 61' ' ' GLY . 8.1 pt -80.35 -21.03 11.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.97 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.75 -33.01 83.72 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.78 ' N ' HD22 ' A' ' 59' ' ' LEU . 1.8 mm? -80.26 -54.73 5.46 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.483 ' HB3' HG12 ' A' ' 66' ' ' VAL . . . -79.42 -29.54 41.98 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.882 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 75.0 2.85 66.65 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.438 -0.887 . . . . 0.0 110.982 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.494 ' C ' ' H ' ' A' ' 64' ' ' GLU . 9.1 t -136.37 86.78 2.25 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.886 0.374 . . . . 0.0 111.253 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -49.08 -11.23 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.72 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.494 ' H ' ' C ' ' A' ' 62' ' ' SER . 25.3 tt0 -86.07 -35.71 20.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.512 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -98.27 -14.46 20.25 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.483 HG12 ' HB3' ' A' ' 60' ' ' ALA . 17.9 m -50.16 -25.83 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.475 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -52.31 -14.44 0.46 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.589 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 67.3 mtt -104.25 -22.21 13.41 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.67 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.448 ' HG ' ' H ' ' A' ' 71' ' ' THR . 37.8 tp -51.97 120.26 5.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.2 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 44.5 t0 -39.94 -33.13 0.19 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.194 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.448 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 62.9 m -60.7 119.65 45.98 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.071 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.439 ' O ' HD21 ' A' ' 76' ' ' LEU . 56.1 Cg_endo -69.71 -156.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 121.143 1.228 . . . . 0.0 111.348 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 8.8 ptm -106.8 -16.17 14.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.789 0.328 . . . . 0.0 111.147 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.7 m -92.76 -25.17 18.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.486 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.52 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -61.25 -33.12 73.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.371 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.908 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.2 mm? -64.95 -45.62 84.98 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.303 -0.959 . . . . 0.0 108.958 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.472 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 2.1 mptp? -59.97 -34.74 73.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.547 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -66.4 -58.8 4.51 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.708 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.49 -65.12 0.74 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.455 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.444 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.5 p -34.88 -27.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.05 0.452 . . . . 0.0 111.419 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.556 ' N ' ' O ' ' A' ' 79' ' ' ALA . 45.5 ttm-85 -77.3 -58.71 3.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.815 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.9 mt -45.01 -41.64 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.291 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.863 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -78.03 -35.62 49.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.64 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -51.44 -14.9 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.646 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.443 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 81.08 19.37 67.33 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 87' ' ' ALA . 8.0 tp10 -113.0 7.63 18.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.514 ' HB3' ' NH2' ' A' ' 14' ' ' ARG . . . -33.6 -57.11 0.44 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.494 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -53.3 140.3 27.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.521 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.8 p -83.2 142.36 13.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.608 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.08 -98.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.62 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.5 t -63.12 179.35 0.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.604 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.66 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.0 mm? -78.01 150.13 77.59 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.721 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.5 123.22 9.66 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.065 1.843 . . . . 0.0 111.798 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -74.37 151.74 87.69 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.252 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.77 164.78 34.57 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.211 1.941 . . . . 0.0 111.873 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.577 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.3 p -75.78 151.84 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.584 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.4 p -63.0 150.32 88.51 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.442 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.2 73.31 3.25 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.144 1.896 . . . . 0.0 111.781 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.454 ' C ' ' H ' ' A' ' 7' ' ' MET . 16.2 m -61.31 -169.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.595 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.6 t30 55.15 7.22 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.493 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.454 ' H ' ' C ' ' A' ' 5' ' ' VAL . 18.2 ttm -172.59 60.33 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.405 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.0 m -82.45 148.53 28.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.537 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' A' ' 12' ' ' ALA . 4.2 ptp180 -65.54 -41.77 92.69 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.319 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -41.73 -27.42 0.11 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.924 0.393 . . . . 0.0 110.774 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.403 ' N ' ' O ' ' A' ' 9' ' ' ARG . 87.9 m -83.59 -37.08 23.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.327 0.584 . . . . 0.0 109.53 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -82.78 8.44 12.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.265 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 mp -109.66 -35.47 6.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.176 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -82.07 -28.81 32.19 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.1 mt -64.3 -19.2 24.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.248 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.421 ' HA ' HG13 ' A' ' 27' ' ' VAL . . . -89.47 -17.94 27.7 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.337 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.3 -30.82 66.7 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.5 -43.76 75.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.13 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.66 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.04 -37.36 0.82 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.487 ' C ' ' H ' ' A' ' 22' ' ' LEU . 66.2 mtp180 -68.39 -42.48 79.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.283 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.6 -5.76 0.25 Allowed 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.968 0.413 . . . . 0.0 110.275 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.487 ' H ' ' C ' ' A' ' 20' ' ' ARG . 13.9 mt -119.21 122.43 29.52 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.398 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -79.13 79.42 3.39 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.712 1.608 . . . . 0.0 112.75 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 130.17 -52.27 0.83 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.8 m -55.35 137.97 46.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.987 0.422 . . . . 0.0 111.435 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.61 171.68 9.51 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.72 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.66 HG22 ' HB2' ' A' ' 19' ' ' ALA . 20.2 t -60.25 -59.15 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.438 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.29 6.94 9.07 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.241 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.945 ' OE1' ' OE2' ' A' ' 32' ' ' GLU . 20.7 mm-40 -96.93 -20.83 17.83 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 117.283 0.542 . . . . 0.0 110.182 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 pp -90.78 -20.89 21.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.548 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -91.72 -39.13 11.99 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.619 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.945 ' OE2' ' OE1' ' A' ' 29' ' ' GLN . 16.3 pt-20 -35.25 -25.67 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.999 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.55 ' N ' ' O ' ' A' ' 31' ' ' LEU . 78.7 mt -49.61 -36.22 10.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.684 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.7 tp -83.39 -7.28 59.59 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.941 0.4 . . . . 0.0 110.292 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 58.58 102.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.099 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -82.08 19.12 1.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.817 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.5 ttm-85 -49.54 -75.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.774 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.4 tt -90.15 136.72 23.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.396 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -48.24 130.25 15.97 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -153.64 -167.09 15.45 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -46.15 174.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.669 2.246 . . . . 0.0 112.164 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.6 tp -172.16 53.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.803 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 35.8 p -120.28 172.91 7.46 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.123 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.89 -25.97 40.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.042 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -78.31 -37.75 43.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.0 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.3 t -53.91 -39.65 66.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.639 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.545 ' O ' HD13 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -64.79 -40.52 95.37 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.393 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 84' ' ' TRP . 76.2 mt-30 -62.0 70.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.669 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -154.66 9.49 0.39 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.404 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -127.77 175.76 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.433 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 37.0 m -116.57 162.66 17.27 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.455 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.1 t -54.29 -47.83 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 123.254 0.347 . . . . 0.0 110.857 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -52.89 -25.27 11.16 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 116.365 -0.38 . . . . 0.0 112.003 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.404 ' CB ' HG22 ' A' ' 50' ' ' VAL . 13.2 t0 -75.43 -31.95 60.52 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.018 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.711 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.9 mp -66.38 -63.75 1.01 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.227 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.418 ' HB2' HD21 ' A' ' 76' ' ' LEU . 26.0 ttpt -52.87 -34.77 56.01 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.9 pt -80.31 -19.92 11.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.022 0.439 . . . . 0.0 109.834 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.29 -38.5 91.59 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.668 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.4 mm? -76.61 -54.57 6.49 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 120.645 -0.422 . . . . 0.0 109.999 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.72 -35.06 79.23 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 118.53 -53.79 0.65 Allowed Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.651 ' C ' ' H ' ' A' ' 64' ' ' GLU . 26.8 t -140.05 152.69 46.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.995 0.426 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.34 20.89 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.891 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.651 ' H ' ' C ' ' A' ' 62' ' ' SER . 60.8 mt-10 -97.34 -59.8 1.71 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.694 0.283 . . . . 0.0 110.886 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.41 ' OD1' ' CG ' ' A' ' 68' ' ' MET . 12.4 t0 -82.45 -11.91 58.2 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 m -51.92 -28.35 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.13 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -55.92 -24.15 36.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.541 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.41 ' CG ' ' OD1' ' A' ' 65' ' ' ASP . 8.1 mmt -93.75 -36.63 12.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.521 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.519 HD23 ' OG1' ' A' ' 71' ' ' THR . 12.7 tp -48.85 115.98 1.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.4 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -43.74 -16.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.773 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.519 ' OG1' HD23 ' A' ' 69' ' ' LEU . 2.8 m -51.58 116.17 7.45 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.535 ' C ' ' H ' ' A' ' 74' ' ' SER . 93.0 Cg_endo -79.58 20.29 0.88 Allowed 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.319 2.013 . . . . 0.0 113.655 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 18.7 ttm 66.13 -13.42 0.16 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.633 0.254 . . . . 0.0 111.2 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.535 ' H ' ' C ' ' A' ' 72' ' ' PRO . 5.7 t -96.91 -13.6 22.32 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.063 0.459 . . . . 0.0 109.933 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.426 ' HB1' HD23 ' A' ' 22' ' ' LEU . . . -73.3 -31.53 64.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.904 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.567 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -67.69 -59.15 3.55 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.886 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -52.82 -15.92 0.87 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.252 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 74' ' ' SER . 8.2 m-20 -86.33 -51.96 5.92 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -69.34 -56.35 7.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.439 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.447 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.2 p -35.73 -26.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.297 0.57 . . . . 0.0 111.048 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.55 ' N ' ' O ' ' A' ' 79' ' ' ALA . 40.3 ttm-85 -76.52 -55.35 5.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.925 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.567 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 53.2 mt -49.95 -42.78 19.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.463 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.887 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -79.13 -32.9 44.62 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.755 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.508 ' O ' ' NE2' ' A' ' 48' ' ' GLN . 0.6 OUTLIER -46.85 -29.64 2.08 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.44 14.9 39.65 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 88' ' ' GLU . 1.1 mp0 -110.74 0.65 17.45 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -33.07 -33.42 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.478 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 86' ' ' GLU . 56.8 mm-40 -47.46 -45.26 25.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.9 t -59.74 109.84 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.466 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -79.59 148.58 31.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.649 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.2 m -71.97 -143.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.458 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.672 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.1 mm? -86.48 149.94 50.23 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.947 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.03 35.97 0.36 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.159 1.906 . . . . 0.0 111.843 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 92' ' ' LEU . 6.6 pt20 -66.43 151.3 96.28 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.277 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.3 128.78 15.05 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.195 1.93 . . . . 0.0 111.866 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.431 ' H ' HG22 ' A' ' 96' ' ' VAL . 12.6 m . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.511 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 ptt? . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.5 t -80.72 101.28 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.568 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.5 m -160.66 60.33 1.32 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.708 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -76.7 92.62 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.777 2.318 . . . . 0.0 111.831 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.5 p -161.15 -18.95 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.598 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.461 ' CG ' ' H ' ' A' ' 7' ' ' MET . 8.8 t-20 -157.05 -176.8 6.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.859 0.362 . . . . 0.0 110.718 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.461 ' H ' ' CG ' ' A' ' 6' ' ' ASN . 3.1 ttt -161.93 -135.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.466 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.417 ' H ' ' CG ' ' A' ' 7' ' ' MET . 48.1 t -86.7 138.14 31.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.331 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.472 ' O ' ' N ' ' A' ' 12' ' ' ALA . 10.4 ptt180 -51.92 -56.12 16.05 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.075 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.418 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 14.2 pt-20 -44.36 -34.64 2.05 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 83.4 m -72.0 -19.71 61.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.339 0.59 . . . . 0.0 109.877 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -91.39 -72.15 0.6 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.236 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.71 HD23 ' H ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -39.83 -55.54 1.95 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.451 -178.434 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.458 ' O ' ' CG2' ' A' ' 82' ' ' ILE . 94.5 mtt-85 -42.59 -41.25 2.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.5 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.4 mm -64.44 -24.01 34.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.552 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.98 -18.76 20.01 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.99 -31.0 70.4 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -58.02 -41.53 83.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.779 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.711 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -42.38 -37.46 1.57 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.015 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.9 mtt-85 -64.06 -38.66 91.86 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.026 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.98 -7.2 0.98 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.332 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.43 HD23 ' HB1' ' A' ' 75' ' ' ALA . 25.3 mt -112.96 146.86 35.98 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -39.19 -71.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.196 1.931 . . . . 0.0 112.206 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -140.51 4.71 2.54 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.3 m -57.38 137.33 56.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.46 162.9 20.81 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.094 0.473 . . . . 0.0 110.806 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.711 HG22 ' HB2' ' A' ' 19' ' ' ALA . 22.1 t -61.04 -55.74 22.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.83 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.15 13.34 2.7 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.087 -0.577 . . . . 0.0 112.654 -178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -97.66 -19.31 18.36 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.018 0.909 . . . . 0.0 111.954 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.91 -17.53 20.07 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.988 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.686 HD22 ' N ' ' A' ' 31' ' ' LEU . 3.0 mm? -96.3 -49.13 5.33 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.163 0.438 . . . . 0.0 110.624 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -35.48 -28.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.303 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.562 HG23 ' N ' ' A' ' 34' ' ' LEU . 14.4 tt -76.17 -51.57 19.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.516 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.562 ' N ' HG23 ' A' ' 33' ' ' ILE . 2.9 pp -87.6 -4.92 58.94 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.74 0.305 . . . . 0.0 110.728 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.876 ' NE2' ' CD2' ' A' ' 42' ' ' LEU . 60.5 t-80 -132.85 105.47 7.15 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.564 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -140.12 137.59 34.6 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.301 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 39' ' ' GLU . 39.8 mmm-85 52.69 -159.25 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.297 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' A' ' 39' ' ' GLU . 66.7 mt 57.34 -83.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.168 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 37' ' ' ARG . 35.7 mt-10 60.15 124.04 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.225 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.2 -65.45 0.13 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.89 -71.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.52 2.146 . . . . 0.0 112.082 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.876 ' CD2' ' NE2' ' A' ' 35' ' ' HIS . 6.4 mt 47.83 29.32 1.58 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.363 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.3 p -76.05 170.03 17.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.989 0.423 . . . . 0.0 111.014 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -68.29 -22.09 64.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.965 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -85.97 -30.98 22.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.639 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.0 p -56.26 -45.89 79.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 47' ' ' LEU . 10.2 mp -64.15 -22.24 66.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.8 0.333 . . . . 0.0 110.481 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -81.93 65.03 6.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.935 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.13 3.15 0.76 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.52 172.73 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.453 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 60.6 m -115.43 162.28 17.38 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.507 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.7 t -55.41 -42.2 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 120.67 0.272 . . . . 0.0 111.058 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.3 m -58.11 -23.93 56.74 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.26 -31.98 60.94 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.995 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.737 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.5 mp -64.67 -65.86 0.62 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.533 -177.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -53.24 -36.13 60.72 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.538 ' O ' ' N ' ' A' ' 61' ' ' GLY . 11.6 pt -79.18 -19.02 12.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.188 0.518 . . . . 0.0 109.713 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.96 -40.02 95.14 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.011 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.781 ' N ' HD22 ' A' ' 59' ' ' LEU . 1.8 mm? -75.81 -53.09 9.02 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.283 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.26 -37.03 74.82 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 119.93 -53.24 0.69 Allowed Glycine 0 N--CA 1.465 0.61 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.582 ' C ' ' H ' ' A' ' 64' ' ' GLU . 2.5 t -137.54 147.38 45.1 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.98 0.419 . . . . 0.0 110.864 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -59.99 7.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.485 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.582 ' H ' ' C ' ' A' ' 62' ' ' SER . 53.2 mm-40 -81.5 -52.51 7.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.434 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -96.79 -7.27 34.14 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.3 m -47.36 -31.32 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.786 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -52.38 -33.29 42.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 0.0 110.235 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 17.2 mtt -80.6 -21.19 41.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.395 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.424 ' HG ' ' H ' ' A' ' 71' ' ' THR . 23.0 tp -65.41 122.4 17.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.499 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -47.09 -20.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.336 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.424 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 4.1 m -58.12 124.46 70.29 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.59 -86.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.532 1.488 . . . . 0.0 111.976 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 18.1 ptt? -173.59 -28.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.051 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.4 m -86.05 -17.97 33.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HB1' HD23 ' A' ' 22' ' ' LEU . . . -62.22 -35.78 79.95 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.96 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.714 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -66.73 -51.95 50.05 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.28 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.29 -32.41 64.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -69.52 -55.58 9.79 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.945 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -67.07 -61.94 1.68 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.439 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.447 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.7 p -35.18 -27.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.013 0.435 . . . . 0.0 111.355 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.55 ' N ' ' O ' ' A' ' 79' ' ' ALA . 47.3 ttm-85 -75.9 -59.56 2.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.149 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.515 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 49.4 mt -46.04 -40.53 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.692 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.88 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -79.84 -33.09 40.53 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 119.341 -0.944 . . . . 0.0 109.527 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -52.01 -21.52 3.19 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.771 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.67 16.07 55.52 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -104.33 -1.33 27.09 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.515 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -36.0 -35.31 0.07 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.382 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -47.6 -73.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.66 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 92.6 t -81.42 128.15 38.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.803 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' A' ' 91' ' ' SER . 25.8 t0 -87.03 -175.6 5.41 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.457 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.507 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 79.7 p -62.0 -173.53 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.89 0.376 . . . . 0.0 110.5 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.657 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.1 mm? -81.49 150.47 67.05 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.109 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.34 107.22 2.43 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.077 1.851 . . . . 0.0 111.392 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -54.89 151.21 16.3 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.376 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -36.06 -56.77 0.61 Allowed 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 122.573 2.182 . . . . 0.0 112.458 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.3 m . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.624 -179.924 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 mmt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.9 m -75.41 162.39 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.532 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.456 ' H ' ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -178.69 -50.93 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.302 179.69 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.456 ' HD2' ' H ' ' A' ' 3' ' ' THR . 61.1 Cg_endo -87.51 62.69 3.84 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.532 2.155 . . . . 0.0 112.371 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 7' ' ' MET . 14.9 p -169.46 -37.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.908 0.385 . . . . 0.0 110.884 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.447 ' N ' HG13 ' A' ' 5' ' ' VAL . 41.7 m-20 -54.63 84.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.71 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.498 ' N ' ' O ' ' A' ' 5' ' ' VAL . 39.1 mtt 51.97 -176.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.254 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.449 ' HB2' ' H ' ' A' ' 12' ' ' ALA . 16.2 m -58.29 -155.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.322 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.468 ' O ' HD13 ' A' ' 13' ' ' LEU . 53.1 ttt85 -142.23 -34.95 0.44 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.276 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -101.99 -33.6 9.67 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.869 0.366 . . . . 0.0 110.064 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.534 ' O ' ' N ' ' A' ' 14' ' ' ARG . 5.7 m -75.65 -62.19 1.67 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.449 ' H ' ' HB2' ' A' ' 8' ' ' SER . . . -28.38 -51.38 0.08 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.01 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.553 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 3.5 mp -56.69 -42.32 78.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.624 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' THR . 98.2 mtt180 -49.77 -46.5 50.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.152 0.501 . . . . 0.0 110.646 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.466 ' O ' HG22 ' A' ' 15' ' ' ILE . 25.2 mt -65.17 -8.0 5.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.588 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 13' ' ' LEU . . . -99.15 -15.0 19.11 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.651 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.38 -28.32 61.96 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -57.89 -42.83 85.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.121 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.673 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.77 -33.55 0.52 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.49 ' C ' ' H ' ' A' ' 22' ' ' LEU . 37.4 ttm180 -69.7 -42.99 73.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.017 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.64 -7.49 0.43 Allowed 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.061 0.458 . . . . 0.0 110.051 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' A' ' 20' ' ' ARG . 14.1 mt -116.46 147.62 40.05 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.438 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -60.34 -78.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.968 1.779 . . . . 0.0 113.005 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.87 -10.5 26.39 Favored Glycine 0 N--CA 1.469 0.89 0 C-N-CA 121.409 -0.424 . . . . 0.0 112.654 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.3 m -60.48 130.57 47.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.317 0.559 . . . . 0.0 110.644 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.18 166.89 15.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.551 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.673 HG22 ' HB2' ' A' ' 19' ' ' ALA . 21.6 t -58.44 -59.59 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.739 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.13 10.55 2.45 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.702 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -101.59 -25.78 13.76 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 117.986 0.893 . . . . 0.0 110.572 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.3 tp -86.75 -27.15 23.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.902 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.538 ' O ' ' N ' ' A' ' 33' ' ' ILE . 4.9 mt -86.88 -41.22 14.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.677 0.275 . . . . 0.0 110.799 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -34.44 -27.36 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.017 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 31' ' ' LEU . 58.4 mt -46.76 -44.51 6.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.566 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.546 HD22 ' N ' ' A' ' 34' ' ' LEU . 3.9 mm? -63.3 -76.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.244 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 1.292 ' ND1' ' N ' ' A' ' 36' ' ' GLN . 0.8 OUTLIER 54.33 165.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.663 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 1.292 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 37.4 mt-30 47.9 -123.47 1.6 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.67 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.421 ' O ' ' O ' ' A' ' 36' ' ' GLN . 14.7 mmt180 58.61 135.21 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.095 0.474 . . . . 0.0 110.893 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 39' ' ' GLU . 3.6 mm -67.83 -19.47 24.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.974 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 38' ' ' ILE . 27.7 mm-40 -46.12 175.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.058 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.498 ' H ' ' HD2' ' A' ' 41' ' ' PRO . . . -141.09 -66.12 0.03 OUTLIER Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.498 ' HD2' ' H ' ' A' ' 40' ' ' GLY . 97.0 Cg_endo -78.41 100.14 1.34 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.845 2.363 . . . . 0.0 112.53 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.637 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.5 mm? -81.37 64.88 6.28 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.8 p -61.35 174.63 0.68 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.282 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -76.11 -21.7 56.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.204 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -87.89 -41.37 13.25 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.693 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.2 m -53.1 -32.9 49.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.856 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 49' ' ' GLY . 77.8 mt -60.8 -28.57 68.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.638 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -63.16 71.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.801 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -149.7 16.04 1.08 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.461 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -134.84 178.39 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.467 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 67.2 m -115.98 164.23 14.74 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.472 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.6 t -57.41 -47.33 84.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.158 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 57' ' ' ILE . 3.4 m -54.77 -24.69 23.65 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.457 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.461 ' CB ' HG22 ' A' ' 50' ' ' VAL . 9.8 t70 -72.94 -30.95 64.26 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.053 0.454 . . . . 0.0 110.734 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.708 ' N ' HD12 ' A' ' 55' ' ' LEU . 6.6 mp -66.35 -63.35 1.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.529 -178.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -55.95 -37.93 69.67 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.0 pt -73.72 -21.4 18.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.617 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.7 -35.46 91.95 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.872 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.746 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.2 mm? -75.81 -55.48 5.59 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.899 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.551 ' HB2' ' CD1' ' A' ' 69' ' ' LEU . . . -76.29 -31.47 58.24 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.484 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 77.17 -2.36 61.5 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.098 -1.049 . . . . 0.0 111.248 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.526 ' C ' ' H ' ' A' ' 64' ' ' GLU . 22.2 t -131.03 99.37 4.87 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.921 0.391 . . . . 0.0 111.409 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -54.11 -2.73 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.036 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 62' ' ' SER . 27.9 tt0 -95.5 -44.28 7.59 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.298 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.79 -12.35 48.29 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 62' ' ' SER . 15.2 m -54.12 -22.4 7.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.856 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -65.19 -14.2 60.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.193 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 51.7 mtt -105.71 -18.59 14.02 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.843 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.551 ' CD1' ' HB2' ' A' ' 60' ' ' ALA . 1.2 mt -49.05 139.96 9.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.121 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 20.2 p-10 -58.27 -30.39 66.56 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.3 m -60.89 119.53 45.59 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.225 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.41 ' O ' HD21 ' A' ' 76' ' ' LEU . 72.2 Cg_endo -72.94 -154.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.313 1.342 . . . . 0.0 111.233 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.43 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 37.1 ttm -112.72 1.29 15.6 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.872 0.368 . . . . 0.0 110.059 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.0 m -107.1 -27.89 10.33 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.101 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.453 ' HB1' HD23 ' A' ' 22' ' ' LEU . . . -60.35 -35.42 75.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.548 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.905 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -63.75 -49.74 71.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.448 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.522 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 2.0 mptp? -54.63 -35.86 63.9 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.445 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.73 -59.4 3.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.92 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.45 -61.77 2.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.9 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.438 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 2.7 p -35.19 -27.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.049 0.452 . . . . 0.0 111.545 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 79' ' ' ALA . 29.0 ttm180 -78.01 -56.65 4.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.619 0.723 . . . . 0.0 109.818 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.544 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 42.8 mt -46.5 -45.09 6.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.901 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.866 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -74.49 -36.58 63.27 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.702 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -47.33 -19.58 0.16 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.104 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.434 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 85.16 15.46 66.86 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 88' ' ' GLU . 25.0 tt0 -108.29 0.37 21.26 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.544 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -32.97 -31.95 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.63 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 86' ' ' GLU . 37.5 mt-10 -53.36 125.19 16.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.707 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 66.0 t -84.3 118.94 32.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.497 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -82.0 -81.2 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.647 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.8 m -76.33 -178.92 4.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.724 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.656 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.2 mm? -76.8 150.82 81.93 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.849 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -36.61 -41.86 0.67 Allowed 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.297 1.998 . . . . 0.0 112.362 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -64.68 151.03 93.22 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.146 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -72.39 -52.56 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.186 1.924 . . . . 0.0 111.862 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 64.4 t . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.536 -179.968 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.477 ' H ' HG22 ' A' ' 2' ' ' VAL . 1.8 m -56.77 -104.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.192 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.475 ' H ' HG23 ' A' ' 2' ' ' VAL . 36.8 p -137.67 63.6 40.45 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.623 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -77.85 8.15 3.58 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.64 2.227 . . . . 0.0 111.646 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.8 t -67.72 -71.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.458 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 7' ' ' MET . 63.5 m-80 52.06 -173.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.796 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' A' ' 7' ' ' MET . 0.6 OUTLIER 57.52 141.51 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.952 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -71.41 -152.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.128 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.514 ' O ' HD13 ' A' ' 13' ' ' LEU . 39.2 ptt85 -144.33 -31.47 0.44 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.383 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -102.84 -34.2 9.07 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 14' ' ' ARG . 10.1 m -78.09 -62.03 1.81 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 11' ' ' THR . . . -28.57 -51.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.139 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 4.5 mp -49.42 -44.82 45.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.884 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 11' ' ' THR . 53.2 mtp180 -45.72 -44.75 13.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.965 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.666 HD12 ' N ' ' A' ' 15' ' ' ILE . 1.8 mp -64.37 -15.72 17.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.336 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 13' ' ' LEU . . . -99.6 -17.29 17.9 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.368 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -71.74 -28.14 63.47 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -60.56 -39.98 89.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.458 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.701 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -42.93 -34.78 1.03 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.659 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.437 ' C ' ' H ' ' A' ' 22' ' ' LEU . 65.8 ttt180 -66.12 -39.05 89.6 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.884 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -59.43 -6.87 1.15 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.134 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.437 ' H ' ' C ' ' A' ' 20' ' ' ARG . 14.9 mt -119.81 117.33 32.54 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.62 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.49 70.29 7.59 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.889 1.726 . . . . 0.0 112.48 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 146.14 -52.14 0.58 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.0 m -60.47 133.0 55.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.974 0.416 . . . . 0.0 111.145 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.99 168.23 13.02 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.077 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.701 HG22 ' HB2' ' A' ' 19' ' ' ALA . 18.2 t -58.77 -58.56 6.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.141 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.7 11.13 3.51 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.643 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.402 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 40.0 mm-40 -99.51 -15.26 18.73 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.952 0.876 . . . . 0.0 110.587 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.5 tp -100.75 -27.74 13.19 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.66 HD22 ' N ' ' A' ' 31' ' ' LEU . 3.0 mm? -90.28 -46.43 8.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 110.846 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -36.89 -25.78 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.737 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.689 ' N ' HD12 ' A' ' 33' ' ' ILE . 1.8 mp -86.08 -42.26 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.631 0.253 . . . . 0.0 110.494 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 31' ' ' LEU . 17.2 tp -52.94 -81.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.613 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.498 ' O ' ' NE2' ' A' ' 36' ' ' GLN . 16.6 p80 -70.13 158.14 36.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.357 . . . . 0.0 110.532 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.498 ' NE2' ' O ' ' A' ' 35' ' ' HIS . 33.9 mm-40 -128.89 -113.35 0.26 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.613 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -69.09 -137.79 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.863 0.363 . . . . 0.0 110.801 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 tp -41.68 143.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.942 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -162.13 -178.06 6.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.265 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.58 -69.24 0.02 OUTLIER Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -41.47 143.01 0.99 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.516 2.144 . . . . 0.0 111.89 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.583 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -161.07 14.72 0.1 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.239 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 p -81.0 160.63 24.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.225 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -48.13 -23.35 0.82 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.687 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -76.09 -39.91 54.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.096 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.9 m -53.86 -34.45 59.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.899 0.381 . . . . 0.0 110.432 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.515 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 3.0 mm? -61.43 -35.62 78.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.961 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -70.81 72.82 0.56 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.438 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.42 5.68 0.46 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.447 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -133.82 176.12 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.953 0.376 . . . . 0.0 110.163 179.811 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.474 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 9.3 m -115.38 165.59 12.8 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.462 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.5 t -57.64 -49.11 81.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.31 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.4 m -53.18 -24.62 11.25 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.592 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.447 ' CB ' HG22 ' A' ' 50' ' ' VAL . 32.9 t0 -74.16 -31.4 62.68 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.33 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.712 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.9 mp -66.1 -62.26 1.58 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 -178.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -55.55 -38.98 70.03 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 61' ' ' GLY . 15.1 pt -73.77 -24.96 20.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.418 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.79 -33.06 81.43 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.943 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.755 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.0 mm? -80.19 -56.39 4.25 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.107 0.453 . . . . 0.0 111.291 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.64 -30.44 61.63 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.726 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 81.48 -13.82 32.62 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.747 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.542 ' O ' HG13 ' A' ' 66' ' ' VAL . 2.7 p -121.67 103.76 9.12 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.918 0.39 . . . . 0.0 111.313 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.96 -0.06 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.597 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.536 ' H ' ' C ' ' A' ' 62' ' ' SER . 47.1 tt0 -96.27 -41.56 8.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.172 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -90.88 -12.11 37.18 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 62' ' ' SER . 13.7 m -54.91 -22.05 9.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.982 0.42 . . . . 0.0 111.232 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -57.73 -19.89 30.68 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.136 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 28.8 mtt -108.21 -5.16 17.02 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.553 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.498 HD23 ' H ' ' A' ' 70' ' ' ASP . 0.5 OUTLIER -48.84 151.11 1.28 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.283 -179.472 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.498 ' H ' HD23 ' A' ' 69' ' ' LEU . 8.4 t70 -67.63 -39.36 84.67 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 72' ' ' PRO . 81.9 m -61.1 112.99 6.66 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.682 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 71' ' ' THR . 50.1 Cg_exo -51.82 -164.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.594 1.53 . . . . 0.0 112.084 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.4 ptt? -105.32 -15.9 14.91 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.659 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.3 m -96.63 -19.25 19.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.243 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.436 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -67.44 -30.91 70.77 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.123 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.886 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.5 mm? -64.5 -49.6 70.68 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.526 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.7 OUTLIER -54.45 -33.58 59.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.548 179.448 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -72.09 -59.78 2.57 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.79 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -57.05 -63.45 1.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.342 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.425 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 2.3 p -35.1 -27.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.923 0.392 . . . . 0.0 111.744 -178.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 79' ' ' ALA . 46.6 ttm-85 -76.44 -60.07 2.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.534 0.683 . . . . 0.0 110.423 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.487 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 36.3 mt -43.61 -43.11 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.156 -178.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.877 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -76.65 -34.39 58.28 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 119.137 -1.025 . . . . 0.0 109.873 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -52.64 -18.03 1.58 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.676 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.56 14.67 67.61 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -102.3 1.62 35.92 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.487 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -36.78 -37.24 0.13 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.086 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.52 70.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.679 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.5 p -79.74 135.57 25.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.636 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 18.4 p-10 -76.02 -170.32 1.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.535 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.2 t -74.23 158.04 34.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.481 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.638 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.2 mm? -75.4 150.22 84.71 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.861 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -37.68 -50.54 1.87 Allowed 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 122.18 1.92 . . . . 0.0 112.228 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -81.12 150.96 69.33 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.375 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.03 178.59 5.76 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.115 1.877 . . . . 0.0 111.699 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.1 m . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.617 -179.979 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.57 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 63.5 t -66.94 -71.29 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.746 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.594 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 2.7 m -80.59 -36.58 0.94 Allowed Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.355 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 3' ' ' THR . 64.2 Cg_endo -91.05 94.77 0.23 Allowed 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.324 2.016 . . . . 0.0 111.849 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.8 p -82.49 144.86 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.475 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 7' ' ' MET . 13.2 p30 -148.02 171.78 15.28 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.367 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.403 ' C ' ' O ' ' A' ' 6' ' ' ASN . 6.8 ptt? 32.13 91.64 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.643 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.497 ' OG ' ' N ' ' A' ' 9' ' ' ARG . 3.8 t -117.2 179.29 4.08 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.213 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 12' ' ' ALA . 24.6 ptt180 -70.66 -35.39 72.83 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -40.71 -28.89 0.08 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.645 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 93.0 m -86.22 -28.21 24.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.043 0.449 . . . . 0.0 110.679 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -84.43 8.89 14.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.056 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.79 -27.36 10.31 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 120.685 0.279 . . . . 0.0 110.269 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 1.395 ' CD ' ' CG2' ' A' ' 82' ' ' ILE . 1.9 tmm_? -81.52 -20.6 39.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.156 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.503 HD13 ' HE ' ' A' ' 14' ' ' ARG . 7.6 mm -62.84 -26.03 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.218 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.02 -23.85 19.39 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.7 -33.62 76.38 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.19 -45.63 75.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.454 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.67 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -43.48 -36.07 1.87 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -63.43 -41.99 98.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.187 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -63.19 -7.26 5.53 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.045 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.4 mt -120.03 110.24 36.62 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.81 65.07 8.57 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.741 1.627 . . . . 0.0 112.394 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.33 -37.35 0.52 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.636 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.8 m -80.59 139.55 36.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.003 0.43 . . . . 0.0 111.432 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.43 166.79 15.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.91 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.67 HG22 ' HB2' ' A' ' 19' ' ' ALA . 25.7 t -60.52 -60.27 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.078 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.52 11.65 5.28 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.298 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.454 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 13.0 mm100 -99.0 -17.49 18.27 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.695 0.748 . . . . 0.0 110.286 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 45.8 tp -93.38 -18.28 22.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.826 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 33' ' ' ILE . 12.0 mt -83.84 -39.74 19.56 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.741 0.305 . . . . 0.0 111.155 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -41.36 -22.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.253 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 31' ' ' LEU . 28.8 pt -52.14 -32.86 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.563 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.529 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -74.62 -41.9 59.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.759 -179.129 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.4 ' O ' ' O ' ' A' ' 36' ' ' GLN . 19.6 t60 58.39 73.33 0.48 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.509 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.4 ' O ' ' O ' ' A' ' 35' ' ' HIS . 17.5 pt20 -57.45 -157.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.757 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.403 ' H ' ' H ' ' A' ' 38' ' ' ILE . 32.4 ttm180 -169.38 -14.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.759 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.466 ' CG1' ' N ' ' A' ' 39' ' ' GLU . 8.5 tt -157.28 161.67 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.468 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.497 ' CD ' ' H ' ' A' ' 39' ' ' GLU . 3.8 mp0 -61.27 138.36 58.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.407 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 175.96 172.73 41.01 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -72.93 171.48 17.39 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.71 2.273 . . . . 0.0 111.86 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.4 tp -159.48 59.12 0.39 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.118 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 p -68.94 -177.42 1.02 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.743 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -76.42 -26.03 55.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.313 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -72.51 -33.72 67.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.812 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.3 m -69.79 -32.78 71.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.59 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 49' ' ' GLY . 5.7 tp -71.03 -28.73 64.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.699 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -64.1 70.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.169 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -153.12 7.67 0.47 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.413 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -124.24 175.74 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.444 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 67.0 m -119.57 164.04 16.43 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.479 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.9 t -56.45 -43.99 79.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.333 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.7 m -56.85 -23.46 44.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.413 ' CB ' HG22 ' A' ' 50' ' ' VAL . 11.8 t70 -75.21 -32.52 61.21 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.231 0.539 . . . . 0.0 110.837 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.724 ' N ' HD12 ' A' ' 55' ' ' LEU . 6.0 mp -63.87 -66.63 0.52 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.629 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -54.25 -34.82 61.61 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.7 pt -78.58 -20.51 13.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.8 -37.03 88.16 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.858 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.704 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.3 mm? -76.45 -53.63 7.85 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.579 -0.448 . . . . 0.0 109.902 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.56 -36.71 76.56 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 121.25 -53.23 0.71 Allowed Glycine 0 N--CA 1.466 0.668 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.663 ' C ' ' H ' ' A' ' 64' ' ' GLU . 4.1 m -139.19 150.87 46.07 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.94 0.4 . . . . 0.0 110.916 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -60.13 22.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.639 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.663 ' H ' ' C ' ' A' ' 62' ' ' SER . 27.3 mt-10 -96.62 -60.33 1.63 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.698 0.285 . . . . 0.0 110.624 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -83.4 -13.08 55.66 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.5 m -47.51 -24.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.377 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -58.95 -35.0 72.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.345 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 24.9 mmt -84.97 -33.59 22.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.653 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.4 tp -49.89 122.01 6.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 110.16 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -55.88 -25.35 42.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.666 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 72' ' ' PRO . 26.1 m -50.13 108.62 1.05 Allowed Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.226 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 71' ' ' THR . 32.5 Cg_exo -54.8 -154.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.37 1.38 . . . . 0.0 112.196 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.4 ptm -115.75 -20.89 9.88 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.565 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.4 m -90.26 -19.87 23.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.538 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -64.78 -34.89 79.42 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.202 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.932 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.3 mm? -66.49 -50.88 61.78 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.31 -31.84 64.06 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -70.9 -56.82 5.41 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.779 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -64.7 -61.25 2.3 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.433 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.426 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 2.4 p -35.87 -26.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.22 0.533 . . . . 0.0 111.21 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 79' ' ' ALA . 15.9 ttm180 -78.87 -53.54 6.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.108 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 1.395 ' CG2' ' CD ' ' A' ' 14' ' ' ARG . 46.3 mt -50.29 -44.38 23.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.138 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 1.146 ' HA ' ' CZ ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -76.38 -35.57 58.57 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.639 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.636 ' N ' HH12 ' A' ' 14' ' ' ARG . 0.6 OUTLIER -45.6 -28.0 0.88 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.249 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.833 ' H ' HH12 ' A' ' 14' ' ' ARG . . . 96.13 13.66 48.32 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 88' ' ' GLU . 27.0 tt0 -105.95 -2.91 22.36 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.581 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -33.48 -34.44 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.392 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 86' ' ' GLU . 69.3 mm-40 -45.44 -47.99 13.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.539 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 99.5 t -61.38 93.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.681 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -82.83 132.71 35.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.433 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 85.8 p -62.37 172.59 1.46 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.934 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.635 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.0 mm? -82.47 150.52 63.62 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.88 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.34 119.2 6.1 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.269 1.979 . . . . 0.0 111.755 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -64.44 147.84 96.91 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.232 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.06 113.91 3.21 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.078 1.852 . . . . 0.0 111.825 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.498 -179.975 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.491 ' C ' ' H ' ' A' ' 3' ' ' THR . 37.9 mtt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.5 t 62.33 -1.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.528 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.491 ' H ' ' C ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -176.07 63.7 0.22 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.987 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.31 -44.12 0.33 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.512 2.142 . . . . 0.0 111.675 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.5 t 58.44 115.13 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.797 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.417 ' ND2' ' N ' ' A' ' 7' ' ' MET . 4.3 p-10 40.84 -155.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.216 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.417 ' N ' ' ND2' ' A' ' 6' ' ' ASN . 6.7 tpt 73.13 30.53 1.58 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.714 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.5 t -61.37 133.33 55.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.346 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.548 ' O ' ' N ' ' A' ' 12' ' ' ALA . 0.5 OUTLIER -49.03 -56.55 8.65 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.476 ' O ' ' NE ' ' A' ' 14' ' ' ARG . 21.6 pt-20 -43.81 -31.38 0.82 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.431 ' O ' ' CD1' ' A' ' 15' ' ' ILE . 61.0 m -76.39 -23.59 54.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.49 0.662 . . . . 0.0 109.776 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -85.92 -74.61 0.41 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.937 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.764 HD23 ' H ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -42.59 -27.92 0.19 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.661 -178.628 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.476 ' NE ' ' O ' ' A' ' 10' ' ' GLU . 29.4 mtm180 -75.09 -39.98 60.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.445 ' O ' HG22 ' A' ' 15' ' ' ILE . 55.1 mt -63.63 -13.04 12.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.456 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.73 -17.51 24.14 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.797 0.332 . . . . 0.0 110.771 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -70.79 -32.44 69.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.17 -44.19 74.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.291 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.691 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.59 -37.02 1.04 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.012 0.434 . . . . 0.0 109.969 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.405 ' C ' ' H ' ' A' ' 22' ' ' LEU . 54.8 ttm-85 -63.55 -41.72 98.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.527 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.75 -7.12 0.89 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.55 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 20' ' ' ARG . 12.0 mt -119.0 114.06 35.41 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -79.35 68.94 8.13 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.657 1.571 . . . . 0.0 112.293 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.81 -49.6 0.56 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.3 m -66.79 133.77 50.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.971 0.415 . . . . 0.0 111.589 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.14 173.03 11.4 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.038 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.691 HG22 ' HB2' ' A' ' 19' ' ' ALA . 21.4 t -63.62 -63.55 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.139 0.495 . . . . 0.0 111.09 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.52 11.93 2.91 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.045 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.442 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 10.9 mm100 -99.62 -24.97 14.57 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.514 0.657 . . . . 0.0 110.607 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.7 tt -85.3 -19.8 30.98 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.926 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.508 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -93.96 -44.9 7.85 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.004 0.431 . . . . 0.0 109.981 179.87 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.427 ' C ' ' N ' ' A' ' 34' ' ' LEU . 84.2 mt-10 -56.45 -4.87 0.16 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.952 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.442 ' H ' ' C ' ' A' ' 31' ' ' LEU . 27.5 pt -52.13 -12.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.942 0.401 . . . . 0.0 110.515 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.427 ' N ' ' C ' ' A' ' 32' ' ' GLU . 33.9 mt -83.05 -22.15 33.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.825 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 58.22 174.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.221 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 60.53 109.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.284 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -51.01 146.6 5.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.478 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.8 tt -173.38 -23.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.735 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 52.71 -103.54 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.17 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.36 171.84 33.53 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.21 -174.08 1.1 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.755 2.303 . . . . 0.0 111.717 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 tp -157.48 99.27 1.74 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.082 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.9 p -101.64 179.82 4.23 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -75.53 -23.23 56.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.995 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -84.34 -31.53 24.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.426 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.2 t -53.1 -54.44 35.58 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.732 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.473 HD22 ' N ' ' A' ' 47' ' ' LEU . 3.7 mm? -57.15 -30.37 64.39 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.343 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -84.11 69.65 10.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.938 0.399 . . . . 0.0 110.533 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.0 -2.85 0.14 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.458 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -123.23 172.82 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.637 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.444 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 3.5 m -115.95 161.71 18.43 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.459 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.4 t -53.37 -44.26 54.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 123.213 0.321 . . . . 0.0 110.985 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 57' ' ' ILE . 3.6 m -58.12 -22.92 53.02 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.458 ' CB ' HG22 ' A' ' 50' ' ' VAL . 9.6 t0 -75.39 -31.93 60.62 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.452 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.726 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.8 mp -64.5 -67.57 0.42 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.42 -177.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -52.12 -34.73 45.62 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.6 pt -79.7 -19.17 12.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.71 -41.08 84.79 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.681 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.4 mm? -73.48 -54.37 8.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.583 -0.447 . . . . 0.0 109.833 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.75 -37.06 79.11 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 118.8 -51.96 0.73 Allowed Glycine 0 N--CA 1.468 0.809 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.593 ' C ' ' H ' ' A' ' 64' ' ' GLU . 83.8 p -138.38 145.91 41.63 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.75 0.31 . . . . 0.0 110.842 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -59.92 6.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.195 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.593 ' H ' ' C ' ' A' ' 62' ' ' SER . 32.7 mt-10 -82.3 -54.72 5.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.299 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -96.74 -5.3 38.93 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 m -44.82 -26.33 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.611 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -57.04 -32.17 65.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.017 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 25.3 mmm -92.04 -7.64 48.23 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.363 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.483 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 30.1 tp -49.57 -84.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.212 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 1.3 t70 154.23 -26.78 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.408 ' OG1' ' CD2' ' A' ' 69' ' ' LEU . 3.4 m -62.4 135.12 95.17 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.018 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.6 -92.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.793 1.662 . . . . 0.0 112.28 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -172.59 -26.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.1 m -88.52 -18.9 27.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.9 -35.84 81.73 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.714 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.944 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.4 mm? -64.46 -49.78 70.11 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -70.15 -9.21 54.93 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.954 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -86.04 -50.4 7.07 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.577 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -70.21 -57.84 4.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.301 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.411 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.3 p -35.22 -25.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.11 0.481 . . . . 0.0 111.167 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.577 ' N ' ' O ' ' A' ' 79' ' ' ALA . 21.4 ttm180 -78.44 -55.61 5.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.819 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.517 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 49.7 mt -50.72 -41.5 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.287 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.858 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.54 -35.82 52.88 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.309 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.401 ' CE3' ' O ' ' A' ' 80' ' ' VAL . 0.6 OUTLIER -45.86 -22.13 0.17 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.439 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.442 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 86.57 18.18 59.0 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 89' ' ' VAL . 85.0 mt-10 -111.29 -0.23 16.48 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.479 0.18 . . . . 0.0 110.518 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.517 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -31.86 -58.36 0.28 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.689 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -47.53 -40.45 18.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.749 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.499 ' N ' ' O ' ' A' ' 86' ' ' GLU . 48.0 t -72.52 78.58 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.342 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.463 ' CG ' ' N ' ' A' ' 91' ' ' SER . 7.5 p-10 -89.3 -56.63 3.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.799 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.463 ' N ' ' CG ' ' A' ' 90' ' ' ASP . 93.5 p -71.5 166.86 20.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.653 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.613 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.2 mm? -70.61 150.16 95.45 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.33 -38.17 2.15 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.132 1.888 . . . . 0.0 111.861 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.409 ' HG2' ' H ' ' A' ' 94' ' ' GLN . 3.2 pt20 -65.12 151.99 92.46 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.223 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -71.67 122.96 9.03 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.234 1.956 . . . . 0.0 111.947 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.0 t . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.589 -179.998 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 3' ' ' THR . 12.5 t -98.57 84.95 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.555 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 2' ' ' VAL . 15.5 p 58.07 148.47 0.06 OUTLIER Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.659 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.482 ' O ' ' N ' ' A' ' 6' ' ' ASN . 73.1 Cg_exo -37.23 -62.46 0.28 Allowed 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.357 2.038 . . . . 0.0 112.61 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.2 t -61.99 74.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.95 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 4' ' ' PRO . 68.2 m-80 -80.63 50.81 1.38 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.884 0.374 . . . . 0.0 110.267 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 17.3 ptp -167.63 157.87 10.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.302 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.3 m -92.47 123.2 35.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.958 0.409 . . . . 0.0 111.149 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 12' ' ' ALA . 6.4 ptm180 -55.25 -50.94 68.18 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.259 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -45.25 -30.41 1.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 m -75.43 -21.46 58.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.546 0.689 . . . . 0.0 109.532 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -86.47 -72.74 0.49 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.251 -1.341 . . . . 0.0 111.642 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.729 HD23 ' H ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -35.25 -51.26 0.57 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.637 -178.88 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.1 mtm-85 -50.04 -34.68 22.23 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.6 mm -64.16 -24.03 34.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.905 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.73 -19.8 22.23 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.567 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.99 -32.48 69.32 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -56.24 -43.93 79.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.329 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.688 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -40.41 -36.36 0.54 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.435 ' C ' ' H ' ' A' ' 22' ' ' LEU . 72.8 mtt-85 -65.9 -42.51 90.12 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.342 -0.39 . . . . 0.0 109.948 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.48 -6.14 0.65 Allowed 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.345 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.435 ' H ' ' C ' ' A' ' 20' ' ' ARG . 8.7 mt -121.11 112.41 33.27 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.633 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -83.5 65.46 7.56 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.959 1.773 . . . . 0.0 112.414 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.9 -35.87 0.62 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.472 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.8 m -81.9 135.0 35.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.947 0.403 . . . . 0.0 111.333 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.77 170.47 14.13 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.015 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.688 HG22 ' HB2' ' A' ' 19' ' ' ALA . 23.4 t -61.72 -61.44 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.75 10.32 4.19 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.19 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.419 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 21.0 mm100 -99.19 -25.4 14.53 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.427 0.614 . . . . 0.0 110.574 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.7 tp -88.09 -26.17 22.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.444 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 31' ' ' LEU . 3.4 mm? -82.72 -38.75 22.88 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -32.86 -32.08 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.772 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.603 ' N ' HD12 ' A' ' 33' ' ' ILE . 1.7 mp -51.99 -47.27 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 31' ' ' LEU . 5.1 tp -64.29 -8.0 11.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.9 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.406 ' O ' ' O ' ' A' ' 34' ' ' LEU . 4.7 m-70 57.12 116.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.022 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.444 ' C ' ' H ' ' A' ' 38' ' ' ILE . 5.8 pt20 -177.86 50.63 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.58 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -59.4 -3.69 0.47 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.834 0.35 . . . . 0.0 110.67 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.444 ' H ' ' C ' ' A' ' 36' ' ' GLN . 10.1 pt -146.4 68.46 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.938 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 38' ' ' ILE . 15.6 mp0 55.33 163.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.285 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 161.75 -167.44 36.51 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -46.05 150.34 1.94 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.82 2.347 . . . . 0.0 112.232 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.1 tp -172.27 33.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.622 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 34.4 p -80.43 172.39 13.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.746 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -68.12 -26.7 65.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.891 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.451 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 3.9 mp0 -85.9 -29.04 23.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.491 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.5 t -53.67 -47.47 70.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.115 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.527 HD22 ' N ' ' A' ' 47' ' ' LEU . 3.3 mm? -65.22 -34.7 78.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.677 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -78.06 63.9 3.13 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.388 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.64 1.34 0.6 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.457 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -130.16 173.62 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.469 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 36.0 m -116.0 164.8 13.9 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.463 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.2 t -55.23 -47.71 77.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 O-C-N 123.27 0.356 . . . . 0.0 111.313 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.4 m -54.81 -24.32 22.26 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.457 ' CB ' HG22 ' A' ' 50' ' ' VAL . 38.1 t0 -74.74 -31.76 61.91 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.846 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.719 ' N ' HD12 ' A' ' 55' ' ' LEU . 6.2 mp -65.27 -65.52 0.66 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.241 -178.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -53.63 -34.25 57.88 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.5 pt -78.77 -18.63 13.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.66 -38.79 67.49 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.656 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.5 mm? -74.76 -55.5 5.78 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.47 -37.15 84.48 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 100.26 -28.9 13.63 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.801 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.597 ' C ' ' H ' ' A' ' 64' ' ' GLU . 14.9 p -138.2 132.42 31.82 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.386 0.612 . . . . 0.0 112.131 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.434 ' HG3' ' H ' ' A' ' 63' ' ' GLU . 2.2 mt-10 -58.59 7.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.867 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.597 ' H ' ' C ' ' A' ' 62' ' ' SER . 54.2 mt-10 -93.81 -52.44 4.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.895 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -80.96 -16.28 53.93 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.3 m -50.18 -23.69 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.263 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -61.04 -30.39 70.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.425 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 37.8 mtt -91.77 -34.34 14.64 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.982 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.2 tp -49.28 108.4 0.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.944 0.402 . . . . 0.0 110.06 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -42.84 -24.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.812 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 72' ' ' PRO . 14.8 m -45.69 106.29 0.54 Allowed Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.633 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.447 ' O ' HD21 ' A' ' 76' ' ' LEU . 52.5 Cg_exo -52.73 -168.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.311 1.341 . . . . 0.0 111.262 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 40.8 ttp -106.07 -7.55 17.96 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.2 t -100.18 -26.27 13.99 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.209 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.02 -34.5 70.11 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.036 0.445 . . . . 0.0 110.301 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.915 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -67.78 -59.66 3.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.563 0.696 . . . . 0.0 109.603 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -60.08 -10.17 4.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.205 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -87.64 -52.88 5.08 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -68.84 -56.74 7.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.182 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.424 ' O ' ' CE3' ' A' ' 84' ' ' TRP . 1.4 p -35.06 -25.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 121.219 0.533 . . . . 0.0 111.316 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 79' ' ' ALA . 39.5 ttm180 -78.75 -56.58 4.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.565 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.557 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 41.8 mt -47.33 -42.48 7.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.896 -178.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.845 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.37 -36.17 53.82 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.892 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.424 ' CE3' ' O ' ' A' ' 80' ' ' VAL . 0.7 OUTLIER -46.63 -24.35 0.53 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.674 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 90.63 18.94 46.36 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 88' ' ' GLU . 45.2 mt-10 -110.15 -0.05 18.07 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.557 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -35.94 -26.58 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.358 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 86' ' ' GLU . 67.0 mm-40 -52.01 -60.84 2.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.238 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 89' ' ' VAL . 18.0 m -74.74 40.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.026 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.403 ' H ' ' C ' ' A' ' 88' ' ' GLU . 14.3 t70 -87.7 102.84 15.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.782 0.325 . . . . 0.0 110.362 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.0 t -75.51 158.61 32.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.232 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.663 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.0 mm? -78.87 149.68 74.25 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.015 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -37.68 -44.09 1.53 Allowed 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 122.141 1.894 . . . . 0.0 112.192 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -75.01 153.2 86.64 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.111 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.46 101.14 1.1 Allowed 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.199 1.932 . . . . 0.0 111.835 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.536 -179.899 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.544 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.8 mpt? . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 2' ' ' VAL . 17.2 m -72.12 -178.23 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.511 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.5 m 49.3 68.26 3.68 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.472 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -46.07 169.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.881 2.388 . . . . 0.0 112.196 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.0 m -152.35 -165.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.239 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 51.29 94.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.465 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.44 ' O ' ' SD ' ' A' ' 7' ' ' MET . 0.0 OUTLIER -165.49 15.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.734 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.2 m -68.35 179.07 1.72 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.613 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 12' ' ' ALA . 9.6 ptp180 -50.58 -57.5 8.02 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.652 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -43.95 -35.59 2.1 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.6 m -72.18 -19.46 61.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.549 0.69 . . . . 0.0 109.724 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -90.04 -71.36 0.62 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.469 -1.242 . . . . 0.0 111.844 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.69 HD23 ' H ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -40.99 -51.53 3.24 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.329 -178.685 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.752 HH21 ' HB3' ' A' ' 87' ' ' ALA . 71.9 mtp180 -43.54 -43.33 5.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.645 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 mm -63.53 -21.62 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.625 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -97.45 -17.24 19.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -69.73 -32.28 70.73 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.07 -46.03 71.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.313 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.66 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -39.7 -36.37 0.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.337 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.481 ' C ' ' H ' ' A' ' 22' ' ' LEU . 73.6 ttt-85 -64.33 -42.37 96.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.837 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.39 -4.72 0.41 Allowed 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.348 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 20' ' ' ARG . 8.5 mt -122.8 111.96 30.86 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.566 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.04 67.18 8.71 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 121.713 1.609 . . . . 0.0 112.22 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.39 -43.97 0.58 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.637 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.3 m -75.2 133.43 41.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.938 0.399 . . . . 0.0 111.34 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.64 173.3 11.49 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.081 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.66 HG22 ' HB2' ' A' ' 19' ' ' ALA . 22.2 t -62.8 -62.59 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.672 -179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.84 11.37 3.52 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.091 -178.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.456 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 20.1 mm-40 -100.14 -24.36 14.6 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 117.487 0.644 . . . . 0.0 110.891 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.107 ' O ' HD13 ' A' ' 33' ' ' ILE . 6.6 tt -92.79 -23.52 18.84 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.981 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 33' ' ' ILE . 25.6 mt -76.22 -37.37 57.84 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.87 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -36.16 -25.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.917 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.107 HD13 ' O ' ' A' ' 30' ' ' LEU . 1.9 mp -48.13 -68.87 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.556 -0.458 . . . . 0.0 109.963 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.501 HD23 ' C ' ' A' ' 34' ' ' LEU . 4.9 tt -68.14 -61.32 1.91 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.498 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -44.5 153.5 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.95 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.46 ' C ' ' H ' ' A' ' 38' ' ' ILE . 23.0 mt-30 60.16 160.74 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.704 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 66.22 -3.06 0.86 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.481 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.476 HG23 ' N ' ' A' ' 39' ' ' GLU . 9.0 tp -163.01 -41.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.821 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.476 ' N ' HG23 ' A' ' 38' ' ' ILE . 95.0 mt-10 54.71 163.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.852 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.14 -161.63 28.97 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.504 ' C ' HD13 ' A' ' 42' ' ' LEU . 76.4 Cg_exo -47.11 168.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.292 1.994 . . . . 0.0 111.763 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.868 HD13 ' N ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -139.39 27.57 2.3 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.881 0.372 . . . . 0.0 110.378 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.0 p -72.94 167.99 19.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.597 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -73.51 -22.57 60.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.245 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -87.44 -32.3 19.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.317 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.4 t -53.44 -46.2 69.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.224 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -50.22 -21.23 1.26 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.936 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -70.51 70.76 0.45 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.361 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.22 7.45 0.74 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.78 175.7 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.488 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 9.0 m -113.21 163.84 14.28 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.503 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.4 t -56.27 -43.77 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 123.209 0.318 . . . . 0.0 111.414 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.8 m -55.33 -25.72 36.43 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -76.47 -30.94 57.49 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.912 0.387 . . . . 0.0 111.544 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.737 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.6 mp -65.62 -65.09 0.72 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -50.81 -34.86 29.39 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 61' ' ' GLY . 8.9 pt -83.08 -21.69 8.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.336 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.26 -38.12 95.68 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.727 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.1 mm? -74.59 -62.3 1.58 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.711 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.11 -34.17 77.04 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.325 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 86.93 -8.74 74.96 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.479 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.506 ' C ' ' H ' ' A' ' 64' ' ' GLU . 1.9 m -138.01 104.52 5.27 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 117.106 0.453 . . . . 0.0 112.022 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -54.24 -6.5 0.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.218 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' A' ' 62' ' ' SER . 28.3 mp0 -83.76 -45.25 13.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.719 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.06 -12.97 34.09 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.416 ' C ' ' N ' ' A' ' 68' ' ' MET . 12.9 m -50.66 -29.39 6.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.105 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -51.52 -15.12 0.38 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.48 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.416 ' N ' ' C ' ' A' ' 66' ' ' VAL . 48.6 mtt -104.45 -25.81 12.66 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.741 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.463 ' HG ' ' H ' ' A' ' 71' ' ' THR . 38.7 tp -51.86 119.26 4.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.165 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -38.99 -29.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.444 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.463 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 33.1 m -65.9 115.08 19.52 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.643 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.487 ' O ' HD21 ' A' ' 76' ' ' LEU . 60.4 Cg_endo -71.27 -156.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.261 1.307 . . . . 0.0 111.43 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -102.15 -17.58 15.94 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.823 0.344 . . . . 0.0 111.526 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.3 m -92.35 -22.96 19.4 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.702 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -63.61 -32.81 74.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.41 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.862 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.0 OUTLIER -66.37 -48.05 71.39 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.422 -0.911 . . . . 0.0 108.922 179.754 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -32.34 66.51 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.48 -58.77 3.2 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.303 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -62.45 -63.25 1.29 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.403 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 p -34.56 -24.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.991 0.424 . . . . 0.0 111.673 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 79' ' ' ALA . 32.4 ttm180 -78.24 -57.53 3.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 109.82 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.464 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 42.0 mt -48.09 -41.44 9.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.148 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.824 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.44 -36.28 53.24 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.332 179.774 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -49.75 -15.1 0.15 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.482 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 79.46 19.53 71.22 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 88' ' ' GLU . 79.4 mt-10 -113.0 7.1 18.01 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.752 ' HB3' HH21 ' A' ' 14' ' ' ARG . . . -35.73 -26.01 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.279 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 86' ' ' GLU . 28.9 mt-10 -37.48 -69.25 0.12 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.222 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.5 t -60.77 75.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.426 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 88' ' ' GLU . 46.3 t0 -91.9 140.53 29.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.556 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 85.4 p -62.89 153.96 31.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.285 0.564 . . . . 0.0 110.552 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.499 ' N ' ' CD1' ' A' ' 92' ' ' LEU . 6.8 mp -88.7 154.78 50.66 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.276 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -35.14 95.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 122.49 2.127 . . . . 0.0 112.243 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -53.91 129.67 56.93 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.223 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.22 121.43 6.49 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.759 1.639 . . . . 0.0 111.826 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.533 -179.959 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.7 mtt . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.8 m -80.64 138.54 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.676 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.3 m -158.52 63.57 2.56 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.371 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -42.19 160.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.739 2.293 . . . . 0.0 112.388 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.3 p -161.32 153.06 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.339 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 7' ' ' MET . 8.2 p30 -170.01 -106.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.341 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.402 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 23.7 ttt -46.82 115.9 1.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.793 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.2 t -83.36 -156.26 0.19 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.822 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.693 ' O ' HD13 ' A' ' 13' ' ' LEU . 12.6 tpt180 -136.83 -28.3 0.97 Allowed 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 116.713 -0.222 . . . . 0.0 111.208 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 10' ' ' GLU . 1.2 pm0 -95.23 -27.14 15.66 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.33 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.566 ' C ' ' H ' ' A' ' 13' ' ' LEU . 22.2 m -84.88 -44.95 12.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.43 0.633 . . . . 0.0 110.155 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.526 ' C ' HD12 ' A' ' 13' ' ' LEU . . . -66.55 14.44 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.538 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.693 HD13 ' O ' ' A' ' 9' ' ' ARG . 7.0 mp -117.13 -35.51 4.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.932 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.664 ' HE ' ' CB ' ' A' ' 87' ' ' ALA . 15.4 ttt85 -71.54 -32.31 67.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.229 -178.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.3 mm -54.35 -16.19 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.476 ' HA ' HG13 ' A' ' 27' ' ' VAL . . . -97.75 -25.35 15.1 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.248 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.91 -38.2 84.9 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.14 -42.34 69.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.377 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.679 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.82 -38.89 1.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.12 178.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.453 ' C ' ' H ' ' A' ' 22' ' ' LEU . 39.0 ttt85 -66.08 -42.26 89.6 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.839 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.48 -5.77 0.24 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.975 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 20' ' ' ARG . 8.6 mt -122.39 105.45 36.4 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.423 -178.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -80.48 78.06 3.82 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 121.562 1.508 . . . . 0.0 112.086 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.62 -30.64 1.26 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.6 m -96.18 142.7 28.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.026 0.441 . . . . 0.0 111.296 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.14 178.52 6.61 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.219 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.679 HG22 ' HB2' ' A' ' 19' ' ' ALA . 22.9 t -66.4 -65.47 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.904 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.74 13.77 3.9 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.129 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -100.33 -16.11 17.78 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.166 0.483 . . . . 0.0 110.472 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 pp -94.65 -20.81 19.24 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 pp -99.95 -39.59 8.08 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.249 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -55.47 -8.22 0.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.0 mt -43.72 -51.32 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.779 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.582 ' N ' HD12 ' A' ' 34' ' ' LEU . 8.0 mp -64.66 -61.72 2.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.268 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.516 ' CG ' ' O ' ' A' ' 34' ' ' LEU . 68.5 m80 -157.74 -112.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.353 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -161.96 -134.93 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.756 0.312 . . . . 0.0 110.462 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -97.4 79.42 2.77 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.748 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 38' ' ' ILE . 23.9 mt -83.39 -74.14 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.377 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.23 -170.57 2.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.409 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.33 176.45 3.62 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.61 -176.36 3.21 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.838 2.359 . . . . 0.0 112.129 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 42' ' ' LEU . 1.6 tt -159.15 82.11 0.77 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.955 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 p -94.31 159.66 15.02 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.577 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -53.65 -21.64 7.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.427 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -81.67 -34.37 30.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.007 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.4 t -59.93 -32.44 70.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.374 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.0 tp -69.65 -5.12 22.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.825 0.345 . . . . 0.0 110.75 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -85.52 71.73 10.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.512 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.34 7.44 0.84 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 120.949 -0.644 . . . . 0.0 111.643 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.1 177.92 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.676 0.274 . . . . 0.0 110.361 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.48 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 33.7 m -112.78 162.46 15.75 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.505 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.9 t -57.2 -44.32 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 120.667 0.27 . . . . 0.0 111.139 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.9 m -56.88 -22.07 34.34 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -77.25 -30.59 54.51 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.211 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.73 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.9 mp -65.93 -64.47 0.85 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.211 -177.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -52.99 -34.13 54.74 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 61' ' ' GLY . 7.4 pt -83.38 -18.86 10.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.668 0.271 . . . . 0.0 110.948 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.29 -33.22 86.66 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.757 ' N ' HD22 ' A' ' 59' ' ' LEU . 1.8 mm? -79.23 -57.25 3.81 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.578 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.58 -32.78 64.3 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.125 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 84.75 -5.11 83.3 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.538 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.511 ' C ' ' H ' ' A' ' 64' ' ' GLU . 69.0 m -137.9 99.22 3.84 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.942 0.401 . . . . 0.0 111.635 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 63' ' ' GLU . 0.1 OUTLIER -50.88 -8.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.72 179.246 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.511 ' H ' ' C ' ' A' ' 62' ' ' SER . 32.6 tt0 -87.62 -41.31 13.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.835 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -89.8 -18.17 26.78 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.6 m -46.74 -23.07 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.967 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 67' ' ' ASP . 56.1 t0 -50.72 -34.57 27.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.46 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 68' ' ' MET . 0.0 OUTLIER -82.5 -32.83 28.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.637 179.761 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.403 ' HG ' ' H ' ' A' ' 71' ' ' THR . 25.3 tp -49.91 116.22 1.72 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.114 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -42.45 -26.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.89 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.403 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 6.7 m -62.15 112.51 6.47 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 119.343 -0.36 . . . . 0.0 110.699 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.517 ' O ' HD21 ' A' ' 76' ' ' LEU . 72.5 Cg_endo -73.47 -157.58 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.345 1.364 . . . . 0.0 111.748 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.7 ttm -103.72 -10.85 18.01 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.557 0.217 . . . . 0.0 110.776 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.2 m -94.51 -23.2 17.79 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.881 0.372 . . . . 0.0 110.39 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -63.93 -36.24 83.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.921 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -67.55 -47.26 70.34 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.654 -0.818 . . . . 0.0 109.092 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -26.03 61.06 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.48 -57.88 3.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.721 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.21 -64.69 0.86 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.06 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.427 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.2 p -34.89 -27.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.3 0.571 . . . . 0.0 111.146 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.564 ' N ' ' O ' ' A' ' 79' ' ' ALA . 23.7 ttm180 -78.47 -55.84 4.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.654 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.475 ' N ' ' O ' ' A' ' 79' ' ' ALA . 33.7 mt -47.68 -41.53 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.22 -178.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.854 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -78.16 -34.99 49.37 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.714 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -52.49 -14.26 0.47 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.744 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.429 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 81.12 17.71 71.32 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 87' ' ' ALA . 52.0 mt-10 -114.05 8.84 17.17 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.664 ' CB ' ' HE ' ' A' ' 14' ' ' ARG . . . -31.89 -48.81 0.16 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.776 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -55.83 139.5 45.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.67 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.5 m -85.92 179.07 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.744 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -95.55 -95.39 0.18 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.793 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.0 t -62.05 -179.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.736 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.656 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.0 mm? -81.08 150.23 67.99 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.012 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -37.75 108.78 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 122.156 1.904 . . . . 0.0 112.259 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.621 ' N ' ' CD ' ' A' ' 95' ' ' PRO . 6.0 tm0? -78.67 -36.11 1.18 Allowed Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.265 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 94' ' ' GLN . 32.1 Cg_exo -57.49 171.83 1.22 Allowed 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.176 1.917 . . . . 0.0 111.987 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.912 -1.042 . . . . 0.0 110.506 179.877 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 mtt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.78 151.59 9.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.468 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.3 m -148.11 84.24 6.91 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.335 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.96 151.03 4.19 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.513 2.142 . . . . 0.0 112.262 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.82 -4.01 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.131 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -51.19 -17.84 0.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.54 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -171.39 54.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.589 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.443 ' OG ' ' N ' ' A' ' 9' ' ' ARG . 26.5 t -61.0 179.91 0.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.259 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.48 ' O ' ' N ' ' A' ' 12' ' ' ALA . 14.5 ptt85 -50.29 -56.03 12.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.558 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.462 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 19.4 pt-20 -45.68 -35.15 3.95 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.4 m -71.7 -16.78 62.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.445 0.641 . . . . 0.0 109.672 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -94.03 -71.14 0.67 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.955 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.656 HD23 ' H ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -50.2 -49.85 51.34 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.518 -178.382 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -44.42 -48.9 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.973 0.416 . . . . 0.0 110.992 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.2 mm -65.39 -15.47 18.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.586 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.73 -16.68 17.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.093 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -71.62 -30.14 65.45 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -59.38 -42.04 90.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.512 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.694 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -40.35 -33.44 0.25 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.461 ' C ' ' H ' ' A' ' 22' ' ' LEU . 56.7 ttt-85 -69.26 -42.48 75.51 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.294 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.73 -7.65 0.47 Allowed 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.078 0.466 . . . . 0.0 110.207 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' ' 79' ' ' ALA . 14.0 mt -113.91 149.69 42.27 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.855 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.18 -88.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.094 1.863 . . . . 0.0 112.552 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.34 -7.03 52.65 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.455 -0.403 . . . . 0.0 112.303 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.9 m -60.84 137.51 58.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.149 0.474 . . . . 0.0 110.628 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.16 164.34 13.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.985 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.694 HG22 ' HB2' ' A' ' 19' ' ' ALA . 17.0 t -55.2 -53.27 36.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.659 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.82 5.37 24.6 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.451 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -97.23 -24.34 15.75 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.74 0.77 . . . . 0.0 110.305 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 pp -84.12 -24.72 30.15 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.352 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 34' ' ' LEU . 6.6 tp -91.59 -34.82 14.57 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.882 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 31' ' ' LEU . 78.7 tt0 -34.29 -49.99 0.4 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.777 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 33' ' ' ILE . 2.3 tt -65.47 -37.43 80.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.426 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 31' ' ' LEU . 19.5 mt -82.93 -3.09 56.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.646 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.786 ' O ' HG22 ' A' ' 38' ' ' ILE . 10.8 t-80 -64.6 -0.01 1.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.126 0.489 . . . . 0.0 110.04 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 1.356 ' HG3' ' NH2' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -90.81 171.53 9.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.596 -180.0 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 1.356 ' NH2' ' HG3' ' A' ' 36' ' ' GLN . 23.3 mtm-85 45.48 15.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.872 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.786 HG22 ' O ' ' A' ' 35' ' ' HIS . 19.3 tt -110.23 159.21 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.238 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 40' ' ' GLY . 78.6 mt-10 -145.63 -109.33 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.928 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 39' ' ' GLU . . . -56.7 -160.2 0.02 OUTLIER Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.69 81.87 2.5 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.429 2.086 . . . . 0.0 112.326 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.29 159.13 15.71 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.826 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 p -87.7 157.54 19.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.606 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -60.23 -21.89 62.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.686 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -68.36 -44.65 74.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.662 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.4 t -55.97 -36.79 68.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.627 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 49' ' ' GLY . 1.3 tt -45.65 -41.02 9.8 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.049 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 84' ' ' TRP . 71.9 mt-30 -61.41 70.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.514 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -151.9 13.56 0.75 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.503 HG21 HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -128.63 173.05 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.471 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 40.3 m -112.75 161.59 16.71 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.512 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.6 t -55.62 -39.93 57.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 120.798 0.332 . . . . 0.0 110.546 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 m -58.62 -25.11 62.32 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.053 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -75.47 -31.64 60.33 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.183 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.758 ' N ' HD12 ' A' ' 55' ' ' LEU . 4.9 mp -66.45 -60.85 2.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.439 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -56.91 -36.04 69.71 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 61' ' ' GLY . 15.6 pt -75.93 -29.66 20.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.62 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.26 -27.49 39.76 Favored Glycine 0 CA--C 1.517 0.195 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.5 HD23 ' N ' ' A' ' 59' ' ' LEU . 3.8 mt -83.27 -64.15 1.22 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.805 -0.697 . . . . 0.0 112.433 -176.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.76 -20.93 60.36 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.169 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 70.83 -0.61 27.81 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.399 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.488 ' C ' ' H ' ' A' ' 64' ' ' GLU . 15.0 t -136.0 95.69 3.26 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.929 0.395 . . . . 0.0 111.437 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -54.29 -6.41 0.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.707 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.488 ' H ' ' C ' ' A' ' 62' ' ' SER . 28.8 mt-10 -90.23 -32.49 16.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.732 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -101.53 -11.64 19.12 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 m -52.82 -25.46 8.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.443 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -53.74 -23.33 11.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.208 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 7.0 mmt -94.83 -31.11 13.87 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.663 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.476 ' CD2' ' OG1' ' A' ' 71' ' ' THR . 30.4 tp -49.67 127.47 15.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.219 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -39.74 -31.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.391 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.476 ' OG1' ' CD2' ' A' ' 69' ' ' LEU . 1.4 m -48.57 110.28 1.42 Allowed Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.616 ' C ' ' H ' ' A' ' 74' ' ' SER . 91.5 Cg_endo -80.23 29.48 0.51 Allowed 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.321 2.014 . . . . 0.0 113.507 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.468 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 19.4 ttp 55.78 -7.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.616 ' H ' ' C ' ' A' ' 72' ' ' PRO . 22.8 t -100.82 -16.14 17.38 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.165 0.507 . . . . 0.0 109.91 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -74.02 -31.22 62.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.264 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.921 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.1 mm? -65.9 -51.8 55.58 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.63 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.5 OUTLIER -48.25 -36.97 15.02 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.254 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.63 -59.05 3.05 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.375 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.573 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.5 -62.86 1.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.482 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.455 ' N ' ' O ' ' A' ' 76' ' ' LEU . 2.1 p -35.26 -25.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.007 0.432 . . . . 0.0 111.475 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 79' ' ' ALA . 28.1 ttm180 -78.3 -56.47 4.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.635 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.488 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 44.7 mt -47.78 -43.81 10.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.849 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.854 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -75.48 -36.51 60.62 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 119.253 -0.979 . . . . 0.0 109.751 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.49 ' O ' ' NE2' ' A' ' 48' ' ' GLN . 0.7 OUTLIER -46.9 -22.08 0.28 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.836 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.419 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 88.18 13.87 63.25 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 87' ' ' ALA . 5.5 tp10 -109.28 2.54 20.89 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -28.96 -42.68 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.996 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -56.05 135.8 52.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.772 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 89' ' ' VAL . 10.7 p -84.28 128.0 39.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.269 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -84.77 -75.78 0.34 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.6 m -72.11 -155.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.75 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.669 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.1 mm? -77.2 149.59 79.5 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.922 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.18 -91.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.059 1.839 . . . . 0.0 111.829 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -74.35 152.02 87.8 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.21 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.91 104.31 1.61 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.216 1.944 . . . . 0.0 111.785 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.571 -179.951 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.6 mtt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 2' ' ' VAL . 7.4 p -64.45 116.04 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.037 0.446 . . . . 0.0 110.495 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 2' ' ' VAL . 22.6 m -167.5 65.8 0.77 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.237 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.12 159.32 37.35 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.587 2.191 . . . . 0.0 112.144 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.411 ' O ' ' O ' ' A' ' 6' ' ' ASN . 11.7 t -143.51 -57.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.272 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.547 HD22 ' H ' ' A' ' 6' ' ' ASN . 1.3 p30 -56.07 -111.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.765 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.438 ' H ' ' CG ' ' A' ' 6' ' ' ASN . 11.6 mmt -138.33 -60.97 0.61 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.646 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.9 t -120.46 158.39 27.33 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.107 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.575 ' O ' ' N ' ' A' ' 12' ' ' ALA . 4.1 ptm85 -79.61 -25.76 41.39 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.096 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.44 ' OE2' ' O ' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -50.39 -29.57 10.38 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.818 179.467 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.466 ' O ' ' CD1' ' A' ' 15' ' ' ILE . 83.3 m -71.09 -25.4 62.6 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.575 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -81.76 -71.19 0.49 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.688 -1.596 . . . . 0.0 110.801 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.539 ' CD1' ' H ' ' A' ' 13' ' ' LEU . 5.9 mp -32.62 -40.77 0.05 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.162 -0.926 . . . . 0.0 113.017 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 46.3 mtt85 -78.27 -32.08 49.34 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.466 ' CD1' ' O ' ' A' ' 11' ' ' THR . 63.9 mt -66.11 -16.14 20.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.75 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.36 -17.28 21.72 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.275 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.435 HD23 ' O ' ' A' ' 13' ' ' LEU . 1.9 mm? -73.25 -30.42 63.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.37 -42.22 73.64 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.096 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.687 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.12 -36.3 0.7 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.171 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 22' ' ' LEU . 70.9 mtp180 -63.68 -40.3 96.46 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.58 -4.32 0.4 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.443 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.48 ' H ' ' C ' ' A' ' 20' ' ' ARG . 10.2 mt -122.89 115.55 29.26 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -82.01 64.02 8.38 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.814 1.676 . . . . 0.0 112.437 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.57 -48.84 0.48 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.56 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.2 m -68.41 133.46 48.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.959 0.409 . . . . 0.0 111.225 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.22 171.45 11.94 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.025 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.687 HG22 ' HB2' ' A' ' 19' ' ' ALA . 21.7 t -60.93 -60.38 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.431 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.1 9.32 7.01 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.595 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.48 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 28.0 mm100 -99.61 -18.95 17.08 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 117.948 0.874 . . . . 0.0 110.411 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.5 tp -93.36 -19.64 21.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.063 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 21.6 mt -95.12 -42.54 8.54 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 110.849 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -54.73 -20.72 8.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.042 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.406 ' C ' HD12 ' A' ' 33' ' ' ILE . 2.3 pp -49.16 -17.93 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.998 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.4 mt -60.6 -89.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.393 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.17 -135.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.29 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -46.35 167.7 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.813 0.339 . . . . 0.0 110.384 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -83.03 -76.41 0.28 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.532 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 39' ' ' GLU . 40.1 pt -44.48 140.38 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.869 0.366 . . . . 0.0 110.768 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.438 ' O ' ' O ' ' A' ' 38' ' ' ILE . 0.6 OUTLIER 55.59 113.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.64 -76.88 0.2 Allowed Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.28 69.2 1.95 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.656 2.238 . . . . 0.0 111.526 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.1 mt -84.53 -107.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.05 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.01 169.53 11.12 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.772 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' A' ' 83' ' ' LEU . 32.0 tt0 -62.76 -27.17 69.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.494 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -64.3 -39.2 93.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.568 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.3 p -59.8 -43.81 94.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.494 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.492 ' N ' HD12 ' A' ' 47' ' ' LEU . 10.9 mp -59.45 -33.66 71.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.881 0.372 . . . . 0.0 110.334 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -75.97 73.89 2.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.816 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -157.66 14.56 0.29 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.447 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.4 OUTLIER -124.96 174.19 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.686 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.441 ' N ' HG13 ' A' ' 50' ' ' VAL . 14.1 m -115.33 160.13 20.2 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.479 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.2 t -53.32 -37.82 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 120.788 0.328 . . . . 0.0 110.494 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 m -61.09 -25.28 66.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.998 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.447 ' CB ' HG22 ' A' ' 50' ' ' VAL . 11.2 t0 -74.56 -30.55 61.78 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.64 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.749 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.9 mp -66.67 -66.53 0.54 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -51.39 -34.79 36.02 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 61' ' ' GLY . 9.6 pt -82.03 -17.36 11.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.28 -41.27 79.53 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.808 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.727 ' N ' HD22 ' A' ' 59' ' ' LEU . 1.9 mm? -74.93 -52.41 11.27 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.789 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.39 -37.93 74.59 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 116.81 -51.57 0.72 Allowed Glycine 0 N--CA 1.468 0.833 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.504 ' C ' ' H ' ' A' ' 64' ' ' GLU . 46.0 p -135.63 141.23 45.02 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.089 0.471 . . . . 0.0 111.116 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -57.91 1.15 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.347 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.504 ' H ' ' C ' ' A' ' 62' ' ' SER . 72.2 mm-40 -75.92 -53.88 7.74 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.422 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -93.24 -9.01 40.63 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -177.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.4 m -50.16 -24.2 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.517 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.26 -15.32 2.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.616 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 52.6 mtp -99.37 -34.76 10.16 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.62 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.7 tp -51.07 124.57 11.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.228 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -61.38 -22.97 65.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.345 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.1 m -49.68 107.65 0.83 Allowed Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.413 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.95 -171.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.224 1.283 . . . . 0.0 111.808 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.3 ptm -98.17 -22.02 16.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.724 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.9 t -89.06 -25.38 21.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.437 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.48 -33.47 69.82 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.302 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.595 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -67.39 -52.96 33.6 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.429 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -65.09 -9.44 22.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.466 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -87.61 -52.18 5.48 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -70.04 -57.79 4.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.587 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.409 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.5 p -34.8 -28.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.287 0.565 . . . . 0.0 110.943 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 79' ' ' ALA . 20.4 ttm105 -74.04 -62.12 1.61 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.807 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.435 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 55.5 mt -45.44 -39.94 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.897 -178.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.883 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -81.42 -28.52 34.23 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.472 179.306 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -64.89 2.87 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.481 -0.488 . . . . 0.0 109.793 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 83' ' ' LEU . . . 65.93 22.16 70.15 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -107.26 2.23 24.48 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.921 0.391 . . . . 0.0 110.157 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.435 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -40.03 -68.88 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.956 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -50.24 -34.66 23.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.723 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.5 t -77.94 84.41 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.814 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -95.56 150.56 20.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.555 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.1 t -68.29 171.01 7.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.551 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.655 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.1 mm? -76.15 149.74 82.49 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.817 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.35 -40.87 1.42 Allowed 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.102 1.868 . . . . 0.0 112.026 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -71.52 129.33 88.82 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.213 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -76.21 80.67 2.64 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.737 1.625 . . . . 0.0 111.845 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.3 t . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.676 -179.956 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 mtm . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.538 ' O ' HG22 ' A' ' 2' ' ' VAL . 10.9 p -161.66 15.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.094 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.3 p -137.79 69.32 51.43 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.045 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -47.83 119.88 4.22 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.676 2.251 . . . . 0.0 112.367 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.4 p -54.46 142.43 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.208 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -160.75 113.63 2.0 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.641 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 39.4 mtm -130.05 175.04 9.21 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.219 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.5 m -88.3 119.14 28.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.596 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.596 ' O ' ' N ' ' A' ' 12' ' ' ALA . 10.6 ptm180 -51.5 -57.06 10.07 Favored 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.405 ' H ' ' CG ' ' A' ' 9' ' ' ARG . 87.5 tt0 -35.39 -28.21 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 9' ' ' ARG . 50.9 m -84.62 -31.41 24.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.197 0.522 . . . . 0.0 110.51 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.596 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -84.23 4.65 29.85 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.634 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.444 HD23 ' C ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -115.42 -36.9 4.16 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 120.81 0.338 . . . . 0.0 110.474 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 71.3 mtm180 -84.63 -36.41 22.01 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.44 ' CD1' ' N ' ' A' ' 15' ' ' ILE . 1.2 mp -65.35 -8.92 6.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.257 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.18 -16.81 25.75 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.806 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.34 -30.5 63.38 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.94 -44.99 74.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.732 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.622 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -40.91 -36.16 0.61 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.98 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.443 ' C ' ' H ' ' A' ' 22' ' ' LEU . 57.1 mtp85 -68.1 -40.56 82.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.162 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.08 -6.8 0.65 Allowed 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 120.945 0.402 . . . . 0.0 110.496 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.443 ' H ' ' C ' ' A' ' 20' ' ' ARG . 11.4 mt -118.75 120.3 31.72 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.814 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.3 71.31 7.1 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.879 1.72 . . . . 0.0 112.557 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.42 -54.75 0.6 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.6 m -59.63 128.33 36.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.923 0.392 . . . . 0.0 110.949 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.82 178.19 7.07 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.29 0.567 . . . . 0.0 110.875 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.622 HG22 ' HB2' ' A' ' 19' ' ' ALA . 11.8 t -61.8 -58.77 6.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.904 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.43 2.89 3.9 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.675 -178.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.507 ' OE1' ' N ' ' A' ' 29' ' ' GLN . 3.9 mp0 -100.38 -30.46 11.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.575 0.688 . . . . 0.0 111.236 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 pp -88.37 -27.45 21.6 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.537 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -85.71 -41.18 15.37 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.718 0.294 . . . . 0.0 110.733 -179.234 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 34' ' ' LEU . 35.0 tp10 -41.41 -26.52 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.296 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 33' ' ' ILE . 28.4 pt -45.62 -12.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.311 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 32' ' ' GLU . 39.5 tp -64.7 -26.47 68.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.258 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.0 m170 55.28 -132.36 1.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.611 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.434 ' O ' ' CG ' ' A' ' 36' ' ' GLN . 3.6 pt20 -40.16 111.64 0.21 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.029 0.443 . . . . 0.0 110.936 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -72.66 82.89 1.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.551 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.586 HG23 ' O ' ' A' ' 38' ' ' ILE . 14.3 tt -65.89 116.02 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.177 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.435 ' O ' ' O ' ' A' ' 38' ' ' ILE . 10.4 mm-40 56.18 158.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.523 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.86 -82.52 0.09 OUTLIER Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.194 -0.527 . . . . 0.0 111.858 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -34.22 146.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.842 2.361 . . . . 0.0 113.029 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.488 HD21 HD22 ' A' ' 34' ' ' LEU . 8.0 tp -167.28 93.16 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.877 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.31 166.53 12.25 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.231 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.21 -23.71 56.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.478 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -61.01 -47.99 83.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.239 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.5 t -59.27 -47.51 85.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.92 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -44.8 -25.48 0.3 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.42 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -75.41 52.14 0.6 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.324 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -136.0 15.87 3.99 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.432 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -128.42 177.96 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.437 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 20.3 m -119.05 164.01 16.14 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.452 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.6 t -56.55 -47.19 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.177 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 57' ' ' ILE . 3.4 m -54.15 -24.18 16.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -178.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.432 ' CB ' HG22 ' A' ' 50' ' ' VAL . 9.7 t70 -74.59 -31.72 62.13 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.074 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.714 ' N ' HD12 ' A' ' 55' ' ' LEU . 6.2 mp -64.96 -64.96 0.74 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.404 -178.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -54.75 -39.53 68.4 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.7 pt -71.52 -23.72 22.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.316 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.75 -30.8 78.74 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 121.164 -0.541 . . . . 0.0 111.756 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.777 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.1 mm? -79.51 -52.96 7.36 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.294 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.5 -30.19 33.35 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.603 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 74.21 4.85 69.69 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.266 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.509 ' C ' ' H ' ' A' ' 64' ' ' GLU . 10.2 t -135.95 93.44 2.93 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.824 0.345 . . . . 0.0 111.307 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -48.57 -10.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.762 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.509 ' H ' ' C ' ' A' ' 62' ' ' SER . 30.9 tt0 -88.66 -42.61 11.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.714 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.17 -15.02 34.75 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.1 m -49.75 -28.96 4.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.77 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -55.47 -27.65 49.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.925 0.393 . . . . 0.0 110.244 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 48.8 mtm -92.33 -24.31 18.97 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.766 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.424 ' HG ' ' H ' ' A' ' 71' ' ' THR . 60.4 tp -53.37 123.0 10.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.931 0.396 . . . . 0.0 110.076 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -40.65 -38.56 0.91 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.661 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.424 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 20.1 m -52.66 107.76 0.92 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.973 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.12 -162.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.161 1.24 . . . . 0.0 111.423 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.467 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 32.4 ttm -109.11 -6.44 15.61 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 61.3 m -100.78 -20.83 15.38 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.138 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.57 -34.06 76.28 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.822 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.933 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -64.08 -45.92 86.6 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.83 179.379 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.531 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 1.1 mptp? -55.83 -34.87 65.79 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.312 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.03 -59.93 2.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.495 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -59.03 -62.99 1.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.432 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.429 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 3.0 p -35.37 -25.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.917 0.389 . . . . 0.0 111.721 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.568 ' N ' ' O ' ' A' ' 79' ' ' ALA . 28.3 ttm180 -77.56 -57.35 3.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.668 0.747 . . . . 0.0 110.074 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.572 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 41.4 mt -47.79 -43.74 10.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.929 -178.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.853 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -75.03 -36.64 61.87 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.557 179.871 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -47.38 -18.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.457 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 83.1 15.52 72.03 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 88' ' ' GLU . 50.2 mm-40 -105.57 -0.63 25.58 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.572 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -36.7 -26.0 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.088 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.587 ' H ' ' CD ' ' A' ' 88' ' ' GLU . 2.7 mp0 -53.31 -78.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.1 m -73.81 58.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.906 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -77.36 -33.46 55.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.523 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 65.5 m -70.56 158.81 35.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.691 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.662 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.1 mm? -78.61 150.39 76.05 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.828 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.99 87.37 0.86 Allowed 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.167 1.911 . . . . 0.0 111.975 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.403 ' HG2' ' H ' ' A' ' 94' ' ' GLN . 6.6 pt20 -57.59 152.09 36.88 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.206 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.31 -170.56 0.59 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.333 2.022 . . . . 0.0 111.917 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.524 -179.948 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.52 ' O ' HD23 ' A' ' 17' ' ' LEU . 5.5 mp . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 30.8 mtm105 -80.65 -39.49 27.24 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.438 ' O ' HG22 ' A' ' 15' ' ' ILE . 54.7 mt -62.8 -14.68 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.446 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.35 -15.71 17.9 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 13' ' ' LEU . 1.2 mm? -72.73 -31.91 65.32 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.6 -42.87 75.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.218 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.712 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -39.9 -34.36 0.27 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.504 ' C ' ' H ' ' A' ' 22' ' ' LEU . 75.9 ttt-85 -67.23 -41.66 85.32 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.227 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -55.32 -6.73 0.18 Allowed 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.465 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.504 ' H ' ' C ' ' A' ' 20' ' ' ARG . 9.5 mt -116.23 149.33 43.34 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.27 -80.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 121.881 1.721 . . . . 0.0 112.548 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -116.24 7.89 18.48 Favored Glycine 0 N--CA 1.47 0.908 0 C-N-CA 121.44 -0.409 . . . . 0.0 112.467 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.0 m -73.97 126.84 31.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.43 0.615 . . . . 0.0 110.13 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.07 168.11 20.39 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.985 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.712 HG22 ' HB2' ' A' ' 19' ' ' ALA . 21.2 t -61.72 -61.15 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.23 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.91 10.64 4.11 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.085 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -98.57 -25.27 14.79 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 117.44 0.62 . . . . 0.0 110.391 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.2 tt -95.5 -17.8 21.16 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.588 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.571 ' O ' HD23 ' A' ' 31' ' ' LEU . 1.8 tt . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 120.965 0.412 . . . . 0.0 110.785 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.5 mt . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.722 0.296 . . . . 0.0 110.696 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -80.36 71.63 7.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.453 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -153.43 -0.28 0.2 Allowed Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.433 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -123.36 175.98 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.449 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 55.7 m -117.03 162.96 16.96 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.481 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.3 t -56.01 -43.71 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.905 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 57' ' ' ILE . 3.2 m -56.52 -25.16 50.92 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.433 ' CB ' HG22 ' A' ' 50' ' ' VAL . 12.5 t70 -74.2 -31.76 62.78 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.08 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.725 HD12 ' N ' ' A' ' 55' ' ' LEU . 5.8 mp -64.92 -65.36 0.68 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.378 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -53.58 -37.21 62.72 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.54 ' O ' ' N ' ' A' ' 61' ' ' GLY . 11.3 pt -77.95 -18.23 13.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.121 0.486 . . . . 0.0 109.994 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.72 -38.64 93.29 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.761 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.0 mm? -73.68 -56.94 4.37 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.242 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.42 -35.68 73.56 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 103.99 -33.86 6.24 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.798 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.521 ' C ' ' H ' ' A' ' 64' ' ' GLU . 68.8 m -136.3 127.68 28.43 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.037 0.446 . . . . 0.0 111.192 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -58.68 -0.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.453 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.521 ' H ' ' C ' ' A' ' 62' ' ' SER . 33.7 mt-10 -79.44 -45.22 19.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 67' ' ' ASP . 16.7 m-20 -99.05 -7.85 26.18 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.0 m -49.23 -27.24 2.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.62 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 17.8 p-10 -51.67 -35.36 42.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.012 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.22 -19.21 43.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.861 0.362 . . . . 0.0 110.61 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.445 ' HG ' ' H ' ' A' ' 71' ' ' THR . 20.5 tp -64.84 125.9 26.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.496 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -51.68 -22.82 3.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.048 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.445 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 3.3 m -64.49 115.94 24.35 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.232 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.449 ' O ' HD21 ' A' ' 76' ' ' LEU . 74.4 Cg_endo -73.68 -154.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.375 1.384 . . . . 0.0 111.126 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.439 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 29.7 ttm -112.66 1.82 15.88 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.2 t -109.58 -18.53 13.47 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.521 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.46 -33.46 71.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.822 0.344 . . . . 0.0 110.345 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.93 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -65.74 -47.14 76.28 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.507 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 1.6 mptp? -55.96 -35.75 67.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.37 -58.84 3.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.852 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -63.23 -62.7 1.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.679 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.431 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 3.1 p -35.24 -26.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 120.922 0.392 . . . . 0.0 111.429 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.556 ' N ' ' O ' ' A' ' 79' ' ' ALA . 50.4 ttm-85 -75.98 -58.1 3.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.603 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 52.1 mt -47.49 -41.22 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.622 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.88 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -80.02 -32.08 39.61 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.587 179.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -49.12 -27.92 3.85 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.956 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.22 13.04 50.31 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 88' ' ' GLU . 74.8 mt-10 -113.88 8.69 17.36 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -28.08 -37.5 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.194 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 86' ' ' GLU . 5.8 pt-20 . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 120.835 0.35 . . . . 0.0 110.46 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.472 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 5.6 mp . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 120.927 0.394 . . . . 0.0 112.062 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.42 ' O ' ' CG2' ' A' ' 82' ' ' ILE . 20.3 mmt85 -56.03 -30.38 61.8 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.7 mm -65.11 -18.21 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.369 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.66 -18.24 16.63 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.31 -28.57 65.28 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -57.77 -42.75 84.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.424 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.693 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -40.48 -33.4 0.26 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.529 ' C ' ' H ' ' A' ' 22' ' ' LEU . 50.3 ttt85 -69.16 -42.59 75.72 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.23 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.13 -6.11 0.23 Allowed 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.243 0.544 . . . . 0.0 110.082 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.529 ' H ' ' C ' ' A' ' 20' ' ' ARG . 13.2 mt -117.0 149.52 44.32 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.177 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.43 -88.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.037 1.825 . . . . 0.0 112.485 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.12 -8.92 49.71 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.48 -0.391 . . . . 0.0 112.293 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.4 m -59.54 132.28 53.5 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.474 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.525 ' H ' ' NE2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -90.74 165.53 13.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.202 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.693 HG22 ' HB2' ' A' ' 19' ' ' ALA . 18.0 t -57.44 -55.88 18.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.149 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.18 8.36 8.89 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.808 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.525 ' NE2' ' H ' ' A' ' 26' ' ' THR . 19.2 mt-30 -96.82 -18.87 19.28 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.008 0.904 . . . . 0.0 110.753 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.4 tp -85.47 -37.93 19.18 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.526 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 pp . . . . . 0 N--CA 1.463 0.223 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.991 -179.643 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 47' ' ' LEU . 10.3 mp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.777 0.322 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -73.0 67.17 0.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.456 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.68 15.03 0.81 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.469 ' CG2' ' OD2' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -127.61 177.38 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.445 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 5.2 m -119.23 164.01 16.25 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.469 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.9 t -57.22 -45.49 84.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.751 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.4 m -54.3 -25.22 22.51 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.665 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.469 ' OD2' ' CG2' ' A' ' 50' ' ' VAL . 42.6 t0 -74.74 -31.1 61.72 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.916 0.388 . . . . 0.0 111.296 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.72 HD12 ' N ' ' A' ' 55' ' ' LEU . 6.2 mp -65.94 -63.38 1.1 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -54.54 -36.29 64.13 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.446 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.1 pt -77.38 -19.22 14.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.035 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.63 -34.83 88.71 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.743 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.2 mm? -76.52 -57.07 4.07 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.658 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.81 -32.97 68.13 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.481 -0.487 . . . . 0.0 109.947 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 85.51 -9.13 68.79 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.506 ' C ' ' H ' ' A' ' 64' ' ' GLU . 3.2 m -137.87 107.53 6.23 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.101 0.477 . . . . 0.0 112.243 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -56.39 -4.6 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.016 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' A' ' 62' ' ' SER . 19.0 mm-40 -86.35 -43.48 12.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.762 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -92.47 -11.91 33.42 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.2 m -50.9 -26.65 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 119.689 -0.805 . . . . 0.0 110.283 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -56.25 -17.07 6.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.399 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 43.7 mtt -101.93 -32.47 10.19 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.529 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.419 ' HG ' ' H ' ' A' ' 71' ' ' THR . 25.5 tp -49.57 131.95 21.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.221 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 9.6 p-10 -57.05 -32.49 66.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.395 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 72' ' ' PRO . 10.7 m -46.45 105.45 0.48 Allowed Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.502 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 71' ' ' THR . 33.0 Cg_exo -54.92 -163.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.174 1.25 . . . . 0.0 111.219 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 30.4 ttm -107.84 -4.98 17.52 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 82.6 p -102.52 -26.75 13.12 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.429 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.87 -33.37 70.4 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.885 0.374 . . . . 0.0 110.169 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.886 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -66.27 -53.37 37.51 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.528 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.4 OUTLIER -52.15 -35.43 48.54 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.475 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -68.36 -58.52 4.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.962 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -63.91 -60.47 3.23 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.834 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.425 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 2.4 p -35.24 -25.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.096 0.474 . . . . 0.0 111.686 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 79' ' ' ALA . 25.5 ttm180 -78.9 -56.31 4.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.544 0.688 . . . . 0.0 109.72 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.549 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 36.5 mt -47.88 -43.81 10.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.904 -178.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.849 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -74.23 -37.74 63.73 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 119.205 -0.998 . . . . 0.0 109.645 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -46.17 -19.05 0.06 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.94 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 83' ' ' LEU . . . 83.76 13.26 75.78 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 88' ' ' GLU . 91.6 mt-10 -103.4 -3.18 25.83 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.549 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -31.98 -32.61 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.525 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 86' ' ' GLU . 18.1 mm-40 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.337 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 4.8 mp . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 120.602 0.239 . . . . 0.0 111.571 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.417 HH22 ' C ' ' A' ' 85' ' ' GLY . 61.0 mtp180 -55.38 -32.94 63.02 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.3 mm -63.23 -16.54 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.382 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.36 -16.2 17.73 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.4 ' HA ' HD13 ' A' ' 17' ' ' LEU . 3.9 mm? -69.99 -30.7 68.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -56.71 -44.7 81.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.235 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.672 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -42.02 -36.76 1.2 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.487 ' C ' ' H ' ' A' ' 22' ' ' LEU . 67.6 ttt-85 -65.19 -40.83 94.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.943 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.18 -4.84 0.39 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.624 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.487 ' H ' ' C ' ' A' ' 20' ' ' ARG . 16.1 mt -118.1 139.76 27.05 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.145 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -39.67 -70.95 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.927 1.751 . . . . 0.0 112.855 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -134.4 0.0 3.79 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.521 -0.631 . . . . 0.0 111.521 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.1 m -57.43 131.21 49.44 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.611 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.69 160.92 27.25 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.343 0.592 . . . . 0.0 111.808 -178.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 19' ' ' ALA . 21.5 t -58.18 -55.81 19.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.1 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.04 8.36 8.35 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.358 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -100.32 -20.27 15.93 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 117.867 0.834 . . . . 0.0 109.932 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.404 HD22 HD11 ' A' ' 22' ' ' LEU . 45.1 tp -98.68 -23.78 15.32 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.982 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 31' ' ' LEU . 3.9 mm? . . . . . 0 N--CA 1.467 0.411 0 CA-C-O 120.73 0.3 . . . . 0.0 110.829 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.604 ' O ' HD13 ' A' ' 47' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.144 0 CA-C-O 120.941 0.4 . . . . 0.0 110.149 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -61.17 71.29 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.593 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -155.08 4.98 0.24 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.454 ' CG2' ' OD2' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -123.67 176.96 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.396 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.428 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 45.2 m -119.03 161.75 19.72 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.467 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.4 t -55.33 -43.03 69.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.67 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 m -56.43 -26.0 52.2 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.871 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.454 ' OD2' ' CG2' ' A' ' 50' ' ' VAL . 53.1 t0 -73.87 -31.44 63.16 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.041 0.448 . . . . 0.0 110.859 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.728 HD12 ' N ' ' A' ' 55' ' ' LEU . 6.3 mp -65.23 -65.01 0.73 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -53.29 -36.59 61.37 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.1 pt -78.08 -18.95 13.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.62 -38.13 89.93 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.705 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.3 mm? -75.07 -56.75 4.42 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.029 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.96 -35.31 78.15 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 93.29 -20.43 46.32 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.553 ' C ' ' H ' ' A' ' 64' ' ' GLU . 23.0 t -138.22 117.25 12.5 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.038 0.446 . . . . 0.0 111.871 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -59.34 4.06 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.686 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.553 ' H ' ' C ' ' A' ' 62' ' ' SER . 43.5 mt-10 -90.74 -45.71 8.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.194 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.65 -11.43 42.54 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.4 m -52.97 -27.44 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.035 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 19.4 p-10 -56.17 -12.61 1.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.278 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.9 mmt -106.09 -32.47 8.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.406 ' HG ' ' H ' ' A' ' 71' ' ' THR . 20.3 tp -48.45 123.59 6.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.423 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 71' ' ' THR . 47.3 p30 -48.52 -25.21 1.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.99 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.53 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 7.0 m -55.23 110.25 2.1 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.538 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 71' ' ' THR . 29.5 Cg_exo -57.14 -146.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.104 1.203 . . . . 0.0 110.948 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.432 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 33.8 ttp -123.96 -0.35 8.45 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.7 t -106.16 -27.47 11.05 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.287 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.43 -32.97 71.87 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.975 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.3 mm? -64.82 -49.98 68.48 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.516 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 1.3 mptp? -56.67 -33.79 66.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.434 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -70.11 -58.56 3.67 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.406 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.4 -63.58 1.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.42 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.408 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 3.0 p -34.69 -24.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.904 0.383 . . . . 0.0 111.909 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 79' ' ' ALA . 17.6 ttm105 -77.29 -60.55 2.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.56 0.695 . . . . 0.0 109.965 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.449 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 39.4 mt -45.48 -41.44 3.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.209 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.834 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -76.96 -35.61 57.11 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 119.278 -0.969 . . . . 0.0 109.584 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -48.89 -20.06 0.46 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.792 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.419 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 86.66 18.46 58.38 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 88' ' ' GLU . 8.8 tp10 -112.07 1.54 16.38 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.69 0.281 . . . . 0.0 110.337 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.449 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -29.94 -39.31 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.986 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 86' ' ' GLU . 5.3 pt-20 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.95 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.524 ' N ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.334 0 CA-C-O 120.702 0.287 . . . . 0.0 111.148 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 67.7 mtt-85 -63.76 -40.78 97.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.2 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.436 ' O ' HG22 ' A' ' 15' ' ' ILE . 29.2 mt -63.24 -11.3 7.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.457 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -103.56 -15.89 15.7 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.564 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' A' ' 17' ' ' LEU . 1.3 mm? -72.93 -28.95 62.75 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -58.2 -40.56 81.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.285 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.737 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -38.75 -35.53 0.2 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.495 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.501 ' C ' ' H ' ' A' ' 22' ' ' LEU . 55.5 mtp85 -65.12 -38.39 90.52 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.806 0.336 . . . . 0.0 110.404 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.53 -5.7 0.23 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.725 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.501 ' H ' ' C ' ' A' ' 20' ' ' ARG . 15.6 mt -117.46 149.84 45.51 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.919 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.05 -88.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.014 1.81 . . . . 0.0 112.474 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.72 3.25 42.11 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.537 -0.363 . . . . 0.0 112.235 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.5 m -72.43 129.36 38.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.124 0.462 . . . . 0.0 110.652 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.22 170.61 11.97 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.271 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.737 HG22 ' HB2' ' A' ' 19' ' ' ALA . 16.5 t -60.2 -57.37 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.855 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.48 5.37 10.67 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.353 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -94.17 -28.07 15.86 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 117.744 0.772 . . . . 0.0 110.276 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 tt -80.47 -17.89 50.32 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.803 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.0 tp . . . . . 0 N--CA 1.464 0.258 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.506 -179.957 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 49' ' ' GLY . 10.5 mp . . . . . 0 CA--C 1.532 0.266 0 CA-C-O 120.546 0.213 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -64.16 71.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.019 0.437 . . . . 0.0 110.443 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -152.95 7.89 0.49 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.401 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -130.73 177.43 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.467 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 71.8 m -118.97 165.6 13.89 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.467 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.8 t -55.97 -45.84 80.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.751 0.31 . . . . 0.0 111.241 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 57' ' ' ILE . 1.8 m -53.35 -25.93 17.21 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 54' ' ' ASP . 42.9 t0 -75.81 -31.28 59.35 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.4 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.728 HD12 ' N ' ' A' ' 55' ' ' LEU . 5.7 mp -65.79 -63.33 1.11 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -54.4 -36.46 63.97 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 61' ' ' GLY . 13.1 pt -77.6 -18.39 14.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.56 -36.72 84.01 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.692 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.6 mm? -73.99 -57.14 4.16 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.068 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.68 -34.45 72.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 114.37 -48.29 0.95 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.562 ' C ' ' H ' ' A' ' 64' ' ' GLU . 26.3 p -135.89 144.0 45.31 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.143 0.496 . . . . 0.0 111.356 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.99 9.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.836 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.603 ' OE1' ' OD1' ' A' ' 65' ' ' ASP . 5.5 tm-20 -86.6 -55.51 3.84 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.651 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.603 ' OD1' ' OE1' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -86.58 -13.09 46.8 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.031 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.0 m -49.02 -20.34 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.272 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 65' ' ' ASP . 62.9 m-20 -56.76 -33.34 66.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.132 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.428 ' C ' ' SD ' ' A' ' 68' ' ' MET . 0.0 OUTLIER -92.16 -27.86 17.44 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.786 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 71' ' ' THR . 32.5 tp -50.99 117.79 2.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.389 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -39.24 -24.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.346 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.489 ' N ' ' O ' ' A' ' 69' ' ' LEU . 2.5 m -68.27 116.18 36.88 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.56 -108.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.583 1.522 . . . . 0.0 111.643 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 24.1 ttm -150.91 2.99 0.45 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 121.094 -0.243 . . . . 0.0 110.825 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.425 ' O ' ' OD2' ' A' ' 78' ' ' ASP . 3.4 m -107.44 -23.23 12.27 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.927 0.394 . . . . 0.0 110.08 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -66.66 -33.09 74.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.479 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.986 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.0 OUTLIER -66.36 -52.63 44.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.485 179.62 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.539 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 2.6 mptp? -51.88 -36.78 49.78 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 74' ' ' SER . 4.8 m-20 -67.41 -58.76 4.18 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.18 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -63.01 -64.55 0.88 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.632 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.404 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 2.8 p -34.08 -24.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.59 ' N ' ' O ' ' A' ' 79' ' ' ALA . 15.1 ttm180 -76.65 -61.26 2.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.382 0.61 . . . . 0.0 110.21 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.485 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 43.7 mt -45.28 -40.2 2.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.162 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.83 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.91 -35.42 50.63 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.535 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -50.32 -20.07 0.98 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.041 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.38 11.14 69.62 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 87' ' ' ALA . 21.5 tp10 -102.4 1.18 35.04 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.485 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -31.21 -39.31 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.656 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 86' ' ' GLU . 9.5 mm-40 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.682 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -85.11 -27.25 26.39 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 15' ' ' ILE . 60.7 mt -63.28 -14.95 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.405 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.407 ' HA ' HG13 ' A' ' 27' ' ' VAL . . . -91.4 -16.45 27.37 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.427 ' N ' HD22 ' A' ' 17' ' ' LEU . 4.0 mm? -72.68 -30.71 64.47 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.9 -41.34 70.82 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.921 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.676 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -44.24 -36.37 2.69 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -66.98 -42.37 85.22 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.469 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -57.57 -8.07 0.78 Allowed 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.259 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 21.1 mt -113.05 147.22 36.79 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.299 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.8 -73.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.168 1.912 . . . . 0.0 112.828 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -119.22 43.47 1.57 Allowed Glycine 0 N--CA 1.471 0.979 0 C-N-CA 121.503 -0.379 . . . . 0.0 112.222 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.2 m -117.89 132.88 56.37 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.869 0.334 . . . . 0.0 110.244 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.45 169.14 15.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.183 0.516 . . . . 0.0 110.568 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.676 HG22 ' HB2' ' A' ' 19' ' ' ALA . 27.9 t -60.85 -59.57 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.169 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.59 9.6 5.92 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.532 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -99.51 -12.2 20.37 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.753 0.776 . . . . 0.0 110.764 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 pp -98.15 -16.13 19.64 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.351 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.489 ' O ' HD23 ' A' ' 31' ' ' LEU . 1.6 tt . . . . . 0 N--CA 1.469 0.491 0 CA-C-O 120.837 0.351 . . . . 0.0 110.765 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 49' ' ' GLY . 10.2 mt . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.757 0.313 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -66.85 69.97 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.437 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -151.95 3.14 0.39 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.17 174.26 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.478 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 52.9 m -115.09 163.53 15.48 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.515 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.4 t -56.46 -42.14 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 O-C-N 123.265 0.353 . . . . 0.0 111.404 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.4 m -57.39 -25.41 59.47 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -74.44 -32.15 62.52 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.083 0.468 . . . . 0.0 110.956 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.735 HD12 ' N ' ' A' ' 55' ' ' LEU . 5.7 mp -64.25 -65.59 0.66 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.503 -177.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -52.67 -37.42 58.73 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 61' ' ' GLY . 10.3 pt -79.34 -18.11 12.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.51 -41.77 96.06 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.41 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.749 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.0 mm? -73.64 -57.12 4.21 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.031 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.99 88.13 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 104.95 -34.42 5.81 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.527 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.519 ' C ' ' H ' ' A' ' 64' ' ' GLU . 22.6 t -137.24 129.6 29.69 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.106 0.479 . . . . 0.0 111.405 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -59.17 1.81 0.07 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.902 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.519 ' H ' ' C ' ' A' ' 62' ' ' SER . 42.7 mt-10 -83.02 -47.75 11.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.781 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -92.78 -7.44 46.5 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.6 m -55.72 -17.72 3.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.864 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -53.22 -31.88 45.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.286 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.8 ptm -100.27 -21.0 15.63 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.485 ' HG ' ' H ' ' A' ' 71' ' ' THR . 27.5 tp -52.17 124.09 12.21 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.256 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -41.14 -23.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.07 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.485 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 2.2 m -74.73 117.94 66.34 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.954 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.41 -104.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.892 1.728 . . . . 0.0 111.785 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.471 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 31.8 ttp -153.95 1.79 0.24 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.997 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.9 m -108.27 -18.77 13.68 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.784 0.326 . . . . 0.0 110.197 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.35 -34.04 70.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.619 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.958 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -64.0 -45.92 86.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.033 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.502 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 1.8 mptp? -56.22 -37.83 70.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.37 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -66.75 -56.92 8.31 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.432 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -63.92 -64.27 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.677 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.437 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.8 p -35.11 -27.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.112 0.482 . . . . 0.0 111.42 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 79' ' ' ALA . 52.6 ttm-85 -75.57 -58.92 2.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.111 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.473 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 50.1 mt -45.83 -41.71 3.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.821 -1.082 . . . . 0.0 112.656 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.884 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -79.77 -33.0 40.99 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.628 179.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -50.2 -21.55 1.38 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.869 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.51 17.4 55.05 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 88' ' ' GLU . 68.5 mt-10 -112.82 2.56 16.0 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -31.68 -34.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.849 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 86' ' ' GLU . 3.6 pt-20 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.686 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mp . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 -88.26 -34.06 17.86 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.2 mp -62.54 -11.36 6.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.38 -16.41 22.36 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.7 -29.01 66.33 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.62 -46.25 73.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.873 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.637 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.87 -36.07 0.98 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 22' ' ' LEU . 36.9 ttt180 -65.61 -43.14 90.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.743 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.35 -6.9 0.74 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.745 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.409 ' H ' ' C ' ' A' ' 20' ' ' ARG . 11.7 mt -117.94 121.61 31.39 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.57 72.77 6.35 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.781 1.654 . . . . 0.0 112.604 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.83 -53.33 0.68 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.7 m -59.23 132.42 53.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.006 0.432 . . . . 0.0 111.491 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.85 173.82 9.16 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.359 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.637 HG22 ' HB2' ' A' ' 19' ' ' ALA . 15.3 t -61.61 -59.64 3.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.697 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.66 6.71 8.19 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.53 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.445 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 57.5 mt-30 -97.1 -22.81 16.55 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 117.86 0.83 . . . . 0.0 110.084 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.0 tp -90.2 -19.75 23.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.836 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.441 HD12 ' N ' ' A' ' 31' ' ' LEU . 10.9 mp . . . . . 0 N--CA 1.466 0.357 0 CA-C-O 120.897 0.379 . . . . 0.0 110.408 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 49' ' ' GLY . 10.3 mp . . . . . 0 N--CA 1.465 0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.67 ' N ' ' NE2' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -62.06 72.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.359 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -152.76 11.61 0.61 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.91 175.07 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.472 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 49.1 m -113.79 161.97 16.9 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.496 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.2 t -55.52 -43.46 72.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 123.196 0.31 . . . . 0.0 110.999 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.3 m -57.37 -23.95 52.27 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 54' ' ' ASP . 16.6 t0 -75.7 -31.32 59.63 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.016 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.735 HD12 ' N ' ' A' ' 55' ' ' LEU . 5.9 mp -65.31 -65.9 0.61 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.489 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -52.79 -34.98 55.88 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.8 pt -80.19 -19.78 12.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.23 -37.79 91.33 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.711 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.699 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.4 mm? -75.98 -52.61 9.88 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.284 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.66 -33.38 64.45 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.464 -0.494 . . . . 0.0 109.803 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 83.42 -9.24 62.08 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.104 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.528 ' C ' ' H ' ' A' ' 64' ' ' GLU . 3.9 t -137.75 104.24 5.24 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.924 0.392 . . . . 0.0 111.819 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -56.51 -1.24 0.05 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.701 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.528 ' H ' ' C ' ' A' ' 62' ' ' SER . 36.2 mt-10 -91.51 -41.37 10.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.3 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -92.45 -13.0 30.62 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 m -46.79 -29.8 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.622 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -52.92 -30.69 35.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.919 0.39 . . . . 0.0 110.234 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 13.2 mmt -83.96 -31.08 25.74 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.92 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.485 ' O ' ' N ' ' A' ' 71' ' ' THR . 29.7 tp -49.56 122.4 6.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.283 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 51.2 t0 -39.69 -24.9 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.021 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.485 ' N ' ' O ' ' A' ' 69' ' ' LEU . 2.8 m -65.05 122.08 77.65 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.016 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -74.71 -86.74 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.644 1.563 . . . . 0.0 112.281 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -172.13 -23.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.676 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.6 p -89.34 -14.59 35.33 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.476 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -69.89 -33.7 72.56 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.4 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.915 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.5 mm? -65.25 -47.69 75.87 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.214 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.497 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 1.8 mptp? -57.95 -34.4 69.86 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.82 -58.67 3.85 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.895 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.604 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.31 -64.64 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.29 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.5 p -34.72 -23.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.961 0.41 . . . . 0.0 111.653 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.604 ' N ' ' O ' ' A' ' 79' ' ' ALA . 46.9 ttm-85 -78.71 -58.22 3.36 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.456 0.646 . . . . 0.0 109.617 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.462 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 43.4 mt -47.7 -42.06 8.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.988 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.82 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -76.7 -36.65 57.1 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.564 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -48.88 -18.07 0.25 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.795 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.448 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 85.01 18.7 60.61 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 88' ' ' GLU . 24.3 tt0 -112.44 2.93 16.6 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.462 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -30.32 -34.96 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.874 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 86' ' ' GLU . 41.9 mt-10 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.677 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mp . . . . . 0 CA--C 1.534 0.328 0 CA-C-O 120.981 0.42 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 50.4 ttm-85 -86.04 -38.35 17.95 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.35 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.417 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 1.4 mp -65.29 -7.16 4.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.173 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.54 -18.91 21.72 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.74 0.305 . . . . 0.0 110.493 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -70.15 -30.35 67.49 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -57.87 -41.44 82.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.408 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.696 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.28 -33.97 0.44 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.486 ' C ' ' H ' ' A' ' 22' ' ' LEU . 86.5 mtt180 -67.93 -42.24 81.33 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.224 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -57.88 -5.19 0.38 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.424 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 20' ' ' ARG . 19.3 mt -115.07 148.61 40.97 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.056 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.83 -92.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.219 1.946 . . . . 0.0 112.401 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.28 46.51 1.28 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.7 m -118.21 141.73 48.2 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.827 0.346 . . . . 0.0 110.387 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.67 159.4 15.01 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.232 0.539 . . . . 0.0 110.393 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.696 HG22 ' HB2' ' A' ' 19' ' ' ALA . 23.5 t -54.84 -51.9 47.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.124 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.01 3.57 56.99 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.11 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -89.22 -20.27 24.37 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 117.597 0.699 . . . . 0.0 109.836 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.578 ' O ' HD23 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -95.5 -27.25 15.47 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.617 0.246 . . . . 0.0 110.523 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.7 mt . . . . . 0 C--N 1.333 -0.121 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.876 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.4 mp . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -69.56 67.27 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.852 0.358 . . . . 0.0 110.424 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.71 11.15 0.36 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.77 171.78 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.47 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 31.6 m -113.66 161.72 17.12 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.545 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.3 t -55.07 -38.11 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 120.872 0.367 . . . . 0.0 110.415 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.6 m -59.18 -26.89 65.19 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -75.09 -30.53 60.94 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.974 0.416 . . . . 0.0 111.041 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.753 HD12 ' N ' ' A' ' 55' ' ' LEU . 5.0 mp -67.05 -62.79 1.26 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.197 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -54.01 -35.0 61.43 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.42 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.9 pt -78.96 -19.46 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.285 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.76 -33.5 84.42 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.757 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.1 mm? -77.55 -54.79 5.98 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 116.873 0.337 . . . . 0.0 110.944 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.39 -32.4 62.69 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.967 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 80.0 -4.36 66.63 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 64' ' ' GLU . 13.0 t -137.12 97.53 3.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.008 0.432 . . . . 0.0 111.45 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -53.45 -6.16 0.07 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.258 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.531 ' H ' ' C ' ' A' ' 62' ' ' SER . 20.2 tp10 -86.31 -41.11 14.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.409 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -92.74 -14.77 27.49 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.7 m -49.1 -21.41 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 119.816 -0.753 . . . . 0.0 110.518 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -53.93 -34.46 59.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.226 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.5 ptp -92.59 -24.29 18.75 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.222 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.473 ' CD2' ' OG1' ' A' ' 71' ' ' THR . 21.9 tp -49.46 121.62 5.27 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -35.97 -30.26 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.598 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.473 ' OG1' ' CD2' ' A' ' 69' ' ' LEU . 2.1 m -48.92 114.46 3.77 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.547 ' C ' ' H ' ' A' ' 74' ' ' SER . 93.8 Cg_endo -80.45 19.85 1.03 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.168 1.912 . . . . 0.0 113.148 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.435 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 34.2 ttm 65.91 -12.89 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.825 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 72' ' ' PRO . 30.1 t -96.49 -14.19 22.51 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.04 0.448 . . . . 0.0 110.053 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.13 -30.13 60.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.414 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.568 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -65.55 -53.15 46.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.67 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -46.66 -38.01 9.12 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.179 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -70.51 -58.24 3.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.068 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.587 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -62.72 -61.31 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.594 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.407 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 2.8 p -34.85 -24.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.992 0.425 . . . . 0.0 111.745 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 79' ' ' ALA . 24.1 ttm180 -79.22 -55.7 4.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.549 0.69 . . . . 0.0 109.654 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.46 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 41.5 mt -49.62 -43.49 18.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.973 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.842 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -74.25 -38.07 63.58 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.484 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -45.47 -19.48 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.859 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 83' ' ' LEU . . . 83.46 14.85 72.75 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 87' ' ' ALA . 94.4 mt-10 -110.7 3.82 19.54 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.46 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -28.28 -46.19 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.839 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.126 179.784 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.551 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 3.8 mp . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.883 0.373 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.514 ' NH2' ' HB3' ' A' ' 87' ' ' ALA . 36.4 ttt180 -47.01 -46.54 21.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.009 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.607 ' N ' HD12 ' A' ' 15' ' ' ILE . 1.5 mp -63.84 -7.65 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.2 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 13' ' ' LEU . . . -97.71 -15.66 20.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.275 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.01 -28.75 61.59 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -57.4 -41.98 81.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.959 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.679 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -42.67 -36.79 1.52 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.926 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.415 ' C ' ' H ' ' A' ' 22' ' ' LEU . 75.0 ttt180 -64.38 -39.17 93.34 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -60.05 -6.19 1.28 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.47 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 20' ' ' ARG . 10.6 mt -121.47 109.24 34.85 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.141 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.16 66.89 7.73 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.917 1.745 . . . . 0.0 112.412 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.67 -11.68 0.45 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.001 -0.619 . . . . 0.0 111.841 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 m -113.81 137.31 51.82 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.955 0.407 . . . . 0.0 111.08 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.689 ' H ' ' NE2' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -87.97 170.72 10.88 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.314 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.679 HG22 ' HB2' ' A' ' 19' ' ' ALA . 17.6 t -60.45 -59.69 3.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.184 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.16 11.11 4.02 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.364 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.689 ' NE2' ' H ' ' A' ' 26' ' ' THR . 18.2 mt-30 -98.87 -10.0 23.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.714 0.757 . . . . 0.0 110.487 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 pp -107.57 -19.18 13.64 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.609 ' O ' HD23 ' A' ' 31' ' ' LEU . 2.3 tt . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.759 0.314 . . . . 0.0 111.631 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.546 HD22 ' N ' ' A' ' 47' ' ' LEU . 3.8 mm? . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 120.718 0.294 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -76.18 75.63 3.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.69 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.36 6.48 0.49 Allowed Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.69 175.85 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 117.068 0.434 . . . . 0.0 110.428 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.49 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 24.0 m -111.62 164.55 12.88 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.519 ' HA ' HD13 ' A' ' 55' ' ' LEU . 4.9 t -58.25 -43.98 87.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.645 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.3 m -55.98 -25.35 43.61 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -74.85 -30.56 61.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.954 0.407 . . . . 0.0 111.468 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.722 HD12 ' N ' ' A' ' 55' ' ' LEU . 6.2 mp -65.3 -64.0 0.97 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -177.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -53.66 -36.45 62.14 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 61' ' ' GLY . 8.1 pt -80.35 -21.03 11.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.97 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.75 -33.01 83.72 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.78 HD22 ' N ' ' A' ' 59' ' ' LEU . 1.8 mm? -80.26 -54.73 5.46 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.483 ' HB3' HG12 ' A' ' 66' ' ' VAL . . . -79.42 -29.54 41.98 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.882 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 75.0 2.85 66.65 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.438 -0.887 . . . . 0.0 110.982 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.494 ' C ' ' H ' ' A' ' 64' ' ' GLU . 9.1 t -136.37 86.78 2.25 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.886 0.374 . . . . 0.0 111.253 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -49.08 -11.23 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.72 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.494 ' H ' ' C ' ' A' ' 62' ' ' SER . 25.3 tt0 -86.07 -35.71 20.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.512 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -98.27 -14.46 20.25 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.483 HG12 ' HB3' ' A' ' 60' ' ' ALA . 17.9 m -50.16 -25.83 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.475 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -52.31 -14.44 0.46 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.589 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 67.3 mtt -104.25 -22.21 13.41 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.67 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.448 ' HG ' ' H ' ' A' ' 71' ' ' THR . 37.8 tp -51.97 120.26 5.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.2 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 44.5 t0 -39.94 -33.13 0.19 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.194 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.448 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 62.9 m -60.7 119.65 45.98 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.071 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.439 ' O ' HD21 ' A' ' 76' ' ' LEU . 56.1 Cg_endo -69.71 -156.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 121.143 1.228 . . . . 0.0 111.348 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 8.8 ptm -106.8 -16.17 14.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.789 0.328 . . . . 0.0 111.147 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.7 m -92.76 -25.17 18.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.486 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.52 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -61.25 -33.12 73.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.371 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.908 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.2 mm? -64.95 -45.62 84.98 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.303 -0.959 . . . . 0.0 108.958 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.472 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 2.1 mptp? -59.97 -34.74 73.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.547 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -66.4 -58.8 4.51 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.708 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.49 -65.12 0.74 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.455 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.444 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.5 p -34.88 -27.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.05 0.452 . . . . 0.0 111.419 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.556 ' N ' ' O ' ' A' ' 79' ' ' ALA . 45.5 ttm-85 -77.3 -58.71 3.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.815 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.9 mt -45.01 -41.64 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.291 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.863 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -78.03 -35.62 49.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.64 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -51.44 -14.9 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.646 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.443 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 81.08 19.37 67.33 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 87' ' ' ALA . 8.0 tp10 -113.0 7.63 18.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.514 ' HB3' ' NH2' ' A' ' 14' ' ' ARG . . . -33.6 -57.11 0.44 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.494 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.521 179.858 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 mp . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -82.07 -28.81 32.19 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.1 mt -64.3 -19.2 24.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.248 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.421 ' HA ' HG13 ' A' ' 27' ' ' VAL . . . -89.47 -17.94 27.7 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.337 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.3 -30.82 66.7 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.5 -43.76 75.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.13 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.66 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.04 -37.36 0.82 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.487 ' C ' ' H ' ' A' ' 22' ' ' LEU . 66.2 mtp180 -68.39 -42.48 79.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.283 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.6 -5.76 0.25 Allowed 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.968 0.413 . . . . 0.0 110.275 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.487 ' H ' ' C ' ' A' ' 20' ' ' ARG . 13.9 mt -119.21 122.43 29.52 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.398 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -79.13 79.42 3.39 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.712 1.608 . . . . 0.0 112.75 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 130.17 -52.27 0.83 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.8 m -55.35 137.97 46.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.987 0.422 . . . . 0.0 111.435 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.61 171.68 9.51 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.72 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.66 HG22 ' HB2' ' A' ' 19' ' ' ALA . 20.2 t -60.25 -59.15 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.438 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.29 6.94 9.07 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.241 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.93 -20.83 17.83 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 117.283 0.542 . . . . 0.0 110.182 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 pp -90.78 -20.89 21.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.548 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.546 ' O ' HD23 ' A' ' 31' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.534 0.331 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.619 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.545 ' O ' HD13 ' A' ' 47' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 120.738 0.304 . . . . 0.0 110.393 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 84' ' ' TRP . 76.2 mt-30 -62.0 70.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.669 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -154.66 9.49 0.39 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.404 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -127.77 175.76 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.433 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 37.0 m -116.57 162.66 17.27 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.455 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.1 t -54.29 -47.83 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 123.254 0.347 . . . . 0.0 110.857 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -52.89 -25.27 11.16 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 116.365 -0.38 . . . . 0.0 112.003 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.404 ' CB ' HG22 ' A' ' 50' ' ' VAL . 13.2 t0 -75.43 -31.95 60.52 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.018 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.711 HD12 ' N ' ' A' ' 55' ' ' LEU . 5.9 mp -66.38 -63.75 1.01 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.227 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.418 ' HB2' HD21 ' A' ' 76' ' ' LEU . 26.0 ttpt -52.87 -34.77 56.01 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.9 pt -80.31 -19.92 11.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.022 0.439 . . . . 0.0 109.834 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.29 -38.5 91.59 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.668 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.4 mm? -76.61 -54.57 6.49 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 120.645 -0.422 . . . . 0.0 109.999 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.72 -35.06 79.23 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 118.53 -53.79 0.65 Allowed Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.651 ' C ' ' H ' ' A' ' 64' ' ' GLU . 26.8 t -140.05 152.69 46.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.995 0.426 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.34 20.89 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.891 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.651 ' H ' ' C ' ' A' ' 62' ' ' SER . 60.8 mt-10 -97.34 -59.8 1.71 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.694 0.283 . . . . 0.0 110.886 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.41 ' OD1' ' CG ' ' A' ' 68' ' ' MET . 12.4 t0 -82.45 -11.91 58.2 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 m -51.92 -28.35 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.13 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -55.92 -24.15 36.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.541 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.41 ' CG ' ' OD1' ' A' ' 65' ' ' ASP . 8.1 mmt -93.75 -36.63 12.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.521 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.519 HD23 ' OG1' ' A' ' 71' ' ' THR . 12.7 tp -48.85 115.98 1.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.4 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -43.74 -16.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.773 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.519 ' OG1' HD23 ' A' ' 69' ' ' LEU . 2.8 m -51.58 116.17 7.45 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.535 ' C ' ' H ' ' A' ' 74' ' ' SER . 93.0 Cg_endo -79.58 20.29 0.88 Allowed 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.319 2.013 . . . . 0.0 113.655 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 18.7 ttm 66.13 -13.42 0.16 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.633 0.254 . . . . 0.0 111.2 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.535 ' H ' ' C ' ' A' ' 72' ' ' PRO . 5.7 t -96.91 -13.6 22.32 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.063 0.459 . . . . 0.0 109.933 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.426 ' HB1' HD23 ' A' ' 22' ' ' LEU . . . -73.3 -31.53 64.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.904 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.567 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -67.69 -59.15 3.55 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -52.82 -15.92 0.87 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.252 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 74' ' ' SER . 8.2 m-20 -86.33 -51.96 5.92 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -69.34 -56.35 7.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.439 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.447 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.2 p -35.73 -26.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.297 0.57 . . . . 0.0 111.048 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.55 ' N ' ' O ' ' A' ' 79' ' ' ALA . 40.3 ttm-85 -76.52 -55.35 5.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.925 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.567 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 53.2 mt -49.95 -42.78 19.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.463 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.887 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -79.13 -32.9 44.62 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.755 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.508 ' O ' ' NE2' ' A' ' 48' ' ' GLN . 0.6 OUTLIER -46.85 -29.64 2.08 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.44 14.9 39.65 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 88' ' ' GLU . 1.1 mp0 -110.74 0.65 17.45 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -33.07 -33.42 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.478 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 86' ' ' GLU . 56.8 mm-40 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.592 ' N ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 120.575 0.226 . . . . 0.0 111.451 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.458 ' O ' ' CG2' ' A' ' 82' ' ' ILE . 94.5 mtt-85 -42.59 -41.25 2.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.5 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.4 mm -64.44 -24.01 34.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.552 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.98 -18.76 20.01 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.99 -31.0 70.4 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -58.02 -41.53 83.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.779 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.711 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -42.38 -37.46 1.57 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.015 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.9 mtt-85 -64.06 -38.66 91.86 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.026 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.98 -7.2 0.98 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.332 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.43 HD23 ' HB1' ' A' ' 75' ' ' ALA . 25.3 mt -112.96 146.86 35.98 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -39.19 -71.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.196 1.931 . . . . 0.0 112.206 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -140.51 4.71 2.54 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.3 m -57.38 137.33 56.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.46 162.9 20.81 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.094 0.473 . . . . 0.0 110.806 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.711 HG22 ' HB2' ' A' ' 19' ' ' ALA . 22.1 t -61.04 -55.74 22.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.83 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.15 13.34 2.7 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.087 -0.577 . . . . 0.0 112.654 -178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -97.66 -19.31 18.36 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.018 0.909 . . . . 0.0 111.954 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.91 -17.53 20.07 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.988 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.686 HD22 ' N ' ' A' ' 31' ' ' LEU . 3.0 mm? . . . . . 0 N--CA 1.471 0.618 0 CA-C-N 118.163 0.438 . . . . 0.0 110.624 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 47' ' ' LEU . 10.2 mp . . . . . 0 N--CA 1.463 0.187 0 CA-C-O 120.8 0.333 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -81.93 65.03 6.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.935 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.13 3.15 0.76 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.52 172.73 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.453 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 60.6 m -115.43 162.28 17.38 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.507 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.7 t -55.41 -42.2 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 120.67 0.272 . . . . 0.0 111.058 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.3 m -58.11 -23.93 56.74 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.26 -31.98 60.94 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.995 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 55' ' ' LEU . 5.5 mp -64.67 -65.86 0.62 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.533 -177.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -53.24 -36.13 60.72 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.538 ' O ' ' N ' ' A' ' 61' ' ' GLY . 11.6 pt -79.18 -19.02 12.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.188 0.518 . . . . 0.0 109.713 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.96 -40.02 95.14 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.011 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.781 HD22 ' N ' ' A' ' 59' ' ' LEU . 1.8 mm? -75.81 -53.09 9.02 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.283 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.26 -37.03 74.82 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 119.93 -53.24 0.69 Allowed Glycine 0 N--CA 1.465 0.61 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.582 ' C ' ' H ' ' A' ' 64' ' ' GLU . 2.5 t -137.54 147.38 45.1 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.98 0.419 . . . . 0.0 110.864 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -59.99 7.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.485 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.582 ' H ' ' C ' ' A' ' 62' ' ' SER . 53.2 mm-40 -81.5 -52.51 7.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.434 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -96.79 -7.27 34.14 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.3 m -47.36 -31.32 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.786 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -52.38 -33.29 42.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 0.0 110.235 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 17.2 mtt -80.6 -21.19 41.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.395 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.424 ' HG ' ' H ' ' A' ' 71' ' ' THR . 23.0 tp -65.41 122.4 17.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.499 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -47.09 -20.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.336 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.424 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 4.1 m -58.12 124.46 70.29 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.59 -86.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.532 1.488 . . . . 0.0 111.976 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 18.1 ptt? -173.59 -28.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.051 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.4 m -86.05 -17.97 33.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HB1' HD23 ' A' ' 22' ' ' LEU . . . -62.22 -35.78 79.95 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.96 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.714 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -66.73 -51.95 50.05 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.28 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.29 -32.41 64.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -69.52 -55.58 9.79 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.945 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -67.07 -61.94 1.68 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.439 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.447 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.7 p -35.18 -27.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.013 0.435 . . . . 0.0 111.355 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.55 ' N ' ' O ' ' A' ' 79' ' ' ALA . 47.3 ttm-85 -75.9 -59.56 2.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.149 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.515 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 49.4 mt -46.04 -40.53 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.692 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.88 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -79.84 -33.09 40.53 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 119.341 -0.944 . . . . 0.0 109.527 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -52.01 -21.52 3.19 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.771 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.67 16.07 55.52 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -104.33 -1.33 27.09 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.515 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -36.0 -35.31 0.07 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.382 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.66 -179.907 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.553 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 3.5 mp . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -49.77 -46.5 50.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.152 0.501 . . . . 0.0 110.646 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 15' ' ' ILE . 25.2 mt -65.17 -8.0 5.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.588 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 13' ' ' LEU . . . -99.15 -15.0 19.11 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.651 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.38 -28.32 61.96 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -57.89 -42.83 85.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.121 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.673 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.77 -33.55 0.52 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.49 ' C ' ' H ' ' A' ' 22' ' ' LEU . 37.4 ttm180 -69.7 -42.99 73.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.017 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.64 -7.49 0.43 Allowed 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.061 0.458 . . . . 0.0 110.051 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' A' ' 20' ' ' ARG . 14.1 mt -116.46 147.62 40.05 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.438 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -60.34 -78.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.968 1.779 . . . . 0.0 113.005 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.87 -10.5 26.39 Favored Glycine 0 N--CA 1.469 0.89 0 C-N-CA 121.409 -0.424 . . . . 0.0 112.654 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.3 m -60.48 130.57 47.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.317 0.559 . . . . 0.0 110.644 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.18 166.89 15.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.551 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.673 HG22 ' HB2' ' A' ' 19' ' ' ALA . 21.6 t -58.44 -59.59 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.739 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.13 10.55 2.45 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.702 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -101.59 -25.78 13.76 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 117.986 0.893 . . . . 0.0 110.572 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.3 tp -86.75 -27.15 23.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.902 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.9 mt . . . . . 0 N--CA 1.464 0.271 0 CA-C-O 120.677 0.275 . . . . 0.0 110.799 -179.786 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 49' ' ' GLY . 77.8 mt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.833 0.349 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 84' ' ' TRP . 70.1 mt-30 -63.16 71.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.801 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -149.7 16.04 1.08 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.461 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -134.84 178.39 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.467 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 67.2 m -115.98 164.23 14.74 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.472 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.6 t -57.41 -47.33 84.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.158 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 57' ' ' ILE . 3.4 m -54.77 -24.69 23.65 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.457 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.461 ' CB ' HG22 ' A' ' 50' ' ' VAL . 9.8 t70 -72.94 -30.95 64.26 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.053 0.454 . . . . 0.0 110.734 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.708 HD12 ' N ' ' A' ' 55' ' ' LEU . 6.6 mp -66.35 -63.35 1.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.529 -178.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -55.95 -37.93 69.67 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.0 pt -73.72 -21.4 18.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.617 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.7 -35.46 91.95 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.872 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.746 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.2 mm? -75.81 -55.48 5.59 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.899 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.551 ' HB2' ' CD1' ' A' ' 69' ' ' LEU . . . -76.29 -31.47 58.24 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.484 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 77.17 -2.36 61.5 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.098 -1.049 . . . . 0.0 111.248 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.526 ' C ' ' H ' ' A' ' 64' ' ' GLU . 22.2 t -131.03 99.37 4.87 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.921 0.391 . . . . 0.0 111.409 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -54.11 -2.73 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.036 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 62' ' ' SER . 27.9 tt0 -95.5 -44.28 7.59 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.298 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.79 -12.35 48.29 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 62' ' ' SER . 15.2 m -54.12 -22.4 7.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.856 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -65.19 -14.2 60.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.193 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 51.7 mtt -105.71 -18.59 14.02 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.843 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.551 ' CD1' ' HB2' ' A' ' 60' ' ' ALA . 1.2 mt -49.05 139.96 9.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.121 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 20.2 p-10 -58.27 -30.39 66.56 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.3 m -60.89 119.53 45.59 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.225 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.41 ' O ' HD21 ' A' ' 76' ' ' LEU . 72.2 Cg_endo -72.94 -154.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.313 1.342 . . . . 0.0 111.233 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.43 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 37.1 ttm -112.72 1.29 15.6 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.872 0.368 . . . . 0.0 110.059 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.0 m -107.1 -27.89 10.33 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.101 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.453 ' HB1' HD23 ' A' ' 22' ' ' LEU . . . -60.35 -35.42 75.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.548 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.905 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -63.75 -49.74 71.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.448 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.522 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 2.0 mptp? -54.63 -35.86 63.9 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.445 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.73 -59.4 3.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.92 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.45 -61.77 2.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.9 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.438 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 2.7 p -35.19 -27.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.049 0.452 . . . . 0.0 111.545 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 79' ' ' ALA . 29.0 ttm180 -78.01 -56.65 4.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.619 0.723 . . . . 0.0 109.818 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.544 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 42.8 mt -46.5 -45.09 6.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.901 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.866 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -74.49 -36.58 63.27 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.702 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.495 ' O ' ' NE2' ' A' ' 48' ' ' GLN . 0.7 OUTLIER -47.33 -19.58 0.16 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.104 -179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.434 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 85.16 15.46 66.86 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 88' ' ' GLU . 25.0 tt0 -108.29 0.37 21.26 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.544 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -32.97 -31.95 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.63 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 86' ' ' GLU . 37.5 mt-10 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.707 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 4.5 mp . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.756 0.312 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.471 HH21 ' HB3' ' A' ' 87' ' ' ALA . 53.2 mtp180 -45.72 -44.75 13.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.965 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.666 ' N ' HD12 ' A' ' 15' ' ' ILE . 1.8 mp -64.37 -15.72 17.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.336 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 13' ' ' LEU . . . -99.6 -17.29 17.9 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.368 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -71.74 -28.14 63.47 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -60.56 -39.98 89.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.458 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.701 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -42.93 -34.78 1.03 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.659 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.437 ' C ' ' H ' ' A' ' 22' ' ' LEU . 65.8 ttt180 -66.12 -39.05 89.6 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.884 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -59.43 -6.87 1.15 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.134 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.437 ' H ' ' C ' ' A' ' 20' ' ' ARG . 14.9 mt -119.81 117.33 32.54 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.62 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.49 70.29 7.59 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.889 1.726 . . . . 0.0 112.48 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 146.14 -52.14 0.58 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.0 m -60.47 133.0 55.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.974 0.416 . . . . 0.0 111.145 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.99 168.23 13.02 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.077 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.701 HG22 ' HB2' ' A' ' 19' ' ' ALA . 18.2 t -58.77 -58.56 6.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.141 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.7 11.13 3.51 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.643 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.402 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 40.0 mm-40 -99.51 -15.26 18.73 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.952 0.876 . . . . 0.0 110.587 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.5 tp -100.75 -27.74 13.19 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.66 HD22 ' N ' ' A' ' 31' ' ' LEU . 3.0 mm? . . . . . 0 N--CA 1.465 0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 110.846 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.515 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 3.0 mm? . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.04 0.448 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -70.81 72.82 0.56 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.438 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.42 5.68 0.46 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.447 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -133.82 176.12 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.953 0.376 . . . . 0.0 110.163 179.811 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.474 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 9.3 m -115.38 165.59 12.8 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.462 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.5 t -57.64 -49.11 81.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.31 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.4 m -53.18 -24.62 11.25 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.592 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.447 ' CB ' HG22 ' A' ' 50' ' ' VAL . 32.9 t0 -74.16 -31.4 62.68 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.33 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.712 HD12 ' N ' ' A' ' 55' ' ' LEU . 5.9 mp -66.1 -62.26 1.58 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 -178.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -55.55 -38.98 70.03 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 61' ' ' GLY . 15.1 pt -73.77 -24.96 20.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.418 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.79 -33.06 81.43 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.943 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.755 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.0 mm? -80.19 -56.39 4.25 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.107 0.453 . . . . 0.0 111.291 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.64 -30.44 61.63 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.726 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 81.48 -13.82 32.62 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.747 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.542 ' O ' HG13 ' A' ' 66' ' ' VAL . 2.7 p -121.67 103.76 9.12 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.918 0.39 . . . . 0.0 111.313 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.96 -0.06 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.597 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.536 ' H ' ' C ' ' A' ' 62' ' ' SER . 47.1 tt0 -96.27 -41.56 8.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.172 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -90.88 -12.11 37.18 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 62' ' ' SER . 13.7 m -54.91 -22.05 9.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.982 0.42 . . . . 0.0 111.232 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -57.73 -19.89 30.68 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.136 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 28.8 mtt -108.21 -5.16 17.02 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.553 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.498 HD23 ' H ' ' A' ' 70' ' ' ASP . 0.5 OUTLIER -48.84 151.11 1.28 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.283 -179.472 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.498 ' H ' HD23 ' A' ' 69' ' ' LEU . 8.4 t70 -67.63 -39.36 84.67 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 72' ' ' PRO . 81.9 m -61.1 112.99 6.66 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.682 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 71' ' ' THR . 50.1 Cg_exo -51.82 -164.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.594 1.53 . . . . 0.0 112.084 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.4 ptt? -105.32 -15.9 14.91 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.659 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.3 m -96.63 -19.25 19.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.243 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.436 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -67.44 -30.91 70.77 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.123 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.886 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.5 mm? -64.5 -49.6 70.68 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.526 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.7 OUTLIER -54.45 -33.58 59.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.548 179.448 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -72.09 -59.78 2.57 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.79 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -57.05 -63.45 1.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.342 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.425 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 2.3 p -35.1 -27.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.923 0.392 . . . . 0.0 111.744 -178.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 79' ' ' ALA . 46.6 ttm-85 -76.44 -60.07 2.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.534 0.683 . . . . 0.0 110.423 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.487 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 36.3 mt -43.61 -43.11 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.156 -178.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.877 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -76.65 -34.39 58.28 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 119.137 -1.025 . . . . 0.0 109.873 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -52.64 -18.03 1.58 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.676 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.56 14.67 67.61 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -102.3 1.62 35.92 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.487 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -36.78 -37.24 0.13 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.086 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.679 -179.924 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 120.685 0.279 . . . . 0.0 110.269 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 1.395 ' CD ' ' CG2' ' A' ' 82' ' ' ILE . 1.9 tmm_? -81.52 -20.6 39.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.156 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.503 HD13 ' HE ' ' A' ' 14' ' ' ARG . 7.6 mm -62.84 -26.03 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.218 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.02 -23.85 19.39 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.7 -33.62 76.38 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.19 -45.63 75.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.454 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.67 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -43.48 -36.07 1.87 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -63.43 -41.99 98.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.187 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -63.19 -7.26 5.53 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.045 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.4 mt -120.03 110.24 36.62 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.81 65.07 8.57 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.741 1.627 . . . . 0.0 112.394 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.33 -37.35 0.52 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.636 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.8 m -80.59 139.55 36.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.003 0.43 . . . . 0.0 111.432 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.43 166.79 15.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.91 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.67 HG22 ' HB2' ' A' ' 19' ' ' ALA . 25.7 t -60.52 -60.27 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.078 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.52 11.65 5.28 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.298 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.454 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 13.0 mm100 -99.0 -17.49 18.27 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.695 0.748 . . . . 0.0 110.286 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 45.8 tp -93.38 -18.28 22.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.826 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.741 0.305 . . . . 0.0 111.155 -179.797 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 49' ' ' GLY . 5.7 tp . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.65 0.262 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -64.1 70.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.169 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -153.12 7.67 0.47 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.413 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -124.24 175.74 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.444 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 67.0 m -119.57 164.04 16.43 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.479 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.9 t -56.45 -43.99 79.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.333 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.7 m -56.85 -23.46 44.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.413 ' CB ' HG22 ' A' ' 50' ' ' VAL . 11.8 t70 -75.21 -32.52 61.21 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.231 0.539 . . . . 0.0 110.837 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.724 HD12 ' N ' ' A' ' 55' ' ' LEU . 6.0 mp -63.87 -66.63 0.52 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.629 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -54.25 -34.82 61.61 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.7 pt -78.58 -20.51 13.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.8 -37.03 88.16 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.858 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.704 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.3 mm? -76.45 -53.63 7.85 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.579 -0.448 . . . . 0.0 109.902 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.56 -36.71 76.56 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 121.25 -53.23 0.71 Allowed Glycine 0 N--CA 1.466 0.668 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.663 ' C ' ' H ' ' A' ' 64' ' ' GLU . 4.1 m -139.19 150.87 46.07 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.94 0.4 . . . . 0.0 110.916 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -60.13 22.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.639 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.663 ' H ' ' C ' ' A' ' 62' ' ' SER . 27.3 mt-10 -96.62 -60.33 1.63 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.698 0.285 . . . . 0.0 110.624 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -83.4 -13.08 55.66 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.5 m -47.51 -24.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.377 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -58.95 -35.0 72.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.345 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 24.9 mmt -84.97 -33.59 22.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.653 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.4 tp -49.89 122.01 6.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 110.16 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -55.88 -25.35 42.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.666 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 72' ' ' PRO . 26.1 m -50.13 108.62 1.05 Allowed Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.226 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 71' ' ' THR . 32.5 Cg_exo -54.8 -154.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.37 1.38 . . . . 0.0 112.196 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.4 ptm -115.75 -20.89 9.88 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.565 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.4 m -90.26 -19.87 23.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.538 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -64.78 -34.89 79.42 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.202 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.932 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.3 mm? -66.49 -50.88 61.78 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.31 -31.84 64.06 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -70.9 -56.82 5.41 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.779 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -64.7 -61.25 2.3 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.433 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.426 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 2.4 p -35.87 -26.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.22 0.533 . . . . 0.0 111.21 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 79' ' ' ALA . 15.9 ttm180 -78.87 -53.54 6.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.108 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 1.395 ' CG2' ' CD ' ' A' ' 14' ' ' ARG . 46.3 mt -50.29 -44.38 23.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.138 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 1.146 ' HA ' ' CZ ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -76.38 -35.57 58.57 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.639 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.636 ' N ' HH12 ' A' ' 14' ' ' ARG . 0.6 OUTLIER -45.6 -28.0 0.88 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.249 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.833 ' H ' HH12 ' A' ' 14' ' ' ARG . . . 96.13 13.66 48.32 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 88' ' ' GLU . 27.0 tt0 -105.95 -2.91 22.36 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.581 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -33.48 -34.44 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.392 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 86' ' ' GLU . 69.3 mm-40 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.539 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.566 ' N ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -75.09 -39.98 60.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 15' ' ' ILE . 55.1 mt -63.63 -13.04 12.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.456 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.73 -17.51 24.14 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.797 0.332 . . . . 0.0 110.771 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -70.79 -32.44 69.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.17 -44.19 74.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.291 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.691 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.59 -37.02 1.04 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.012 0.434 . . . . 0.0 109.969 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.405 ' C ' ' H ' ' A' ' 22' ' ' LEU . 54.8 ttm-85 -63.55 -41.72 98.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.527 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.75 -7.12 0.89 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.55 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 20' ' ' ARG . 12.0 mt -119.0 114.06 35.41 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -79.35 68.94 8.13 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.657 1.571 . . . . 0.0 112.293 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.81 -49.6 0.56 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.3 m -66.79 133.77 50.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.971 0.415 . . . . 0.0 111.589 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.14 173.03 11.4 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.038 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.691 HG22 ' HB2' ' A' ' 19' ' ' ALA . 21.4 t -63.62 -63.55 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.139 0.495 . . . . 0.0 111.09 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.52 11.93 2.91 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.045 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.442 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 10.9 mm100 -99.62 -24.97 14.57 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.514 0.657 . . . . 0.0 110.607 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.7 tt -85.3 -19.8 30.98 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.926 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.3 0 CA-C-O 121.004 0.431 . . . . 0.0 109.981 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.473 HD22 ' N ' ' A' ' 47' ' ' LEU . 3.7 mm? . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.753 0.311 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -84.11 69.65 10.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.938 0.399 . . . . 0.0 110.533 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.0 -2.85 0.14 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.458 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -123.23 172.82 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.444 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 3.5 m -115.95 161.71 18.43 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.459 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.4 t -53.37 -44.26 54.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 123.213 0.321 . . . . 0.0 110.985 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 57' ' ' ILE . 3.6 m -58.12 -22.92 53.02 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.458 ' CB ' HG22 ' A' ' 50' ' ' VAL . 9.6 t0 -75.39 -31.93 60.62 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.452 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.726 HD12 ' N ' ' A' ' 55' ' ' LEU . 5.8 mp -64.5 -67.57 0.42 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.42 -177.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -52.12 -34.73 45.62 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.6 pt -79.7 -19.17 12.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.71 -41.08 84.79 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.681 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.4 mm? -73.48 -54.37 8.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.583 -0.447 . . . . 0.0 109.833 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.75 -37.06 79.11 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 118.8 -51.96 0.73 Allowed Glycine 0 N--CA 1.468 0.809 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.593 ' C ' ' H ' ' A' ' 64' ' ' GLU . 83.8 p -138.38 145.91 41.63 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.75 0.31 . . . . 0.0 110.842 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -59.92 6.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.195 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.593 ' H ' ' C ' ' A' ' 62' ' ' SER . 32.7 mt-10 -82.3 -54.72 5.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.299 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -96.74 -5.3 38.93 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 m -44.82 -26.33 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.611 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -57.04 -32.17 65.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.017 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 25.3 mmm -92.04 -7.64 48.23 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.363 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.483 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 30.1 tp -49.57 -84.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.212 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 1.3 t70 154.23 -26.78 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.408 ' OG1' ' CD2' ' A' ' 69' ' ' LEU . 3.4 m -62.4 135.12 95.17 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.018 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.6 -92.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.793 1.662 . . . . 0.0 112.28 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -172.59 -26.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.1 m -88.52 -18.9 27.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.9 -35.84 81.73 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.714 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.944 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.4 mm? -64.46 -49.78 70.11 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -70.15 -9.21 54.93 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.954 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -86.04 -50.4 7.07 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.577 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -70.21 -57.84 4.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.301 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.411 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.3 p -35.22 -25.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.11 0.481 . . . . 0.0 111.167 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.577 ' N ' ' O ' ' A' ' 79' ' ' ALA . 21.4 ttm180 -78.44 -55.61 5.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.819 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.517 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 49.7 mt -50.72 -41.5 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.287 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.858 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.54 -35.82 52.88 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.309 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.401 ' CE3' ' O ' ' A' ' 80' ' ' VAL . 0.6 OUTLIER -45.86 -22.13 0.17 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.439 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.442 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 86.57 18.18 59.0 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 87' ' ' ALA . 85.0 mt-10 -111.29 -0.23 16.48 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.479 0.18 . . . . 0.0 110.518 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.517 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -31.86 -58.36 0.28 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.689 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.749 -179.764 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.595 ' N ' HD23 ' A' ' 13' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 120.636 0.255 . . . . 0.0 111.637 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.1 mtm-85 -50.04 -34.68 22.23 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.6 mm -64.16 -24.03 34.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.905 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.73 -19.8 22.23 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.567 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.99 -32.48 69.32 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -56.24 -43.93 79.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.329 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.688 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -40.41 -36.36 0.54 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.435 ' C ' ' H ' ' A' ' 22' ' ' LEU . 72.8 mtt-85 -65.9 -42.51 90.12 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.342 -0.39 . . . . 0.0 109.948 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.48 -6.14 0.65 Allowed 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.345 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.435 ' H ' ' C ' ' A' ' 20' ' ' ARG . 8.7 mt -121.11 112.41 33.27 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.633 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -83.5 65.46 7.56 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.959 1.773 . . . . 0.0 112.414 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.9 -35.87 0.62 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.472 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.8 m -81.9 135.0 35.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.947 0.403 . . . . 0.0 111.333 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.77 170.47 14.13 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.015 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.688 HG22 ' HB2' ' A' ' 19' ' ' ALA . 23.4 t -61.72 -61.44 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.75 10.32 4.19 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.19 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.419 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 21.0 mm100 -99.19 -25.4 14.53 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.427 0.614 . . . . 0.0 110.574 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.7 tp -88.09 -26.17 22.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.444 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 31' ' ' LEU . 3.4 mm? . . . . . 0 C--N 1.331 -0.239 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.527 HD22 ' N ' ' A' ' 47' ' ' LEU . 3.3 mm? . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.535 0.207 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -78.06 63.9 3.13 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.388 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.64 1.34 0.6 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.457 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -130.16 173.62 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.469 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 36.0 m -116.0 164.8 13.9 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.463 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.2 t -55.23 -47.71 77.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 O-C-N 123.27 0.356 . . . . 0.0 111.313 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.4 m -54.81 -24.32 22.26 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.457 ' CB ' HG22 ' A' ' 50' ' ' VAL . 38.1 t0 -74.74 -31.76 61.91 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.846 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.719 HD12 ' N ' ' A' ' 55' ' ' LEU . 6.2 mp -65.27 -65.52 0.66 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.241 -178.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -53.63 -34.25 57.88 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.5 pt -78.77 -18.63 13.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.66 -38.79 67.49 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.656 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.5 mm? -74.76 -55.5 5.78 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.47 -37.15 84.48 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 100.26 -28.9 13.63 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.801 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.597 ' C ' ' H ' ' A' ' 64' ' ' GLU . 14.9 p -138.2 132.42 31.82 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.386 0.612 . . . . 0.0 112.131 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.434 ' HG3' ' H ' ' A' ' 63' ' ' GLU . 2.2 mt-10 -58.59 7.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.867 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.597 ' H ' ' C ' ' A' ' 62' ' ' SER . 54.2 mt-10 -93.81 -52.44 4.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.895 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -80.96 -16.28 53.93 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.3 m -50.18 -23.69 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.263 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -61.04 -30.39 70.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.425 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 37.8 mtt -91.77 -34.34 14.64 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.982 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.2 tp -49.28 108.4 0.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.944 0.402 . . . . 0.0 110.06 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -42.84 -24.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.812 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 72' ' ' PRO . 14.8 m -45.69 106.29 0.54 Allowed Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.633 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.447 ' O ' HD21 ' A' ' 76' ' ' LEU . 52.5 Cg_exo -52.73 -168.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.311 1.341 . . . . 0.0 111.262 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 40.8 ttp -106.07 -7.55 17.96 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.2 t -100.18 -26.27 13.99 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.209 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.02 -34.5 70.11 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.036 0.445 . . . . 0.0 110.301 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.915 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -67.78 -59.66 3.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.563 0.696 . . . . 0.0 109.603 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -60.08 -10.17 4.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.205 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -87.64 -52.88 5.08 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -68.84 -56.74 7.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.182 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.424 ' O ' ' CE3' ' A' ' 84' ' ' TRP . 1.4 p -35.06 -25.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 121.219 0.533 . . . . 0.0 111.316 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 79' ' ' ALA . 39.5 ttm180 -78.75 -56.58 4.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.565 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.557 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 41.8 mt -47.33 -42.48 7.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.896 -178.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.845 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.37 -36.17 53.82 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.892 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.424 ' CE3' ' O ' ' A' ' 80' ' ' VAL . 0.7 OUTLIER -46.63 -24.35 0.53 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.674 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 90.63 18.94 46.36 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 88' ' ' GLU . 45.2 mt-10 -110.15 -0.05 18.07 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.557 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -35.94 -26.58 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.358 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 86' ' ' GLU . 67.0 mm-40 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.238 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.596 ' N ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.437 0 CA-C-O 120.733 0.301 . . . . 0.0 111.329 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.752 HH21 ' HB3' ' A' ' 87' ' ' ALA . 71.9 mtp180 -43.54 -43.33 5.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.645 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 mm -63.53 -21.62 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.625 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -97.45 -17.24 19.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -69.73 -32.28 70.73 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.07 -46.03 71.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.313 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.66 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -39.7 -36.37 0.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.337 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.481 ' C ' ' H ' ' A' ' 22' ' ' LEU . 73.6 ttt-85 -64.33 -42.37 96.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.837 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.39 -4.72 0.41 Allowed 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.348 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 20' ' ' ARG . 8.5 mt -122.8 111.96 30.86 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.566 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.04 67.18 8.71 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 121.713 1.609 . . . . 0.0 112.22 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.39 -43.97 0.58 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.637 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.3 m -75.2 133.43 41.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.938 0.399 . . . . 0.0 111.34 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.64 173.3 11.49 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.081 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.66 HG22 ' HB2' ' A' ' 19' ' ' ALA . 22.2 t -62.8 -62.59 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.672 -179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.84 11.37 3.52 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.091 -178.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.456 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 20.1 mm-40 -100.14 -24.36 14.6 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 117.487 0.644 . . . . 0.0 110.891 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.6 tt -92.79 -23.52 18.84 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.981 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.6 mt . . . . . 0 C--N 1.328 -0.34 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.87 -179.761 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.504 0.193 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -70.51 70.76 0.45 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.361 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.22 7.45 0.74 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.78 175.7 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.488 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 9.0 m -113.21 163.84 14.28 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.503 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.4 t -56.27 -43.77 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 123.209 0.318 . . . . 0.0 111.414 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.8 m -55.33 -25.72 36.43 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -76.47 -30.94 57.49 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.912 0.387 . . . . 0.0 111.544 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 55' ' ' LEU . 5.6 mp -65.62 -65.09 0.72 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -50.81 -34.86 29.39 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 61' ' ' GLY . 8.9 pt -83.08 -21.69 8.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.336 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.26 -38.12 95.68 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.727 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.1 mm? -74.59 -62.3 1.58 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.711 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.11 -34.17 77.04 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.325 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 86.93 -8.74 74.96 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.479 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.506 ' C ' ' H ' ' A' ' 64' ' ' GLU . 1.9 m -138.01 104.52 5.27 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 117.106 0.453 . . . . 0.0 112.022 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -54.24 -6.5 0.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.218 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' A' ' 62' ' ' SER . 28.3 mp0 -83.76 -45.25 13.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.719 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.06 -12.97 34.09 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.416 ' C ' ' N ' ' A' ' 68' ' ' MET . 12.9 m -50.66 -29.39 6.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.105 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -51.52 -15.12 0.38 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.48 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.416 ' N ' ' C ' ' A' ' 66' ' ' VAL . 48.6 mtt -104.45 -25.81 12.66 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.741 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.463 ' HG ' ' H ' ' A' ' 71' ' ' THR . 38.7 tp -51.86 119.26 4.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.165 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -38.99 -29.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.444 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.463 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 33.1 m -65.9 115.08 19.52 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.643 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.487 ' O ' HD21 ' A' ' 76' ' ' LEU . 60.4 Cg_endo -71.27 -156.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.261 1.307 . . . . 0.0 111.43 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -102.15 -17.58 15.94 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.823 0.344 . . . . 0.0 111.526 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.3 m -92.35 -22.96 19.4 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.702 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -63.61 -32.81 74.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.41 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.862 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.0 OUTLIER -66.37 -48.05 71.39 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.422 -0.911 . . . . 0.0 108.922 179.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -32.34 66.51 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.48 -58.77 3.2 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.303 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -62.45 -63.25 1.29 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.403 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 p -34.56 -24.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.991 0.424 . . . . 0.0 111.673 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 79' ' ' ALA . 32.4 ttm180 -78.24 -57.53 3.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 109.82 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.464 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 42.0 mt -48.09 -41.44 9.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.148 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.824 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.44 -36.28 53.24 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.332 179.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -49.75 -15.1 0.15 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.482 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 79.46 19.53 71.22 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 88' ' ' GLU . 79.4 mt-10 -113.0 7.1 18.01 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.752 ' HB3' HH21 ' A' ' 14' ' ' ARG . . . -35.73 -26.01 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.279 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 86' ' ' GLU . 28.9 mt-10 . . . . . 0 N--CA 1.463 0.211 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.222 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 N--CA 1.465 0.278 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.664 ' HE ' ' CB ' ' A' ' 87' ' ' ALA . 15.4 ttt85 -71.54 -32.31 67.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.229 -178.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.3 mm -54.35 -16.19 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.476 ' HA ' HG13 ' A' ' 27' ' ' VAL . . . -97.75 -25.35 15.1 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.248 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.91 -38.2 84.9 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.14 -42.34 69.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.377 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.679 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.82 -38.89 1.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.12 178.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.453 ' C ' ' H ' ' A' ' 22' ' ' LEU . 39.0 ttt85 -66.08 -42.26 89.6 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.839 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.48 -5.77 0.24 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.975 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 20' ' ' ARG . 8.6 mt -122.39 105.45 36.4 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.423 -178.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -80.48 78.06 3.82 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 121.562 1.508 . . . . 0.0 112.086 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.62 -30.64 1.26 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.6 m -96.18 142.7 28.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.026 0.441 . . . . 0.0 111.296 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.14 178.52 6.61 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.219 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.679 HG22 ' HB2' ' A' ' 19' ' ' ALA . 22.9 t -66.4 -65.47 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.904 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.74 13.77 3.9 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.129 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -100.33 -16.11 17.78 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.166 0.483 . . . . 0.0 110.472 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 pp -94.65 -20.81 19.24 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.469 0.515 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.249 -179.78 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.0 tp . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.825 0.345 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -85.52 71.73 10.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.512 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.34 7.44 0.84 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 120.949 -0.644 . . . . 0.0 111.643 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.1 177.92 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.676 0.274 . . . . 0.0 110.361 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.48 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 33.7 m -112.78 162.46 15.75 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.505 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.9 t -57.2 -44.32 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 120.667 0.27 . . . . 0.0 111.139 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.9 m -56.88 -22.07 34.34 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -77.25 -30.59 54.51 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.211 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.73 HD12 ' N ' ' A' ' 55' ' ' LEU . 5.9 mp -65.93 -64.47 0.85 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.211 -177.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -52.99 -34.13 54.74 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 61' ' ' GLY . 7.4 pt -83.38 -18.86 10.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.668 0.271 . . . . 0.0 110.948 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.29 -33.22 86.66 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.757 HD22 ' N ' ' A' ' 59' ' ' LEU . 1.8 mm? -79.23 -57.25 3.81 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.578 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.58 -32.78 64.3 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.125 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 84.75 -5.11 83.3 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.538 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.511 ' C ' ' H ' ' A' ' 64' ' ' GLU . 69.0 m -137.9 99.22 3.84 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.942 0.401 . . . . 0.0 111.635 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 63' ' ' GLU . 0.1 OUTLIER -50.88 -8.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.72 179.246 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.511 ' H ' ' C ' ' A' ' 62' ' ' SER . 32.6 tt0 -87.62 -41.31 13.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.835 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -89.8 -18.17 26.78 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.6 m -46.74 -23.07 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.967 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 67' ' ' ASP . 56.1 t0 -50.72 -34.57 27.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.46 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 68' ' ' MET . 0.0 OUTLIER -82.5 -32.83 28.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.637 179.761 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.403 ' HG ' ' H ' ' A' ' 71' ' ' THR . 25.3 tp -49.91 116.22 1.72 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.114 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -42.45 -26.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.89 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.403 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 6.7 m -62.15 112.51 6.47 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 119.343 -0.36 . . . . 0.0 110.699 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.517 ' O ' HD21 ' A' ' 76' ' ' LEU . 72.5 Cg_endo -73.47 -157.58 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.345 1.364 . . . . 0.0 111.748 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.7 ttm -103.72 -10.85 18.01 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.557 0.217 . . . . 0.0 110.776 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.2 m -94.51 -23.2 17.79 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.881 0.372 . . . . 0.0 110.39 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -63.93 -36.24 83.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.921 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -67.55 -47.26 70.34 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.654 -0.818 . . . . 0.0 109.092 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -26.03 61.06 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.48 -57.88 3.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.721 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.21 -64.69 0.86 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.06 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.427 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.2 p -34.89 -27.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.3 0.571 . . . . 0.0 111.146 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.564 ' N ' ' O ' ' A' ' 79' ' ' ALA . 23.7 ttm180 -78.47 -55.84 4.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.654 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.475 ' N ' ' O ' ' A' ' 79' ' ' ALA . 33.7 mt -47.68 -41.53 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.22 -178.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.854 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -78.16 -34.99 49.37 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.714 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -52.49 -14.26 0.47 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.744 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.429 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 81.12 17.71 71.32 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 87' ' ' ALA . 52.0 mt-10 -114.05 8.84 17.17 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.664 ' CB ' ' HE ' ' A' ' 14' ' ' ARG . . . -31.89 -48.81 0.16 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.776 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.67 -179.872 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.55 ' N ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 120.743 0.306 . . . . 0.0 111.518 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -44.42 -48.9 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.973 0.416 . . . . 0.0 110.992 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.2 mm -65.39 -15.47 18.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.586 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.73 -16.68 17.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.093 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -71.62 -30.14 65.45 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -59.38 -42.04 90.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.512 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.694 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -40.35 -33.44 0.25 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.461 ' C ' ' H ' ' A' ' 22' ' ' LEU . 56.7 ttt-85 -69.26 -42.48 75.51 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.294 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.73 -7.65 0.47 Allowed 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.078 0.466 . . . . 0.0 110.207 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' ' 79' ' ' ALA . 14.0 mt -113.91 149.69 42.27 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.855 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.18 -88.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.094 1.863 . . . . 0.0 112.552 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.34 -7.03 52.65 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.455 -0.403 . . . . 0.0 112.303 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.9 m -60.84 137.51 58.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.149 0.474 . . . . 0.0 110.628 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.16 164.34 13.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.985 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.694 HG22 ' HB2' ' A' ' 19' ' ' ALA . 17.0 t -55.2 -53.27 36.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.659 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.82 5.37 24.6 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.451 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -97.23 -24.34 15.75 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.74 0.77 . . . . 0.0 110.305 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 pp -84.12 -24.72 30.15 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.352 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.6 tp . . . . . 0 N--CA 1.463 0.203 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.882 -179.879 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 49' ' ' GLY . 1.3 tt . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -61.41 70.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.514 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -151.9 13.56 0.75 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -128.63 173.05 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.471 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 40.3 m -112.75 161.59 16.71 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.512 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.6 t -55.62 -39.93 57.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 120.798 0.332 . . . . 0.0 110.546 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 m -58.62 -25.11 62.32 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.053 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -75.47 -31.64 60.33 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.183 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.758 HD12 ' N ' ' A' ' 55' ' ' LEU . 4.9 mp -66.45 -60.85 2.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.439 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -56.91 -36.04 69.71 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 61' ' ' GLY . 15.6 pt -75.93 -29.66 20.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.62 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.26 -27.49 39.76 Favored Glycine 0 CA--C 1.517 0.195 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.5 HD23 ' N ' ' A' ' 59' ' ' LEU . 3.8 mt -83.27 -64.15 1.22 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.805 -0.697 . . . . 0.0 112.433 -176.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.76 -20.93 60.36 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.169 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 70.83 -0.61 27.81 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.399 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.488 ' C ' ' H ' ' A' ' 64' ' ' GLU . 15.0 t -136.0 95.69 3.26 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.929 0.395 . . . . 0.0 111.437 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -54.29 -6.41 0.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.707 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.488 ' H ' ' C ' ' A' ' 62' ' ' SER . 28.8 mt-10 -90.23 -32.49 16.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.732 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -101.53 -11.64 19.12 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 m -52.82 -25.46 8.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.443 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -53.74 -23.33 11.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.208 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 7.0 mmt -94.83 -31.11 13.87 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.663 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.476 ' CD2' ' OG1' ' A' ' 71' ' ' THR . 30.4 tp -49.67 127.47 15.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.219 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -39.74 -31.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.391 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.476 ' OG1' ' CD2' ' A' ' 69' ' ' LEU . 1.4 m -48.57 110.28 1.42 Allowed Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.616 ' C ' ' H ' ' A' ' 74' ' ' SER . 91.5 Cg_endo -80.23 29.48 0.51 Allowed 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.321 2.014 . . . . 0.0 113.507 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.468 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 19.4 ttp 55.78 -7.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.616 ' H ' ' C ' ' A' ' 72' ' ' PRO . 22.8 t -100.82 -16.14 17.38 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.165 0.507 . . . . 0.0 109.91 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -74.02 -31.22 62.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.264 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.921 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.1 mm? -65.9 -51.8 55.58 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.63 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.5 OUTLIER -48.25 -36.97 15.02 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.254 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.63 -59.05 3.05 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.375 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.573 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.5 -62.86 1.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.482 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.455 ' N ' ' O ' ' A' ' 76' ' ' LEU . 2.1 p -35.26 -25.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.007 0.432 . . . . 0.0 111.475 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 79' ' ' ALA . 28.1 ttm180 -78.3 -56.47 4.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.635 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.488 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 44.7 mt -47.78 -43.81 10.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.849 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.854 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -75.48 -36.51 60.62 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 119.253 -0.979 . . . . 0.0 109.751 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -46.9 -22.08 0.28 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.836 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.419 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 88.18 13.87 63.25 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 87' ' ' ALA . 5.5 tp10 -109.28 2.54 20.89 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -28.96 -42.68 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.996 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.772 -179.854 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 5.9 mp . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 46.3 mtt85 -78.27 -32.08 49.34 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 15' ' ' ILE . 63.9 mt -66.11 -16.14 20.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.75 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.36 -17.28 21.72 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.275 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.435 HD23 ' O ' ' A' ' 13' ' ' LEU . 1.9 mm? -73.25 -30.42 63.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.37 -42.22 73.64 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.096 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.687 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.12 -36.3 0.7 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.171 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 22' ' ' LEU . 70.9 mtp180 -63.68 -40.3 96.46 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.58 -4.32 0.4 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.443 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.48 ' H ' ' C ' ' A' ' 20' ' ' ARG . 10.2 mt -122.89 115.55 29.26 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -82.01 64.02 8.38 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.814 1.676 . . . . 0.0 112.437 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.57 -48.84 0.48 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.56 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.2 m -68.41 133.46 48.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.959 0.409 . . . . 0.0 111.225 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.22 171.45 11.94 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.025 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.687 HG22 ' HB2' ' A' ' 19' ' ' ALA . 21.7 t -60.93 -60.38 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.431 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.1 9.32 7.01 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.595 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.48 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 28.0 mm100 -99.61 -18.95 17.08 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 117.948 0.874 . . . . 0.0 110.411 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.5 tp -93.36 -19.64 21.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.063 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 21.6 mt . . . . . 0 N--CA 1.465 0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 110.849 -179.874 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.492 ' N ' HD12 ' A' ' 47' ' ' LEU . 10.9 mp . . . . . 0 CA--C 1.529 0.146 0 CA-C-O 120.881 0.372 . . . . 0.0 110.334 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -75.97 73.89 2.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.816 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -157.66 14.56 0.29 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.447 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.4 OUTLIER -124.96 174.19 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.686 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.441 ' N ' HG13 ' A' ' 50' ' ' VAL . 14.1 m -115.33 160.13 20.2 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.479 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.2 t -53.32 -37.82 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 120.788 0.328 . . . . 0.0 110.494 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 m -61.09 -25.28 66.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.998 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.447 ' CB ' HG22 ' A' ' 50' ' ' VAL . 11.2 t0 -74.56 -30.55 61.78 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.64 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.749 HD12 ' N ' ' A' ' 55' ' ' LEU . 5.9 mp -66.67 -66.53 0.54 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -51.39 -34.79 36.02 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 61' ' ' GLY . 9.6 pt -82.03 -17.36 11.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.28 -41.27 79.53 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.808 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.727 HD22 ' N ' ' A' ' 59' ' ' LEU . 1.9 mm? -74.93 -52.41 11.27 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.789 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.39 -37.93 74.59 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 116.81 -51.57 0.72 Allowed Glycine 0 N--CA 1.468 0.833 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.504 ' C ' ' H ' ' A' ' 64' ' ' GLU . 46.0 p -135.63 141.23 45.02 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.089 0.471 . . . . 0.0 111.116 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -57.91 1.15 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.347 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.504 ' H ' ' C ' ' A' ' 62' ' ' SER . 72.2 mm-40 -75.92 -53.88 7.74 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.422 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -93.24 -9.01 40.63 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -177.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.4 m -50.16 -24.2 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.517 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.26 -15.32 2.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.616 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 52.6 mtp -99.37 -34.76 10.16 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.62 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.7 tp -51.07 124.57 11.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.228 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -61.38 -22.97 65.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.345 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.1 m -49.68 107.65 0.83 Allowed Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.413 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.95 -171.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.224 1.283 . . . . 0.0 111.808 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.3 ptm -98.17 -22.02 16.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.724 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.9 t -89.06 -25.38 21.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.437 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.48 -33.47 69.82 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.302 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.595 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -67.39 -52.96 33.6 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.429 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -65.09 -9.44 22.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.466 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -87.61 -52.18 5.48 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -70.04 -57.79 4.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.587 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.409 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.5 p -34.8 -28.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.287 0.565 . . . . 0.0 110.943 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 79' ' ' ALA . 20.4 ttm105 -74.04 -62.12 1.61 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.807 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.435 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 55.5 mt -45.44 -39.94 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.897 -178.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.883 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -81.42 -28.52 34.23 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.472 179.306 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -64.89 2.87 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.481 -0.488 . . . . 0.0 109.793 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 83' ' ' LEU . . . 65.93 22.16 70.15 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -107.26 2.23 24.48 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.921 0.391 . . . . 0.0 110.157 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.435 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -40.03 -68.88 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.956 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.723 -179.877 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.81 0.338 . . . . 0.0 110.474 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 71.3 mtm180 -84.63 -36.41 22.01 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.44 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 1.2 mp -65.35 -8.92 6.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.257 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.18 -16.81 25.75 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.806 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.34 -30.5 63.38 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.94 -44.99 74.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.732 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.622 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -40.91 -36.16 0.61 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.98 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.443 ' C ' ' H ' ' A' ' 22' ' ' LEU . 57.1 mtp85 -68.1 -40.56 82.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.162 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.08 -6.8 0.65 Allowed 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 120.945 0.402 . . . . 0.0 110.496 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.443 ' H ' ' C ' ' A' ' 20' ' ' ARG . 11.4 mt -118.75 120.3 31.72 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.814 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.3 71.31 7.1 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.879 1.72 . . . . 0.0 112.557 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.42 -54.75 0.6 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.6 m -59.63 128.33 36.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.923 0.392 . . . . 0.0 110.949 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.416 ' HB ' HE21 ' A' ' 29' ' ' GLN . 0.0 OUTLIER -86.82 178.19 7.07 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.29 0.567 . . . . 0.0 110.875 -179.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.622 HG22 ' HB2' ' A' ' 19' ' ' ALA . 11.8 t -61.8 -58.77 6.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.904 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.421 ' C ' ' NE2' ' A' ' 29' ' ' GLN . . . -66.43 2.89 3.9 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.675 -178.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.646 ' N ' ' NE2' ' A' ' 29' ' ' GLN . 1.1 mp0 -100.38 -30.46 11.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.575 0.688 . . . . 0.0 111.236 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 pp -88.37 -27.45 21.6 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.537 HD13 ' O ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 120.718 0.294 . . . . 0.0 110.733 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.625 0.25 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -75.41 52.14 0.6 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.324 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -136.0 15.87 3.99 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.432 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -128.42 177.96 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.437 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 20.3 m -119.05 164.01 16.14 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.452 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.6 t -56.55 -47.19 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.177 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 57' ' ' ILE . 3.4 m -54.15 -24.18 16.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -178.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.432 ' CB ' HG22 ' A' ' 50' ' ' VAL . 9.7 t70 -74.59 -31.72 62.13 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.074 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.714 HD12 ' N ' ' A' ' 55' ' ' LEU . 6.2 mp -64.96 -64.96 0.74 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.404 -178.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -54.75 -39.53 68.4 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.7 pt -71.52 -23.72 22.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.316 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.75 -30.8 78.74 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 121.164 -0.541 . . . . 0.0 111.756 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.777 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.1 mm? -79.51 -52.96 7.36 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.294 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.5 -30.19 33.35 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.603 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 74.21 4.85 69.69 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.266 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.509 ' C ' ' H ' ' A' ' 64' ' ' GLU . 10.2 t -135.95 93.44 2.93 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.824 0.345 . . . . 0.0 111.307 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -48.57 -10.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.762 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.509 ' H ' ' C ' ' A' ' 62' ' ' SER . 30.9 tt0 -88.66 -42.61 11.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.714 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.17 -15.02 34.75 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.1 m -49.75 -28.96 4.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.77 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -55.47 -27.65 49.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.925 0.393 . . . . 0.0 110.244 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 48.8 mtm -92.33 -24.31 18.97 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.766 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.424 ' HG ' ' H ' ' A' ' 71' ' ' THR . 60.4 tp -53.37 123.0 10.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.931 0.396 . . . . 0.0 110.076 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -40.65 -38.56 0.91 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.661 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.424 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 20.1 m -52.66 107.76 0.92 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.973 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.12 -162.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.161 1.24 . . . . 0.0 111.423 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.467 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 32.4 ttm -109.11 -6.44 15.61 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 61.3 m -100.78 -20.83 15.38 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.138 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.57 -34.06 76.28 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.822 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.933 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -64.08 -45.92 86.6 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.83 179.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.531 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 1.1 mptp? -55.83 -34.87 65.79 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.312 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.03 -59.93 2.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.495 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -59.03 -62.99 1.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.432 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.429 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 3.0 p -35.37 -25.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.917 0.389 . . . . 0.0 111.721 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.568 ' N ' ' O ' ' A' ' 79' ' ' ALA . 28.3 ttm180 -77.56 -57.35 3.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.668 0.747 . . . . 0.0 110.074 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.572 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 41.4 mt -47.79 -43.74 10.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.929 -178.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.853 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -75.03 -36.64 61.87 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.557 179.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -47.38 -18.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.457 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 83.1 15.52 72.03 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 88' ' ' GLU . 50.2 mm-40 -105.57 -0.63 25.58 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.572 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -36.7 -26.0 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.088 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 88' ' ' GLU . 2.7 mp0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.9 ptt? . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 2' ' ' VAL . 4.8 p -166.79 -9.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.368 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.426 ' H ' ' H ' ' A' ' 2' ' ' VAL . 13.1 m 59.26 74.65 0.57 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.37 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.55 121.92 4.86 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.408 2.072 . . . . 0.0 111.966 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.9 p -82.24 -34.92 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.57 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -147.03 164.84 31.72 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.307 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.5 ptt? -75.57 -37.01 60.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.78 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.7 m -119.72 139.41 52.32 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.342 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.606 ' O ' ' N ' ' A' ' 12' ' ' ALA . 35.2 ptt180 -70.64 -34.21 71.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -48.35 -31.46 6.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.434 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.3 m -71.19 -24.65 62.27 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.606 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -82.81 -70.16 0.57 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 113.613 -1.631 . . . . 0.0 109.893 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.547 ' CD1' ' H ' ' A' ' 13' ' ' LEU . 5.5 mp -37.02 -31.65 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.808 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 30.8 mtm105 -80.65 -39.49 27.24 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -177.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.438 ' O ' HG22 ' A' ' 15' ' ' ILE . 54.7 mt -62.8 -14.68 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.446 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.35 -15.71 17.9 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 13' ' ' LEU . 1.2 mm? -72.73 -31.91 65.32 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.6 -42.87 75.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.218 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.712 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -39.9 -34.36 0.27 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.504 ' C ' ' H ' ' A' ' 22' ' ' LEU . 75.9 ttt-85 -67.23 -41.66 85.32 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.227 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -55.32 -6.73 0.18 Allowed 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.465 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.504 ' H ' ' C ' ' A' ' 20' ' ' ARG . 9.5 mt -116.23 149.33 43.34 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.27 -80.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 121.881 1.721 . . . . 0.0 112.548 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -116.24 7.89 18.48 Favored Glycine 0 N--CA 1.47 0.908 0 C-N-CA 121.44 -0.409 . . . . 0.0 112.467 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.0 m -73.97 126.84 31.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.43 0.615 . . . . 0.0 110.13 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.07 168.11 20.39 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.985 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.712 HG22 ' HB2' ' A' ' 19' ' ' ALA . 21.2 t -61.72 -61.15 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.23 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.91 10.64 4.11 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.085 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -98.57 -25.27 14.79 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 117.44 0.62 . . . . 0.0 110.391 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.2 tt -95.5 -17.8 21.16 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.588 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.571 ' O ' HD23 ' A' ' 31' ' ' LEU . 1.8 tt -89.51 -47.24 8.12 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.965 0.412 . . . . 0.0 110.785 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -43.89 -24.75 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.384 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.2 mm -49.39 -33.2 6.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.452 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.7 tp -56.11 -15.14 3.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.985 0.421 . . . . 0.0 110.029 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.668 ' CD2' ' H ' ' A' ' 36' ' ' GLN . 5.2 t60 62.9 -127.66 0.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.435 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.668 ' H ' ' CD2' ' A' ' 35' ' ' HIS . 15.9 mm100 53.06 105.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.89 0.376 . . . . 0.0 110.435 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 mtm180 -49.22 -63.67 1.03 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.9 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.9 tt -46.51 144.15 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.813 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -79.75 -76.2 0.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.017 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.4 161.34 2.74 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.41 128.52 11.22 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.647 2.231 . . . . 0.0 111.99 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.57 HD22 ' N ' ' A' ' 42' ' ' LEU . 3.5 mm? -86.84 94.48 9.57 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.985 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 p -81.81 -176.06 5.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.018 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -75.51 -26.04 57.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.417 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -82.19 -33.93 29.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.482 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.0 m -55.7 -46.73 77.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.548 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.5 mt -61.08 -36.17 78.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.696 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -80.36 71.63 7.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.453 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -153.43 -0.28 0.2 Allowed Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.433 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -123.36 175.98 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.449 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 55.7 m -117.03 162.96 16.96 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.481 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.3 t -56.01 -43.71 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.905 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 57' ' ' ILE . 3.2 m -56.52 -25.16 50.92 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.433 ' CB ' HG22 ' A' ' 50' ' ' VAL . 12.5 t70 -74.2 -31.76 62.78 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.08 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.725 HD12 ' N ' ' A' ' 55' ' ' LEU . 5.8 mp -64.92 -65.36 0.68 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.378 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -53.58 -37.21 62.72 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.54 ' O ' ' N ' ' A' ' 61' ' ' GLY . 11.3 pt -77.95 -18.23 13.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.121 0.486 . . . . 0.0 109.994 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.72 -38.64 93.29 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.761 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.0 mm? -73.68 -56.94 4.37 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.242 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.42 -35.68 73.56 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 103.99 -33.86 6.24 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.798 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.521 ' C ' ' H ' ' A' ' 64' ' ' GLU . 68.8 m -136.3 127.68 28.43 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.037 0.446 . . . . 0.0 111.192 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -58.68 -0.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.453 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.521 ' H ' ' C ' ' A' ' 62' ' ' SER . 33.7 mt-10 -79.44 -45.22 19.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 67' ' ' ASP . 16.7 m-20 -99.05 -7.85 26.18 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.0 m -49.23 -27.24 2.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.62 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 17.8 p-10 -51.67 -35.36 42.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.012 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.22 -19.21 43.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.861 0.362 . . . . 0.0 110.61 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.445 ' HG ' ' H ' ' A' ' 71' ' ' THR . 20.5 tp -64.84 125.9 26.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.496 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -51.68 -22.82 3.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.048 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.445 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 3.3 m -64.49 115.94 24.35 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.232 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.449 ' O ' HD21 ' A' ' 76' ' ' LEU . 74.4 Cg_endo -73.68 -154.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.375 1.384 . . . . 0.0 111.126 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.439 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 29.7 ttm -112.66 1.82 15.88 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.2 t -109.58 -18.53 13.47 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.521 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.46 -33.46 71.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.822 0.344 . . . . 0.0 110.345 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.93 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.5 OUTLIER -65.74 -47.14 76.28 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.507 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 1.6 mptp? -55.96 -35.75 67.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.37 -58.84 3.49 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.852 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -63.23 -62.7 1.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.679 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.431 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 3.1 p -35.24 -26.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 120.922 0.392 . . . . 0.0 111.429 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.556 ' N ' ' O ' ' A' ' 79' ' ' ALA . 50.4 ttm-85 -75.98 -58.1 3.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.603 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 52.1 mt -47.49 -41.22 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.622 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.88 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -80.02 -32.08 39.61 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.587 179.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -49.12 -27.92 3.85 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.956 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.22 13.04 50.31 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 88' ' ' GLU . 74.8 mt-10 -113.88 8.69 17.36 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 86' ' ' GLU . . . -28.08 -37.5 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.194 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 86' ' ' GLU . 5.8 pt-20 -66.33 142.26 57.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.835 0.35 . . . . 0.0 110.46 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' ' 90' ' ' ASP . 62.1 t -68.43 153.12 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.858 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.404 ' N ' HG12 ' A' ' 89' ' ' VAL . 21.4 p-10 -84.58 -142.75 0.08 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.66 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 61.6 p -65.08 -172.61 0.09 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.78 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.639 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.1 mm? -81.39 150.52 67.48 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.177 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -37.59 -68.93 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 122.285 1.99 . . . . 0.0 112.542 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.4 ' HG2' ' H ' ' A' ' 94' ' ' GLN . 7.2 pt20 -60.37 150.83 71.45 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.604 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.98 113.69 3.85 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.303 2.002 . . . . 0.0 111.828 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.518 179.937 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.0 mtp . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.424 ' O ' HG22 ' A' ' 2' ' ' VAL . 7.7 p -163.35 -14.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.206 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.41 ' H ' ' H ' ' A' ' 2' ' ' VAL . 7.5 m -155.82 59.65 2.17 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.311 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -73.06 98.05 0.97 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.669 2.246 . . . . 0.0 111.854 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.4 m -82.2 32.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.816 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 6' ' ' ASN . 11.8 p30 -41.59 97.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.964 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.44 ' CE ' HD11 ' A' ' 42' ' ' LEU . 31.8 mtt -64.51 143.67 57.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.453 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.3 m -87.66 -149.84 0.17 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 12' ' ' ALA . 30.0 ptt180 -143.35 -54.57 0.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -43.16 -23.88 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.026 0.441 . . . . 0.0 109.841 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 9' ' ' ARG . 10.0 m -74.51 -50.95 16.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -59.56 -72.14 0.11 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.917 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.597 ' CD1' ' H ' ' A' ' 13' ' ' LEU . 5.6 mp -30.27 -51.75 0.14 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.062 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.42 ' O ' ' CG2' ' A' ' 82' ' ' ILE . 20.3 mmt85 -56.03 -30.38 61.8 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.7 mm -65.11 -18.21 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.369 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.66 -18.24 16.63 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.31 -28.57 65.28 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -57.77 -42.75 84.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.424 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.693 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -40.48 -33.4 0.26 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.529 ' C ' ' H ' ' A' ' 22' ' ' LEU . 50.3 ttt85 -69.16 -42.59 75.72 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.23 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.13 -6.11 0.23 Allowed 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.243 0.544 . . . . 0.0 110.082 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.529 ' H ' ' C ' ' A' ' 20' ' ' ARG . 13.2 mt -117.0 149.52 44.32 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.177 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.43 -88.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.037 1.825 . . . . 0.0 112.485 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.12 -8.92 49.71 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.48 -0.391 . . . . 0.0 112.293 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.4 m -59.54 132.28 53.5 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.474 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.525 ' H ' ' NE2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -90.74 165.53 13.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.202 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.693 HG22 ' HB2' ' A' ' 19' ' ' ALA . 18.0 t -57.44 -55.88 18.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.149 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.18 8.36 8.89 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.808 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.525 ' NE2' ' H ' ' A' ' 26' ' ' THR . 19.2 mt-30 -96.82 -18.87 19.28 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.008 0.904 . . . . 0.0 110.753 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.4 tp -85.47 -37.93 19.18 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.526 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 33' ' ' ILE . 2.9 pp -78.25 -32.72 49.82 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.991 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -35.3 -27.72 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.765 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 31' ' ' LEU . 16.1 tt -56.05 -41.18 67.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.769 0.319 . . . . 0.0 110.842 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.479 ' N ' HG23 ' A' ' 33' ' ' ILE . 29.7 tp -80.13 -78.14 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.506 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.698 ' CD2' ' H ' ' A' ' 36' ' ' GLN . 63.9 t60 60.01 -133.01 0.85 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.559 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.698 ' H ' ' CD2' ' A' ' 35' ' ' HIS . 32.6 mt-30 52.33 179.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.961 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -72.06 137.94 47.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.411 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.9 pt -57.12 127.41 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.503 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.427 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 1.8 tm-20 -72.15 -42.07 66.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.306 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.16 -84.45 0.08 OUTLIER Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.87 141.38 53.67 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.45 2.1 . . . . 0.0 111.629 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.44 HD11 ' CE ' ' A' ' 7' ' ' MET . 0.6 OUTLIER -139.43 33.98 2.06 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.017 0.437 . . . . 0.0 110.535 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.404 ' OG1' ' OE2' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -98.21 177.15 5.48 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.93 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.538 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -55.23 -33.69 63.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.4 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.481 ' HG3' ' OE2' ' A' ' 44' ' ' GLU . 81.0 mt-10 -59.6 -37.44 78.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.628 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.4 t -64.41 -33.51 76.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.014 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 47' ' ' LEU . 10.3 mp -70.94 -33.23 70.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.777 0.322 . . . . 0.0 110.502 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -73.0 67.17 0.84 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.456 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.68 15.03 0.81 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.469 ' CG2' ' OD2' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -127.61 177.38 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.445 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 5.2 m -119.23 164.01 16.25 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.469 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.9 t -57.22 -45.49 84.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.751 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.4 m -54.3 -25.22 22.51 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.665 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.469 ' OD2' ' CG2' ' A' ' 50' ' ' VAL . 42.6 t0 -74.74 -31.1 61.72 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.916 0.388 . . . . 0.0 111.296 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.72 HD12 ' N ' ' A' ' 55' ' ' LEU . 6.2 mp -65.94 -63.38 1.1 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -54.54 -36.29 64.13 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.446 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.1 pt -77.38 -19.22 14.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.035 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.63 -34.83 88.71 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.743 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.2 mm? -76.52 -57.07 4.07 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.658 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.81 -32.97 68.13 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.481 -0.487 . . . . 0.0 109.947 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 85.51 -9.13 68.79 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.506 ' C ' ' H ' ' A' ' 64' ' ' GLU . 3.2 m -137.87 107.53 6.23 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.101 0.477 . . . . 0.0 112.243 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -56.39 -4.6 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.016 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' A' ' 62' ' ' SER . 19.0 mm-40 -86.35 -43.48 12.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.762 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -92.47 -11.91 33.42 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.2 m -50.9 -26.65 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 119.689 -0.805 . . . . 0.0 110.283 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -56.25 -17.07 6.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.399 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 43.7 mtt -101.93 -32.47 10.19 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.529 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.419 ' HG ' ' H ' ' A' ' 71' ' ' THR . 25.5 tp -49.57 131.95 21.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.221 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 9.6 p-10 -57.05 -32.49 66.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.395 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 72' ' ' PRO . 10.7 m -46.45 105.45 0.48 Allowed Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.502 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 71' ' ' THR . 33.0 Cg_exo -54.92 -163.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.174 1.25 . . . . 0.0 111.219 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 30.4 ttm -107.84 -4.98 17.52 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 82.6 p -102.52 -26.75 13.12 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.429 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.87 -33.37 70.4 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.885 0.374 . . . . 0.0 110.169 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.886 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -66.27 -53.37 37.51 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.528 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.4 OUTLIER -52.15 -35.43 48.54 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.475 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -68.36 -58.52 4.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.962 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -63.91 -60.47 3.23 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.834 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.425 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 2.4 p -35.24 -25.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.096 0.474 . . . . 0.0 111.686 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 79' ' ' ALA . 25.5 ttm180 -78.9 -56.31 4.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.544 0.688 . . . . 0.0 109.72 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.549 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 36.5 mt -47.88 -43.81 10.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.904 -178.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.849 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -74.23 -37.74 63.73 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 119.205 -0.998 . . . . 0.0 109.645 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -46.17 -19.05 0.06 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.94 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 83' ' ' LEU . . . 83.76 13.26 75.78 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 88' ' ' GLU . 91.6 mt-10 -103.4 -3.18 25.83 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.549 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -31.98 -32.61 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.525 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 86' ' ' GLU . 18.1 mm-40 -42.2 -51.65 4.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.337 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 89' ' ' VAL . 9.0 m -54.38 130.57 16.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.814 0.34 . . . . 0.0 110.629 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' A' ' 91' ' ' SER . 3.5 p-10 -81.93 -108.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.519 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.4 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 98.9 p -76.45 172.47 12.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.937 0.398 . . . . 0.0 110.454 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.647 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.2 mm? -77.52 150.46 79.5 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.904 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -36.99 -66.7 0.12 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.214 1.942 . . . . 0.0 112.186 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.424 ' O ' ' O ' ' A' ' 95' ' ' PRO . 3.0 pt20 -61.05 152.27 71.76 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.056 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 94' ' ' GLN . 75.4 Cg_exo -37.18 160.94 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.32 2.013 . . . . 0.0 112.374 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.9 t . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.627 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 mtt . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 3' ' ' THR . 8.0 p -163.94 -30.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.496 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.431 ' O ' ' O ' ' A' ' 2' ' ' VAL . 6.5 p 59.05 148.09 0.07 OUTLIER Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.373 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.19 -12.46 25.54 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.002 1.801 . . . . 0.0 111.87 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -164.42 138.54 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.593 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -164.84 166.93 19.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.606 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 32.3 mtm 59.81 58.08 2.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.603 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.9 m -82.86 178.4 8.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.297 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 12' ' ' ALA . 44.2 ptt85 -79.67 -39.87 30.38 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.45 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -43.06 -28.11 0.25 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.905 0.383 . . . . 0.0 110.598 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.3 m -76.88 -50.01 14.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -51.63 -69.94 0.1 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.362 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.569 ' CD1' ' H ' ' A' ' 13' ' ' LEU . 4.8 mp -34.11 -50.16 0.38 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.571 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.417 HH22 ' C ' ' A' ' 85' ' ' GLY . 61.0 mtp180 -55.38 -32.94 63.02 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.407 ' N ' ' O ' ' A' ' 12' ' ' ALA . 28.3 mm -63.23 -16.54 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.382 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.36 -16.2 17.73 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.4 ' HA ' HD13 ' A' ' 17' ' ' LEU . 3.9 mm? -69.99 -30.7 68.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -56.71 -44.7 81.8 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.235 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.672 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -42.02 -36.76 1.2 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.487 ' C ' ' H ' ' A' ' 22' ' ' LEU . 67.6 ttt-85 -65.19 -40.83 94.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.943 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.18 -4.84 0.39 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.624 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.487 ' H ' ' C ' ' A' ' 20' ' ' ARG . 16.1 mt -118.1 139.76 27.05 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.145 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -39.67 -70.95 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.927 1.751 . . . . 0.0 112.855 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -134.4 0.0 3.79 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.521 -0.631 . . . . 0.0 111.521 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.1 m -57.43 131.21 49.44 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.611 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.69 160.92 27.25 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.343 0.592 . . . . 0.0 111.808 -178.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 19' ' ' ALA . 21.5 t -58.18 -55.81 19.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.1 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.04 8.36 8.35 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.358 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -100.32 -20.27 15.93 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 117.867 0.834 . . . . 0.0 109.932 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.404 HD22 HD11 ' A' ' 22' ' ' LEU . 45.1 tp -98.68 -23.78 15.32 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.982 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 31' ' ' LEU . 3.9 mm? -92.33 -46.75 7.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.73 0.3 . . . . 0.0 110.829 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.474 ' O ' ' N ' ' A' ' 34' ' ' LEU . 45.4 tt0 -39.15 -25.26 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.404 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.474 ' N ' ' O ' ' A' ' 31' ' ' LEU . 31.1 pt -47.61 -13.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.926 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 32' ' ' GLU . 7.8 tp -72.04 -50.4 28.78 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.144 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 63.08 103.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.954 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -152.17 171.44 17.92 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.351 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -158.22 -56.27 0.07 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.945 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.8 mm -47.24 -66.06 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.506 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -87.78 -157.41 0.4 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.269 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.66 65.72 0.09 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.12 168.37 11.98 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.921 2.414 . . . . 0.0 111.769 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.411 ' C ' HD23 ' A' ' 42' ' ' LEU . 1.8 tt -169.74 77.36 0.09 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.035 0.445 . . . . 0.0 110.297 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 33.2 p -127.09 160.38 31.36 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.497 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -78.27 -21.54 49.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.202 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -80.68 -43.88 19.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.079 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.3 m -56.74 -34.73 67.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.289 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.604 ' O ' HD13 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -60.51 -38.48 84.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.941 0.4 . . . . 0.0 110.149 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -61.17 71.29 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.593 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -155.08 4.98 0.24 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.454 ' CG2' ' OD2' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -123.67 176.96 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.396 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.428 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 45.2 m -119.03 161.75 19.72 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.467 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.4 t -55.33 -43.03 69.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.67 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 m -56.43 -26.0 52.2 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.871 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.454 ' OD2' ' CG2' ' A' ' 50' ' ' VAL . 53.1 t0 -73.87 -31.44 63.16 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.041 0.448 . . . . 0.0 110.859 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.728 HD12 ' N ' ' A' ' 55' ' ' LEU . 6.3 mp -65.23 -65.01 0.73 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -53.29 -36.59 61.37 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.1 pt -78.08 -18.95 13.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.62 -38.13 89.93 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.705 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.3 mm? -75.07 -56.75 4.42 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.029 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.96 -35.31 78.15 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 93.29 -20.43 46.32 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.553 ' C ' ' H ' ' A' ' 64' ' ' GLU . 23.0 t -138.22 117.25 12.5 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.038 0.446 . . . . 0.0 111.871 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -59.34 4.06 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.686 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.553 ' H ' ' C ' ' A' ' 62' ' ' SER . 43.5 mt-10 -90.74 -45.71 8.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.194 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.65 -11.43 42.54 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.4 m -52.97 -27.44 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.035 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 19.4 p-10 -56.17 -12.61 1.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.278 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 18.9 mmt -106.09 -32.47 8.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.406 ' HG ' ' H ' ' A' ' 71' ' ' THR . 20.3 tp -48.45 123.59 6.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.423 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 71' ' ' THR . 47.3 p30 -48.52 -25.21 1.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.99 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.53 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 7.0 m -55.23 110.25 2.1 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.538 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 71' ' ' THR . 29.5 Cg_exo -57.14 -146.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.104 1.203 . . . . 0.0 110.948 178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.432 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 33.8 ttp -123.96 -0.35 8.45 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.7 t -106.16 -27.47 11.05 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.287 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.43 -32.97 71.87 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.975 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.3 mm? -64.82 -49.98 68.48 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.516 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 1.3 mptp? -56.67 -33.79 66.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.434 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -70.11 -58.56 3.67 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.406 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.4 -63.58 1.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.42 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.408 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 3.0 p -34.69 -24.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.904 0.383 . . . . 0.0 111.909 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 79' ' ' ALA . 17.6 ttm105 -77.29 -60.55 2.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.56 0.695 . . . . 0.0 109.965 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.449 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 39.4 mt -45.48 -41.44 3.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.209 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.834 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -76.96 -35.61 57.11 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 119.278 -0.969 . . . . 0.0 109.584 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -48.89 -20.06 0.46 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.792 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.419 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 86.66 18.46 58.38 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 88' ' ' GLU . 8.8 tp10 -112.07 1.54 16.38 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.69 0.281 . . . . 0.0 110.337 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.449 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -29.94 -39.31 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.986 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 86' ' ' GLU . 5.3 pt-20 -75.93 59.86 1.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.95 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.0 p -85.57 143.57 11.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.33 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -57.23 123.89 16.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.584 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.1 m -62.35 165.66 5.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.609 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.669 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.0 mm? -83.48 150.13 59.35 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.043 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.11 27.51 0.3 Allowed 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.162 1.908 . . . . 0.0 111.895 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.432 ' H ' ' C ' ' A' ' 92' ' ' LEU . 4.9 pt20 -55.16 151.93 16.27 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.279 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -36.09 152.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 122.45 2.1 . . . . 0.0 112.412 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.0 m . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.541 179.989 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.5 mtt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.8 t 41.48 90.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.767 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 63.59 155.63 0.12 Allowed Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.236 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.11 -175.6 0.53 Allowed 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.422 2.081 . . . . 0.0 111.59 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 t -145.38 148.08 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.449 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.401 ' ND2' ' H ' ' A' ' 6' ' ' ASN . 3.6 p30 -77.96 125.6 29.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.811 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.6 tpt 63.13 159.49 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.196 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.481 ' OG ' ' N ' ' A' ' 9' ' ' ARG . 26.2 t -89.04 -174.11 4.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.242 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 12' ' ' ALA . 21.1 ptt180 -83.86 -28.47 27.97 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -45.76 -25.85 0.56 Allowed 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.175 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -78.51 -42.28 29.98 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -53.29 -71.29 0.07 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.28 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.655 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -43.4 -42.15 4.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.148 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 67.7 mtt-85 -63.76 -40.78 97.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.2 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.436 ' O ' HG22 ' A' ' 15' ' ' ILE . 29.2 mt -63.24 -11.3 7.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.457 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -103.56 -15.89 15.7 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.564 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' A' ' 17' ' ' LEU . 1.3 mm? -72.93 -28.95 62.75 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -58.2 -40.56 81.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.285 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.737 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -38.75 -35.53 0.2 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.495 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.501 ' C ' ' H ' ' A' ' 22' ' ' LEU . 55.5 mtp85 -65.12 -38.39 90.52 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.806 0.336 . . . . 0.0 110.404 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.53 -5.7 0.23 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.725 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.501 ' H ' ' C ' ' A' ' 20' ' ' ARG . 15.6 mt -117.46 149.84 45.51 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.919 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.05 -88.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.014 1.81 . . . . 0.0 112.474 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.72 3.25 42.11 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.537 -0.363 . . . . 0.0 112.235 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.5 m -72.43 129.36 38.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.124 0.462 . . . . 0.0 110.652 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.22 170.61 11.97 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.271 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.737 HG22 ' HB2' ' A' ' 19' ' ' ALA . 16.5 t -60.2 -57.37 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.855 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.48 5.37 10.67 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.353 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -94.17 -28.07 15.86 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 117.744 0.772 . . . . 0.0 110.276 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 tt -80.47 -17.89 50.32 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.803 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 33' ' ' ILE . 13.0 tp -89.82 -37.2 14.64 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.506 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -38.85 -21.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.681 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.173 HD11 ' OD1' ' A' ' 54' ' ' ASP . 12.8 tt -51.2 -25.28 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.694 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 80.5 mt -82.17 -81.0 0.15 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.673 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 56.61 78.78 0.2 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.405 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -159.77 -165.0 1.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.027 0.441 . . . . 0.0 110.923 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -70.09 79.01 0.5 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.182 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.54 HD13 ' N ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -57.07 -177.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.391 179.598 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -166.3 -18.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.728 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -157.79 174.65 35.15 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -73.32 -6.33 18.66 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.839 2.36 . . . . 0.0 111.903 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.3 mt 61.0 115.42 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.62 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.9 p -83.6 160.34 21.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.988 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -50.43 -24.64 3.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.671 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -82.14 -39.65 22.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.502 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.1 p -57.9 -34.63 70.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.779 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 49' ' ' GLY . 10.5 mp -66.67 -29.28 69.25 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.507 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -64.16 71.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.019 0.437 . . . . 0.0 110.443 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -152.95 7.89 0.49 Allowed Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.401 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -130.73 177.43 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.467 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 71.8 m -118.97 165.6 13.89 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.467 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.8 t -55.97 -45.84 80.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.751 0.31 . . . . 0.0 111.241 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 57' ' ' ILE . 1.8 m -53.35 -25.93 17.21 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 1.173 ' OD1' HD11 ' A' ' 33' ' ' ILE . 42.9 t0 -75.81 -31.28 59.35 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.4 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.728 HD12 ' N ' ' A' ' 55' ' ' LEU . 5.7 mp -65.79 -63.33 1.11 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -54.4 -36.46 63.97 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 61' ' ' GLY . 13.1 pt -77.6 -18.39 14.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.56 -36.72 84.01 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.692 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.6 mm? -73.99 -57.14 4.16 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.068 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.68 -34.45 72.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 114.37 -48.29 0.95 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.562 ' C ' ' H ' ' A' ' 64' ' ' GLU . 26.3 p -135.89 144.0 45.31 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.143 0.496 . . . . 0.0 111.356 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.99 9.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.836 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.603 ' OE1' ' OD1' ' A' ' 65' ' ' ASP . 5.5 tm-20 -86.6 -55.51 3.84 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.651 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.603 ' OD1' ' OE1' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -86.58 -13.09 46.8 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.031 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.0 m -49.02 -20.34 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.272 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 65' ' ' ASP . 62.9 m-20 -56.76 -33.34 66.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.132 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.428 ' C ' ' SD ' ' A' ' 68' ' ' MET . 0.0 OUTLIER -92.16 -27.86 17.44 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.786 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 71' ' ' THR . 32.5 tp -50.99 117.79 2.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.389 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -39.24 -24.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.346 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.489 ' N ' ' O ' ' A' ' 69' ' ' LEU . 2.5 m -68.27 116.18 36.88 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.56 -108.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.583 1.522 . . . . 0.0 111.643 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 24.1 ttm -150.91 2.99 0.45 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 121.094 -0.243 . . . . 0.0 110.825 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.425 ' O ' ' OD2' ' A' ' 78' ' ' ASP . 3.4 m -107.44 -23.23 12.27 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.927 0.394 . . . . 0.0 110.08 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -66.66 -33.09 74.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.479 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.986 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.0 OUTLIER -66.36 -52.63 44.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.485 179.62 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.539 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 2.6 mptp? -51.88 -36.78 49.78 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 74' ' ' SER . 4.8 m-20 -67.41 -58.76 4.18 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.18 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -63.01 -64.55 0.88 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.632 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.404 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 2.8 p -34.08 -24.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.59 ' N ' ' O ' ' A' ' 79' ' ' ALA . 15.1 ttm180 -76.65 -61.26 2.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.382 0.61 . . . . 0.0 110.21 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.485 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 43.7 mt -45.28 -40.2 2.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.162 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.83 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.91 -35.42 50.63 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.535 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -50.32 -20.07 0.98 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.041 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.38 11.14 69.62 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 87' ' ' ALA . 21.5 tp10 -102.4 1.18 35.04 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.485 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -31.21 -39.31 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.656 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 86' ' ' GLU . 9.5 mm-40 -49.9 161.31 0.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.682 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.0 t -72.17 142.7 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.443 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -79.22 -171.51 2.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.046 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.5 m -62.38 -176.3 0.1 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.728 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.65 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.1 mm? -83.07 148.79 57.48 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.023 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -38.9 119.25 0.42 Allowed 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.137 1.892 . . . . 0.0 112.287 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -70.83 151.17 95.22 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -36.81 142.14 0.14 Allowed 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.291 1.994 . . . . 0.0 112.339 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.569 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ptp . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.6 m -90.79 24.52 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.843 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -61.96 5.2 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.221 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.96 126.85 15.88 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.138 1.892 . . . . 0.0 111.638 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.317 HG22 ' CG ' ' A' ' 41' ' ' PRO . 6.3 p -163.19 156.22 2.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.561 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 1.037 ' CA ' ' HB3' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -149.19 140.71 23.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.237 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.502 ' N ' ' CB ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -70.3 -72.31 0.21 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.471 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 t -118.18 -144.58 0.37 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.344 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.573 ' O ' ' N ' ' A' ' 12' ' ' ALA . 27.5 ptt-85 -142.46 -52.6 0.4 Allowed 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -40.0 -25.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.172 0.51 . . . . 0.0 110.714 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 9' ' ' ARG . 13.0 m -82.98 -39.4 21.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.925 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -82.35 8.05 12.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.027 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mp -109.01 -35.68 6.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.224 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -85.11 -27.25 26.39 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 15' ' ' ILE . 60.7 mt -63.28 -14.95 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.405 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.407 ' HA ' HG13 ' A' ' 27' ' ' VAL . . . -91.4 -16.45 27.37 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.427 ' N ' HD22 ' A' ' 17' ' ' LEU . 4.0 mm? -72.68 -30.71 64.47 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.9 -41.34 70.82 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.921 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.676 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -44.24 -36.37 2.69 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -66.98 -42.37 85.22 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.469 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -57.57 -8.07 0.78 Allowed 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.259 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 21.1 mt -113.05 147.22 36.79 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.299 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.8 -73.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.168 1.912 . . . . 0.0 112.828 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -119.22 43.47 1.57 Allowed Glycine 0 N--CA 1.471 0.979 0 C-N-CA 121.503 -0.379 . . . . 0.0 112.222 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.2 m -117.89 132.88 56.37 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.869 0.334 . . . . 0.0 110.244 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.45 169.14 15.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.183 0.516 . . . . 0.0 110.568 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.676 HG22 ' HB2' ' A' ' 19' ' ' ALA . 27.9 t -60.85 -59.57 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.169 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.59 9.6 5.92 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.532 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.445 ' O ' HD13 ' A' ' 33' ' ' ILE . 48.7 mt-30 -99.51 -12.2 20.37 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.753 0.776 . . . . 0.0 110.764 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 pp -98.15 -16.13 19.64 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.351 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 33' ' ' ILE . 1.6 tt -110.35 -58.31 2.09 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.837 0.351 . . . . 0.0 110.765 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -36.9 -26.18 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.768 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.595 ' N ' HD12 ' A' ' 33' ' ' ILE . 1.4 mp -66.87 -47.86 81.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.062 -0.348 . . . . 0.0 110.062 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 31' ' ' LEU . 9.4 tp -67.46 -57.44 6.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.689 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.56 ' ND1' ' N ' ' A' ' 36' ' ' GLN . 2.0 t-80 46.37 -120.71 1.03 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.855 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.56 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 51.1 tt0 58.26 -79.51 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 35' ' ' HIS . 5.9 tpp180 -57.37 138.81 54.48 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 40' ' ' GLY . 18.3 tt -159.91 -14.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.829 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.419 ' H ' ' H ' ' A' ' 38' ' ' ILE . 38.2 mt-10 -45.42 90.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.74 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 38' ' ' ILE . . . 76.37 -177.52 50.88 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 1.317 ' CG ' HG22 ' A' ' 5' ' ' VAL . 60.1 Cg_exo -50.0 124.1 12.04 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.602 2.201 . . . . 0.0 112.038 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.589 HD22 ' N ' ' A' ' 42' ' ' LEU . 3.7 mm? -58.02 99.25 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.423 ' H ' HG23 ' A' ' 43' ' ' THR . 1.5 p -79.86 177.99 8.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.058 0.456 . . . . 0.0 111.19 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -68.92 -23.23 64.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.41 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.56 ' HA ' HE21 ' A' ' 48' ' ' GLN . 61.2 tt0 -71.99 -40.17 68.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.335 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.0 t -54.36 -38.87 66.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.363 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 49' ' ' GLY . 10.2 mt -66.28 -47.28 74.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.74 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.56 HE21 ' HA ' ' A' ' 45' ' ' GLU . 32.7 mt-30 -66.85 69.97 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.437 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -151.95 3.14 0.39 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.17 174.26 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.478 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 52.9 m -115.09 163.53 15.48 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.515 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.4 t -56.46 -42.14 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 O-C-N 123.265 0.353 . . . . 0.0 111.404 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.4 m -57.39 -25.41 59.47 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -74.44 -32.15 62.52 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.083 0.468 . . . . 0.0 110.956 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.735 HD12 ' N ' ' A' ' 55' ' ' LEU . 5.7 mp -64.25 -65.59 0.66 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.503 -177.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -52.67 -37.42 58.73 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 61' ' ' GLY . 10.3 pt -79.34 -18.11 12.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.51 -41.77 96.06 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.41 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.749 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.0 mm? -73.64 -57.12 4.21 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.031 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.63 -37.99 88.13 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 104.95 -34.42 5.81 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.527 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.519 ' C ' ' H ' ' A' ' 64' ' ' GLU . 22.6 t -137.24 129.6 29.69 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.106 0.479 . . . . 0.0 111.405 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -59.17 1.81 0.07 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.902 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.519 ' H ' ' C ' ' A' ' 62' ' ' SER . 42.7 mt-10 -83.02 -47.75 11.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.781 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -92.78 -7.44 46.5 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.6 m -55.72 -17.72 3.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.864 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -53.22 -31.88 45.4 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.286 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.8 ptm -100.27 -21.0 15.63 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.485 ' HG ' ' H ' ' A' ' 71' ' ' THR . 27.5 tp -52.17 124.09 12.21 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.256 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -41.14 -23.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.07 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.485 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 2.2 m -74.73 117.94 66.34 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.954 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.41 -104.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.892 1.728 . . . . 0.0 111.785 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.471 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 31.8 ttp -153.95 1.79 0.24 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.997 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.9 m -108.27 -18.77 13.68 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.784 0.326 . . . . 0.0 110.197 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.35 -34.04 70.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.619 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.958 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -64.0 -45.92 86.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.033 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.502 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 1.8 mptp? -56.22 -37.83 70.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.37 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -66.75 -56.92 8.31 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.432 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -63.92 -64.27 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.677 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.437 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.8 p -35.11 -27.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.112 0.482 . . . . 0.0 111.42 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.543 ' N ' ' O ' ' A' ' 79' ' ' ALA . 52.6 ttm-85 -75.57 -58.92 2.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.111 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.473 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 50.1 mt -45.83 -41.71 3.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.821 -1.082 . . . . 0.0 112.656 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.884 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -79.77 -33.0 40.99 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.628 179.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -50.2 -21.55 1.38 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.869 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.51 17.4 55.05 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 88' ' ' GLU . 68.5 mt-10 -112.82 2.56 16.0 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -31.68 -34.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.849 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 86' ' ' GLU . 3.6 pt-20 -58.66 -105.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.686 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.0 m -56.2 140.98 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.603 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -85.47 -143.33 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.703 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.2 m -63.34 -139.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.797 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.656 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.0 mm? -82.45 150.4 63.41 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.17 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.34 -165.51 0.22 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.259 1.973 . . . . 0.0 112.044 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -60.58 132.89 91.28 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.2 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.94 96.31 1.01 Allowed 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.917 1.744 . . . . 0.0 111.858 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 25.6 m . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.529 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.9 mtt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.0 t -76.23 -36.97 31.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.64 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.5 m -155.76 74.15 5.19 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.541 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -50.81 -64.19 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.498 2.132 . . . . 0.0 111.578 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.4 p -173.7 146.02 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.001 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -140.24 -85.96 0.21 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.659 0.266 . . . . 0.0 110.632 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 85.7 mtp -47.05 151.34 0.66 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.87 0.367 . . . . 0.0 110.506 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.4 t -63.2 -149.36 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.642 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 11' ' ' THR . 5.7 ptm85 -136.79 -59.47 0.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 9' ' ' ARG . 10.9 pt-20 -39.8 -24.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.157 0.503 . . . . 0.0 110.489 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 9' ' ' ARG . 23.4 m -81.52 -52.53 7.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.445 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -68.51 4.75 1.24 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.508 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.479 ' H ' ' C ' ' A' ' 11' ' ' THR . 3.1 mp -109.12 -41.7 4.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.248 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 -88.26 -34.06 17.86 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.2 mp -62.54 -11.36 6.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.38 -16.41 22.36 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.7 -29.01 66.33 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.62 -46.25 73.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.873 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.637 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.87 -36.07 0.98 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 22' ' ' LEU . 36.9 ttt180 -65.61 -43.14 90.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.743 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.35 -6.9 0.74 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.745 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.409 ' H ' ' C ' ' A' ' 20' ' ' ARG . 11.7 mt -117.94 121.61 31.39 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.57 72.77 6.35 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 121.781 1.654 . . . . 0.0 112.604 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.83 -53.33 0.68 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.7 m -59.23 132.42 53.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.006 0.432 . . . . 0.0 111.491 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.85 173.82 9.16 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.359 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.637 HG22 ' HB2' ' A' ' 19' ' ' ALA . 15.3 t -61.61 -59.64 3.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.697 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.66 6.71 8.19 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.53 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.445 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 57.5 mt-30 -97.1 -22.81 16.55 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 117.86 0.83 . . . . 0.0 110.084 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.0 tp -90.2 -19.75 23.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.836 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 33' ' ' ILE . 10.9 mp -100.16 -50.33 4.0 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.897 0.379 . . . . 0.0 110.408 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -44.71 -15.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.053 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 31' ' ' LEU . 7.2 pt -71.78 -39.86 68.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.742 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 36' ' ' GLN . 14.2 mt -91.98 9.25 33.93 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.781 0.324 . . . . 0.0 110.461 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -44.5 89.82 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.887 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 34' ' ' LEU . 49.9 tt0 -171.05 137.66 1.2 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.577 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.422 ' O ' ' CD2' ' A' ' 42' ' ' LEU . 0.6 OUTLIER 56.8 36.7 28.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.758 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.767 ' HA ' HD22 ' A' ' 42' ' ' LEU . 14.4 pt -88.06 -38.03 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.712 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -46.9 99.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 0.0 110.538 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.9 179.9 28.81 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.58 46.43 1.22 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.699 2.266 . . . . 0.0 111.66 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.767 HD22 ' HA ' ' A' ' 38' ' ' ILE . 9.6 mp -80.67 121.66 26.14 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.596 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.36 -175.86 2.78 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.515 ' O ' ' NE2' ' A' ' 48' ' ' GLN . 22.1 pt-20 -49.45 -36.68 23.24 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -56.95 -36.49 70.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.358 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.7 p -65.13 -29.4 70.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.779 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 49' ' ' GLY . 10.3 mp -71.59 -31.58 67.1 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 110.576 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.67 ' N ' ' NE2' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -62.06 72.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.359 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -152.76 11.61 0.61 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.91 175.07 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.472 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 49.1 m -113.79 161.97 16.9 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.496 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.2 t -55.52 -43.46 72.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 123.196 0.31 . . . . 0.0 110.999 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.3 m -57.37 -23.95 52.27 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 54' ' ' ASP . 16.6 t0 -75.7 -31.32 59.63 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.016 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.735 HD12 ' N ' ' A' ' 55' ' ' LEU . 5.9 mp -65.31 -65.9 0.61 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.489 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -52.79 -34.98 55.88 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.8 pt -80.19 -19.78 12.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.23 -37.79 91.33 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.711 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.699 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.4 mm? -75.98 -52.61 9.88 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.284 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.66 -33.38 64.45 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.464 -0.494 . . . . 0.0 109.803 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 83.42 -9.24 62.08 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.104 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.528 ' C ' ' H ' ' A' ' 64' ' ' GLU . 3.9 t -137.75 104.24 5.24 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.924 0.392 . . . . 0.0 111.819 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -56.51 -1.24 0.05 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.701 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.528 ' H ' ' C ' ' A' ' 62' ' ' SER . 36.2 mt-10 -91.51 -41.37 10.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.3 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -92.45 -13.0 30.62 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 m -46.79 -29.8 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.622 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -52.92 -30.69 35.92 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.919 0.39 . . . . 0.0 110.234 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 13.2 mmt -83.96 -31.08 25.74 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.92 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.485 ' O ' ' N ' ' A' ' 71' ' ' THR . 29.7 tp -49.56 122.4 6.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.283 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 51.2 t0 -39.69 -24.9 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.021 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.485 ' N ' ' O ' ' A' ' 69' ' ' LEU . 2.8 m -65.05 122.08 77.65 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.016 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -74.71 -86.74 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.644 1.563 . . . . 0.0 112.281 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -172.13 -23.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.676 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.6 p -89.34 -14.59 35.33 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.476 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -69.89 -33.7 72.56 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.4 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.915 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.5 mm? -65.25 -47.69 75.87 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.214 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.497 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 1.8 mptp? -57.95 -34.4 69.86 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.82 -58.67 3.85 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.895 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.604 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.31 -64.64 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.29 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.5 p -34.72 -23.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.961 0.41 . . . . 0.0 111.653 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.604 ' N ' ' O ' ' A' ' 79' ' ' ALA . 46.9 ttm-85 -78.71 -58.22 3.36 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.456 0.646 . . . . 0.0 109.617 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.462 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 43.4 mt -47.7 -42.06 8.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.988 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.82 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -76.7 -36.65 57.1 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 119.273 -0.971 . . . . 0.0 109.564 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -48.88 -18.07 0.25 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.795 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.448 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 85.01 18.7 60.61 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 88' ' ' GLU . 24.3 tt0 -112.44 2.93 16.6 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.462 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -30.32 -34.96 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.874 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 86' ' ' GLU . 41.9 mt-10 -47.24 114.29 0.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.677 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 91' ' ' SER . 3.9 t -60.63 -11.13 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.641 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -61.49 73.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.461 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 89' ' ' VAL . 69.0 m -75.02 -170.19 1.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.6 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.656 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.1 mm? -79.73 150.16 72.2 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.793 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.4 179.23 4.74 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.192 1.928 . . . . 0.0 111.887 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -74.02 150.57 88.07 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.314 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -37.88 149.97 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.265 0 C-N-CA 122.149 1.899 . . . . 0.0 112.156 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.527 179.854 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.0 mtt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.4 t -81.27 86.29 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.933 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -159.91 151.19 16.19 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.737 -179.536 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 3' ' ' THR . 77.6 Cg_exo -38.11 163.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 122.38 2.053 . . . . 0.0 112.391 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 t -82.1 105.35 11.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.344 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -136.9 164.31 28.61 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.962 0.41 . . . . 0.0 110.371 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.53 145.29 52.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.661 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.23 133.72 52.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.593 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 11' ' ' THR . 7.4 ptt180 -69.64 -38.08 77.04 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -41.78 -22.45 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.257 0.551 . . . . 0.0 110.198 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.532 ' N ' ' O ' ' A' ' 9' ' ' ARG . 8.3 m -83.86 -49.33 9.13 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -66.36 2.34 1.27 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.132 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.495 ' H ' ' C ' ' A' ' 11' ' ' THR . 3.6 mp -111.07 -41.38 4.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.025 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 50.4 ttm-85 -86.04 -38.35 17.95 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.35 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.417 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 1.4 mp -65.29 -7.16 4.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.173 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.54 -18.91 21.72 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.74 0.305 . . . . 0.0 110.493 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -70.15 -30.35 67.49 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -57.87 -41.44 82.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.408 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.696 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.28 -33.97 0.44 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.486 ' C ' ' H ' ' A' ' 22' ' ' LEU . 86.5 mtt180 -67.93 -42.24 81.33 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.224 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -57.88 -5.19 0.38 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.424 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 20' ' ' ARG . 19.3 mt -115.07 148.61 40.97 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.056 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.83 -92.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.219 1.946 . . . . 0.0 112.401 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.28 46.51 1.28 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.7 m -118.21 141.73 48.2 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.827 0.346 . . . . 0.0 110.387 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.67 159.4 15.01 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.232 0.539 . . . . 0.0 110.393 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.696 HG22 ' HB2' ' A' ' 19' ' ' ALA . 23.5 t -54.84 -51.9 47.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.124 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.01 3.57 56.99 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.11 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -89.22 -20.27 24.37 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 117.597 0.699 . . . . 0.0 109.836 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.578 ' O ' HD23 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -95.5 -27.25 15.47 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.617 0.246 . . . . 0.0 110.523 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.453 ' C ' ' N ' ' A' ' 33' ' ' ILE . 24.7 mt -83.01 -41.19 18.99 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.876 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.4 ' C ' ' N ' ' A' ' 34' ' ' LEU . 10.4 pt-20 -48.47 -13.36 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.826 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.453 ' N ' ' C ' ' A' ' 31' ' ' LEU . 10.1 tt -49.33 -16.9 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.609 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 35' ' ' HIS . 96.7 mt -61.86 -94.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.519 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER 47.73 98.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.487 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.418 ' O ' ' O ' ' A' ' 37' ' ' ARG . 6.2 pt20 -177.12 33.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.948 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 36' ' ' GLN . 69.1 mtt-85 54.74 165.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.78 0.324 . . . . 0.0 110.543 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 38' ' ' ILE . 17.7 mt 40.04 71.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.921 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 39' ' ' GLU . 1.0 OUTLIER -80.56 112.55 18.02 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.853 0.358 . . . . 0.0 110.097 179.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.17 -178.13 45.9 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.32 174.53 12.35 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.62 2.213 . . . . 0.0 111.974 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.696 HD23 ' N ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -166.57 133.22 2.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.599 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.489 ' N ' ' OG ' ' A' ' 46' ' ' SER . 1.1 p -128.97 -176.52 3.88 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.559 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.629 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 1.8 pm0 -50.61 -26.48 5.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.651 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.452 ' CG ' ' N ' ' A' ' 46' ' ' SER . 10.2 pt-20 -86.3 -43.38 12.96 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.933 0.397 . . . . 0.0 111.223 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.489 ' OG ' ' N ' ' A' ' 43' ' ' THR . 87.7 p -54.0 -45.71 71.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.264 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.4 mp -56.96 -33.2 66.81 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.379 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -69.56 67.27 0.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.852 0.358 . . . . 0.0 110.424 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.71 11.15 0.36 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.77 171.78 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.47 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 31.6 m -113.66 161.72 17.12 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.545 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.3 t -55.07 -38.11 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 120.872 0.367 . . . . 0.0 110.415 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.6 m -59.18 -26.89 65.19 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -75.09 -30.53 60.94 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.974 0.416 . . . . 0.0 111.041 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.753 HD12 ' N ' ' A' ' 55' ' ' LEU . 5.0 mp -67.05 -62.79 1.26 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.197 -178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -54.01 -35.0 61.43 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.42 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.9 pt -78.96 -19.46 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.285 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.76 -33.5 84.42 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.757 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.1 mm? -77.55 -54.79 5.98 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 116.873 0.337 . . . . 0.0 110.944 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.39 -32.4 62.69 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.967 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 80.0 -4.36 66.63 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 64' ' ' GLU . 13.0 t -137.12 97.53 3.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.008 0.432 . . . . 0.0 111.45 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -53.45 -6.16 0.07 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.258 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.531 ' H ' ' C ' ' A' ' 62' ' ' SER . 20.2 tp10 -86.31 -41.11 14.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.409 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -92.74 -14.77 27.49 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.7 m -49.1 -21.41 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 119.816 -0.753 . . . . 0.0 110.518 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -53.93 -34.46 59.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.226 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 3.5 ptp -92.59 -24.29 18.75 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.222 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.473 ' CD2' ' OG1' ' A' ' 71' ' ' THR . 21.9 tp -49.46 121.62 5.27 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -35.97 -30.26 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.598 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.473 ' OG1' ' CD2' ' A' ' 69' ' ' LEU . 2.1 m -48.92 114.46 3.77 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.547 ' C ' ' H ' ' A' ' 74' ' ' SER . 93.8 Cg_endo -80.45 19.85 1.03 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.168 1.912 . . . . 0.0 113.148 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.435 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 34.2 ttm 65.91 -12.89 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.825 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 72' ' ' PRO . 30.1 t -96.49 -14.19 22.51 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.04 0.448 . . . . 0.0 110.053 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.13 -30.13 60.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.414 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.568 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -65.55 -53.15 46.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.67 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.3 OUTLIER -46.66 -38.01 9.12 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.179 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -70.51 -58.24 3.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.068 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.587 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -62.72 -61.31 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.594 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.407 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 2.8 p -34.85 -24.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.992 0.425 . . . . 0.0 111.745 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 79' ' ' ALA . 24.1 ttm180 -79.22 -55.7 4.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.549 0.69 . . . . 0.0 109.654 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.46 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 41.5 mt -49.62 -43.49 18.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.973 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.842 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -74.25 -38.07 63.58 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.484 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -45.47 -19.48 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.859 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 83' ' ' LEU . . . 83.46 14.85 72.75 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 87' ' ' ALA . 94.4 mt-10 -110.7 3.82 19.54 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.46 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -28.28 -46.19 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.839 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.417 ' C ' ' H ' ' A' ' 90' ' ' ASP . 65.2 mm-40 -49.15 167.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.126 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 91' ' ' SER . 16.9 m -77.94 36.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.593 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 88' ' ' GLU . 28.4 t70 -74.18 39.54 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.464 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.447 ' H ' ' C ' ' A' ' 89' ' ' VAL . 83.5 p -73.21 -149.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.567 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.674 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.1 mm? -77.18 150.31 80.38 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.899 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -36.96 -36.1 0.25 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.285 1.99 . . . . 0.0 112.3 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -70.6 151.05 95.51 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.081 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -72.27 176.92 7.91 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.232 1.955 . . . . 0.0 111.793 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 t . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.643 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 mtt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.4 m -56.79 -15.77 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.393 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 40.2 p -40.6 104.46 0.34 Allowed Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.861 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -44.86 106.07 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.896 1.73 . . . . 0.0 111.964 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.6 m -51.12 172.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.827 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.457 ' OD1' ' SD ' ' A' ' 7' ' ' MET . 0.7 OUTLIER -155.98 -45.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.157 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.457 ' SD ' ' OD1' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -75.04 -178.33 3.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.3 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.2 m -69.28 -148.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.672 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.471 ' O ' HD13 ' A' ' 13' ' ' LEU . 56.8 ttt-85 -148.3 -30.32 0.29 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.32 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.568 ' CD ' ' H ' ' A' ' 10' ' ' GLU . 1.4 pm0 -101.3 -31.4 10.99 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 14' ' ' ARG . 8.8 m -78.46 -62.59 1.63 Allowed 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 11' ' ' THR . . . -28.84 -50.77 0.09 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.358 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.551 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 3.8 mp -53.31 -42.88 67.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.028 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 11' ' ' THR . 36.4 ttt180 -47.01 -46.54 21.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.009 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.607 ' N ' HD12 ' A' ' 15' ' ' ILE . 1.5 mp -63.84 -7.65 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.2 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 13' ' ' LEU . . . -97.71 -15.66 20.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.275 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.01 -28.75 61.59 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -57.4 -41.98 81.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.959 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.679 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -42.67 -36.79 1.52 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.926 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.415 ' C ' ' H ' ' A' ' 22' ' ' LEU . 75.0 ttt180 -64.38 -39.17 93.34 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -60.05 -6.19 1.28 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.47 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 20' ' ' ARG . 10.6 mt -121.47 109.24 34.85 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.141 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.16 66.89 7.73 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.917 1.745 . . . . 0.0 112.412 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.67 -11.68 0.45 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.001 -0.619 . . . . 0.0 111.841 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.4 m -113.81 137.31 51.82 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.955 0.407 . . . . 0.0 111.08 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.689 ' H ' ' NE2' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -87.97 170.72 10.88 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.314 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.679 HG22 ' HB2' ' A' ' 19' ' ' ALA . 17.6 t -60.45 -59.69 3.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.184 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.432 ' O ' ' OE1' ' A' ' 32' ' ' GLU . . . -72.16 11.11 4.02 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.364 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.689 ' NE2' ' H ' ' A' ' 26' ' ' THR . 18.2 mt-30 -98.87 -10.0 23.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.714 0.757 . . . . 0.0 110.487 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 pp -107.57 -19.18 13.64 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.609 ' O ' HD23 ' A' ' 31' ' ' LEU . 2.3 tt -91.63 -47.68 7.26 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.759 0.314 . . . . 0.0 111.631 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.561 ' OE1' ' N ' ' A' ' 32' ' ' GLU . 4.4 pm0 -47.08 -10.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.473 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.523 ' N ' ' O ' ' A' ' 31' ' ' LEU . 37.4 mm -77.79 -60.25 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.837 0.351 . . . . 0.0 110.366 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.577 HD12 ' N ' ' A' ' 34' ' ' LEU . 9.7 mp -48.8 -54.4 15.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.868 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.548 ' CD2' ' O ' ' A' ' 34' ' ' LEU . 1.3 p80 57.9 142.0 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.4 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -167.84 143.73 3.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.623 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -159.49 88.4 0.86 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.814 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.6 tt -175.97 -33.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.397 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -82.47 -106.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.283 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.14 -76.83 0.1 OUTLIER Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.61 103.49 1.76 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.652 2.235 . . . . 0.0 112.023 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.3 mt -85.38 69.14 10.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.04 0.448 . . . . 0.0 110.138 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.8 p -68.3 172.68 5.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.477 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -55.05 -23.7 21.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.67 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -75.62 -35.42 60.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.494 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.1 p -54.81 -32.14 59.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.149 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.546 HD22 ' N ' ' A' ' 47' ' ' LEU . 3.8 mm? -64.64 -22.88 67.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.774 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -76.18 75.63 3.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.69 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.36 6.48 0.49 Allowed Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.69 175.85 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 117.068 0.434 . . . . 0.0 110.428 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.49 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 24.0 m -111.62 164.55 12.88 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.519 ' HA ' HD13 ' A' ' 55' ' ' LEU . 4.9 t -58.25 -43.98 87.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.645 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.3 m -55.98 -25.35 43.61 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -74.85 -30.56 61.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.954 0.407 . . . . 0.0 111.468 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.722 HD12 ' N ' ' A' ' 55' ' ' LEU . 6.2 mp -65.3 -64.0 0.97 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -177.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -53.66 -36.45 62.14 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 61' ' ' GLY . 8.1 pt -80.35 -21.03 11.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.97 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.75 -33.01 83.72 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.78 HD22 ' N ' ' A' ' 59' ' ' LEU . 1.8 mm? -80.26 -54.73 5.46 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.483 ' HB3' HG12 ' A' ' 66' ' ' VAL . . . -79.42 -29.54 41.98 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.882 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 75.0 2.85 66.65 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.438 -0.887 . . . . 0.0 110.982 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.494 ' C ' ' H ' ' A' ' 64' ' ' GLU . 9.1 t -136.37 86.78 2.25 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.886 0.374 . . . . 0.0 111.253 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -49.08 -11.23 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.72 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.494 ' H ' ' C ' ' A' ' 62' ' ' SER . 25.3 tt0 -86.07 -35.71 20.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.512 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -98.27 -14.46 20.25 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.483 HG12 ' HB3' ' A' ' 60' ' ' ALA . 17.9 m -50.16 -25.83 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.475 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -52.31 -14.44 0.46 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.589 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 67.3 mtt -104.25 -22.21 13.41 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.67 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.448 ' HG ' ' H ' ' A' ' 71' ' ' THR . 37.8 tp -51.97 120.26 5.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.2 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 44.5 t0 -39.94 -33.13 0.19 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.194 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.448 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 62.9 m -60.7 119.65 45.98 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.071 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.439 ' O ' HD21 ' A' ' 76' ' ' LEU . 56.1 Cg_endo -69.71 -156.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 121.143 1.228 . . . . 0.0 111.348 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 8.8 ptm -106.8 -16.17 14.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.789 0.328 . . . . 0.0 111.147 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.7 m -92.76 -25.17 18.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.486 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.52 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -61.25 -33.12 73.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.371 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.908 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.2 mm? -64.95 -45.62 84.98 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.303 -0.959 . . . . 0.0 108.958 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.472 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 2.1 mptp? -59.97 -34.74 73.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.547 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -66.4 -58.8 4.51 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.708 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.49 -65.12 0.74 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.455 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.444 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.5 p -34.88 -27.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.05 0.452 . . . . 0.0 111.419 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.556 ' N ' ' O ' ' A' ' 79' ' ' ALA . 45.5 ttm-85 -77.3 -58.71 3.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.815 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.9 mt -45.01 -41.64 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.291 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.863 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -78.03 -35.62 49.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.64 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -51.44 -14.9 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.646 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.443 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 81.08 19.37 67.33 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 87' ' ' ALA . 8.0 tp10 -113.0 7.63 18.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.514 ' HB3' ' NH2' ' A' ' 14' ' ' ARG . . . -33.6 -57.11 0.44 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.494 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -53.3 140.3 27.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.521 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.8 p -83.2 142.36 13.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.608 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.08 -98.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.62 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.5 t -63.12 179.35 0.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.604 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.66 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.0 mm? -78.01 150.13 77.59 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.721 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.5 123.22 9.66 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.065 1.843 . . . . 0.0 111.798 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -74.37 151.74 87.69 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.252 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.77 164.78 34.57 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.211 1.941 . . . . 0.0 111.873 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.577 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.3 p -75.78 151.84 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.584 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.4 p -63.0 150.32 88.51 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.442 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.2 73.31 3.25 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.144 1.896 . . . . 0.0 111.781 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.454 ' C ' ' H ' ' A' ' 7' ' ' MET . 16.2 m -61.31 -169.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.595 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.6 t30 55.15 7.22 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.493 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.454 ' H ' ' C ' ' A' ' 5' ' ' VAL . 18.2 ttm -172.59 60.33 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.405 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.0 m -82.45 148.53 28.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.537 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' A' ' 12' ' ' ALA . 4.2 ptp180 -65.54 -41.77 92.69 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.319 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -41.73 -27.42 0.11 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.924 0.393 . . . . 0.0 110.774 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.403 ' N ' ' O ' ' A' ' 9' ' ' ARG . 87.9 m -83.59 -37.08 23.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.327 0.584 . . . . 0.0 109.53 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -82.78 8.44 12.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.265 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 mp -109.66 -35.47 6.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.176 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -82.07 -28.81 32.19 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.1 mt -64.3 -19.2 24.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.248 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.421 ' HA ' HG13 ' A' ' 27' ' ' VAL . . . -89.47 -17.94 27.7 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.337 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.3 -30.82 66.7 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.5 -43.76 75.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.13 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.66 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.04 -37.36 0.82 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.487 ' C ' ' H ' ' A' ' 22' ' ' LEU . 66.2 mtp180 -68.39 -42.48 79.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.283 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.6 -5.76 0.25 Allowed 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.968 0.413 . . . . 0.0 110.275 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.487 ' H ' ' C ' ' A' ' 20' ' ' ARG . 13.9 mt -119.21 122.43 29.52 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.398 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -79.13 79.42 3.39 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.712 1.608 . . . . 0.0 112.75 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 130.17 -52.27 0.83 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.8 m -55.35 137.97 46.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.987 0.422 . . . . 0.0 111.435 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.61 171.68 9.51 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.72 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.66 HG22 ' HB2' ' A' ' 19' ' ' ALA . 20.2 t -60.25 -59.15 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.438 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.29 6.94 9.07 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.241 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 1.091 ' NE2' ' OE2' ' A' ' 32' ' ' GLU . 1.0 OUTLIER -96.93 -20.83 17.83 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 117.283 0.542 . . . . 0.0 110.182 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 pp -90.78 -20.89 21.87 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.548 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -91.72 -39.13 11.99 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.619 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 1.091 ' OE2' ' NE2' ' A' ' 29' ' ' GLN . 16.3 pt-20 -35.25 -25.67 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.999 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.55 ' N ' ' O ' ' A' ' 31' ' ' LEU . 78.7 mt -49.61 -36.22 10.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.684 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.7 tp -83.39 -7.28 59.59 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.941 0.4 . . . . 0.0 110.292 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 58.58 102.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.099 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -82.08 19.12 1.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.817 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.5 ttm-85 -49.54 -75.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.774 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.4 tt -90.15 136.72 23.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.396 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -48.24 130.25 15.97 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -153.64 -167.09 15.45 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -46.15 174.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.669 2.246 . . . . 0.0 112.164 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.6 tp -172.16 53.32 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.803 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 35.8 p -120.28 172.91 7.46 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.123 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.89 -25.97 40.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.042 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -78.31 -37.75 43.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.0 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.3 t -53.91 -39.65 66.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.639 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.545 ' O ' HD13 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -64.79 -40.52 95.37 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.393 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 84' ' ' TRP . 76.2 mt-30 -62.0 70.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.669 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -154.66 9.49 0.39 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.404 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -127.77 175.76 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.433 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 37.0 m -116.57 162.66 17.27 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.455 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.1 t -54.29 -47.83 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 123.254 0.347 . . . . 0.0 110.857 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -52.89 -25.27 11.16 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 116.365 -0.38 . . . . 0.0 112.003 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.404 ' CB ' HG22 ' A' ' 50' ' ' VAL . 13.2 t0 -75.43 -31.95 60.52 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.018 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.711 HD12 ' N ' ' A' ' 55' ' ' LEU . 5.9 mp -66.38 -63.75 1.01 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.227 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.418 ' HB2' HD21 ' A' ' 76' ' ' LEU . 26.0 ttpt -52.87 -34.77 56.01 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.9 pt -80.31 -19.92 11.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.022 0.439 . . . . 0.0 109.834 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.29 -38.5 91.59 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.668 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.4 mm? -76.61 -54.57 6.49 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 120.645 -0.422 . . . . 0.0 109.999 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.72 -35.06 79.23 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 118.53 -53.79 0.65 Allowed Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.651 ' C ' ' H ' ' A' ' 64' ' ' GLU . 26.8 t -140.05 152.69 46.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.995 0.426 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.34 20.89 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.891 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.651 ' H ' ' C ' ' A' ' 62' ' ' SER . 60.8 mt-10 -97.34 -59.8 1.71 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.694 0.283 . . . . 0.0 110.886 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.41 ' OD1' ' CG ' ' A' ' 68' ' ' MET . 12.4 t0 -82.45 -11.91 58.2 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 m -51.92 -28.35 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.13 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -55.92 -24.15 36.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.541 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.41 ' CG ' ' OD1' ' A' ' 65' ' ' ASP . 8.1 mmt -93.75 -36.63 12.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.521 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.519 HD23 ' OG1' ' A' ' 71' ' ' THR . 12.7 tp -48.85 115.98 1.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.4 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -43.74 -16.56 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.773 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.519 ' OG1' HD23 ' A' ' 69' ' ' LEU . 2.8 m -51.58 116.17 7.45 Favored Pre-proline 0 CA--C 1.545 0.758 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.535 ' C ' ' H ' ' A' ' 74' ' ' SER . 93.0 Cg_endo -79.58 20.29 0.88 Allowed 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.319 2.013 . . . . 0.0 113.655 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 18.7 ttm 66.13 -13.42 0.16 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.633 0.254 . . . . 0.0 111.2 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.535 ' H ' ' C ' ' A' ' 72' ' ' PRO . 5.7 t -96.91 -13.6 22.32 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.063 0.459 . . . . 0.0 109.933 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.426 ' HB1' HD23 ' A' ' 22' ' ' LEU . . . -73.3 -31.53 64.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.904 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.567 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -67.69 -59.15 3.55 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -52.82 -15.92 0.87 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.252 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 74' ' ' SER . 8.2 m-20 -86.33 -51.96 5.92 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -69.34 -56.35 7.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.439 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.447 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.2 p -35.73 -26.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.297 0.57 . . . . 0.0 111.048 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.55 ' N ' ' O ' ' A' ' 79' ' ' ALA . 40.3 ttm-85 -76.52 -55.35 5.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.925 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.567 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 53.2 mt -49.95 -42.78 19.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.463 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.887 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -79.13 -32.9 44.62 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.755 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.508 ' O ' ' NE2' ' A' ' 48' ' ' GLN . 0.6 OUTLIER -46.85 -29.64 2.08 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.44 14.9 39.65 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 88' ' ' GLU . 1.1 mp0 -110.74 0.65 17.45 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -33.07 -33.42 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.478 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 86' ' ' GLU . 56.8 mm-40 -47.46 -45.26 25.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.9 t -59.74 109.84 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.466 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -79.59 148.58 31.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.649 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.2 m -71.97 -143.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.458 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.672 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.1 mm? -86.48 149.94 50.23 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.947 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.03 35.97 0.36 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.159 1.906 . . . . 0.0 111.843 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 92' ' ' LEU . 6.6 pt20 -66.43 151.3 96.28 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.277 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.3 128.78 15.05 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.195 1.93 . . . . 0.0 111.866 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.431 ' H ' HG22 ' A' ' 96' ' ' VAL . 12.6 m . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.511 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 ptt? . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.5 t -80.72 101.28 5.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.568 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.5 m -160.66 60.33 1.32 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.708 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -76.7 92.62 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.777 2.318 . . . . 0.0 111.831 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.5 p -161.15 -18.95 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.598 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.461 ' CG ' ' H ' ' A' ' 7' ' ' MET . 8.8 t-20 -157.05 -176.8 6.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.859 0.362 . . . . 0.0 110.718 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.461 ' H ' ' CG ' ' A' ' 6' ' ' ASN . 3.1 ttt -161.93 -135.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.466 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.417 ' H ' ' CG ' ' A' ' 7' ' ' MET . 48.1 t -86.7 138.14 31.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.331 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.472 ' O ' ' N ' ' A' ' 12' ' ' ALA . 10.4 ptt180 -51.92 -56.12 16.05 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.075 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.418 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 14.2 pt-20 -44.36 -34.64 2.05 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 83.4 m -72.0 -19.71 61.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.339 0.59 . . . . 0.0 109.877 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -91.39 -72.15 0.6 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.236 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.71 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -39.83 -55.54 1.95 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.451 -178.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.458 ' O ' ' CG2' ' A' ' 82' ' ' ILE . 94.5 mtt-85 -42.59 -41.25 2.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.5 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.4 mm -64.44 -24.01 34.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.552 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.98 -18.76 20.01 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 111.744 0.275 . . . . 0.0 111.744 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.99 -31.0 70.4 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -58.02 -41.53 83.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.779 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.711 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -42.38 -37.46 1.57 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.015 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.9 mtt-85 -64.06 -38.66 91.86 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.026 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.98 -7.2 0.98 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.332 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.43 HD23 ' HB1' ' A' ' 75' ' ' ALA . 25.3 mt -112.96 146.86 35.98 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -39.19 -71.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.196 1.931 . . . . 0.0 112.206 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -140.51 4.71 2.54 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.3 m -57.38 137.33 56.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.46 162.9 20.81 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.094 0.473 . . . . 0.0 110.806 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.711 HG22 ' HB2' ' A' ' 19' ' ' ALA . 22.1 t -61.04 -55.74 22.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.83 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.15 13.34 2.7 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.087 -0.577 . . . . 0.0 112.654 -178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -97.66 -19.31 18.36 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.018 0.909 . . . . 0.0 111.954 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.91 -17.53 20.07 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.988 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.686 HD22 ' N ' ' A' ' 31' ' ' LEU . 3.0 mm? -96.3 -49.13 5.33 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.163 0.438 . . . . 0.0 110.624 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -35.48 -28.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.303 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.562 HG23 ' N ' ' A' ' 34' ' ' LEU . 14.4 tt -76.17 -51.57 19.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.516 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.562 ' N ' HG23 ' A' ' 33' ' ' ILE . 2.9 pp -87.6 -4.92 58.94 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.74 0.305 . . . . 0.0 110.728 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 1.138 ' HE1' HD21 ' A' ' 42' ' ' LEU . 25.6 t60 -132.85 105.47 7.15 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.564 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -140.12 137.59 34.6 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.301 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 39' ' ' GLU . 39.8 mmm-85 52.69 -159.25 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.297 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' A' ' 39' ' ' GLU . 66.7 mt 57.34 -83.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.168 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 37' ' ' ARG . 35.7 mt-10 60.15 124.04 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.225 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.2 -65.45 0.13 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.89 -71.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.52 2.146 . . . . 0.0 112.082 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.138 HD21 ' HE1' ' A' ' 35' ' ' HIS . 6.4 mt 47.83 29.32 1.58 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.363 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.3 p -76.05 170.03 17.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.989 0.423 . . . . 0.0 111.014 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -68.29 -22.09 64.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.965 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -85.97 -30.98 22.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.639 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.0 p -56.26 -45.89 79.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 47' ' ' LEU . 10.2 mp -64.15 -22.24 66.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.8 0.333 . . . . 0.0 110.481 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -81.93 65.03 6.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.935 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.13 3.15 0.76 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.52 172.73 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.453 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 60.6 m -115.43 162.28 17.38 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.507 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.7 t -55.41 -42.2 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 120.67 0.272 . . . . 0.0 111.058 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.3 m -58.11 -23.93 56.74 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.26 -31.98 60.94 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.995 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 55' ' ' LEU . 5.5 mp -64.67 -65.86 0.62 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.533 -177.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -53.24 -36.13 60.72 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.538 ' O ' ' N ' ' A' ' 61' ' ' GLY . 11.6 pt -79.18 -19.02 12.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.188 0.518 . . . . 0.0 109.713 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.96 -40.02 95.14 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.011 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.781 HD22 ' N ' ' A' ' 59' ' ' LEU . 1.8 mm? -75.81 -53.09 9.02 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.283 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.26 -37.03 74.82 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 119.93 -53.24 0.69 Allowed Glycine 0 N--CA 1.465 0.61 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.582 ' C ' ' H ' ' A' ' 64' ' ' GLU . 2.5 t -137.54 147.38 45.1 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.98 0.419 . . . . 0.0 110.864 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -59.99 7.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.485 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.582 ' H ' ' C ' ' A' ' 62' ' ' SER . 53.2 mm-40 -81.5 -52.51 7.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.434 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -96.79 -7.27 34.14 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.3 m -47.36 -31.32 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.786 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -52.38 -33.29 42.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 0.0 110.235 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 17.2 mtt -80.6 -21.19 41.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.395 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.424 ' HG ' ' H ' ' A' ' 71' ' ' THR . 23.0 tp -65.41 122.4 17.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.499 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -47.09 -20.53 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.336 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.424 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 4.1 m -58.12 124.46 70.29 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.59 -86.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.532 1.488 . . . . 0.0 111.976 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 18.1 ptt? -173.59 -28.07 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.051 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.4 m -86.05 -17.97 33.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HB1' HD23 ' A' ' 22' ' ' LEU . . . -62.22 -35.78 79.95 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.96 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.714 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -66.73 -51.95 50.05 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.28 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.29 -32.41 64.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -69.52 -55.58 9.79 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.945 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -67.07 -61.94 1.68 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.439 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.447 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.7 p -35.18 -27.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.013 0.435 . . . . 0.0 111.355 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.55 ' N ' ' O ' ' A' ' 79' ' ' ALA . 47.3 ttm-85 -75.9 -59.56 2.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.149 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.515 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 49.4 mt -46.04 -40.53 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.692 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.88 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -79.84 -33.09 40.53 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 119.341 -0.944 . . . . 0.0 109.527 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -52.01 -21.52 3.19 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.518 -0.473 . . . . 0.0 109.771 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.67 16.07 55.52 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -104.33 -1.33 27.09 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.515 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -36.0 -35.31 0.07 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.382 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -47.6 -73.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.66 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 92.6 t -81.42 128.15 38.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.803 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' A' ' 91' ' ' SER . 25.8 t0 -87.03 -175.6 5.41 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.457 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.507 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 79.7 p -62.0 -173.53 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.89 0.376 . . . . 0.0 110.5 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.657 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.1 mm? -81.49 150.47 67.05 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.109 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.34 107.22 2.43 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.077 1.851 . . . . 0.0 111.392 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -54.89 151.21 16.3 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.376 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -36.06 -56.77 0.61 Allowed 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 122.573 2.182 . . . . 0.0 112.458 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.3 m . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.624 -179.924 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 mmt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.9 m -75.41 162.39 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.532 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.456 ' H ' ' HD2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -178.69 -50.93 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.302 179.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.456 ' HD2' ' H ' ' A' ' 3' ' ' THR . 61.1 Cg_endo -87.51 62.69 3.84 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.532 2.155 . . . . 0.0 112.371 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 7' ' ' MET . 14.9 p -169.46 -37.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.908 0.385 . . . . 0.0 110.884 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.447 ' N ' HG13 ' A' ' 5' ' ' VAL . 41.7 m-20 -54.63 84.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.71 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.498 ' N ' ' O ' ' A' ' 5' ' ' VAL . 39.1 mtt 51.97 -176.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.254 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.449 ' HB2' ' H ' ' A' ' 12' ' ' ALA . 16.2 m -58.29 -155.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.322 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.468 ' O ' HD13 ' A' ' 13' ' ' LEU . 53.1 ttt85 -142.23 -34.95 0.44 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.276 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -101.99 -33.6 9.67 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.869 0.366 . . . . 0.0 110.064 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.534 ' O ' ' N ' ' A' ' 14' ' ' ARG . 5.7 m -75.65 -62.19 1.67 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.449 ' H ' ' HB2' ' A' ' 8' ' ' SER . . . -28.38 -51.38 0.08 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.01 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.553 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 3.5 mp -56.69 -42.32 78.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.624 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' THR . 98.2 mtt180 -49.77 -46.5 50.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.152 0.501 . . . . 0.0 110.646 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 15' ' ' ILE . 25.2 mt -65.17 -8.0 5.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.588 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 13' ' ' LEU . . . -99.15 -15.0 19.11 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.651 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.38 -28.32 61.96 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -57.89 -42.83 85.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.121 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.673 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.77 -33.55 0.52 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.49 ' C ' ' H ' ' A' ' 22' ' ' LEU . 37.4 ttm180 -69.7 -42.99 73.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.017 178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.64 -7.49 0.43 Allowed 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.061 0.458 . . . . 0.0 110.051 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' A' ' 20' ' ' ARG . 14.1 mt -116.46 147.62 40.05 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.438 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -60.34 -78.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.968 1.779 . . . . 0.0 113.005 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.87 -10.5 26.39 Favored Glycine 0 N--CA 1.469 0.89 0 C-N-CA 121.409 -0.424 . . . . 0.0 112.654 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.3 m -60.48 130.57 47.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.317 0.559 . . . . 0.0 110.644 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.18 166.89 15.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.551 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.673 HG22 ' HB2' ' A' ' 19' ' ' ALA . 21.6 t -58.44 -59.59 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.739 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.13 10.55 2.45 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.702 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -101.59 -25.78 13.76 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 117.986 0.893 . . . . 0.0 110.572 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.3 tp -86.75 -27.15 23.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.902 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.538 ' O ' ' N ' ' A' ' 33' ' ' ILE . 4.9 mt -86.88 -41.22 14.17 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.677 0.275 . . . . 0.0 110.799 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -34.44 -27.36 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.017 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 31' ' ' LEU . 58.4 mt -46.76 -44.51 6.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.566 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.546 HD22 ' N ' ' A' ' 34' ' ' LEU . 3.9 mm? -63.3 -76.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.244 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 1.292 ' ND1' ' N ' ' A' ' 36' ' ' GLN . 0.8 OUTLIER 54.33 165.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.663 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 1.292 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 37.4 mt-30 47.9 -123.47 1.6 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.67 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.421 ' O ' ' O ' ' A' ' 36' ' ' GLN . 14.7 mmt180 58.61 135.21 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.095 0.474 . . . . 0.0 110.893 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 39' ' ' GLU . 3.6 mm -67.83 -19.47 24.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.974 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 38' ' ' ILE . 27.7 mm-40 -46.12 175.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.058 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.498 ' H ' ' HD2' ' A' ' 41' ' ' PRO . . . -141.09 -66.12 0.03 OUTLIER Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.498 ' HD2' ' H ' ' A' ' 40' ' ' GLY . 97.0 Cg_endo -78.41 100.14 1.34 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.845 2.363 . . . . 0.0 112.53 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.637 HD22 ' N ' ' A' ' 42' ' ' LEU . 3.5 mm? -81.37 64.88 6.28 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.8 p -61.35 174.63 0.68 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.282 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -76.11 -21.7 56.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.204 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -87.89 -41.37 13.25 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.693 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.2 m -53.1 -32.9 49.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.856 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 49' ' ' GLY . 77.8 mt -60.8 -28.57 68.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.638 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 84' ' ' TRP . 70.1 mt-30 -63.16 71.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.801 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -149.7 16.04 1.08 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.461 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -134.84 178.39 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.467 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 67.2 m -115.98 164.23 14.74 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.472 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.6 t -57.41 -47.33 84.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.158 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 57' ' ' ILE . 3.4 m -54.77 -24.69 23.65 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.457 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.461 ' CB ' HG22 ' A' ' 50' ' ' VAL . 9.8 t70 -72.94 -30.95 64.26 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.053 0.454 . . . . 0.0 110.734 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.708 HD12 ' N ' ' A' ' 55' ' ' LEU . 6.6 mp -66.35 -63.35 1.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.529 -178.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -55.95 -37.93 69.67 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.0 pt -73.72 -21.4 18.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.617 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.7 -35.46 91.95 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.872 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.746 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.2 mm? -75.81 -55.48 5.59 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.899 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.551 ' HB2' ' CD1' ' A' ' 69' ' ' LEU . . . -76.29 -31.47 58.24 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.484 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 77.17 -2.36 61.5 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.098 -1.049 . . . . 0.0 111.248 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.526 ' C ' ' H ' ' A' ' 64' ' ' GLU . 22.2 t -131.03 99.37 4.87 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.921 0.391 . . . . 0.0 111.409 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -54.11 -2.73 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.036 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 62' ' ' SER . 27.9 tt0 -95.5 -44.28 7.59 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.298 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.79 -12.35 48.29 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 62' ' ' SER . 15.2 m -54.12 -22.4 7.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.856 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -65.19 -14.2 60.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.193 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 51.7 mtt -105.71 -18.59 14.02 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.843 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.551 ' CD1' ' HB2' ' A' ' 60' ' ' ALA . 1.2 mt -49.05 139.96 9.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.121 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 20.2 p-10 -58.27 -30.39 66.56 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.3 m -60.89 119.53 45.59 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.225 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.41 ' O ' HD21 ' A' ' 76' ' ' LEU . 72.2 Cg_endo -72.94 -154.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.313 1.342 . . . . 0.0 111.233 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.43 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 37.1 ttm -112.72 1.29 15.6 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.872 0.368 . . . . 0.0 110.059 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.0 m -107.1 -27.89 10.33 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.101 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.453 ' HB1' HD23 ' A' ' 22' ' ' LEU . . . -60.35 -35.42 75.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.548 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.905 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -63.75 -49.74 71.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.448 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.522 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 2.0 mptp? -54.63 -35.86 63.9 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.445 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.73 -59.4 3.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.92 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.45 -61.77 2.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.9 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.438 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 2.7 p -35.19 -27.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.049 0.452 . . . . 0.0 111.545 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.554 ' N ' ' O ' ' A' ' 79' ' ' ALA . 29.0 ttm180 -78.01 -56.65 4.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.619 0.723 . . . . 0.0 109.818 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.544 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 42.8 mt -46.5 -45.09 6.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.901 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.866 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -74.49 -36.58 63.27 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.702 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.495 ' O ' ' NE2' ' A' ' 48' ' ' GLN . 0.7 OUTLIER -47.33 -19.58 0.16 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.104 -179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.434 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 85.16 15.46 66.86 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 88' ' ' GLU . 25.0 tt0 -108.29 0.37 21.26 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.544 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -32.97 -31.95 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.63 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 86' ' ' GLU . 37.5 mt-10 -53.36 125.19 16.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.707 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 66.0 t -84.3 118.94 32.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.497 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -82.0 -81.2 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.647 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.8 m -76.33 -178.92 4.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.724 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.656 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.2 mm? -76.8 150.82 81.93 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.849 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -36.61 -41.86 0.67 Allowed 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.297 1.998 . . . . 0.0 112.362 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -64.68 151.03 93.22 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.146 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -72.39 -52.56 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.186 1.924 . . . . 0.0 111.862 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 64.4 t . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.536 -179.968 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.477 ' H ' HG22 ' A' ' 2' ' ' VAL . 1.8 m -56.77 -104.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.192 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.475 ' H ' HG23 ' A' ' 2' ' ' VAL . 36.8 p -137.67 63.6 40.45 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.623 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -77.85 8.15 3.58 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.64 2.227 . . . . 0.0 111.646 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.8 t -67.72 -71.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.458 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 7' ' ' MET . 63.5 m-80 52.06 -173.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.796 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' A' ' 7' ' ' MET . 0.6 OUTLIER 57.52 141.51 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.952 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -71.41 -152.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.128 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.514 ' O ' HD13 ' A' ' 13' ' ' LEU . 39.2 ptt85 -144.33 -31.47 0.44 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.383 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -102.84 -34.2 9.07 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 14' ' ' ARG . 10.1 m -78.09 -62.03 1.81 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 11' ' ' THR . . . -28.57 -51.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.139 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 4.5 mp -49.42 -44.82 45.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.884 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 11' ' ' THR . 53.2 mtp180 -45.72 -44.75 13.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.965 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.666 ' N ' HD12 ' A' ' 15' ' ' ILE . 1.8 mp -64.37 -15.72 17.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.336 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 13' ' ' LEU . . . -99.6 -17.29 17.9 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.368 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -71.74 -28.14 63.47 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -60.56 -39.98 89.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.458 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.701 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -42.93 -34.78 1.03 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.659 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.437 ' C ' ' H ' ' A' ' 22' ' ' LEU . 65.8 ttt180 -66.12 -39.05 89.6 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.884 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -59.43 -6.87 1.15 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.134 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.437 ' H ' ' C ' ' A' ' 20' ' ' ARG . 14.9 mt -119.81 117.33 32.54 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.62 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.49 70.29 7.59 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.889 1.726 . . . . 0.0 112.48 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 146.14 -52.14 0.58 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.0 m -60.47 133.0 55.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.974 0.416 . . . . 0.0 111.145 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.99 168.23 13.02 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.077 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.701 HG22 ' HB2' ' A' ' 19' ' ' ALA . 18.2 t -58.77 -58.56 6.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.141 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.7 11.13 3.51 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.643 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.402 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 40.0 mm-40 -99.51 -15.26 18.73 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.952 0.876 . . . . 0.0 110.587 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.5 tp -100.75 -27.74 13.19 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.66 HD22 ' N ' ' A' ' 31' ' ' LEU . 3.0 mm? -90.28 -46.43 8.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.894 0.378 . . . . 0.0 110.846 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -36.89 -25.78 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.737 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.689 ' N ' HD12 ' A' ' 33' ' ' ILE . 1.8 mp -86.08 -42.26 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.631 0.253 . . . . 0.0 110.494 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 31' ' ' LEU . 17.2 tp -52.94 -81.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.613 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.402 ' O ' ' OE1' ' A' ' 36' ' ' GLN . 16.6 p80 -70.13 158.14 36.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.357 . . . . 0.0 110.532 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.402 ' OE1' ' O ' ' A' ' 35' ' ' HIS . 13.9 mm100 -128.89 -113.35 0.26 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.613 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -69.09 -137.79 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.863 0.363 . . . . 0.0 110.801 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 tp -41.68 143.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.942 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -162.13 -178.06 6.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.265 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.58 -69.24 0.02 OUTLIER Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -41.47 143.01 0.99 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.516 2.144 . . . . 0.0 111.89 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.583 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -161.07 14.72 0.1 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.239 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 p -81.0 160.63 24.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.225 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -48.13 -23.35 0.82 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.687 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -76.09 -39.91 54.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.096 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.9 m -53.86 -34.45 59.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.899 0.381 . . . . 0.0 110.432 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.515 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 3.0 mm? -61.43 -35.62 78.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.961 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -70.81 72.82 0.56 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.438 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.42 5.68 0.46 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.447 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -133.82 176.12 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.953 0.376 . . . . 0.0 110.163 179.811 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.474 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 9.3 m -115.38 165.59 12.8 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.462 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.5 t -57.64 -49.11 81.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.31 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.4 m -53.18 -24.62 11.25 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.592 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.447 ' CB ' HG22 ' A' ' 50' ' ' VAL . 32.9 t0 -74.16 -31.4 62.68 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.33 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.712 HD12 ' N ' ' A' ' 55' ' ' LEU . 5.9 mp -66.1 -62.26 1.58 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.26 0.466 . . . . 0.0 112.26 -178.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -55.55 -38.98 70.03 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 61' ' ' GLY . 15.1 pt -73.77 -24.96 20.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.418 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.79 -33.06 81.43 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.943 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.755 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.0 mm? -80.19 -56.39 4.25 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.107 0.453 . . . . 0.0 111.291 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -74.64 -30.44 61.63 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.726 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 81.48 -13.82 32.62 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.747 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.542 ' O ' HG13 ' A' ' 66' ' ' VAL . 2.7 p -121.67 103.76 9.12 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.918 0.39 . . . . 0.0 111.313 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.96 -0.06 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.597 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.536 ' H ' ' C ' ' A' ' 62' ' ' SER . 47.1 tt0 -96.27 -41.56 8.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.172 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -90.88 -12.11 37.18 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 62' ' ' SER . 13.7 m -54.91 -22.05 9.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.982 0.42 . . . . 0.0 111.232 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -57.73 -19.89 30.68 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.136 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 28.8 mtt -108.21 -5.16 17.02 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.553 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.498 HD23 ' H ' ' A' ' 70' ' ' ASP . 0.5 OUTLIER -48.84 151.11 1.28 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.283 -179.472 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.498 ' H ' HD23 ' A' ' 69' ' ' LEU . 8.4 t70 -67.63 -39.36 84.67 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 72' ' ' PRO . 81.9 m -61.1 112.99 6.66 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.682 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 71' ' ' THR . 50.1 Cg_exo -51.82 -164.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.594 1.53 . . . . 0.0 112.084 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.4 ptt? -105.32 -15.9 14.91 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.659 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.3 m -96.63 -19.25 19.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.243 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.436 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -67.44 -30.91 70.77 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.123 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.886 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.5 mm? -64.5 -49.6 70.68 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.526 ' HD3' ' H ' ' A' ' 77' ' ' LYS . 0.7 OUTLIER -54.45 -33.58 59.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.548 179.448 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -72.09 -59.78 2.57 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.79 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -57.05 -63.45 1.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.342 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.425 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 2.3 p -35.1 -27.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.923 0.392 . . . . 0.0 111.744 -178.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 79' ' ' ALA . 46.6 ttm-85 -76.44 -60.07 2.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.534 0.683 . . . . 0.0 110.423 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.487 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 36.3 mt -43.61 -43.11 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.156 -178.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.877 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -76.65 -34.39 58.28 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 119.137 -1.025 . . . . 0.0 109.873 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -52.64 -18.03 1.58 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.676 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.56 14.67 67.61 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -102.3 1.62 35.92 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.487 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -36.78 -37.24 0.13 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.086 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.52 70.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.679 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.5 p -79.74 135.57 25.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.636 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 90' ' ' ASP . 18.4 p-10 -76.02 -170.32 1.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.535 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.2 t -74.23 158.04 34.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.481 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.638 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.2 mm? -75.4 150.22 84.71 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.861 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -37.68 -50.54 1.87 Allowed 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 122.18 1.92 . . . . 0.0 112.228 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -81.12 150.96 69.33 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.375 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.03 178.59 5.76 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.115 1.877 . . . . 0.0 111.699 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.1 m . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.617 -179.979 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.57 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 63.5 t -66.94 -71.29 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.746 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.594 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 2.7 m -80.59 -36.58 0.94 Allowed Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.355 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 3' ' ' THR . 64.2 Cg_endo -91.05 94.77 0.23 Allowed 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.324 2.016 . . . . 0.0 111.849 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.8 p -82.49 144.86 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.475 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.519 HD22 ' H ' ' A' ' 6' ' ' ASN . 0.1 OUTLIER -148.02 171.78 15.28 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.367 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.403 ' C ' ' O ' ' A' ' 6' ' ' ASN . 6.8 ptt? 32.13 91.64 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.643 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.497 ' OG ' ' N ' ' A' ' 9' ' ' ARG . 3.8 t -117.2 179.29 4.08 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.213 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 12' ' ' ALA . 24.6 ptt180 -70.66 -35.39 72.83 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -40.71 -28.89 0.08 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.645 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 93.0 m -86.22 -28.21 24.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.043 0.449 . . . . 0.0 110.679 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.578 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -84.43 8.89 14.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.056 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.79 -27.36 10.31 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 120.685 0.279 . . . . 0.0 110.269 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 1.395 ' CD ' ' CG2' ' A' ' 82' ' ' ILE . 1.9 tmm_? -81.52 -20.6 39.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.156 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.503 HD13 ' HE ' ' A' ' 14' ' ' ARG . 7.6 mm -62.84 -26.03 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.218 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.02 -23.85 19.39 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.7 -33.62 76.38 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.19 -45.63 75.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.454 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.67 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -43.48 -36.07 1.87 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -63.43 -41.99 98.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.187 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -63.19 -7.26 5.53 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.045 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.4 mt -120.03 110.24 36.62 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.81 65.07 8.57 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.741 1.627 . . . . 0.0 112.394 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.33 -37.35 0.52 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.636 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.8 m -80.59 139.55 36.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.003 0.43 . . . . 0.0 111.432 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.43 166.79 15.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.91 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.67 HG22 ' HB2' ' A' ' 19' ' ' ALA . 25.7 t -60.52 -60.27 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.078 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.52 11.65 5.28 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.298 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.454 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 13.0 mm100 -99.0 -17.49 18.27 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.695 0.748 . . . . 0.0 110.286 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 45.8 tp -93.38 -18.28 22.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.826 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 33' ' ' ILE . 12.0 mt -83.84 -39.74 19.56 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.741 0.305 . . . . 0.0 111.155 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -41.36 -22.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.253 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 31' ' ' LEU . 28.8 pt -52.14 -32.86 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.563 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -74.62 -41.9 59.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.759 -179.129 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.4 ' O ' ' O ' ' A' ' 36' ' ' GLN . 19.6 t60 58.39 73.33 0.48 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.509 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.4 ' O ' ' O ' ' A' ' 35' ' ' HIS . 17.5 pt20 -57.45 -157.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.757 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.403 ' H ' ' H ' ' A' ' 38' ' ' ILE . 32.4 ttm180 -169.38 -14.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.759 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.466 ' CG1' ' N ' ' A' ' 39' ' ' GLU . 8.5 tt -157.28 161.67 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.468 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.497 ' CD ' ' H ' ' A' ' 39' ' ' GLU . 3.8 mp0 -61.27 138.36 58.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.407 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 175.96 172.73 41.01 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -72.93 171.48 17.39 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.71 2.273 . . . . 0.0 111.86 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.4 tp -159.48 59.12 0.39 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.118 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 p -68.94 -177.42 1.02 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.743 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -76.42 -26.03 55.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.313 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -72.51 -33.72 67.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.812 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.3 m -69.79 -32.78 71.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.59 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 49' ' ' GLY . 5.7 tp -71.03 -28.73 64.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.699 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -64.1 70.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.169 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -153.12 7.67 0.47 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.413 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -124.24 175.74 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.444 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 67.0 m -119.57 164.04 16.43 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.479 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.9 t -56.45 -43.99 79.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.333 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.7 m -56.85 -23.46 44.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.413 ' CB ' HG22 ' A' ' 50' ' ' VAL . 11.8 t70 -75.21 -32.52 61.21 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.231 0.539 . . . . 0.0 110.837 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.724 HD12 ' N ' ' A' ' 55' ' ' LEU . 6.0 mp -63.87 -66.63 0.52 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.629 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -54.25 -34.82 61.61 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.7 pt -78.58 -20.51 13.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.8 -37.03 88.16 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.858 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.704 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.3 mm? -76.45 -53.63 7.85 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.579 -0.448 . . . . 0.0 109.902 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.56 -36.71 76.56 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 121.25 -53.23 0.71 Allowed Glycine 0 N--CA 1.466 0.668 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.663 ' C ' ' H ' ' A' ' 64' ' ' GLU . 4.1 m -139.19 150.87 46.07 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.94 0.4 . . . . 0.0 110.916 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -60.13 22.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.639 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.663 ' H ' ' C ' ' A' ' 62' ' ' SER . 27.3 mt-10 -96.62 -60.33 1.63 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.698 0.285 . . . . 0.0 110.624 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -83.4 -13.08 55.66 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.5 m -47.51 -24.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.377 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -58.95 -35.0 72.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.345 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 24.9 mmt -84.97 -33.59 22.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.653 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.4 tp -49.89 122.01 6.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 110.16 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -55.88 -25.35 42.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.666 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 72' ' ' PRO . 26.1 m -50.13 108.62 1.05 Allowed Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.226 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 71' ' ' THR . 32.5 Cg_exo -54.8 -154.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.37 1.38 . . . . 0.0 112.196 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.4 ptm -115.75 -20.89 9.88 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.565 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.4 m -90.26 -19.87 23.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.538 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -64.78 -34.89 79.42 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.202 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.932 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.3 mm? -66.49 -50.88 61.78 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.31 -31.84 64.06 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -70.9 -56.82 5.41 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.779 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -64.7 -61.25 2.3 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.433 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.426 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 2.4 p -35.87 -26.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.22 0.533 . . . . 0.0 111.21 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 79' ' ' ALA . 15.9 ttm180 -78.87 -53.54 6.98 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.108 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 1.395 ' CG2' ' CD ' ' A' ' 14' ' ' ARG . 46.3 mt -50.29 -44.38 23.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.514 -1.221 . . . . 0.0 112.138 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 1.146 ' HA ' ' CZ ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -76.38 -35.57 58.57 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.639 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.636 ' N ' HH12 ' A' ' 14' ' ' ARG . 0.6 OUTLIER -45.6 -28.0 0.88 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.249 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.833 ' H ' HH12 ' A' ' 14' ' ' ARG . . . 96.13 13.66 48.32 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 88' ' ' GLU . 27.0 tt0 -105.95 -2.91 22.36 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.581 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -33.48 -34.44 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.392 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 86' ' ' GLU . 69.3 mm-40 -45.44 -47.99 13.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.539 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 99.5 t -61.38 93.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.681 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -82.83 132.71 35.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.433 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 85.8 p -62.37 172.59 1.46 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.934 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.635 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.0 mm? -82.47 150.52 63.62 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.88 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.34 119.2 6.1 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.269 1.979 . . . . 0.0 111.755 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -64.44 147.84 96.91 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.232 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.06 113.91 3.21 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.078 1.852 . . . . 0.0 111.825 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.498 -179.975 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.491 ' C ' ' H ' ' A' ' 3' ' ' THR . 37.9 mtt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.5 t 62.33 -1.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.528 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.491 ' H ' ' C ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -176.07 63.7 0.22 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.987 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.31 -44.12 0.33 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.512 2.142 . . . . 0.0 111.675 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.5 t 58.44 115.13 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.797 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.417 ' ND2' ' N ' ' A' ' 7' ' ' MET . 4.3 p-10 40.84 -155.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.216 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.417 ' N ' ' ND2' ' A' ' 6' ' ' ASN . 6.7 tpt 73.13 30.53 1.58 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.714 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.5 t -61.37 133.33 55.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.346 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.548 ' O ' ' N ' ' A' ' 12' ' ' ALA . 0.5 OUTLIER -49.03 -56.55 8.65 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.476 ' O ' ' NE ' ' A' ' 14' ' ' ARG . 21.6 pt-20 -43.81 -31.38 0.82 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.431 ' O ' ' CD1' ' A' ' 15' ' ' ILE . 61.0 m -76.39 -23.59 54.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.49 0.662 . . . . 0.0 109.776 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -85.92 -74.61 0.41 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.937 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.764 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -42.59 -27.92 0.19 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.661 -178.628 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.476 ' NE ' ' O ' ' A' ' 10' ' ' GLU . 29.4 mtm180 -75.09 -39.98 60.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 15' ' ' ILE . 55.1 mt -63.63 -13.04 12.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.456 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.73 -17.51 24.14 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.797 0.332 . . . . 0.0 110.771 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -70.79 -32.44 69.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.17 -44.19 74.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.291 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.691 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.59 -37.02 1.04 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.012 0.434 . . . . 0.0 109.969 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.405 ' C ' ' H ' ' A' ' 22' ' ' LEU . 54.8 ttm-85 -63.55 -41.72 98.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.527 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.75 -7.12 0.89 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.55 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 20' ' ' ARG . 12.0 mt -119.0 114.06 35.41 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -79.35 68.94 8.13 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.657 1.571 . . . . 0.0 112.293 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.81 -49.6 0.56 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.3 m -66.79 133.77 50.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.971 0.415 . . . . 0.0 111.589 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.14 173.03 11.4 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.038 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.691 HG22 ' HB2' ' A' ' 19' ' ' ALA . 21.4 t -63.62 -63.55 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.139 0.495 . . . . 0.0 111.09 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.52 11.93 2.91 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.045 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.442 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 10.9 mm100 -99.62 -24.97 14.57 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.514 0.657 . . . . 0.0 110.607 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.7 tt -85.3 -19.8 30.98 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.926 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -93.96 -44.9 7.85 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.004 0.431 . . . . 0.0 109.981 179.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.427 ' C ' ' N ' ' A' ' 34' ' ' LEU . 84.2 mt-10 -56.45 -4.87 0.16 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.952 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.442 ' H ' ' C ' ' A' ' 31' ' ' LEU . 27.5 pt -52.13 -12.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.942 0.401 . . . . 0.0 110.515 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.427 ' N ' ' C ' ' A' ' 32' ' ' GLU . 33.9 mt -83.05 -22.15 33.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.825 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 58.22 174.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.221 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 60.53 109.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.284 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -51.01 146.6 5.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.478 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.8 tt -173.38 -23.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.735 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 52.71 -103.54 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.17 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.36 171.84 33.53 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.21 -174.08 1.1 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.755 2.303 . . . . 0.0 111.717 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 tp -157.48 99.27 1.74 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.082 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.9 p -101.64 179.82 4.23 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -75.53 -23.23 56.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.995 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -84.34 -31.53 24.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.426 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.2 t -53.1 -54.44 35.58 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.732 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.473 HD22 ' N ' ' A' ' 47' ' ' LEU . 3.7 mm? -57.15 -30.37 64.39 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.343 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -84.11 69.65 10.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.938 0.399 . . . . 0.0 110.533 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.0 -2.85 0.14 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.458 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -123.23 172.82 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.444 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 3.5 m -115.95 161.71 18.43 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.459 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.4 t -53.37 -44.26 54.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 123.213 0.321 . . . . 0.0 110.985 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 57' ' ' ILE . 3.6 m -58.12 -22.92 53.02 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.458 ' CB ' HG22 ' A' ' 50' ' ' VAL . 9.6 t0 -75.39 -31.93 60.62 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.452 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.726 HD12 ' N ' ' A' ' 55' ' ' LEU . 5.8 mp -64.5 -67.57 0.42 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.42 -177.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -52.12 -34.73 45.62 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 61' ' ' GLY . 12.6 pt -79.7 -19.17 12.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.71 -41.08 84.79 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.681 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.4 mm? -73.48 -54.37 8.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.583 -0.447 . . . . 0.0 109.833 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.75 -37.06 79.11 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 118.8 -51.96 0.73 Allowed Glycine 0 N--CA 1.468 0.809 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.593 ' C ' ' H ' ' A' ' 64' ' ' GLU . 83.8 p -138.38 145.91 41.63 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.75 0.31 . . . . 0.0 110.842 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -59.92 6.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.195 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.593 ' H ' ' C ' ' A' ' 62' ' ' SER . 32.7 mt-10 -82.3 -54.72 5.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.299 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -96.74 -5.3 38.93 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 m -44.82 -26.33 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.611 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -57.04 -32.17 65.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.017 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 25.3 mmm -92.04 -7.64 48.23 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.363 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.483 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 30.1 tp -49.57 -84.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.212 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 1.3 t70 154.23 -26.78 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.408 ' OG1' ' CD2' ' A' ' 69' ' ' LEU . 3.4 m -62.4 135.12 95.17 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.018 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.6 -92.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.793 1.662 . . . . 0.0 112.28 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -172.59 -26.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.1 m -88.52 -18.9 27.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.9 -35.84 81.73 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.714 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.944 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.4 mm? -64.46 -49.78 70.11 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -70.15 -9.21 54.93 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.954 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -86.04 -50.4 7.07 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.577 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -70.21 -57.84 4.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.301 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.411 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.3 p -35.22 -25.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.11 0.481 . . . . 0.0 111.167 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.577 ' N ' ' O ' ' A' ' 79' ' ' ALA . 21.4 ttm180 -78.44 -55.61 5.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.819 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.517 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 49.7 mt -50.72 -41.5 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.287 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.858 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.54 -35.82 52.88 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.309 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.401 ' CE3' ' O ' ' A' ' 80' ' ' VAL . 0.6 OUTLIER -45.86 -22.13 0.17 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.439 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.442 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 86.57 18.18 59.0 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 89' ' ' VAL . 85.0 mt-10 -111.29 -0.23 16.48 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.479 0.18 . . . . 0.0 110.518 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.517 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -31.86 -58.36 0.28 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.689 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -47.53 -40.45 18.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.749 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.499 ' N ' ' O ' ' A' ' 86' ' ' GLU . 48.0 t -72.52 78.58 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.342 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.463 ' CG ' ' N ' ' A' ' 91' ' ' SER . 7.5 p-10 -89.3 -56.63 3.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.799 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.463 ' N ' ' CG ' ' A' ' 90' ' ' ASP . 93.5 p -71.5 166.86 20.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.653 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.613 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.2 mm? -70.61 150.16 95.45 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.33 -38.17 2.15 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.132 1.888 . . . . 0.0 111.861 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.409 ' HG2' ' H ' ' A' ' 94' ' ' GLN . 3.2 pt20 -65.12 151.99 92.46 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.223 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -71.67 122.96 9.03 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.234 1.956 . . . . 0.0 111.947 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.0 t . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.589 -179.998 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.454 ' H ' ' ND2' ' A' ' 6' ' ' ASN . 12.5 t -98.57 84.95 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.555 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 2' ' ' VAL . 15.5 p 58.07 148.47 0.06 OUTLIER Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.659 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.482 ' O ' ' N ' ' A' ' 6' ' ' ASN . 73.1 Cg_exo -37.23 -62.46 0.28 Allowed 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.357 2.038 . . . . 0.0 112.61 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.2 t -61.99 74.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.95 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 4' ' ' PRO . 30.0 m120 -80.63 50.81 1.38 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.884 0.374 . . . . 0.0 110.267 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 17.3 ptp -167.63 157.87 10.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.302 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.3 m -92.47 123.2 35.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.958 0.409 . . . . 0.0 111.149 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 12' ' ' ALA . 6.4 ptm180 -55.25 -50.94 68.18 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.259 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -45.25 -30.41 1.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 m -75.43 -21.46 58.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.546 0.689 . . . . 0.0 109.532 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -86.47 -72.74 0.49 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.251 -1.341 . . . . 0.0 111.642 -179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.729 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -35.25 -51.26 0.57 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.637 -178.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.1 mtm-85 -50.04 -34.68 22.23 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.6 mm -64.16 -24.03 34.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.905 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.73 -19.8 22.23 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.567 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.99 -32.48 69.32 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -56.24 -43.93 79.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.329 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.688 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -40.41 -36.36 0.54 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.435 ' C ' ' H ' ' A' ' 22' ' ' LEU . 72.8 mtt-85 -65.9 -42.51 90.12 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.342 -0.39 . . . . 0.0 109.948 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.48 -6.14 0.65 Allowed 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.345 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.435 ' H ' ' C ' ' A' ' 20' ' ' ARG . 8.7 mt -121.11 112.41 33.27 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.633 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -83.5 65.46 7.56 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.959 1.773 . . . . 0.0 112.414 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.9 -35.87 0.62 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.472 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.8 m -81.9 135.0 35.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.947 0.403 . . . . 0.0 111.333 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.77 170.47 14.13 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.015 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.688 HG22 ' HB2' ' A' ' 19' ' ' ALA . 23.4 t -61.72 -61.44 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.75 10.32 4.19 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.19 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.419 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 21.0 mm100 -99.19 -25.4 14.53 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.427 0.614 . . . . 0.0 110.574 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.7 tp -88.09 -26.17 22.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.444 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 31' ' ' LEU . 3.4 mm? -82.72 -38.75 22.88 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.667 ' O ' ' HD2' ' A' ' 35' ' ' HIS . 26.0 tt0 -32.86 -32.08 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.772 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.603 ' N ' HD12 ' A' ' 33' ' ' ILE . 1.7 mp -51.99 -47.27 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.431 ' N ' ' O ' ' A' ' 31' ' ' LEU . 5.1 tp -64.29 -8.0 11.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.9 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.667 ' HD2' ' O ' ' A' ' 32' ' ' GLU . 52.7 m170 57.12 116.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.022 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.444 ' C ' ' H ' ' A' ' 38' ' ' ILE . 5.8 pt20 -177.86 50.63 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.58 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -59.4 -3.69 0.47 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.834 0.35 . . . . 0.0 110.67 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.444 ' H ' ' C ' ' A' ' 36' ' ' GLN . 10.1 pt -146.4 68.46 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.938 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 38' ' ' ILE . 15.6 mp0 55.33 163.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.285 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 161.75 -167.44 36.51 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -46.05 150.34 1.94 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.82 2.347 . . . . 0.0 112.232 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.1 tp -172.27 33.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.622 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 34.4 p -80.43 172.39 13.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.746 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -68.12 -26.7 65.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.891 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.451 ' CD ' ' N ' ' A' ' 45' ' ' GLU . 3.9 mp0 -85.9 -29.04 23.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.491 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.5 t -53.67 -47.47 70.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.115 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.527 HD22 ' N ' ' A' ' 47' ' ' LEU . 3.3 mm? -65.22 -34.7 78.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.677 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -78.06 63.9 3.13 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.388 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.64 1.34 0.6 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.457 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -130.16 173.62 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.469 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 36.0 m -116.0 164.8 13.9 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.463 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.2 t -55.23 -47.71 77.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 O-C-N 123.27 0.356 . . . . 0.0 111.313 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.4 m -54.81 -24.32 22.26 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.457 ' CB ' HG22 ' A' ' 50' ' ' VAL . 38.1 t0 -74.74 -31.76 61.91 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.846 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.719 HD12 ' N ' ' A' ' 55' ' ' LEU . 6.2 mp -65.27 -65.52 0.66 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.241 -178.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -53.63 -34.25 57.88 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.5 pt -78.77 -18.63 13.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.66 -38.79 67.49 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.656 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.5 mm? -74.76 -55.5 5.78 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.47 -37.15 84.48 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 100.26 -28.9 13.63 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.801 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.597 ' C ' ' H ' ' A' ' 64' ' ' GLU . 14.9 p -138.2 132.42 31.82 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.386 0.612 . . . . 0.0 112.131 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.434 ' HG3' ' H ' ' A' ' 63' ' ' GLU . 2.2 mt-10 -58.59 7.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.867 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.597 ' H ' ' C ' ' A' ' 62' ' ' SER . 54.2 mt-10 -93.81 -52.44 4.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.895 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -80.96 -16.28 53.93 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.3 m -50.18 -23.69 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.263 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -61.04 -30.39 70.28 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.425 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 37.8 mtt -91.77 -34.34 14.64 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.982 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.2 tp -49.28 108.4 0.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.944 0.402 . . . . 0.0 110.06 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -42.84 -24.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.812 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 72' ' ' PRO . 14.8 m -45.69 106.29 0.54 Allowed Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.633 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.447 ' O ' HD21 ' A' ' 76' ' ' LEU . 52.5 Cg_exo -52.73 -168.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.311 1.341 . . . . 0.0 111.262 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 40.8 ttp -106.07 -7.55 17.96 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.2 t -100.18 -26.27 13.99 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.209 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.02 -34.5 70.11 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.036 0.445 . . . . 0.0 110.301 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.915 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -67.78 -59.66 3.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.563 0.696 . . . . 0.0 109.603 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -60.08 -10.17 4.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.205 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -87.64 -52.88 5.08 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -68.84 -56.74 7.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.182 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.424 ' O ' ' CE3' ' A' ' 84' ' ' TRP . 1.4 p -35.06 -25.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 121.219 0.533 . . . . 0.0 111.316 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 79' ' ' ALA . 39.5 ttm180 -78.75 -56.58 4.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.565 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.557 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 41.8 mt -47.33 -42.48 7.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.896 -178.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.845 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.37 -36.17 53.82 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.892 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.424 ' CE3' ' O ' ' A' ' 80' ' ' VAL . 0.7 OUTLIER -46.63 -24.35 0.53 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.674 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 90.63 18.94 46.36 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' A' ' 88' ' ' GLU . 45.2 mt-10 -110.15 -0.05 18.07 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.557 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -35.94 -26.58 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.358 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 86' ' ' GLU . 67.0 mm-40 -52.01 -60.84 2.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.238 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 89' ' ' VAL . 18.0 m -74.74 40.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.026 -179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.403 ' H ' ' C ' ' A' ' 88' ' ' GLU . 14.3 t70 -87.7 102.84 15.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.782 0.325 . . . . 0.0 110.362 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.0 t -75.51 158.61 32.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.232 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.663 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.0 mm? -78.87 149.68 74.25 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.015 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -37.68 -44.09 1.53 Allowed 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 122.141 1.894 . . . . 0.0 112.192 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -75.01 153.2 86.64 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.111 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.46 101.14 1.1 Allowed 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.199 1.932 . . . . 0.0 111.835 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.536 -179.899 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.544 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.8 mpt? . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 2' ' ' VAL . 17.2 m -72.12 -178.23 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.511 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.5 m 49.3 68.26 3.68 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.472 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -46.07 169.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.881 2.388 . . . . 0.0 112.196 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.0 m -152.35 -165.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.239 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 51.29 94.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.465 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.44 ' SD ' ' O ' ' A' ' 7' ' ' MET . 0.0 OUTLIER -165.49 15.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.734 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.2 m -68.35 179.07 1.72 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.613 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 12' ' ' ALA . 9.6 ptp180 -50.58 -57.5 8.02 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.652 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -43.95 -35.59 2.1 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.6 m -72.18 -19.46 61.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.549 0.69 . . . . 0.0 109.724 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -90.04 -71.36 0.62 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.469 -1.242 . . . . 0.0 111.844 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.69 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -40.99 -51.53 3.24 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.329 -178.685 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.752 HH21 ' HB3' ' A' ' 87' ' ' ALA . 71.9 mtp180 -43.54 -43.33 5.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.645 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 mm -63.53 -21.62 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.625 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -97.45 -17.24 19.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -69.73 -32.28 70.73 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.07 -46.03 71.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.313 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.66 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -39.7 -36.37 0.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.337 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.481 ' C ' ' H ' ' A' ' 22' ' ' LEU . 73.6 ttt-85 -64.33 -42.37 96.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.837 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.39 -4.72 0.41 Allowed 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.348 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 20' ' ' ARG . 8.5 mt -122.8 111.96 30.86 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.566 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.04 67.18 8.71 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 121.713 1.609 . . . . 0.0 112.22 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.39 -43.97 0.58 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.637 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.3 m -75.2 133.43 41.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.938 0.399 . . . . 0.0 111.34 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.64 173.3 11.49 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.081 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.66 HG22 ' HB2' ' A' ' 19' ' ' ALA . 22.2 t -62.8 -62.59 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.672 -179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.84 11.37 3.52 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.091 -178.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.456 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 20.1 mm-40 -100.14 -24.36 14.6 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 117.487 0.644 . . . . 0.0 110.891 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.107 ' O ' HD13 ' A' ' 33' ' ' ILE . 6.6 tt -92.79 -23.52 18.84 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.981 -179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 33' ' ' ILE . 25.6 mt -76.22 -37.37 57.84 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.87 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -36.16 -25.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.917 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.107 HD13 ' O ' ' A' ' 30' ' ' LEU . 1.9 mp -48.13 -68.87 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.556 -0.458 . . . . 0.0 109.963 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.501 ' C ' HD23 ' A' ' 34' ' ' LEU . 4.9 tt -68.14 -61.32 1.91 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.498 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -44.5 153.5 0.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.95 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.46 ' C ' ' H ' ' A' ' 38' ' ' ILE . 5.2 mt-30 60.16 160.74 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.704 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 66.22 -3.06 0.86 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.481 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.476 HG23 ' N ' ' A' ' 39' ' ' GLU . 9.0 tp -163.01 -41.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.821 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.476 ' N ' HG23 ' A' ' 38' ' ' ILE . 95.0 mt-10 54.71 163.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.852 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.14 -161.63 28.97 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.504 ' C ' HD13 ' A' ' 42' ' ' LEU . 76.4 Cg_exo -47.11 168.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.292 1.994 . . . . 0.0 111.763 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.868 ' N ' HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -139.39 27.57 2.3 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.881 0.372 . . . . 0.0 110.378 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.0 p -72.94 167.99 19.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.597 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -73.51 -22.57 60.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.245 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -87.44 -32.3 19.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.317 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.4 t -53.44 -46.2 69.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.224 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -50.22 -21.23 1.26 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.936 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -70.51 70.76 0.45 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.361 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.22 7.45 0.74 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.78 175.7 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.488 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 9.0 m -113.21 163.84 14.28 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.503 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.4 t -56.27 -43.77 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 123.209 0.318 . . . . 0.0 111.414 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.8 m -55.33 -25.72 36.43 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -76.47 -30.94 57.49 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.912 0.387 . . . . 0.0 111.544 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 55' ' ' LEU . 5.6 mp -65.62 -65.09 0.72 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -50.81 -34.86 29.39 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 61' ' ' GLY . 8.9 pt -83.08 -21.69 8.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.336 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.26 -38.12 95.68 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.727 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.1 mm? -74.59 -62.3 1.58 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.711 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.11 -34.17 77.04 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.325 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 86.93 -8.74 74.96 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.479 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.506 ' C ' ' H ' ' A' ' 64' ' ' GLU . 1.9 m -138.01 104.52 5.27 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 117.106 0.453 . . . . 0.0 112.022 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -54.24 -6.5 0.1 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.218 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' A' ' 62' ' ' SER . 28.3 mp0 -83.76 -45.25 13.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.719 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.06 -12.97 34.09 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.416 ' C ' ' N ' ' A' ' 68' ' ' MET . 12.9 m -50.66 -29.39 6.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.105 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -51.52 -15.12 0.38 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.48 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.416 ' N ' ' C ' ' A' ' 66' ' ' VAL . 48.6 mtt -104.45 -25.81 12.66 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.741 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.463 ' HG ' ' H ' ' A' ' 71' ' ' THR . 38.7 tp -51.86 119.26 4.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.165 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -38.99 -29.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.444 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.463 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 33.1 m -65.9 115.08 19.52 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.643 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.487 ' O ' HD21 ' A' ' 76' ' ' LEU . 60.4 Cg_endo -71.27 -156.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.261 1.307 . . . . 0.0 111.43 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -102.15 -17.58 15.94 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.823 0.344 . . . . 0.0 111.526 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 67.3 m -92.35 -22.96 19.4 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.702 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -63.61 -32.81 74.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.41 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.862 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.0 OUTLIER -66.37 -48.05 71.39 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.422 -0.911 . . . . 0.0 108.922 179.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -32.34 66.51 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.48 -58.77 3.2 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.303 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.597 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -62.45 -63.25 1.29 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.403 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 p -34.56 -24.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.991 0.424 . . . . 0.0 111.673 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 79' ' ' ALA . 32.4 ttm180 -78.24 -57.53 3.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 109.82 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.464 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 42.0 mt -48.09 -41.44 9.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.148 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.824 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -77.44 -36.28 53.24 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.332 179.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -49.75 -15.1 0.15 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.482 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 79.46 19.53 71.22 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 88' ' ' GLU . 79.4 mt-10 -113.0 7.1 18.01 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.752 ' HB3' HH21 ' A' ' 14' ' ' ARG . . . -35.73 -26.01 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.279 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 86' ' ' GLU . 28.9 mt-10 -37.48 -69.25 0.12 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.222 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.5 t -60.77 75.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.426 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 88' ' ' GLU . 46.3 t0 -91.9 140.53 29.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.556 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 85.4 p -62.89 153.96 31.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.285 0.564 . . . . 0.0 110.552 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.499 ' CD1' ' N ' ' A' ' 92' ' ' LEU . 6.8 mp -88.7 154.78 50.66 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.276 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -35.14 95.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 122.49 2.127 . . . . 0.0 112.243 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -53.91 129.67 56.93 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.223 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.22 121.43 6.49 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.759 1.639 . . . . 0.0 111.826 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.533 -179.959 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.7 mtt . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.8 m -80.64 138.54 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.676 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.3 m -158.52 63.57 2.56 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.371 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -42.19 160.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.739 2.293 . . . . 0.0 112.388 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.3 p -161.32 153.06 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.339 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 7' ' ' MET . 8.2 p30 -170.01 -106.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.341 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.402 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 23.7 ttt -46.82 115.9 1.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.793 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.2 t -83.36 -156.26 0.19 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.822 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.693 ' O ' HD13 ' A' ' 13' ' ' LEU . 12.6 tpt180 -136.83 -28.3 0.97 Allowed 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 116.713 -0.222 . . . . 0.0 111.208 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.47 ' CD ' ' H ' ' A' ' 10' ' ' GLU . 1.2 pm0 -95.23 -27.14 15.66 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.33 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.566 ' C ' ' H ' ' A' ' 13' ' ' LEU . 22.2 m -84.88 -44.95 12.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.43 0.633 . . . . 0.0 110.155 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.526 ' C ' HD12 ' A' ' 13' ' ' LEU . . . -66.55 14.44 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.538 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.693 HD13 ' O ' ' A' ' 9' ' ' ARG . 7.0 mp -117.13 -35.51 4.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.932 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.664 ' HE ' ' CB ' ' A' ' 87' ' ' ALA . 15.4 ttt85 -71.54 -32.31 67.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.229 -178.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.3 mm -54.35 -16.19 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.476 ' HA ' HG13 ' A' ' 27' ' ' VAL . . . -97.75 -25.35 15.1 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.248 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.91 -38.2 84.9 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.14 -42.34 69.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.377 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.679 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.82 -38.89 1.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.12 178.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.453 ' C ' ' H ' ' A' ' 22' ' ' LEU . 39.0 ttt85 -66.08 -42.26 89.6 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.839 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.48 -5.77 0.24 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.975 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 20' ' ' ARG . 8.6 mt -122.39 105.45 36.4 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.423 -178.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -80.48 78.06 3.82 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 121.562 1.508 . . . . 0.0 112.086 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.62 -30.64 1.26 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.6 m -96.18 142.7 28.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.026 0.441 . . . . 0.0 111.296 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.14 178.52 6.61 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.219 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.679 HG22 ' HB2' ' A' ' 19' ' ' ALA . 22.9 t -66.4 -65.47 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.904 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.74 13.77 3.9 Favored Glycine 0 CA--C 1.522 0.473 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.129 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -100.33 -16.11 17.78 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.166 0.483 . . . . 0.0 110.472 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 pp -94.65 -20.81 19.24 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 pp -99.95 -39.59 8.08 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.249 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -55.47 -8.22 0.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 73.0 mt -43.72 -51.32 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.779 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.582 HD12 ' N ' ' A' ' 34' ' ' LEU . 8.0 mp -64.66 -61.72 2.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.268 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.516 ' CG ' ' O ' ' A' ' 34' ' ' LEU . 68.5 m80 -157.74 -112.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.353 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -161.96 -134.93 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.756 0.312 . . . . 0.0 110.462 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -97.4 79.42 2.77 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.748 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 38' ' ' ILE . 23.9 mt -83.39 -74.14 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.377 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.23 -170.57 2.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.409 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.33 176.45 3.62 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.61 -176.36 3.21 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.838 2.359 . . . . 0.0 112.129 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.417 ' C ' HD23 ' A' ' 42' ' ' LEU . 1.6 tt -159.15 82.11 0.77 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.955 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 p -94.31 159.66 15.02 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.577 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -53.65 -21.64 7.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.427 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -81.67 -34.37 30.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.007 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.4 t -59.93 -32.44 70.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.374 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.0 tp -69.65 -5.12 22.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.825 0.345 . . . . 0.0 110.75 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -85.52 71.73 10.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.512 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.34 7.44 0.84 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 120.949 -0.644 . . . . 0.0 111.643 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.1 177.92 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.676 0.274 . . . . 0.0 110.361 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.48 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 33.7 m -112.78 162.46 15.75 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.505 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.9 t -57.2 -44.32 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 120.667 0.27 . . . . 0.0 111.139 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.9 m -56.88 -22.07 34.34 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -77.25 -30.59 54.51 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.211 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.73 HD12 ' N ' ' A' ' 55' ' ' LEU . 5.9 mp -65.93 -64.47 0.85 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.211 -177.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -52.99 -34.13 54.74 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 61' ' ' GLY . 7.4 pt -83.38 -18.86 10.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.668 0.271 . . . . 0.0 110.948 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.29 -33.22 86.66 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.757 HD22 ' N ' ' A' ' 59' ' ' LEU . 1.8 mm? -79.23 -57.25 3.81 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.578 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.58 -32.78 64.3 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.125 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 84.75 -5.11 83.3 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.538 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.511 ' C ' ' H ' ' A' ' 64' ' ' GLU . 69.0 m -137.9 99.22 3.84 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.942 0.401 . . . . 0.0 111.635 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 63' ' ' GLU . 0.1 OUTLIER -50.88 -8.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.72 179.246 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.511 ' H ' ' C ' ' A' ' 62' ' ' SER . 32.6 tt0 -87.62 -41.31 13.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.835 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -89.8 -18.17 26.78 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.6 m -46.74 -23.07 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.967 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 67' ' ' ASP . 56.1 t0 -50.72 -34.57 27.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.46 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 68' ' ' MET . 0.0 OUTLIER -82.5 -32.83 28.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.637 179.761 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.403 ' HG ' ' H ' ' A' ' 71' ' ' THR . 25.3 tp -49.91 116.22 1.72 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.114 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -42.45 -26.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.89 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.403 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 6.7 m -62.15 112.51 6.47 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 119.343 -0.36 . . . . 0.0 110.699 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.517 ' O ' HD21 ' A' ' 76' ' ' LEU . 72.5 Cg_endo -73.47 -157.58 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.345 1.364 . . . . 0.0 111.748 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.7 ttm -103.72 -10.85 18.01 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.557 0.217 . . . . 0.0 110.776 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.2 m -94.51 -23.2 17.79 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.881 0.372 . . . . 0.0 110.39 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -63.93 -36.24 83.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.921 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -67.55 -47.26 70.34 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.654 -0.818 . . . . 0.0 109.092 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -26.03 61.06 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.48 -57.88 3.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.721 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.21 -64.69 0.86 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.06 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.427 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.2 p -34.89 -27.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.3 0.571 . . . . 0.0 111.146 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.564 ' N ' ' O ' ' A' ' 79' ' ' ALA . 23.7 ttm180 -78.47 -55.84 4.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.654 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.475 ' N ' ' O ' ' A' ' 79' ' ' ALA . 33.7 mt -47.68 -41.53 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.22 -178.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.854 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -78.16 -34.99 49.37 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.714 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -52.49 -14.26 0.47 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.744 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.429 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 81.12 17.71 71.32 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 87' ' ' ALA . 52.0 mt-10 -114.05 8.84 17.17 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.664 ' CB ' ' HE ' ' A' ' 14' ' ' ARG . . . -31.89 -48.81 0.16 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.776 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -55.83 139.5 45.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.67 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.5 m -85.92 179.07 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.744 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -95.55 -95.39 0.18 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.793 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.0 t -62.05 -179.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.736 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.656 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.0 mm? -81.08 150.23 67.99 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.012 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -37.75 108.78 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 122.156 1.904 . . . . 0.0 112.259 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.621 ' N ' ' CD ' ' A' ' 95' ' ' PRO . 6.0 tm0? -78.67 -36.11 1.18 Allowed Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.265 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 94' ' ' GLN . 32.1 Cg_exo -57.49 171.83 1.22 Allowed 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.176 1.917 . . . . 0.0 111.987 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.912 -1.042 . . . . 0.0 110.506 179.877 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 mtt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.78 151.59 9.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.468 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.3 m -148.11 84.24 6.91 Favored Pre-proline 0 CA--C 1.53 0.195 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.335 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.96 151.03 4.19 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.513 2.142 . . . . 0.0 112.262 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.82 -4.01 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.131 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -51.19 -17.84 0.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.54 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -171.39 54.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.589 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.443 ' OG ' ' N ' ' A' ' 9' ' ' ARG . 26.5 t -61.0 179.91 0.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.259 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.48 ' O ' ' N ' ' A' ' 12' ' ' ALA . 14.5 ptt85 -50.29 -56.03 12.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.558 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.462 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 19.4 pt-20 -45.68 -35.15 3.95 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.4 m -71.7 -16.78 62.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.445 0.641 . . . . 0.0 109.672 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -94.03 -71.14 0.67 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.955 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.656 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -50.2 -49.85 51.34 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.518 -178.382 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -44.42 -48.9 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.973 0.416 . . . . 0.0 110.992 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.2 mm -65.39 -15.47 18.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.586 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.73 -16.68 17.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.093 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -71.62 -30.14 65.45 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -59.38 -42.04 90.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.512 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.694 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -40.35 -33.44 0.25 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.461 ' C ' ' H ' ' A' ' 22' ' ' LEU . 56.7 ttt-85 -69.26 -42.48 75.51 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.294 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -56.73 -7.65 0.47 Allowed 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.078 0.466 . . . . 0.0 110.207 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' ' 79' ' ' ALA . 14.0 mt -113.91 149.69 42.27 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.855 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.18 -88.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.094 1.863 . . . . 0.0 112.552 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.34 -7.03 52.65 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.455 -0.403 . . . . 0.0 112.303 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.9 m -60.84 137.51 58.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.149 0.474 . . . . 0.0 110.628 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.16 164.34 13.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.985 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.694 HG22 ' HB2' ' A' ' 19' ' ' ALA . 17.0 t -55.2 -53.27 36.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.659 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.82 5.37 24.6 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.451 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -97.23 -24.34 15.75 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.74 0.77 . . . . 0.0 110.305 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 pp -84.12 -24.72 30.15 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.352 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 34' ' ' LEU . 6.6 tp -91.59 -34.82 14.57 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.882 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 31' ' ' LEU . 78.7 tt0 -34.29 -49.99 0.4 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.777 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 33' ' ' ILE . 2.3 tt -65.47 -37.43 80.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.426 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 31' ' ' LEU . 19.5 mt -82.93 -3.09 56.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.646 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.786 ' O ' HG22 ' A' ' 38' ' ' ILE . 10.8 t-80 -64.6 -0.01 1.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.126 0.489 . . . . 0.0 110.04 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 1.356 ' HG3' ' NH2' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -90.81 171.53 9.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.596 -180.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 1.356 ' NH2' ' HG3' ' A' ' 36' ' ' GLN . 23.3 mtm-85 45.48 15.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.872 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.786 HG22 ' O ' ' A' ' 35' ' ' HIS . 19.3 tt -110.23 159.21 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.238 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 40' ' ' GLY . 78.6 mt-10 -145.63 -109.33 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.928 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 39' ' ' GLU . . . -56.7 -160.2 0.02 OUTLIER Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.69 81.87 2.5 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.429 2.086 . . . . 0.0 112.326 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.29 159.13 15.71 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.826 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 p -87.7 157.54 19.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.606 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -60.23 -21.89 62.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.686 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -68.36 -44.65 74.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.662 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.4 t -55.97 -36.79 68.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.627 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 49' ' ' GLY . 1.3 tt -45.65 -41.02 9.8 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.049 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -61.41 70.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.514 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 47' ' ' LEU . . . -151.9 13.56 0.75 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.503 HG21 HD21 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -128.63 173.05 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.471 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 40.3 m -112.75 161.59 16.71 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.512 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.6 t -55.62 -39.93 57.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 120.798 0.332 . . . . 0.0 110.546 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 m -58.62 -25.11 62.32 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.053 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -75.47 -31.64 60.33 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.183 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.758 HD12 ' N ' ' A' ' 55' ' ' LEU . 4.9 mp -66.45 -60.85 2.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.439 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -56.91 -36.04 69.71 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 61' ' ' GLY . 15.6 pt -75.93 -29.66 20.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.62 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.26 -27.49 39.76 Favored Glycine 0 CA--C 1.517 0.195 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.5 HD23 ' N ' ' A' ' 59' ' ' LEU . 3.8 mt -83.27 -64.15 1.22 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.805 -0.697 . . . . 0.0 112.433 -176.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.76 -20.93 60.36 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.169 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 70.83 -0.61 27.81 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.399 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.488 ' C ' ' H ' ' A' ' 64' ' ' GLU . 15.0 t -136.0 95.69 3.26 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.929 0.395 . . . . 0.0 111.437 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -54.29 -6.41 0.1 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.707 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.488 ' H ' ' C ' ' A' ' 62' ' ' SER . 28.8 mt-10 -90.23 -32.49 16.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.732 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -101.53 -11.64 19.12 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 m -52.82 -25.46 8.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.443 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -53.74 -23.33 11.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.208 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 7.0 mmt -94.83 -31.11 13.87 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.663 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.476 ' CD2' ' OG1' ' A' ' 71' ' ' THR . 30.4 tp -49.67 127.47 15.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.219 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -39.74 -31.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.391 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.476 ' OG1' ' CD2' ' A' ' 69' ' ' LEU . 1.4 m -48.57 110.28 1.42 Allowed Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.616 ' C ' ' H ' ' A' ' 74' ' ' SER . 91.5 Cg_endo -80.23 29.48 0.51 Allowed 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.321 2.014 . . . . 0.0 113.507 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.468 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 19.4 ttp 55.78 -7.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.616 ' H ' ' C ' ' A' ' 72' ' ' PRO . 22.8 t -100.82 -16.14 17.38 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.165 0.507 . . . . 0.0 109.91 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -74.02 -31.22 62.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.264 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.921 ' H ' HD22 ' A' ' 76' ' ' LEU . 1.1 mm? -65.9 -51.8 55.58 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.63 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.5 OUTLIER -48.25 -36.97 15.02 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.254 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.63 -59.05 3.05 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.375 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.573 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -61.5 -62.86 1.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.482 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.455 ' N ' ' O ' ' A' ' 76' ' ' LEU . 2.1 p -35.26 -25.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 121.007 0.432 . . . . 0.0 111.475 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 79' ' ' ALA . 28.1 ttm180 -78.3 -56.47 4.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.635 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.488 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 44.7 mt -47.78 -43.81 10.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.849 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.854 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -75.48 -36.51 60.62 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 119.253 -0.979 . . . . 0.0 109.751 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -46.9 -22.08 0.28 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.836 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.419 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 88.18 13.87 63.25 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 87' ' ' ALA . 5.5 tp10 -109.28 2.54 20.89 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -28.96 -42.68 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.996 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -56.05 135.8 52.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.772 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 89' ' ' VAL . 10.7 p -84.28 128.0 39.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.269 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -84.77 -75.78 0.34 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.6 m -72.11 -155.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.75 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.669 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.1 mm? -77.2 149.59 79.5 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.922 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.18 -91.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.059 1.839 . . . . 0.0 111.829 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -74.35 152.02 87.8 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.21 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.91 104.31 1.61 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.216 1.944 . . . . 0.0 111.785 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.571 -179.951 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.6 mtt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 2' ' ' VAL . 7.4 p -64.45 116.04 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.037 0.446 . . . . 0.0 110.495 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 2' ' ' VAL . 22.6 m -167.5 65.8 0.77 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.237 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.12 159.32 37.35 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.587 2.191 . . . . 0.0 112.144 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.411 ' O ' ' O ' ' A' ' 6' ' ' ASN . 11.7 t -143.51 -57.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.272 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.547 HD22 ' H ' ' A' ' 6' ' ' ASN . 1.3 p30 -56.07 -111.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.765 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.438 ' H ' ' CG ' ' A' ' 6' ' ' ASN . 11.6 mmt -138.33 -60.97 0.61 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.646 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.9 t -120.46 158.39 27.33 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.107 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.575 ' O ' ' N ' ' A' ' 12' ' ' ALA . 4.1 ptm85 -79.61 -25.76 41.39 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.096 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.44 ' OE2' ' O ' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -50.39 -29.57 10.38 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.818 179.467 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.466 ' O ' ' CD1' ' A' ' 15' ' ' ILE . 83.3 m -71.09 -25.4 62.6 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.575 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -81.76 -71.19 0.49 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.688 -1.596 . . . . 0.0 110.801 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.539 ' CD1' ' H ' ' A' ' 13' ' ' LEU . 5.9 mp -32.62 -40.77 0.05 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.162 -0.926 . . . . 0.0 113.017 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 46.3 mtt85 -78.27 -32.08 49.34 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.466 ' CD1' ' O ' ' A' ' 11' ' ' THR . 63.9 mt -66.11 -16.14 20.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.75 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.36 -17.28 21.72 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.275 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.435 HD23 ' O ' ' A' ' 13' ' ' LEU . 1.9 mm? -73.25 -30.42 63.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -55.37 -42.22 73.64 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.096 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.687 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -41.12 -36.3 0.7 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.171 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 22' ' ' LEU . 70.9 mtp180 -63.68 -40.3 96.46 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.58 -4.32 0.4 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.443 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.48 ' H ' ' C ' ' A' ' 20' ' ' ARG . 10.2 mt -122.89 115.55 29.26 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -82.01 64.02 8.38 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.814 1.676 . . . . 0.0 112.437 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.57 -48.84 0.48 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.56 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.2 m -68.41 133.46 48.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.959 0.409 . . . . 0.0 111.225 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.22 171.45 11.94 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.025 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.687 HG22 ' HB2' ' A' ' 19' ' ' ALA . 21.7 t -60.93 -60.38 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.431 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.1 9.32 7.01 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.595 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.48 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 28.0 mm100 -99.61 -18.95 17.08 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 117.948 0.874 . . . . 0.0 110.411 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.5 tp -93.36 -19.64 21.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.063 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 21.6 mt -95.12 -42.54 8.54 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 110.849 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -54.73 -20.72 8.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.042 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.406 ' C ' HD12 ' A' ' 33' ' ' ILE . 2.3 pp -49.16 -17.93 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.998 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.4 mt -60.6 -89.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.393 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.17 -135.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.29 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -46.35 167.7 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.813 0.339 . . . . 0.0 110.384 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -83.03 -76.41 0.28 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.532 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 39' ' ' GLU . 40.1 pt -44.48 140.38 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.869 0.366 . . . . 0.0 110.768 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.438 ' O ' ' O ' ' A' ' 38' ' ' ILE . 0.6 OUTLIER 55.59 113.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.64 -76.88 0.2 Allowed Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.28 69.2 1.95 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.656 2.238 . . . . 0.0 111.526 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.1 mt -84.53 -107.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.05 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.01 169.53 11.12 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.772 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.431 ' OE2' ' O ' ' A' ' 83' ' ' LEU . 32.0 tt0 -62.76 -27.17 69.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.494 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -64.3 -39.2 93.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.568 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.3 p -59.8 -43.81 94.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.494 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.492 ' N ' HD12 ' A' ' 47' ' ' LEU . 10.9 mp -59.45 -33.66 71.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.881 0.372 . . . . 0.0 110.334 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -75.97 73.89 2.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.816 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -157.66 14.56 0.29 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.447 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.4 OUTLIER -124.96 174.19 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.686 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.441 ' N ' HG13 ' A' ' 50' ' ' VAL . 14.1 m -115.33 160.13 20.2 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.479 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.2 t -53.32 -37.82 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 120.788 0.328 . . . . 0.0 110.494 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 m -61.09 -25.28 66.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.998 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.447 ' CB ' HG22 ' A' ' 50' ' ' VAL . 11.2 t0 -74.56 -30.55 61.78 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.64 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.749 HD12 ' N ' ' A' ' 55' ' ' LEU . 5.9 mp -66.67 -66.53 0.54 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -51.39 -34.79 36.02 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 61' ' ' GLY . 9.6 pt -82.03 -17.36 11.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.28 -41.27 79.53 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.808 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.727 HD22 ' N ' ' A' ' 59' ' ' LEU . 1.9 mm? -74.93 -52.41 11.27 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.789 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.39 -37.93 74.59 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 116.81 -51.57 0.72 Allowed Glycine 0 N--CA 1.468 0.833 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.504 ' C ' ' H ' ' A' ' 64' ' ' GLU . 46.0 p -135.63 141.23 45.02 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.089 0.471 . . . . 0.0 111.116 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -57.91 1.15 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.347 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.504 ' H ' ' C ' ' A' ' 62' ' ' SER . 72.2 mm-40 -75.92 -53.88 7.74 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.422 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -93.24 -9.01 40.63 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -177.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.4 m -50.16 -24.2 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.517 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.26 -15.32 2.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.616 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 52.6 mtp -99.37 -34.76 10.16 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.62 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.7 tp -51.07 124.57 11.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.228 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -61.38 -22.97 65.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.345 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.1 m -49.68 107.65 0.83 Allowed Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.413 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.95 -171.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.224 1.283 . . . . 0.0 111.808 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.3 ptm -98.17 -22.02 16.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.724 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.9 t -89.06 -25.38 21.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.437 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.48 -33.47 69.82 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.302 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.595 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -67.39 -52.96 33.6 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.429 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -65.09 -9.44 22.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.466 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -87.61 -52.18 5.48 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -70.04 -57.79 4.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.587 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.409 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 1.5 p -34.8 -28.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.287 0.565 . . . . 0.0 110.943 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' A' ' 79' ' ' ALA . 20.4 ttm105 -74.04 -62.12 1.61 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.807 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.435 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 55.5 mt -45.44 -39.94 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.897 -178.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.883 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -81.42 -28.52 34.23 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.472 179.306 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -64.89 2.87 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.481 -0.488 . . . . 0.0 109.793 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 83' ' ' LEU . . . 65.93 22.16 70.15 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -107.26 2.23 24.48 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.921 0.391 . . . . 0.0 110.157 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.435 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -40.03 -68.88 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.956 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -50.24 -34.66 23.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.723 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.5 t -77.94 84.41 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.814 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -95.56 150.56 20.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.555 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.1 t -68.29 171.01 7.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.551 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.655 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.1 mm? -76.15 149.74 82.49 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.817 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.35 -40.87 1.42 Allowed 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.102 1.868 . . . . 0.0 112.026 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -71.52 129.33 88.82 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.213 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -76.21 80.67 2.64 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.737 1.625 . . . . 0.0 111.845 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.3 t . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.676 -179.956 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 mtm . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 2' ' ' VAL . 10.9 p -161.66 15.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.094 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.3 p -137.79 69.32 51.43 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.045 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -47.83 119.88 4.22 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.676 2.251 . . . . 0.0 112.367 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.4 p -54.46 142.43 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.208 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -160.75 113.63 2.0 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.641 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 39.4 mtm -130.05 175.04 9.21 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.219 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.5 m -88.3 119.14 28.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.596 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.596 ' O ' ' N ' ' A' ' 12' ' ' ALA . 10.6 ptm180 -51.5 -57.06 10.07 Favored 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.405 ' H ' ' CG ' ' A' ' 9' ' ' ARG . 87.5 tt0 -35.39 -28.21 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 9' ' ' ARG . 50.9 m -84.62 -31.41 24.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.197 0.522 . . . . 0.0 110.51 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.596 ' N ' ' O ' ' A' ' 9' ' ' ARG . . . -84.23 4.65 29.85 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.634 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.444 HD23 ' C ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -115.42 -36.9 4.16 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 120.81 0.338 . . . . 0.0 110.474 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 71.3 mtm180 -84.63 -36.41 22.01 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.44 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 1.2 mp -65.35 -8.92 6.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.257 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.18 -16.81 25.75 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.806 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.34 -30.5 63.38 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 21' ' ' ALA . . . -54.94 -44.99 74.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.732 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.622 ' HB2' HG22 ' A' ' 27' ' ' VAL . . . -40.91 -36.16 0.61 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.98 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.443 ' C ' ' H ' ' A' ' 22' ' ' LEU . 57.1 mtp85 -68.1 -40.56 82.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.162 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 18' ' ' ALA . . . -58.08 -6.8 0.65 Allowed 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 120.945 0.402 . . . . 0.0 110.496 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.443 ' H ' ' C ' ' A' ' 20' ' ' ARG . 11.4 mt -118.75 120.3 31.72 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.814 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.3 71.31 7.1 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.879 1.72 . . . . 0.0 112.557 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.42 -54.75 0.6 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.6 m -59.63 128.33 36.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.923 0.392 . . . . 0.0 110.949 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.416 ' HB ' HE21 ' A' ' 29' ' ' GLN . 0.0 OUTLIER -86.82 178.19 7.07 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.29 0.567 . . . . 0.0 110.875 -179.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.622 HG22 ' HB2' ' A' ' 19' ' ' ALA . 11.8 t -61.8 -58.77 6.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.904 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.421 ' C ' ' NE2' ' A' ' 29' ' ' GLN . . . -66.43 2.89 3.9 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.675 -178.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.646 ' N ' ' NE2' ' A' ' 29' ' ' GLN . 1.1 mp0 -100.38 -30.46 11.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.575 0.688 . . . . 0.0 111.236 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 pp -88.37 -27.45 21.6 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.537 HD13 ' O ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -85.71 -41.18 15.37 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.718 0.294 . . . . 0.0 110.733 -179.234 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 34' ' ' LEU . 35.0 tp10 -41.41 -26.52 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.296 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 33' ' ' ILE . 28.4 pt -45.62 -12.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.311 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 32' ' ' GLU . 39.5 tp -64.7 -26.47 68.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.258 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.0 m170 55.28 -132.36 1.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.611 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.434 ' O ' ' CG ' ' A' ' 36' ' ' GLN . 3.6 pt20 -40.16 111.64 0.21 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.029 0.443 . . . . 0.0 110.936 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -72.66 82.89 1.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.551 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.586 HG23 ' O ' ' A' ' 38' ' ' ILE . 14.3 tt -65.89 116.02 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.177 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.435 ' O ' ' O ' ' A' ' 38' ' ' ILE . 10.4 mm-40 56.18 158.46 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.523 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.86 -82.52 0.09 OUTLIER Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.194 -0.527 . . . . 0.0 111.858 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -34.22 146.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.842 2.361 . . . . 0.0 113.029 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.488 HD21 HD22 ' A' ' 34' ' ' LEU . 8.0 tp -167.28 93.16 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.877 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.31 166.53 12.25 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.231 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.21 -23.71 56.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.478 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.501 ' HA ' HE21 ' A' ' 48' ' ' GLN . 33.0 mt-10 -61.01 -47.99 83.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.239 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.5 t -59.27 -47.51 85.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.92 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -44.8 -25.48 0.3 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.42 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.501 HE21 ' HA ' ' A' ' 45' ' ' GLU . 34.9 mt-30 -75.41 52.14 0.6 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.324 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -136.0 15.87 3.99 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.432 HG22 ' CB ' ' A' ' 54' ' ' ASP . 0.3 OUTLIER -128.42 177.96 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.437 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 20.3 m -119.05 164.01 16.14 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.452 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.6 t -56.55 -47.19 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.177 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 57' ' ' ILE . 3.4 m -54.15 -24.18 16.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -178.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.432 ' CB ' HG22 ' A' ' 50' ' ' VAL . 9.7 t70 -74.59 -31.72 62.13 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.074 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.714 HD12 ' N ' ' A' ' 55' ' ' LEU . 6.2 mp -64.96 -64.96 0.74 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.404 -178.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -54.75 -39.53 68.4 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 61' ' ' GLY . 14.7 pt -71.52 -23.72 22.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.316 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.75 -30.8 78.74 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 121.164 -0.541 . . . . 0.0 111.756 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.777 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.1 mm? -79.51 -52.96 7.36 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.294 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.5 -30.19 33.35 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.603 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 74.21 4.85 69.69 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.266 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.509 ' C ' ' H ' ' A' ' 64' ' ' GLU . 10.2 t -135.95 93.44 2.93 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.824 0.345 . . . . 0.0 111.307 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -48.57 -10.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.762 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.509 ' H ' ' C ' ' A' ' 62' ' ' SER . 30.9 tt0 -88.66 -42.61 11.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.714 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.17 -15.02 34.75 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.1 m -49.75 -28.96 4.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.77 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -55.47 -27.65 49.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.925 0.393 . . . . 0.0 110.244 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 48.8 mtm -92.33 -24.31 18.97 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.766 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.424 ' HG ' ' H ' ' A' ' 71' ' ' THR . 60.4 tp -53.37 123.0 10.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.931 0.396 . . . . 0.0 110.076 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -40.65 -38.56 0.91 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.661 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.424 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 20.1 m -52.66 107.76 0.92 Allowed Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.973 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.12 -162.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.161 1.24 . . . . 0.0 111.423 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.467 ' O ' ' CE ' ' A' ' 77' ' ' LYS . 32.4 ttm -109.11 -6.44 15.61 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 61.3 m -100.78 -20.83 15.38 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.138 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.57 -34.06 76.28 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.822 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.933 ' H ' HD22 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -64.08 -45.92 86.6 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.83 179.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.531 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 1.1 mptp? -55.83 -34.87 65.79 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.312 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.03 -59.93 2.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.495 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 81' ' ' ARG . . . -59.03 -62.99 1.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.432 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.429 ' HA ' ' CD2' ' A' ' 83' ' ' LEU . 3.0 p -35.37 -25.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.917 0.389 . . . . 0.0 111.721 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.568 ' N ' ' O ' ' A' ' 79' ' ' ALA . 28.3 ttm180 -77.56 -57.35 3.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.668 0.747 . . . . 0.0 110.074 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.572 ' HA ' ' HB2' ' A' ' 87' ' ' ALA . 41.4 mt -47.79 -43.74 10.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.929 -178.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.853 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -75.03 -36.64 61.87 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.557 179.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -47.38 -18.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.457 ' N ' ' C ' ' A' ' 83' ' ' LEU . . . 83.1 15.52 72.03 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 88' ' ' GLU . 50.2 mm-40 -105.57 -0.63 25.58 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.572 ' HB2' ' HA ' ' A' ' 82' ' ' ILE . . . -36.7 -26.0 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.088 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 88' ' ' GLU . 2.7 mp0 -53.31 -78.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.1 m -73.81 58.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.906 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -77.36 -33.46 55.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.523 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 65.5 m -70.56 158.81 35.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.691 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.662 ' N ' HD22 ' A' ' 92' ' ' LEU . 3.1 mm? -78.61 150.39 76.05 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.828 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.99 87.37 0.86 Allowed 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.167 1.911 . . . . 0.0 111.975 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.403 ' HG2' ' H ' ' A' ' 94' ' ' GLN . 6.6 pt20 -57.59 152.09 36.88 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.206 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.31 -170.56 0.59 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.333 2.022 . . . . 0.0 111.917 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.524 -179.948 . . . . . . . . 0 0 . 1 stop_ save_